Abstract,DOI,ID,PublishedDate,Source,Title,Type,title_words,abstract_words,abstract_sentences
,10.1016/j.jamda.2020.04.017N/A10.1016/S0140-6736(20)31024-2,DOI:10.1016/j.jamda.2020.04.017N/AN/A,"2020-04-2330 April April 30, 2020",ELSEVIEREMALANCET,"THE GERIATRICIAN: THE FRONTLINE SPECIALIST IN THE TREATMENT OF COVID-19 PATIENTSTreatments and vaccines for COVID-19Obesity could shift
severe COVID-19 disease
to younger ages",Journal of the American Medical Directors AssociationUpdateCorrespondence,"['geriatrician', 'frontline', 'specialist', 'treatment', 'covid', '19', 'patientstreatments', 'vaccine', 'covid', '19obesity', 'could', 'shift', 'severe', 'covid', '19', 'disease', 'younger', 'age']",N/A,N/A
"N/A (Too many requests)EMA provided an update on the measures EU authorities are putting in place to support the continued availability of medicines during the pandemic, following a meeting of the EU Executive Steering Group on Shortages of Medicines Caused by Major Events.Prisons are a hotspot for COVID-19. In theory, prisoners have the same right to health as anyone else, but the reality is very different. Talha Burki reports.We will probably never know the extent to which coronavirus disease 2019 (COVID-19) has penetrated the world's prisons and detention centres. Testing capacity and the supply of personal protective equipment are already constrained, and inmates are rarely a priority. Nonetheless, at least one prison has done mass testing. The Marion Correctional Institution in Ohio, USA, holds around 2500 detainees. As The Lancet went to press, more than 2000 of them had tested positive for COVID-19.According to the New York City Board of Correction, there are currently 378 cases of COVID-19 among inmates in the city jails, equating to an infection rate of around 10%. But this does not include those who contracted the virus in custody and have since been released or transferred, or have died. Hundreds of cases have been registered among prison and jail employees, who can obtain testing far more easily than prisoners, including almost 1000 in New York City alone.“The prisons and jails in the USA that have reported high rates of the coronavirus are the ones who are doing the testing”, points out David Patton, executive director and attorney-in-chief of the Federal Defenders of New York. “It is hard to imagine that the virus is not already rampant throughout the US penal system.” Around 2·2 million individuals are incarcerated in the USA; no other country imprisons as many people.In the UK, COVID-19 has been detected in the majority of prisons, and at least 15 prisoners and four members of staff have died after being infected. For much of the rest of the world, statistics on infection rates and mortality in prisons are hard to come by, but the danger that COVID-19 poses to such institutions can be discerned from another set of statistics.The global prison population is estimated at 11 million. At least 124 prisons worldwide exceed their maximum occupancy rates. The Philippines has imprisoned 215 000 people in a system designed for no more than 40 000. 92 000 inmates are thought to be scattered across Myanmar's 100 or so prisons and labour camps, served by a medical staff that is estimated to consist of 30 doctors and 80 nurses. A quarter of inmates in Canada are over the age of 50 years. The UK Justice Secretary, Robert Buckland, reckons that around 1800 prisoners in the UK would be especially susceptible to severe disease were they to contract COVID-19.The situation in Latin America is particularly worrying. Haiti's prisons are running at 450% occupancy. 773 151 people are imprisoned in Brazil, in a system built to hold 461 026 people. “Conditions in the prisons in South America are ripe for coronavirus to spread”, said Tamara Taraciuk Broner of Human Rights Watch (Buenos Aires, Argentina). “These places are typically very unsanitary and overcrowded and inmates do not always have access to running water.” In such circumstances, regular handwashing and social distancing are impossible to achieve.“Prisoners share toilets, bathrooms, sinks, and dining halls. They are mostly sleeping in bunk beds; in some countries they sleep crammed together on the floor”, explains Frederick Altice of the Yale School of Medicine (New Haven, CT, USA). “These settings are in no way equipped to deal with an outbreak once it gets in.” If an institution is already operating at far beyond its capacity, it is going to be very difficult to find areas where prisoners with suspected COVID-19 can be isolated. “If a prisoner knows he is going to be put in solitary confinement if he admits to being sick, which is usually a punishment, then there is a heavy disincentive to seek medical attention”, adds Patton.Prisoners tend to be in worse health than the wider population. “80–90% of people charged with a crime in the USA are too poor to afford legal counsel”, notes Patton. “They have high rates of asthma, diabetes, and smoking”. Prison itself is hardly a healthy environment. A lot of time is spent sitting around, and the food is typically poor quality. And in some places, even poor-quality food is in short supply.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Maria Tan/AFP/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 Maria Tan/AFP/Getty ImagesThe occupancy rate for prisons in DR Congo is estimated at 432% of capacity, but food is budgeted on official capacity. That means a maximum of one meal a day. According to the UN peacekeeping mission in DR Congo, at least 60 people died from hunger at Kinshasa's central prison during the first 2 months of 2020. In Niger, those in pretrial detention, a cohort that makes up over half the prison population, are not provided with any food at all. If you cannot rely on family or friends to bring in supplies, you are in serious trouble.International norms stipulate that prisoners should receive the same standard of health care as the wider community. The reality is very different. “First of all, if you are a prisoner, you cannot just choose to visit the emergency room; you have to go through the officers and that can be a huge obstacle”, said Altice. “Almost no prisons have real hospitals within their walls, and the ratio of clinical staff to prisoners is extremely low; there is no true equivalence of care”.Sending prisoners for external medical care means seconding officers and transport. Prison administrators can be reluctant to expend such time and resources on a single inmate. “There is both a lack of ability to deal with health issues in-house, because of chronic understaffing, and disincentives to seek outside attention”, said Patton. “It means that prisoners have to be in a very bad state before they get the treatment they need.”View Large
                                            Image
                                        
                                Copyright
                                © 2020 Reuters/Jim VondruskaView Large
                                            Image
                                        
                                Copyright
                                © 2020 Reuters/Jim VondruskaMatters are further complicated during a time of pandemic, when moving prisoners requires all kinds of additional precautions. “It is very likely that prisoners are not getting medical care or even assessments”, said Altice. “Prisons do not usually have any way to manage patients when they start deteriorating or to triage people at higher risk; prisoners who do get shipped out for treatment are at a much later stage of disease because detection abilities are often limited.”The UN High Commissioner for Human Rights, Michelle Bachelet, has encouraged governments to release inmates who are especially vulnerable to COVID-19, such as older people, as well as low-risk offenders. “Imprisonment should be a measure of last resort, particularly during this crisis”, she noted, in a statement on March 25, 2020. Experts believe that there is plenty of scope for prisoner releases. In at least 46 countries worldwide, the majority of prisoners have not been convicted of any crime. Rates of pretrial detention are high. A third of Brazil's sizeable prison population, for example, are in pretrial detention. More than one in six prisoners around the world are serving time for possession of drugs for personal use.“Deincarceration has to be the foremost strategy here”, said Altice. “Several countries, including the USA, have extraordinarily high levels of incarceration. It will certainly be possible to release prisoners and maintain public safety.” He advocates diverting drug offenders to evidence-based treatment programmes. “You can take a lot of people out of the system by doing that, and these are people who are at increased risk of comorbidities such as HIV and hepatitis C, so there is an immediate public health benefit”, said Altice.Several countries have taken action. Iran announced the release of 85 000 prisoners in March. France and Italy have reduced their prison populations by 10 000 and 6000, respectively. Chile has let out 1300 low-risk offenders, and states across the USA are releasing varying numbers of prisoners. “There is absolutely no doubt that this crisis calls for reducing overcrowding and finding alternatives to prison for people in particular categories, definitely those in pretrial detention for non-violent offences”, Broner told The Lancet. She gave the example of semiopen facilities in Brazil, where prisoners spend the day outside the institution and return in the evening. “That is a huge risk for transmission of COVID-19; it would be better to allow these prisoners to just remain outside”, she said.UK prisons are running at 107% capacity, which is modest by international standards. The government has pledged to release 4000 prisoners to alleviate the risk of COVID-19 transmission. However, the Prison Governors Association reckons that 15 000 inmates, representing almost a fifth of the prison population, would have to be let out if prisoners were to not share cells. Making a meaningful difference to overcrowding in prison systems elsewhere will require far larger measures. Whether governments are willing to release prisoners in the numbers necessary to truly cut the risk of COVID-19 from tearing through prisons remains to seen.",10.1016/j.neurol.2020.04.004N/A10.1016/S0140-6736(20)30984-3,DOI:10.1016/j.neurol.2020.04.004N/AN/A,"2020-04-2030 April May 02, 2020",ELSEVIEREMALANCET,Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases NetworkAvailability of medicines during COVID-19 pandemicPrisons are “in no way equipped” to deal with COVID-19,Revue NeurologiqueUpdateWorld Report,"['guidance', 'care', 'neuromuscular', 'patient', 'covid', '19', 'pandemic', 'outbreak', 'french', 'rare', 'health', 'care', 'neuromuscular', 'disease', 'networkavailability', 'medicine', 'covid', '19', 'pandemicprisons', 'way', 'equip', 'deal', 'covid', '19']","['n', 'many', 'request', 'ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', 'follow', 'meet', 'eu', 'executive', 'steer', 'group', 'shortage', 'medicine', 'cause', 'major', 'event', 'prison', 'hotspot', 'covid', '19', 'theory', 'prisoner', 'right', 'health', 'anyone', 'else', 'reality', 'different', 'talha', 'burki', 'report', 'probably', 'never', 'know', 'extent', 'coronavirus', 'disease', '2019', 'covid', '19', 'penetrate', 'world', 'prison', 'detention', 'centre', 'test', 'capacity', 'supply', 'personal', 'protective', 'equipment', 'already', 'constrain', 'inmate', 'rarely', 'priority', 'nonetheless', 'least', 'one', 'prison', 'do', 'mass', 'test', 'marion', 'correctional', 'institution', 'ohio', 'usa', 'hold', 'around', '2500', 'detainee', 'lancet', 'go', 'press', '2000', 'test', 'positive', 'covid', '19', 'accord', 'new', 'york', 'city', 'board', 'correction', 'currently', '378', 'case', 'covid', '19', 'among', 'inmate', 'city', 'jail', 'equate', 'infection', 'rate', 'around', '10', 'include', 'contract', 'virus', 'custody', 'since', 'release', 'transfer', 'die', 'hundred', 'case', 'register', 'among', 'prison', 'jail', 'employee', 'obtain', 'test', 'far', 'easily', 'prisoner', 'include', 'almost', '1000', 'new', 'york', 'city', 'alone', 'prison', 'jail', 'usa', 'report', 'high', 'rate', 'coronavirus', 'one', 'test', 'point', 'david', 'patton', 'executive', 'director', 'attorney', 'chief', 'federal', 'defender', 'new', 'york', 'hard', 'imagine', 'virus', 'already', 'rampant', 'throughout', 'u', 'penal', 'system', 'around', '2', '2', 'million', 'individual', 'incarcerate', 'usa', 'country', 'imprison', 'many', 'people', 'uk', 'covid', '19', 'detect', 'majority', 'prison', 'least', '15', 'prisoner', 'four', 'member', 'staff', 'die', 'infect', 'much', 'rest', 'world', 'statistic', 'infection', 'rate', 'mortality', 'prison', 'hard', 'come', 'danger', 'covid', '19', 'pose', 'institution', 'discern', 'another', 'set', 'statistic', 'global', 'prison', 'population', 'estimate', '11', 'million', 'least', '124', 'prison', 'worldwide', 'exceed', 'maximum', 'occupancy', 'rate', 'philippine', 'imprison', '215', '000', 'people', 'system', 'design', '40', '000', '92', '000', 'inmate', 'think', 'scatter', 'across', 'myanmar', '100', 'prison', 'labour', 'camp', 'serve', 'medical', 'staff', 'estimate', 'consist', '30', 'doctor', '80', 'nurse', 'quarter', 'inmate', 'canada', 'age', '50', 'year', 'uk', 'justice', 'secretary', 'robert', 'buckland', 'reckon', 'around', '1800', 'prisoner', 'uk', 'would', 'especially', 'susceptible', 'severe', 'disease', 'contract', 'covid', '19', 'situation', 'latin', 'america', 'particularly', 'worry', 'haiti', 'prison', 'run', '450', 'occupancy', '773', '151', 'people', 'imprison', 'brazil', 'system', 'build', 'hold', '461', '026', 'people', 'condition', 'prison', 'south', 'america', 'ripe', 'coronavirus', 'spread', 'say', 'tamara', 'taraciuk', 'broner', 'human', 'right', 'watch', 'buenos', 'aire', 'argentina', 'place', 'typically', 'unsanitary', 'overcrowd', 'inmate', 'always', 'access', 'run', 'water', 'circumstance', 'regular', 'handwash', 'social', 'distance', 'impossible', 'achieve', 'prisoner', 'share', 'toilet', 'bathroom', 'sink', 'din', 'hall', 'mostly', 'sleep', 'bunk', 'bed', 'country', 'sleep', 'cram', 'together', 'floor', 'explain', 'frederick', 'altice', 'yale', 'school', 'medicine', 'new', 'ct', 'usa', 'set', 'way', 'equip', 'deal', 'outbreak', 'get', 'institution', 'already', 'operate', 'far', 'beyond', 'capacity', 'go', 'difficult', 'find', 'area', 'prisoner', 'suspect', 'covid', '19', 'isolate', 'prisoner', 'know', 'go', 'put', 'solitary', 'confinement', 'admit', 'sick', 'usually', 'punishment', 'heavy', 'disincentive', 'seek', 'medical', 'attention', 'add', 'patton', 'prisoner', 'tend', 'worse', 'health', 'wider', 'population', '80', '90', 'people', 'charge', 'crime', 'usa', 'poor', 'afford', 'legal', 'counsel', 'note', 'patton', 'high', 'rate', 'asthma', 'diabetes', 'smoke', 'prison', 'hardly', 'healthy', 'environment', 'lot', 'time', 'spend', 'sit', 'around', 'food', 'typically', 'poor', 'quality', 'place', 'even', 'poor', 'quality', 'food', 'short', 'supply', 'view', 'large', 'image', 'copyright', '2020', 'maria', 'tan', 'afp', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'maria', 'tan', 'afp', 'getty', 'imagesthe', 'occupancy', 'rate', 'prison', 'dr', 'congo', 'estimate', '432', 'capacity', 'food', 'budget', 'official', 'capacity', 'mean', 'maximum', 'one', 'meal', 'day', 'accord', 'un', 'peacekeeping', 'mission', 'dr', 'congo', 'least', '60', 'people', 'die', 'hunger', 'kinshasa', 'central', 'prison', 'first', '2', 'month', '2020', 'niger', 'pretrial', 'detention', 'cohort', 'make', 'half', 'prison', 'population', 'provide', 'food', 'rely', 'family', 'friend', 'bring', 'supply', 'serious', 'trouble', 'international', 'norm', 'stipulate', 'prisoner', 'receive', 'standard', 'health', 'care', 'wider', 'community', 'reality', 'different', 'first', 'prisoner', 'choose', 'visit', 'emergency', 'room', 'go', 'officer', 'huge', 'obstacle', 'say', 'altice', 'almost', 'prison', 'real', 'hospital', 'within', 'wall', 'ratio', 'clinical', 'staff', 'prisoner', 'extremely', 'low', 'true', 'equivalence', 'care', 'send', 'prisoner', 'external', 'medical', 'care', 'mean', 'second', 'officer', 'transport', 'prison', 'administrator', 'reluctant', 'expend', 'time', 'resource', 'single', 'inmate', 'lack', 'ability', 'deal', 'health', 'issue', 'house', 'chronic', 'understaffing', 'disincentive', 'seek', 'outside', 'attention', 'say', 'patton', 'mean', 'prisoner', 'bad', 'state', 'get', 'treatment', 'need', 'view', 'large', 'image', 'copyright', '2020', 'reuters', 'jim', 'vondruskaview', 'large', 'image', 'copyright', '2020', 'reuters', 'jim', 'vondruskamatters', 'complicate', 'time', 'pandemic', 'move', 'prisoner', 'require', 'kind', 'additional', 'precaution', 'likely', 'prisoner', 'get', 'medical', 'care', 'even', 'assessment', 'say', 'altice', 'prison', 'usually', 'way', 'manage', 'patient', 'start', 'deteriorate', 'triage', 'people', 'higher', 'risk', 'prisoner', 'get', 'ship', 'treatment', 'much', 'later', 'stage', 'disease', 'detection', 'ability', 'often', 'limit', 'un', 'high', 'commissioner', 'human', 'right', 'michelle', 'bachelet', 'encourage', 'government', 'release', 'inmate', 'especially', 'vulnerable', 'covid', '19', 'older', 'people', 'well', 'low', 'risk', 'offender', 'imprisonment', 'measure', 'last', 'resort', 'particularly', 'crisis', 'note', 'statement', 'march', '25', '2020', 'expert', 'believe', 'plenty', 'scope', 'prisoner', 'release', 'least', '46', 'country', 'worldwide', 'majority', 'prisoner', 'convict', 'crime', 'rate', 'pretrial', 'detention', 'high', 'third', 'brazil', 'sizeable', 'prison', 'population', 'example', 'pretrial', 'detention', 'one', 'six', 'prisoner', 'around', 'world', 'serve', 'time', 'possession', 'drug', 'personal', 'use', 'deincarceration', 'foremost', 'strategy', 'say', 'altice', 'several', 'country', 'include', 'usa', 'extraordinarily', 'high', 'level', 'incarceration', 'certainly', 'possible', 'release', 'prisoner', 'maintain', 'public', 'safety', 'advocate', 'divert', 'drug', 'offender', 'evidence', 'base', 'treatment', 'programme', 'take', 'lot', 'people', 'system', 'people', 'increase', 'risk', 'comorbidities', 'hiv', 'hepatitis', 'c', 'immediate', 'public', 'health', 'benefit', 'say', 'altice', 'several', 'country', 'take', 'action', 'iran', 'announce', 'release', '85', '000', 'prisoner', 'march', 'france', 'italy', 'reduce', 'prison', 'population', '10', '000', '6000', 'respectively', 'chile', 'let', '1300', 'low', 'risk', 'offender', 'state', 'across', 'usa', 'release', 'vary', 'number', 'prisoner', 'absolutely', 'doubt', 'crisis', 'call', 'reduce', 'overcrowd', 'find', 'alternative', 'prison', 'people', 'particular', 'category', 'definitely', 'pretrial', 'detention', 'non', 'violent', 'offence', 'broner', 'tell', 'lancet', 'give', 'example', 'semiopen', 'facility', 'brazil', 'prisoner', 'spend', 'day', 'outside', 'institution', 'return', 'even', 'huge', 'risk', 'transmission', 'covid', '19', 'would', 'better', 'allow', 'prisoner', 'remain', 'outside', 'say', 'uk', 'prison', 'run', '107', 'capacity', 'modest', 'international', 'standard', 'government', 'pledge', 'release', '4000', 'prisoner', 'alleviate', 'risk', 'covid', '19', 'transmission', 'however', 'prison', 'governor', 'association', 'reckon', '15', '000', 'inmate', 'represent', 'almost', 'fifth', 'prison', 'population', 'would', 'let', 'prisoner', 'share', 'cell', 'make', 'meaningful', 'difference', 'overcrowd', 'prison', 'system', 'elsewhere', 'require', 'far', 'larger', 'measure', 'whether', 'government', 'will', 'release', 'prisoner', 'number', 'necessary', 'truly', 'cut', 'risk', 'covid', '19', 'tear', 'prison', 'remain', 'see']",
"N/A (Too many requests)EMA, the European Commission and the Heads of Medicines Agencies updated the Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic. The updated guidance includes more recommendations on simple and flexible measures sponsors can take to manage clinical trials during the COVID-19 pandemic, given the impact it is having on European health systems and society in general.December, 2019, witnessed a massive outbreak of coronavirus disease 2019 (COVID-19) triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei, China, which has now turned into a global public health crisis. Fighting the pandemic of COVID-19 has become the main challenge for all clinicians.The Wuhan Union Hospital is in the eye of the storm, treating patients within three designated medical settings, including a cancer centre. Between January and March, 2020, we have treated more than 5200 hospitalised patients with COVID-19 and cared for more than 20 000 with fever at our outpatient clinics. Moreover, we have attended to more than 80 000 patients on our internet platform and operated two makeshift hospitals (so-called Fangcang hospitals), making Wuhan Union Hospital the hospital that admitted and treated the highest number of patients with COVID-19 in Wuhan. As oncologists, we are also involved in the battle to contain the relentless spread of the epidemic. From Jan 15 to Feb 25, 2020, 1186 patients with cancer (including 165 haematological malignancies) were admitted to the Cancer Center of Wuhan Union Hospital. Unlike many other patients, the immunity of patients with cancer is often compromised and they heavily depend on the availability of medical resources, which renders them extremely vulnerable to the impact of the epidemic and overwhelmed medical resources mean their lives are on the line. Therefore, we were faced with the great challenge of how to protect our patients with cancer from infection while continuing routine patient care.Zhong Nanshan (Guangzhou Medical University, Guangzhou, Guangdong), head of the National Health Commission's team investigating the novel coronavirus outbreak, pointed out that SARS-CoV-2 carried the risk of human-to-human transmission on Jan 20, 2020. Since then, our cancer centre began to screen patients and health-care workers infected with SARS-CoV-2 in the hospital by means of nucleic acid and antibody tests in combination with CT scans. 24 patients with cancer (infection rate of 2%) and 13 of 766 health-care workers (infection rate of 1·7%) were found to have been infected with SARS-CoV-2. These rates were, respectively, 5-times and 4·3-times the rate in the population in Wuhan. We began to realise the gravity of the situation. To prevent cross-infection in the centre, we rapidly set up an isolation area. In 48 h, an isolation ward area equipped with 850 beds was established, with an increased prevention level compared with the rest of the hospital. Because of insufficient stockpile and rapid use of medical supplies, medical resources were severely depleted. At one point, protective equipment supplies could only meet the need for 2 days. Moreover, with increasing numbers of medical workers being diagnosed with COVID-19 and quarantined, the capacity for normal patient care services was conspicuously reduced. We discharged mild and convalescent patients whenever possible, who were followed up with telemedicine and telecare. The first 15 days after Wuhan lockdown, starting from Jan 23, was the toughest time we experienced, during which seven patients with blood cancer and two patients with solid tumours died of COVID-19. After our cancer centre was mandatorily designated a hospital on Feb 15, and thus only admitted patients with COVID-19, a large amount of medical supplies began to arrive and reinforcement medical teams from all parts of China joined us. Since then, no deaths or nosocomial infections occurred. Looking back, we gained a lot of experience and learned some lessons.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuFor the management of hospitalised patients with cancer, the top priority is the control of nosocomial infection. At the early stage of the outbreak, because of a lack of awareness on personal protection, limited knowledge about the new virus, and an inadequate supply of nucleic acid tests, the number of infected patients increased substantially and some medical staff were infected. During the middle of January, some hospitalised patients began to develop fever and diarrhoea, but were not definitively diagnosed with COVID-19 because of a shortage of tests. They interacted with other patients without COVID-19, causing cross-infection. Therefore, we escalated the preventive measures, including early stage testing of patients, caregivers, and medical staff (using nucleic acid tests, antibody tests, and CT scans); isolation of confirmed patients in a single room without visits; wearing of surgical masks by patients and caregivers; mandatory hand sanitisation; and separate disposal of patient waste. Hospital workers are at high risk of developing COVID-19 from nosocomial infection during an outbreak, as in the epidemics of SARS and Middle East Respiratory Syndrome. During a pandemic of an infectious disease, medical workers should be well informed about its status to achieve their own early detection, prompt isolation, and expeditious treatment. Medical workers should take adequate measures to effectively protect themselves from infection. When some of our medical workers were infected and isolated, we suffered from a serious shortage of medical staff. To ensure the normal operation of oncology departments, the hospital authorities redeployed and temporarily relocated 50 doctors and nurses from other not-in-service departments to oncology departments. It is worth mentioning that medical workers in the reinforcement medical teams consisted of specialists in serious infections and management of respiratory tract diseases, and they had important roles in the management of severe and critical patients in the Cancer Center of Wuhan Union Hospital.To treat the growing number of patients with suspected COVID-19 infection, confirmed cases were admitted as early as possible and non-confirmed cases were redirected to other hospitals. We set up a free-of-charge online fever clinic on Feb 1, and received 12 000 visits per day at the peak, including visits by many patients with cancer. For offline services, we opened a separate area of the hospital as a fever clinic, expanded it, and placed 46 beds in the observation area. Because patients with cancer are physically debilitated and tend to have compromised immune systems, they have to be carefully evaluated before admission. Stable patients (ie, those without progression or deterioration in tumour burden or severe complications after treatment) generally should not be hospitalised; patients scheduled for elective operations should, whenever possible, be admitted after the pandemic. Patients with chronic tumours can consult their doctor via internet or telephone, with medicines mailed to the patients. Routine screening and nucleic acid tests can be put off until the pandemic is over. We operated a 24 h emergency department for patients who needed emergency care or are in a serious condition. We also opened a green passage (ie, a quick and efficient service) for pregnant women and patients with cancer who have to be treated immediately. Apart from these measures, when not enough beds are available, patients with suspected or mild-symptom disease can be referred to Fangcang hospitals, but should be under close watch. If their conditions deteriorate, they can be sent to designated hospitals. For instance, nine patients admitted after Feb 15 were transferred to our hospital from Fangcang hospitals and received excellent treatment.Patients with cancer are a special group of patients because treatment of their primary disease cannot be discontinued However, to decrease the risk of infection with SARS-CoV-2, postoperative chemotherapy could be postponed. With patients on radiotherapy, concurrent chemotherapy could be withheld for some time, including preradiotherapy preparation (such as pretreatment imaging for tumour localisation and treatment planning). For patients on chemotherapy, especially elderly, debilitated patients, the chemotherapy protocol should be adjusted, the dose reduced, or both. The fatality rate was six (46·2%) of 13 patients with blood cancer and two (10·0%) of 20 patients with solid tumours in our centre. Patients with blood cancer were more predisposed to SARS-CoV-2 infection than were patients with solid tumours (in hospitalised patients, the rate of SARS-CoV-2 infection was ten [6·1%] of 165 patients with blood tumours and 14 [1·4%] of 1021 patients with solid tumours). The higher fatality rate in patients with blood cancer might be ascribed to aggressive chemotherapeutic protocols, agranulocytosis, and impaired immunity. Given the risk of infection and shortage of blood products, these patients should avoid intense chemotherapy or haematopoietic stem cell transplantation. Among the 33 patients with cancer with COVID-19 (figure 1), eight treated by targeted therapies (kinase inhibitors and proteasome inhibitors) and two receiving immune checkpoint inhibitors had more favourable outcomes than those treated with chemotherapy. With patients who are at home or visiting online clinics, chemotherapy-free alternatives involving oral or targeted drugs—which do not require in-hospital administration—should be given whenever possible. One patient tried to die by suicide after he became infected with SARS-CoV-2 following stem cell transplantation. Although his blood virus tests turned negative after an initial positive result, the long isolation and the pain due to graft-versus-host disease psychologically affected the patient. Therefore, psychological intervention is extremely important for patients with COVID-19 who have experienced other issues, physically and mentally, apart from their primary disease.Figure 1Categorisation of patients with cancer with COVID-19 and treatments they receivedShow full captionALL=acute lymphoblastic leukaemia. AML=acute myeloid leukaemia. CLL=chronic lymphocytic leukaemia. HSCT=haematopoietic stem cell transplantation. ICIs=immune checkpoint inhibitors.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)ALL=acute lymphoblastic leukaemia. AML=acute myeloid leukaemia. CLL=chronic lymphocytic leukaemia. HSCT=haematopoietic stem cell transplantation. ICIs=immune checkpoint inhibitors.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuView Large
                                            Image
                                        
                                Copyright
                                © 2020 Yu HuIt is worth mentioning that telemedicine has an important role in the diagnosis and treatment of patients with cancer in home care. Our online clinic services cover video consultations, text-picture counselling, and medicine delivery, among others. This approach substantially reduced people congregating in hospital. Patients with newly diagnosed cancer or those on anti-tumour therapy should use internet or telephone services as the first choice to contact their doctors, refraining from going directly to hospital, to avoid infection. Doctors should comprehensively evaluate the condition of patients to give the most effective or optimal treatments. Patients and their family members should be made aware that cooperating with their doctor and being compliant with the treatment prescribed will lead to the best outcomes. During this epidemic, we attended more than 80 000 patients online, including 2688 patients with cancer. By comparing the numbers of the patients who sought medical help online, we found that each of 24 oncologists who provided these services, on average, attended 19 patients online and 97 clinic visitors during the first 2 weeks before Jan 20. Conversely, during the 2 weeks after Jan 20, the number of online patients rose to 42 whereas the number of clinic visitors dropped to 36 (figure 2). We believe, in the future, telemedicine will be an important practicing mode for oncologists or other clinicians during pandemics.Figure 2Average number of online and clinic visitors per week per oncologistView Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Between January and March, 2020, we witnessed the infection and deaths of a large number of people because of lack of protection, shortage of beds, and inadequate isolation. We should learn from our mistakes and stay alert. A well established public health system is essential for continuity of care during a massive epidemic. To prevent the epidemic from returning, we should be well informed about COVID-19, do early screening, protect our medical workers, properly equip our hospitals for both routine service and future crises and expand our services to internet platforms. As oncologists, we hope that society extends its compassion towards patients with cancer during the COVID-19 pandemic.We declare no competing interestsYH is funded by a Key Special Project of the Ministry of Science and Technology of China (2020YFC0845700)",10.1016/j.jtcvs.2020.04.059N/A10.1016/S1470-2045(20)30238-2,DOI:10.1016/j.jtcvs.2020.04.059N/AN/A,"2020-04-2728 April May, 2020",ELSEVIEREMALANCET,Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical RecoveryGuidance for medicine developers and companies on COVID-19Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan,The Journal of Thoracic and Cardiovascular SurgeryUpdatePerspectives,"['adult', 'cardiac', 'surgery', 'covid', '19', 'pandemic', 'aggressive', 'infection', 'mitigation', 'strategy', 'necessary', 'operate', 'room', 'surgical', 'recoveryguidance', 'medicine', 'developer', 'company', 'covid', '19managing', 'patient', 'cancer', 'covid', '19', 'pandemic', 'frontline', 'experience', 'wuhan']","['n', 'many', 'request', 'ema', 'european', 'commission', 'head', 'medicine', 'agency', 'update', 'guidance', 'management', 'clinical', 'trial', 'covid', '19', 'coronavirus', 'pandemic', 'update', 'guidance', 'include', 'recommendation', 'simple', 'flexible', 'measure', 'sponsor', 'take', 'manage', 'clinical', 'trial', 'covid', '19', 'pandemic', 'give', 'impact', 'european', 'health', 'system', 'society', 'general', 'december', '2019', 'witness', 'massive', 'outbreak', 'coronavirus', 'disease', '2019', 'covid', '19', 'trigger', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'wuhan', 'hubei', 'china', 'turn', 'global', 'public', 'health', 'crisis', 'fight', 'pandemic', 'covid', '19', 'become', 'main', 'challenge', 'clinician', 'wuhan', 'union', 'hospital', 'eye', 'storm', 'treat', 'patient', 'within', 'three', 'designate', 'medical', 'set', 'include', 'cancer', 'centre', 'january', 'march', '2020', 'treat', '5200', 'hospitalise', 'patient', 'covid', '19', 'care', '20', '000', 'fever', 'outpatient', 'clinic', 'moreover', 'attend', '80', '000', 'patient', 'internet', 'platform', 'operate', 'two', 'makeshift', 'hospital', 'call', 'fangcang', 'hospital', 'make', 'wuhan', 'union', 'hospital', 'hospital', 'admit', 'treat', 'highest', 'number', 'patient', 'covid', '19', 'wuhan', 'oncologist', 'also', 'involve', 'battle', 'contain', 'relentless', 'spread', 'epidemic', 'jan', '15', 'feb', '25', '2020', '1186', 'patient', 'cancer', 'include', '165', 'haematological', 'malignancy', 'admit', 'cancer', 'center', 'wuhan', 'union', 'hospital', 'unlike', 'many', 'patient', 'immunity', 'patient', 'cancer', 'often', 'compromise', 'heavily', 'depend', 'availability', 'medical', 'resource', 'render', 'extremely', 'vulnerable', 'impact', 'epidemic', 'overwhelm', 'medical', 'resource', 'mean', 'life', 'line', 'therefore', 'face', 'great', 'challenge', 'protect', 'patient', 'cancer', 'infection', 'continue', 'routine', 'patient', 'care', 'zhong', 'nanshan', 'guangzhou', 'medical', 'university', 'guangzhou', 'guangdong', 'head', 'national', 'health', 'commission', 'team', 'investigate', 'novel', 'coronavirus', 'outbreak', 'point', 'sars', 'cov', '2', 'carry', 'risk', 'human', 'human', 'transmission', 'jan', '20', '2020', 'since', 'cancer', 'centre', 'begin', 'screen', 'patient', 'health', 'care', 'worker', 'infect', 'sars', 'cov', '2', 'hospital', 'mean', 'nucleic', 'acid', 'antibody', 'test', 'combination', 'ct', 'scan', '24', 'patient', 'cancer', 'infection', 'rate', '2', '13', '766', 'health', 'care', 'worker', 'infection', 'rate', '1', '7', 'find', 'infect', 'sars', 'cov', '2', 'rate', 'respectively', '5', 'time', '4', '3', 'time', 'rate', 'population', 'wuhan', 'begin', 'realise', 'gravity', 'situation', 'prevent', 'cross', 'infection', 'centre', 'rapidly', 'set', 'isolation', 'area', '48', 'h', 'isolation', 'ward', 'area', 'equip', '850', 'bed', 'establish', 'increase', 'prevention', 'level', 'compare', 'rest', 'hospital', 'insufficient', 'stockpile', 'rapid', 'use', 'medical', 'supply', 'medical', 'resource', 'severely', 'deplete', 'one', 'point', 'protective', 'equipment', 'supply', 'could', 'meet', 'need', '2', 'day', 'moreover', 'increase', 'number', 'medical', 'worker', 'diagnose', 'covid', '19', 'quarantine', 'capacity', 'normal', 'patient', 'care', 'service', 'conspicuously', 'reduce', 'discharge', 'mild', 'convalescent', 'patient', 'whenever', 'possible', 'follow', 'telemedicine', 'telecare', 'first', '15', 'day', 'wuhan', 'lockdown', 'start', 'jan', '23', 'toughest', 'time', 'experience', 'seven', 'patient', 'blood', 'cancer', 'two', 'patient', 'solid', 'tumour', 'die', 'covid', '19', 'cancer', 'centre', 'mandatorily', 'designate', 'hospital', 'feb', '15', 'thus', 'admit', 'patient', 'covid', '19', 'large', 'amount', 'medical', 'supply', 'begin', 'arrive', 'reinforcement', 'medical', 'team', 'part', 'china', 'join', 'u', 'since', 'death', 'nosocomial', 'infection', 'occur', 'look', 'back', 'gain', 'lot', 'experience', 'learn', 'lesson', 'view', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'hufor', 'management', 'hospitalise', 'patient', 'cancer', 'top', 'priority', 'control', 'nosocomial', 'infection', 'early', 'stage', 'outbreak', 'lack', 'awareness', 'personal', 'protection', 'limit', 'knowledge', 'new', 'virus', 'inadequate', 'supply', 'nucleic', 'acid', 'test', 'number', 'infect', 'patient', 'increase', 'substantially', 'medical', 'staff', 'infect', 'middle', 'january', 'hospitalise', 'patient', 'begin', 'develop', 'fever', 'diarrhoea', 'definitively', 'diagnose', 'covid', '19', 'shortage', 'test', 'interact', 'patient', 'without', 'covid', '19', 'cause', 'cross', 'infection', 'therefore', 'escalate', 'preventive', 'measure', 'include', 'early', 'stage', 'test', 'patient', 'caregiver', 'medical', 'staff', 'use', 'nucleic', 'acid', 'test', 'antibody', 'test', 'ct', 'scan', 'isolation', 'confirm', 'patient', 'single', 'room', 'without', 'visit', 'wear', 'surgical', 'mask', 'patient', 'caregiver', 'mandatory', 'hand', 'sanitisation', 'separate', 'disposal', 'patient', 'waste', 'hospital', 'worker', 'high', 'risk', 'develop', 'covid', '19', 'nosocomial', 'infection', 'outbreak', 'epidemic', 'sars', 'middle', 'east', 'respiratory', 'syndrome', 'pandemic', 'infectious', 'disease', 'medical', 'worker', 'well', 'inform', 'status', 'achieve', 'early', 'detection', 'prompt', 'isolation', 'expeditious', 'treatment', 'medical', 'worker', 'take', 'adequate', 'measure', 'effectively', 'protect', 'infection', 'medical', 'worker', 'infect', 'isolate', 'suffer', 'serious', 'shortage', 'medical', 'staff', 'ensure', 'normal', 'operation', 'oncology', 'department', 'hospital', 'authority', 'redeploy', 'temporarily', 'relocate', '50', 'doctor', 'nurse', 'service', 'department', 'oncology', 'department', 'worth', 'mention', 'medical', 'worker', 'reinforcement', 'medical', 'team', 'consist', 'specialist', 'serious', 'infection', 'management', 'respiratory', 'tract', 'disease', 'important', 'role', 'management', 'severe', 'critical', 'patient', 'cancer', 'center', 'wuhan', 'union', 'hospital', 'treat', 'grow', 'number', 'patient', 'suspect', 'covid', '19', 'infection', 'confirm', 'case', 'admit', 'early', 'possible', 'non', 'confirm', 'case', 'redirect', 'hospital', 'set', 'free', 'charge', 'online', 'fever', 'clinic', 'feb', '1', 'receive', '12', '000', 'visit', 'per', 'day', 'peak', 'include', 'visit', 'many', 'patient', 'cancer', 'offline', 'service', 'open', 'separate', 'area', 'hospital', 'fever', 'clinic', 'expand', 'place', '46', 'bed', 'observation', 'area', 'patient', 'cancer', 'physically', 'debilitate', 'tend', 'compromise', 'immune', 'system', 'carefully', 'evaluate', 'admission', 'stable', 'patient', 'ie', 'without', 'progression', 'deterioration', 'tumour', 'burden', 'severe', 'complication', 'treatment', 'generally', 'hospitalise', 'patient', 'schedule', 'elective', 'operation', 'whenever', 'possible', 'admit', 'pandemic', 'patient', 'chronic', 'tumour', 'consult', 'doctor', 'via', 'internet', 'telephone', 'medicine', 'mail', 'patient', 'routine', 'screen', 'nucleic', 'acid', 'test', 'put', 'pandemic', 'operate', '24', 'h', 'emergency', 'department', 'patient', 'need', 'emergency', 'care', 'serious', 'condition', 'also', 'open', 'green', 'passage', 'ie', 'quick', 'efficient', 'service', 'pregnant', 'woman', 'patient', 'cancer', 'treat', 'immediately', 'apart', 'measure', 'enough', 'bed', 'available', 'patient', 'suspect', 'mild', 'symptom', 'disease', 'refer', 'fangcang', 'hospital', 'close', 'watch', 'condition', 'deteriorate', 'send', 'designate', 'hospital', 'instance', 'nine', 'patient', 'admit', 'feb', '15', 'transfer', 'hospital', 'fangcang', 'hospital', 'receive', 'excellent', 'treatment', 'patient', 'cancer', 'special', 'group', 'patient', 'treatment', 'primary', 'disease', 'discontinue', 'however', 'decrease', 'risk', 'infection', 'sars', 'cov', '2', 'postoperative', 'chemotherapy', 'could', 'postpone', 'patient', 'radiotherapy', 'concurrent', 'chemotherapy', 'could', 'withhold', 'time', 'include', 'preradiotherapy', 'preparation', 'pretreatment', 'image', 'tumour', 'localisation', 'treatment', 'plan', 'patient', 'chemotherapy', 'especially', 'elderly', 'debilitate', 'patient', 'chemotherapy', 'protocol', 'adjust', 'dose', 'reduce', 'fatality', 'rate', 'six', '46', '2', '13', 'patient', 'blood', 'cancer', 'two', '10', '0', '20', 'patient', 'solid', 'tumour', 'centre', 'patient', 'blood', 'cancer', 'predispose', 'sars', 'cov', '2', 'infection', 'patient', 'solid', 'tumour', 'hospitalise', 'patient', 'rate', 'sars', 'cov', '2', 'infection', 'ten', '6', '1', '165', 'patient', 'blood', 'tumour', '14', '1', '4', '1021', 'patient', 'solid', 'tumour', 'higher', 'fatality', 'rate', 'patient', 'blood', 'cancer', 'might', 'ascribe', 'aggressive', 'chemotherapeutic', 'protocol', 'agranulocytosis', 'impair', 'immunity', 'give', 'risk', 'infection', 'shortage', 'blood', 'product', 'patient', 'avoid', 'intense', 'chemotherapy', 'haematopoietic', 'stem', 'cell', 'transplantation', 'among', '33', 'patient', 'cancer', 'covid', '19', 'figure', '1', 'eight', 'treat', 'target', 'therapy', 'kinase', 'inhibitor', 'proteasome', 'inhibitor', 'two', 'receive', 'immune', 'checkpoint', 'inhibitor', 'favourable', 'outcome', 'treat', 'chemotherapy', 'patient', 'home', 'visit', 'online', 'clinic', 'chemotherapy', 'free', 'alternative', 'involve', 'oral', 'target', 'drug', 'require', 'hospital', 'administration', 'give', 'whenever', 'possible', 'one', 'patient', 'try', 'die', 'suicide', 'become', 'infect', 'sars', 'cov', '2', 'follow', 'stem', 'cell', 'transplantation', 'although', 'blood', 'virus', 'test', 'turn', 'negative', 'initial', 'positive', 'result', 'long', 'isolation', 'pain', 'due', 'graft', 'versus', 'host', 'disease', 'psychologically', 'affect', 'patient', 'therefore', 'psychological', 'intervention', 'extremely', 'important', 'patient', 'covid', '19', 'experience', 'issue', 'physically', 'mentally', 'apart', 'primary', 'disease', 'figure', '1categorisation', 'patient', 'cancer', 'covid', '19', 'treatment', 'receivedshow', 'full', 'captionall', 'acute', 'lymphoblastic', 'leukaemia', 'aml', 'acute', 'myeloid', 'leukaemia', 'cll', 'chronic', 'lymphocytic', 'leukaemia', 'hsct', 'haematopoietic', 'stem', 'cell', 'transplantation', 'icis', 'immune', 'checkpoint', 'inhibitor', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'acute', 'lymphoblastic', 'leukaemia', 'aml', 'acute', 'myeloid', 'leukaemia', 'cll', 'chronic', 'lymphocytic', 'leukaemia', 'hsct', 'haematopoietic', 'stem', 'cell', 'transplantation', 'icis', 'immune', 'checkpoint', 'inhibitor', 'view', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'huview', 'large', 'image', 'copyright', '2020', 'yu', 'huit', 'worth', 'mention', 'telemedicine', 'important', 'role', 'diagnosis', 'treatment', 'patient', 'cancer', 'home', 'care', 'online', 'clinic', 'service', 'cover', 'video', 'consultation', 'text', 'picture', 'counsel', 'medicine', 'delivery', 'among', 'others', 'approach', 'substantially', 'reduce', 'people', 'congregate', 'hospital', 'patient', 'newly', 'diagnose', 'cancer', 'anti', 'tumour', 'therapy', 'use', 'internet', 'telephone', 'service', 'first', 'choice', 'contact', 'doctor', 'refrain', 'go', 'directly', 'hospital', 'avoid', 'infection', 'doctor', 'comprehensively', 'evaluate', 'condition', 'patient', 'give', 'effective', 'optimal', 'treatment', 'patient', 'family', 'member', 'make', 'aware', 'cooperate', 'doctor', 'compliant', 'treatment', 'prescribe', 'lead', 'best', 'outcome', 'epidemic', 'attend', '80', '000', 'patient', 'online', 'include', '2688', 'patient', 'cancer', 'compare', 'number', 'patient', 'seek', 'medical', 'help', 'online', 'find', '24', 'oncologist', 'provide', 'service', 'average', 'attend', '19', 'patient', 'online', '97', 'clinic', 'visitor', 'first', '2', 'week', 'jan', '20', 'conversely', '2', 'week', 'jan', '20', 'number', 'online', 'patient', 'rise', '42', 'whereas', 'number', 'clinic', 'visitor', 'drop', '36', 'figure', '2', 'believe', 'future', 'telemedicine', 'important', 'practice', 'mode', 'oncologist', 'clinician', 'pandemic', 'figure', '2average', 'number', 'online', 'clinic', 'visitor', 'per', 'week', 'per', 'oncologistview', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'january', 'march', '2020', 'witness', 'infection', 'death', 'large', 'number', 'people', 'lack', 'protection', 'shortage', 'bed', 'inadequate', 'isolation', 'learn', 'mistake', 'stay', 'alert', 'well', 'establish', 'public', 'health', 'system', 'essential', 'continuity', 'care', 'massive', 'epidemic', 'prevent', 'epidemic', 'return', 'well', 'inform', 'covid', '19', 'early', 'screen', 'protect', 'medical', 'worker', 'properly', 'equip', 'hospital', 'routine', 'service', 'future', 'crisis', 'expand', 'service', 'internet', 'platform', 'oncologist', 'hope', 'society', 'extend', 'compassion', 'towards', 'patient', 'cancer', 'covid', '19', 'pandemic', 'declare', 'compete', 'interestsyh', 'fund', 'key', 'special', 'project', 'ministry', 'science', 'technology', 'china', '2020yfc0845700']",
"N/A (Too many requests)EMA endorsed a joint statement by the members of the International Coalition of Medicines Regulatory Authorities (ICMRA). The statement commits the international regulators to strengthen global collaboration to facilitate rapid development, approval and roll-out of safe and effective medicines against COVID-19.As the world comes to grips with the coronavirus disease 2019 (COVID-19) pandemic, reports are emerging on how cancer care is being deprioritised, delayed, and discontinued. These decisions made under the duress of the pandemic will have grave consequences for cancer mortality for years to come.Those recently diagnosed with cancer, or in the midst of cancer treatment, are facing disruption for all but the most urgent procedures because of concerns about their susceptibility to the serious risks of COVID-19, and the redeployment of personnel, beds, and equipment to COVID-19 wards. Hospital capacity has also been depleted due to COVID-19 cases in health-care workers themselves, and oncologists have not been spared. Official advice is that urgent cancer care can continue, but other treatments should be rationed and adapted. These decisions, however, are inconsistent, and not evidence-based—multidisciplinary teams are being put in the unenviable position of making best guesses for each patient. However, treatment delays and adaptations can risk, for example, operable or curable cancers developing into inoperable disease with a far worse prognosis. In many cases, and especially in resource-constrained settings, balancing the risks of undertreatment with those of COVID-19 infection will lead to situations where there is no obvious best course of action. As societies and governments scramble to provide guidelines for patients with cancer, frontline medical staff are being forced to make on-the-fly treatment decisions, and, unfortunately, many patients will receive suboptimal care.Importantly, cancer screening and diagnosis is also being affected by reprioritisation of health-care services during the pandemic. For example, in the UK, urgent suspected cancer referrals normally eligible for the 2-week wait target are now subject to prioritisation rules that will cause delays. Additionally, because UK screening programmes have been suspended, diagnoses will depend on presentation of patients with cancer symptoms. Worries about spreading and contracting COVID-19, and fear that COVID-19 is rampant in hospitals and other health-care facilities, might dissuade patients with symptoms from contacting their family doctors. Delayed cancer diagnoses during the next weeks and months risks many thousands of cases going undetected and untreated. Knock-on effects, related to a surge in demand for cancer-related services once the pandemic has passed its peak, coupled with an increase in advanced-stage cancers due to diagnostic delays and under treatment, could overwhelm health services and contribute to an excess in cancer-related mortality in the coming years.The pandemic is also affecting patients with cancer who are in follow up—for example, those in remission or receiving palliative care for late-stage disease. Cancer surveillance and management of cancer-related symptoms and treatment sequelae are managed by primary care physicians in many countries, or as home-based or outpatient services. However, the pandemic has restricted access to just the types of resources these patients need—in-home health-care workers, primary care appointments, and supportive care medications. Because appropriate and timely supportive care can extend overall survival, availability of these services is crucial to prevent not only morbidity, but also premature death.Overall, disruption to the full spectrum of medical cancer care services will undoubtedly have a large effect on cancer-related mortality. A 5–10% decrease in survival in high-income countries has been predicted, which will account for hundreds of thousands of excess deaths, dwarfing those caused by COVID-19—but we are missing precise data on mortality that can be used to anticipate future cancer care needs. Therefore, we call for research into the long-term impact on cancer-related mortality resulting from cancer care decisions being made globally during the COVID-19 pandemic. Moreover, we advocate that pandemic preparedness plans must account for the resources needed to maintain high-quality, evidence-based continuity of care of people with cancer, including workforce and service capacity needs, and a robust referral and diagnostics service. Oncologists must be included in the group of care workers who require essential equipment and resources during a pandemic. Whether governments and health services could have been better prepared for COVID-19 is debatable, but the need for a quickly deployable, and evidence-based, response is urgent and unmet. The next pandemic is not hypothetical—it will happen again—and guidance must be generated now to prevent patients with cancer becoming collateral damage.For more on cancer treatment guidelines during COVID-19 see Comment page 619, and https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0119-_Maintaining-cancer-services-_-letter-to-trusts.pdfFor more on changes to cancer care services see https://www.medscape.com/viewarticle/928878, and https://www.theguardian.com/world/2020/apr/07/life-hanging-by-a-thread-for-italian-cancer-patients-in-coronavirus-crisisFor more on cancer treatment guidelines during COVID-19 see Comment page 619, and https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0119-_Maintaining-cancer-services-_-letter-to-trusts.pdfFor more on changes to cancer care services see https://www.medscape.com/viewarticle/928878, and https://www.theguardian.com/world/2020/apr/07/life-hanging-by-a-thread-for-italian-cancer-patients-in-coronavirus-crisisView Large
                                            Image
                                        
                                Copyright
                                © 2020 Photographee.eu/shutterstockView Large
                                            Image
                                        
                                Copyright
                                © 2020 Photographee.eu/shutterstock",10.1016/j.fertnstert.2020.04.025N/A10.1016/S1470-2045(20)30243-6,DOI:10.1016/j.fertnstert.2020.04.025N/AN/A,"2020-04-1628 April May, 2020",ELSEVIEREMALANCET,"Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known?International Coalition of Medicines Regulatory Authorities (ICMRA)Safeguarding cancer care in a post-COVID-19 world",Fertility and SterilityUpdateEditorial,"['prior', 'novel', 'coronaviruses', 'covid', '19', 'human', 'reproduction', 'know', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'safeguard', 'cancer', 'care', 'post', 'covid', '19', 'world']","['n', 'many', 'request', 'ema', 'endorse', 'joint', 'statement', 'member', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'statement', 'commit', 'international', 'regulator', 'strengthen', 'global', 'collaboration', 'facilitate', 'rapid', 'development', 'approval', 'roll', 'safe', 'effective', 'medicine', 'covid', '19', 'world', 'come', 'grip', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', 'report', 'emerge', 'cancer', 'care', 'deprioritised', 'delay', 'discontinue', 'decision', 'make', 'duress', 'pandemic', 'grave', 'consequence', 'cancer', 'mortality', 'year', 'come', 'recently', 'diagnose', 'cancer', 'midst', 'cancer', 'treatment', 'face', 'disruption', 'urgent', 'procedure', 'concern', 'susceptibility', 'serious', 'risk', 'covid', '19', 'redeployment', 'personnel', 'bed', 'equipment', 'covid', '19', 'ward', 'hospital', 'capacity', 'also', 'deplete', 'due', 'covid', '19', 'case', 'health', 'care', 'worker', 'oncologist', 'spar', 'official', 'advice', 'urgent', 'cancer', 'care', 'continue', 'treatment', 'ration', 'adapt', 'decision', 'however', 'inconsistent', 'evidence', 'base', 'multidisciplinary', 'team', 'put', 'unenviable', 'position', 'make', 'best', 'guess', 'patient', 'however', 'treatment', 'delay', 'adaptation', 'risk', 'example', 'operable', 'curable', 'cancer', 'develop', 'inoperable', 'disease', 'far', 'worse', 'prognosis', 'many', 'case', 'especially', 'resource', 'constrain', 'set', 'balance', 'risk', 'undertreatment', 'covid', '19', 'infection', 'lead', 'situation', 'obvious', 'best', 'course', 'action', 'society', 'government', 'scramble', 'provide', 'guideline', 'patient', 'cancer', 'frontline', 'medical', 'staff', 'force', 'make', 'fly', 'treatment', 'decision', 'unfortunately', 'many', 'patient', 'receive', 'suboptimal', 'care', 'importantly', 'cancer', 'screen', 'diagnosis', 'also', 'affect', 'reprioritisation', 'health', 'care', 'service', 'pandemic', 'example', 'uk', 'urgent', 'suspect', 'cancer', 'referral', 'normally', 'eligible', '2', 'week', 'wait', 'target', 'subject', 'prioritisation', 'rule', 'cause', 'delay', 'additionally', 'uk', 'screen', 'programme', 'suspend', 'diagnosis', 'depend', 'presentation', 'patient', 'cancer', 'symptom', 'worry', 'spread', 'contract', 'covid', '19', 'fear', 'covid', '19', 'rampant', 'hospital', 'health', 'care', 'facility', 'might', 'dissuade', 'patient', 'symptom', 'contact', 'family', 'doctor', 'delay', 'cancer', 'diagnosis', 'next', 'week', 'month', 'risk', 'many', 'thousand', 'case', 'go', 'undetected', 'untreated', 'knock', 'effect', 'relate', 'surge', 'demand', 'cancer', 'relate', 'service', 'pandemic', 'pass', 'peak', 'couple', 'increase', 'advance', 'stage', 'cancer', 'due', 'diagnostic', 'delay', 'treatment', 'could', 'overwhelm', 'health', 'service', 'contribute', 'excess', 'cancer', 'relate', 'mortality', 'come', 'year', 'pandemic', 'also', 'affect', 'patient', 'cancer', 'follow', 'example', 'remission', 'receive', 'palliative', 'care', 'late', 'stage', 'disease', 'cancer', 'surveillance', 'management', 'cancer', 'relate', 'symptom', 'treatment', 'sequela', 'manage', 'primary', 'care', 'physician', 'many', 'country', 'home', 'base', 'outpatient', 'service', 'however', 'pandemic', 'restrict', 'access', 'type', 'resource', 'patient', 'need', 'home', 'health', 'care', 'worker', 'primary', 'care', 'appointment', 'supportive', 'care', 'medication', 'appropriate', 'timely', 'supportive', 'care', 'extend', 'overall', 'survival', 'availability', 'service', 'crucial', 'prevent', 'morbidity', 'also', 'premature', 'death', 'overall', 'disruption', 'full', 'spectrum', 'medical', 'cancer', 'care', 'service', 'undoubtedly', 'large', 'effect', 'cancer', 'relate', 'mortality', '5', '10', 'decrease', 'survival', 'high', 'income', 'country', 'predict', 'account', 'hundred', 'thousand', 'excess', 'death', 'dwarf', 'cause', 'covid', '19', 'miss', 'precise', 'data', 'mortality', 'use', 'anticipate', 'future', 'cancer', 'care', 'need', 'therefore', 'call', 'research', 'long', 'term', 'impact', 'cancer', 'relate', 'mortality', 'result', 'cancer', 'care', 'decision', 'make', 'globally', 'covid', '19', 'pandemic', 'moreover', 'advocate', 'pandemic', 'preparedness', 'plan', 'must', 'account', 'resource', 'need', 'maintain', 'high', 'quality', 'evidence', 'base', 'continuity', 'care', 'people', 'cancer', 'include', 'workforce', 'service', 'capacity', 'need', 'robust', 'referral', 'diagnostics', 'service', 'oncologist', 'must', 'include', 'group', 'care', 'worker', 'require', 'essential', 'equipment', 'resource', 'pandemic', 'whether', 'government', 'health', 'service', 'could', 'better', 'prepare', 'covid', '19', 'debatable', 'need', 'quickly', 'deployable', 'evidence', 'base', 'response', 'urgent', 'unmet', 'next', 'pandemic', 'hypothetical', 'happen', 'guidance', 'must', 'generate', 'prevent', 'patient', 'cancer', 'become', 'collateral', 'damage', 'cancer', 'treatment', 'guideline', 'covid', '19', 'see', 'comment', 'page', '619', 'http', 'www', 'england', 'nh', 'uk', 'coronavirus', 'wp', 'content', 'upload', 'site', '52', '2020', '03', 'c0119', 'maintain', 'cancer', 'service', 'letter', 'trust', 'pdffor', 'change', 'cancer', 'care', 'service', 'see', 'http', 'www', 'medscape', 'com', 'viewarticle', '928878', 'http', 'www', 'theguardian', 'com', 'world', '2020', 'apr', '07', 'life', 'hang', 'thread', 'italian', 'cancer', 'patient', 'coronavirus', 'crisisfor', 'cancer', 'treatment', 'guideline', 'covid', '19', 'see', 'comment', 'page', '619', 'http', 'www', 'england', 'nh', 'uk', 'coronavirus', 'wp', 'content', 'upload', 'site', '52', '2020', '03', 'c0119', 'maintain', 'cancer', 'service', 'letter', 'trust', 'pdffor', 'change', 'cancer', 'care', 'service', 'see', 'http', 'www', 'medscape', 'com', 'viewarticle', '928878', 'http', 'www', 'theguardian', 'com', 'world', '2020', 'apr', '07', 'life', 'hang', 'thread', 'italian', 'cancer', 'patient', 'coronavirus', 'crisisview', 'large', 'image', 'copyright', '2020', 'photographee', 'eu', 'shutterstockview', 'large', 'image', 'copyright', '2020', 'photographee', 'eu', 'shutterstock']",
"N/A (Too many requests)EMA provided an update on the measures EU authorities are putting in place to support the continued availability of medicines during the pandemic, following a meeting of the EU Executive Steering Group on Shortages of Medicines Caused by Major Events. This includes the development of guidance for pharmaceutical companies responsible for veterinary medicines on adaptations of the regulatory framework to address COVID-19-related challenges.“Allegiance, after all, has to work two ways; and one can grow weary of an allegiance which is not reciprocal.” The British playwright David Hare quoted this line by the American writer James Baldwin in his recent reflections on the UK Government's response to the coronavirus disease 2019 (COVID-19) pandemic. Baldwin's reminder and warning in the context of civil rights in the mid-20th century USA speak now in the pandemic to communities the world over who are unsure of their governments' allegiances to them. The give-and-take relationship between the state and the individual—perhaps best viewed through the lens of what Enlightenment philosophers termed the social contract—is being strained, its inadequacy exposed, and must surely be remade in the midst of this global health and economic crisis.Governments now ask heavy sacrifices from their people, with around a third of the global population under some form of lockdown. But demonstration that governments are in fact acting to protect the public, for example, through adequately preparing the health system and giving clear advice aimed at saving lives, has been highly variable. Although international comparisons are not straightforward, there are nonetheless encouraging examples of where strong and swift action has succeeded in staving off the worst effects of the virus, be they Germany's quick escalation of testing, New Zealand's elimination strategy, or South Korea's aggressive pursuit of a test-and-trace approach. By contrast, the UK, USA, and Brazil, among others, have been slow to react and haphazard when they did. The serious deficiencies in pandemic planning and response have sparked protests and condemnation and call into question commitment to the most vital interests of the public.Such failures have too often been accompanied by poor transparency and an ingrained resistance to all forms of accountability. In March, when US President Donald Trump was asked by a reporter if he takes responsibility for the delay in making test kits available, he replied “No, I don't take responsibility at all.” And in April, at a daily COVID-19 briefing when UK Home Secretary Priti Patel was asked twice if she would apologise about the shortage of personal protective equipment for front-line health-care workers, she responded, “I'm sorry if people feel that there have been failings”, in what seemed to be indifference to the sacrifices being made by health-care workers on behalf of the country and its people.Beyond immediate responses, this pandemic is revealing how a longer-term increase in inequalities and neglect of public services have weakened the ability of societies to deal with external shocks and created new vulnerabilities in a crisis. Racial and ethnic minorities, those with weak employment protections, including migrant workers, and populations without adequate access to affordable health care are among the hardest hit.However, at the same time, COVID-19 is also overturning core values, norms, and rules that sit at the heart of long-standing market-oriented political agendas. The willingness with which nations have put the brakes on their economies to protect lives, coupled with massive increases in public spending and government debt, particularly by conservative administrations, was inconceivable a few months ago. According to one analysis, as of April 23, a staggering 151 countries have planned, introduced, or adapted a total of 684 social protection measures in response to the pandemic.Despite important deficiencies in some responses, in many ways the world is witnessing the setting aside of ideology to address the urgent and fundamental need common to all people—the protection of health. So far, the measures taken have been uneven, short-term, and reactive. But it is hard to imagine that when this pandemic is over, the public will be content to go back to the way things were. That it has taken a crisis of this scale to force the recognition that the basic role of a government is to serve and protect its people—that wellbeing has a higher value than gross domestic product—is a shocking demonstration of how the reciprocal rights and responsibilities that form the basis of so many democratic systems have been hollowed out. The kind of societies that are set to emerge from this pandemic is far from clear, but our interconnectedness and interdependence at local, national, and global levels have never been more undeniable. Nor can the importance of well resourced and well prepared health systems continue to be ignored. A renewed and expanded social contract, one with health at the centre, could well be one legacy of COVID-19.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Giles Clarke/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 Giles Clarke/Getty Images",10.1016/j.athoracsur.2020.04.007N/A10.1016/S0140-6736(20)30983-1,DOI:10.1016/j.athoracsur.2020.04.007N/AN/A,"2020-04-2724 April May 02, 2020",ELSEVIEREMALANCET,Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical RecoveryAvailability of medicines during COVID-19 pandemicCOVID-19: remaking the social contract,The Annals of Thoracic SurgeryUpdateEditorial,"['adult', 'cardiac', 'surgery', 'covid', '19', 'pandemic', 'aggressive', 'infection', 'mitigation', 'strategy', 'necessary', 'operate', 'room', 'surgical', 'recoveryavailability', 'medicine', 'covid', '19', 'pandemiccovid', '19', 'remake', 'social', 'contract']","['n', 'many', 'request', 'ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', 'follow', 'meet', 'eu', 'executive', 'steer', 'group', 'shortage', 'medicine', 'cause', 'major', 'event', 'include', 'development', 'guidance', 'pharmaceutical', 'company', 'responsible', 'veterinary', 'medicine', 'adaptation', 'regulatory', 'framework', 'address', 'covid', '19', 'relate', 'challenge', 'allegiance', 'work', 'two', 'way', 'one', 'grow', 'weary', 'allegiance', 'reciprocal', 'british', 'playwright', 'david', 'hare', 'quote', 'line', 'american', 'writer', 'jam', 'baldwin', 'recent', 'reflection', 'uk', 'government', 'response', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', 'baldwin', 'reminder', 'warn', 'context', 'civil', 'right', 'mid', '20th', 'century', 'usa', 'speak', 'pandemic', 'community', 'world', 'unsure', 'government', 'allegiance', 'give', 'take', 'relationship', 'state', 'individual', 'perhaps', 'best', 'view', 'lens', 'enlightenment', 'philosopher', 'term', 'social', 'contract', 'strain', 'inadequacy', 'expose', 'must', 'surely', 'remake', 'midst', 'global', 'health', 'economic', 'crisis', 'government', 'ask', 'heavy', 'sacrifice', 'people', 'around', 'third', 'global', 'population', 'form', 'lockdown', 'demonstration', 'government', 'fact', 'act', 'protect', 'public', 'example', 'adequately', 'prepare', 'health', 'system', 'give', 'clear', 'advice', 'aim', 'save', 'life', 'highly', 'variable', 'although', 'international', 'comparison', 'straightforward', 'nonetheless', 'encourage', 'example', 'strong', 'swift', 'action', 'succeed', 'stave', 'worst', 'effect', 'virus', 'germany', 'quick', 'escalation', 'test', 'new', 'zealand', 'elimination', 'strategy', 'south', 'korea', 'aggressive', 'pursuit', 'test', 'trace', 'approach', 'contrast', 'uk', 'usa', 'brazil', 'among', 'others', 'slow', 'react', 'haphazard', 'serious', 'deficiency', 'pandemic', 'plan', 'response', 'spark', 'protest', 'condemnation', 'call', 'question', 'commitment', 'vital', 'interest', 'public', 'failure', 'often', 'accompany', 'poor', 'transparency', 'ingrain', 'resistance', 'form', 'accountability', 'march', 'u', 'president', 'donald', 'trump', 'ask', 'reporter', 'take', 'responsibility', 'delay', 'make', 'test', 'kit', 'available', 'reply', 'take', 'responsibility', 'april', 'daily', 'covid', '19', 'brief', 'uk', 'home', 'secretary', 'priti', 'patel', 'ask', 'twice', 'would', 'apologise', 'shortage', 'personal', 'protective', 'equipment', 'front', 'line', 'health', 'care', 'worker', 'respond', 'sorry', 'people', 'feel', 'fail', 'seem', 'indifference', 'sacrifice', 'make', 'health', 'care', 'worker', 'behalf', 'country', 'people', 'beyond', 'immediate', 'response', 'pandemic', 'reveal', 'longer', 'term', 'increase', 'inequality', 'neglect', 'public', 'service', 'weaken', 'ability', 'society', 'deal', 'external', 'shock', 'create', 'new', 'vulnerability', 'crisis', 'racial', 'ethnic', 'minority', 'weak', 'employment', 'protection', 'include', 'migrant', 'worker', 'population', 'without', 'adequate', 'access', 'affordable', 'health', 'care', 'among', 'hardest', 'hit', 'however', 'time', 'covid', '19', 'also', 'overturn', 'core', 'value', 'norm', 'rule', 'sit', 'heart', 'long', 'stand', 'market', 'orient', 'political', 'agenda', 'willingness', 'nation', 'put', 'brake', 'economy', 'protect', 'life', 'couple', 'massive', 'increase', 'public', 'spend', 'government', 'debt', 'particularly', 'conservative', 'administration', 'inconceivable', 'month', 'ago', 'accord', 'one', 'analysis', 'april', '23', 'stagger', '151', 'country', 'plan', 'introduce', 'adapt', 'total', '684', 'social', 'protection', 'measure', 'response', 'pandemic', 'despite', 'important', 'deficiency', 'response', 'many', 'way', 'world', 'witness', 'set', 'aside', 'ideology', 'address', 'urgent', 'fundamental', 'need', 'common', 'people', 'protection', 'health', 'far', 'measure', 'take', 'uneven', 'short', 'term', 'reactive', 'hard', 'imagine', 'pandemic', 'public', 'content', 'go', 'back', 'way', 'thing', 'take', 'crisis', 'scale', 'force', 'recognition', 'basic', 'role', 'government', 'serve', 'protect', 'people', 'wellbeing', 'higher', 'value', 'gross', 'domestic', 'product', 'shock', 'demonstration', 'reciprocal', 'right', 'responsibility', 'form', 'basis', 'many', 'democratic', 'system', 'hollow', 'kind', 'society', 'set', 'emerge', 'pandemic', 'far', 'clear', 'interconnectedness', 'interdependence', 'local', 'national', 'global', 'level', 'never', 'undeniable', 'importance', 'well', 'resourced', 'well', 'prepare', 'health', 'system', 'continue', 'ignore', 'renew', 'expand', 'social', 'contract', 'one', 'health', 'centre', 'could', 'well', 'one', 'legacy', 'covid', '19', 'view', 'large', 'image', 'copyright', '2020', 'giles', 'clarke', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'giles', 'clarke', 'getty', 'image']",
"N/A (Too many requests)EMA and the national competent authorities reminded patients with suspected or confirmed COVID-19 to report any suspected side effects that they are experiencing with any medicine, including medicines taken to treat COVID-19 and pre-existing conditions. Healthcare professionals treating COVID-19 patients should also report the suspected side effects that their patients are experiencing. These reports help regulators understand how medicines act in patients with COVID-19, complementing the knowledge generated in clinical trials and other studies.Every evening we scour those graphs looking for signs that the epidemic is in retreat. New cases of coronavirus disease 2019 (COVID-19). People in hospital with COVID-19. Critical care beds with COVID-19 patients. Daily COVID-19 deaths in hospital. And then the final and bluntly worded “global death comparison”. Those with responsibility for leading us through this emergency have called it “a once in a century global health crisis”. This statement is incorrect on two grounds. First, because we cannot know what the rest of the century will bring. It is highly probable that this current pandemic will be neither the last nor the worst global health crisis of the present century. But second, and more importantly, this global calamity is not a crisis concerning health. It is a crisis about life itself. We have been tempted in recent years to assume the omnipotence of our species. The idea of the Anthropocene places human activity as the dominant influence on the future of life on our planet. Although this newest of geological eras is supposed to underline the harm our species is doing to fragile planetary systems, paradoxically it also asserts our supremacy. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has revealed the hubris of this view. Our species has many reasons to be self-critical about the effects of our way of life on planetary sustainability. But we are only one species among many, and we are certainly not a dominant influence when faced with a virus that can destroy life with such ease and facility.View Large
                                            Image
                                        
                                Copyright
                                © 2020 John Moore/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 John Moore/Getty ImagesIf this pandemic is a crisis about life itself, what tentative conclusions might we draw from its effects so far on human society? Some clues will be found in Didier Fassin's Life: A Critical User's Manual (2018). Fassin studied medicine in Paris before turning to public health and anthropology. His starting point is the awareness we must all have for the unequal lives around us. That observation invites us to reflect on the value we attach to human life. In trying to answer that question, we somehow have to reconcile “life as a fact of nature and as a fact of experience”. We can view COVID-19 as a biological challenge to understand, treat, and prevent. But we should also understand it as a biographical event in the lives of millions of people. Fassin divides his inquiry into inequality into three parts. First, he identifies forms of life, by which he means “ways of being in the world”. The daily insecurities faced by so many of our fellow citizens draw attention to “the predicament of contemporary democracies, incapable of living up to the principles that constitute the foundation of their very existence”. Second, he discusses an ethics of life. He contrasts the rising legitimacy of those who have a biologically defined disease with the declining legitimacy of lives lived in a particular social setting (such as one of poverty). The physical has prevailed over the political. Fassin calls this ethical trend one of “biolegitimacy”—a legitimacy of life defined in biological terms. Life is reduced purely to its physical expression. There is no room for understanding the political conditions within which life exists. There is no possibility to mobilise public sentiment to defend threats to political lives, lives marked by, for example, inequality. SARS-CoV-2 preferentially afflicts those who are more vulnerable, less well rewarded, and more invisible to those with power. Third, Fassin focuses on the politics of life, the government of populations, and the effects of politics on human lives. He is interested in how the actions of political regimes differentially influence human lives and reinforce the unequal worth of some of those lives in society. The “politics of life”, he writes, “are always politics of inequality”.View Large
                                            Image
                                        
                                Copyright
                                © 2020 AFP/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 AFP/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 John Moore/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 John Moore/Getty ImagesSo what must we say? We must say that it is our task to uncover the biographies of those who have lived and died with COVID-19. It is our task to resist the biologicalisation of this disease and instead to insist on a social and political critique of COVID-19. It is our task to understand what this disease means to the lives of those it has afflicted and to use that understanding not only to change our perspective on the world but also to change the world itself. As Fassin concludes, our “critique does not have to choose between militancy and lucidity”.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Abdulhamid Hosbas/Anadolu Agency/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 Abdulhamid Hosbas/Anadolu Agency/Getty Images",10.1016/j.thromres.2020.04.024N/A10.1016/S0140-6736(20)31017-5,DOI:10.1016/j.thromres.2020.04.024N/AN/A,"2020-04-2324 April May 02, 2020",ELSEVIEREMALANCET,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, ItalyPublic-health advice during COVID-19 pandemicOffline: A global health crisis? No, something far worse",Thrombosis ResearchUpdateComment,"['venous', 'arterial', 'thromboembolic', 'complication', 'covid', '19', 'patient', 'admit', 'academic', 'hospital', 'milan', 'italypublic', 'health', 'advice', 'covid', '19', 'pandemicoffline', 'global', 'health', 'crisis', 'something', 'far', 'worse']","['n', 'many', 'request', 'ema', 'national', 'competent', 'authority', 'remind', 'patient', 'suspect', 'confirm', 'covid', '19', 'report', 'suspect', 'side', 'effect', 'experience', 'medicine', 'include', 'medicine', 'take', 'treat', 'covid', '19', 'pre', 'exist', 'condition', 'healthcare', 'professional', 'treat', 'covid', '19', 'patient', 'also', 'report', 'suspect', 'side', 'effect', 'patient', 'experience', 'report', 'help', 'regulator', 'understand', 'medicine', 'act', 'patient', 'covid', '19', 'complement', 'knowledge', 'generate', 'clinical', 'trial', 'study', 'every', 'even', 'scour', 'graph', 'look', 'sign', 'epidemic', 'retreat', 'new', 'case', 'coronavirus', 'disease', '2019', 'covid', '19', 'people', 'hospital', 'covid', '19', 'critical', 'care', 'bed', 'covid', '19', 'patient', 'daily', 'covid', '19', 'death', 'hospital', 'final', 'bluntly', 'word', 'global', 'death', 'comparison', 'responsibility', 'lead', 'u', 'emergency', 'call', 'century', 'global', 'health', 'crisis', 'statement', 'incorrect', 'two', 'grind', 'first', 'know', 'rest', 'century', 'bring', 'highly', 'probable', 'current', 'pandemic', 'neither', 'last', 'worst', 'global', 'health', 'crisis', 'present', 'century', 'second', 'importantly', 'global', 'calamity', 'crisis', 'concern', 'health', 'crisis', 'life', 'tempt', 'recent', 'year', 'assume', 'omnipotence', 'specie', 'idea', 'anthropocene', 'place', 'human', 'activity', 'dominant', 'influence', 'future', 'life', 'planet', 'although', 'newest', 'geological', 'era', 'suppose', 'underline', 'harm', 'specie', 'fragile', 'planetary', 'system', 'paradoxically', 'also', 'assert', 'supremacy', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'reveal', 'hubris', 'view', 'specie', 'many', 'reason', 'self', 'critical', 'effect', 'way', 'life', 'planetary', 'sustainability', 'one', 'specie', 'among', 'many', 'certainly', 'dominant', 'influence', 'face', 'virus', 'destroy', 'life', 'ease', 'facility', 'view', 'large', 'image', 'copyright', '2020', 'john', 'moore', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'john', 'moore', 'getty', 'imagesif', 'pandemic', 'crisis', 'life', 'tentative', 'conclusion', 'might', 'draw', 'effect', 'far', 'human', 'society', 'clue', 'find', 'didier', 'fassin', 'life', 'critical', 'user', 'manual', '2018', 'fassin', 'study', 'medicine', 'paris', 'turn', 'public', 'health', 'anthropology', 'start', 'point', 'awareness', 'must', 'unequal', 'life', 'around', 'u', 'observation', 'invite', 'u', 'reflect', 'value', 'attach', 'human', 'life', 'try', 'answer', 'question', 'somehow', 'reconcile', 'life', 'fact', 'nature', 'fact', 'experience', 'view', 'covid', '19', 'biological', 'challenge', 'understand', 'treat', 'prevent', 'also', 'understand', 'biographical', 'event', 'life', 'million', 'people', 'fassin', 'divide', 'inquiry', 'inequality', 'three', 'part', 'first', 'identify', 'form', 'life', 'mean', 'way', 'world', 'daily', 'insecurity', 'face', 'many', 'fellow', 'citizen', 'draw', 'attention', 'predicament', 'contemporary', 'democracy', 'incapable', 'live', 'principle', 'constitute', 'foundation', 'existence', 'second', 'discus', 'ethic', 'life', 'contrast', 'rise', 'legitimacy', 'biologically', 'define', 'disease', 'decline', 'legitimacy', 'life', 'live', 'particular', 'social', 'set', 'one', 'poverty', 'physical', 'prevail', 'political', 'fassin', 'call', 'ethical', 'trend', 'one', 'biolegitimacy', 'legitimacy', 'life', 'define', 'biological', 'term', 'life', 'reduce', 'purely', 'physical', 'expression', 'room', 'understand', 'political', 'condition', 'within', 'life', 'exist', 'possibility', 'mobilise', 'public', 'sentiment', 'defend', 'threat', 'political', 'life', 'life', 'mark', 'example', 'inequality', 'sars', 'cov', '2', 'preferentially', 'afflict', 'vulnerable', 'le', 'well', 'reward', 'invisible', 'power', 'third', 'fassin', 'focus', 'politics', 'life', 'government', 'population', 'effect', 'politics', 'human', 'life', 'interest', 'action', 'political', 'regime', 'differentially', 'influence', 'human', 'life', 'reinforce', 'unequal', 'worth', 'life', 'society', 'politics', 'life', 'write', 'always', 'politics', 'inequality', 'view', 'large', 'image', 'copyright', '2020', 'afp', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'afp', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'john', 'moore', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'john', 'moore', 'getty', 'imagesso', 'must', 'say', 'must', 'say', 'task', 'uncover', 'biography', 'live', 'die', 'covid', '19', 'task', 'resist', 'biologicalisation', 'disease', 'instead', 'insist', 'social', 'political', 'critique', 'covid', '19', 'task', 'understand', 'disease', 'mean', 'life', 'afflict', 'use', 'understand', 'change', 'perspective', 'world', 'also', 'change', 'world', 'fassin', 'conclude', 'critique', 'choose', 'militancy', 'lucidity', 'view', 'large', 'image', 'copyright', '2020', 'abdulhamid', 'hosbas', 'anadolu', 'agency', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'abdulhamid', 'hosbas', 'anadolu', 'agency', 'getty', 'image']",
"N/A (Too many requests)EMA announced that essential work to combat the COVID-19 pandemic would continue during the Agency’s closure on 27 April and on 1 May 2020.In addition to its specific effect against tuberculosis, the BCG vaccine has beneficial nonspecific (off-target) effects on the immune system that protect against a wide range of other infections and are used routinely to treat bladder cancer.1Pollard AJ Finn A Curtis N Non-specific effects of vaccines: plausible and potentially important, but implications uncertain.Arch Dis Child. 2017; 102: 1077-1081Google Scholar,  2Goodridge HS Ahmed SS Curtis N et al.Harnessing the beneficial heterologous effects of vaccination.Nat Rev Immunol. 2016; 16: 392-400Google Scholar This has led to the suggestion that vaccination with BCG might have a role in protecting health-care workers and other vulnerable individuals against severe coronavirus disease 2019 (COVID-19).Randomised controlled trials have provided evidence that the BCG vaccine's immunomodulatory properties can protect against respiratory infections. In Guinea-Bissau, a high-mortality setting, BCG-Danish reduced all-cause neonatal mortality by 38% (95% CI 17–54), mainly because there were fewer deaths from pneumonia and sepsis.3Biering-Sorensen S Aaby P Lund N et al.Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial.Clin Infect Dis. 2017; 65: 1183-1190Google Scholar In South Africa, BCG-Danish reduced respiratory tract infections by 73% (95% CI 39–88) in adolescents.4Nemes E Geldenhuys H Rozot V et al.Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination.N Engl J Med. 2018; 379: 138-149Google ScholarSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded positive-sense RNA virus, and the BCG vaccine has been shown to reduce the severity of infections by other viruses with that structure in controlled trials. For example, the BCG vaccine reduced yellow fever vaccine viraemia by 71% (95% CI 6–91) in volunteers in the Netherlands,5Arts RJW Moorlag S Novakovic B et al.BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.Cell Host Microbe. 2018; 23: 89-100.e5Google Scholar and it markedly reduced the severity of mengovirus (encephalomyocarditis virus) infection in two studies in mice.6Old LJ Benacerraf B Clarke DA Carswell EA Stockert E The role of the reticuloendothelial system in the host reaction to neoplasia.Cancer Res. 1961; 21: 1281-1300Google Scholar,  7Floc'h F Werner GH Increased resistance to virus infections of mice inoculated with BCG (Bacillus Calmette-Guérin).Ann Immunol. 1976; 127: 173-186Google ScholarMany of the mechanisms underlying the beneficial off-target effects of the BCG vaccine are now understood. The BCG vaccine and some other live vaccines induce metabolic and epigenetic changes that enhance the innate immune response to subsequent infections, a process termed trained immunity.8Netea MG Dominguez-Andres J Barreiro LB et al.Defining trained immunity and its role in health and disease.Nat Rev Immunol. 2020;  (published online March 4.)DOI:10.1038/s41577-020-0285-6Google Scholar The BCG vaccine might therefore reduce viraemia after SARS-COV-2 exposure, with consequent less severe COVID-19 and more rapid recovery.Randomised controlled trials are underway in the Netherlands and Australia to assess whether BCG-Danish reduces the incidence and severity of COVID-19 in health-care workers, and the effect this has on time away from work (NCT04327206, NCT04328441). It is possible that BCG-Tokyo would be preferable to BCG-Danish.9Ritz N Hanekom WA Robins-Browne R Britton WJ Curtis N Influence of BCG vaccine strain on the immune response and protection against tuberculosis.FEMS Microbiol Rev. 2008; 32: 821-841Google ScholarUntil these trials are complete, there are four main reasons why it is very important to adhere to WHO's recommendation that the BCG vaccine is used for COVID-19 only in randomised controlled trials.10WHOBacille Calmette-Guérin (BCG) vaccination and COVID-19.https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19Date: April 12, 2020Date accessed: April 29, 2020Google Scholar First, the BCG vaccine is already in short supply, and indiscriminate use could jeopardise the supply needed to protect children against tuberculosis in high-risk areas. Second, whether BCG will be effective remains unknown: findings from the ecological studies suggesting less COVID-19 in countries with routine BCG immunisation are weak evidence because they are based on population rather than individual data and are prone to confounding.11Faust L Huddart S MacLean E Svadzian A Universal BCG vaccination and protection against COVID-19: critique of an ecological study.https://naturemicrobiologycommunity.nature.com/users/36050-emily-maclean/posts/64892-universal-bcg-vaccination-and-protection-against-covid-19-critique-of-an-ecological-studyDate: April 1, 2020Date accessed: April 5, 2020Google Scholar Also, it is unlikely that a BCG vaccine given decades ago in childhood will ameliorate COVID-19 now. One reason for this is that the beneficial off-target effects of the BCG vaccine might be altered by subsequent administration of a different vaccine.1Pollard AJ Finn A Curtis N Non-specific effects of vaccines: plausible and potentially important, but implications uncertain.Arch Dis Child. 2017; 102: 1077-1081Google Scholar Third, if the BCG vaccine is not effective against COVID-19, BCG vaccination could engender a false sense of security. Fourth, careful safety monitoring in randomised trials is needed to guard against the remote possibility that up-regulation of immunity by BCG will exacerbate COVID-19 in a minority of patients with severe disease.If the BCG vaccine or another inducer of trained immunity provides non-specific protection to bridge the gap before a disease-specific vaccine is developed, this would be an important tool in the response to COVID-19 and future pandemics.NC is the lead investigator of the BRACE trial (NCT04327206), and MGN is one of the lead investigators of the BCG-CORONA trial (NCT04328441). TAG is Director General of WHO. AS declares no competing interests.",10.1016/j.ekir.2020.04.001N/A10.1016/S0140-6736(20)31025-4,DOI:10.1016/j.ekir.2020.04.001N/AN/A,"2020-04-0423 April April 30, 2020",ELSEVIEREMALANCET,"Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, ItalyEMA’s governance during COVID-19 pandemicConsidering BCG vaccination to reduce the impact of COVID-19",Kidney International ReportsUpdateCorrespondence,"['management', 'patient', 'dialysis', 'kidney', 'transplantation', 'sars', 'cov', '2', 'covid', '19', 'pandemic', 'brescia', 'italyema', 'governance', 'covid', '19', 'pandemicconsidering', 'bcg', 'vaccination', 'reduce', 'impact', 'covid', '19']","['n', 'many', 'request', 'ema', 'announce', 'essential', 'work', 'combat', 'covid', '19', 'pandemic', 'would', 'continue', 'agency', 'closure', '27', 'april', '1', 'may', '2020', 'addition', 'specific', 'effect', 'tuberculosis', 'bcg', 'vaccine', 'beneficial', 'nonspecific', 'target', 'effect', 'immune', 'system', 'protect', 'wide', 'range', 'infection', 'use', 'routinely', 'treat', 'bladder', 'cancer', '1pollard', 'aj', 'finn', 'curtis', 'n', 'non', 'specific', 'effect', 'vaccine', 'plausible', 'potentially', 'important', 'implication', 'uncertain', 'arch', 'dis', 'child', '2017', '102', '1077', '1081google', 'scholar', '2goodridge', 'h', 'ahmed', 's', 'curtis', 'n', 'et', 'al', 'harness', 'beneficial', 'heterologous', 'effect', 'vaccination', 'nat', 'rev', 'immunol', '2016', '16', '392', '400google', 'scholar', 'lead', 'suggestion', 'vaccination', 'bcg', 'might', 'role', 'protect', 'health', 'care', 'worker', 'vulnerable', 'individual', 'severe', 'coronavirus', 'disease', '2019', 'covid', '19', 'randomise', 'control', 'trial', 'provide', 'evidence', 'bcg', 'vaccine', 'immunomodulatory', 'property', 'protect', 'respiratory', 'infection', 'guinea', 'bissau', 'high', 'mortality', 'set', 'bcg', 'danish', 'reduce', 'cause', 'neonatal', 'mortality', '38', '95', 'ci', '17', '54', 'mainly', 'fewer', 'death', 'pneumonia', 'sepsis', '3biering', 'sorensen', 'aaby', 'p', 'lund', 'n', 'et', 'al', 'early', 'bcg', 'denmark', 'neonatal', 'mortality', 'among', 'infant', 'weigh', '2500', 'g', 'randomize', 'control', 'trial', 'clin', 'infect', 'dis', '2017', '65', '1183', '1190google', 'scholar', 'south', 'africa', 'bcg', 'danish', 'reduce', 'respiratory', 'tract', 'infection', '73', '95', 'ci', '39', '88', 'adolescent', '4nemes', 'e', 'geldenhuys', 'h', 'rozot', 'v', 'et', 'al', 'prevention', 'tuberculosis', 'infection', 'h4', 'ic31', 'vaccine', 'bcg', 'revaccination', 'n', 'engl', 'j', 'med', '2018', '379', '138', '149google', 'scholarsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'single', 'strand', 'positive', 'sense', 'rna', 'virus', 'bcg', 'vaccine', 'show', 'reduce', 'severity', 'infection', 'virus', 'structure', 'control', 'trial', 'example', 'bcg', 'vaccine', 'reduce', 'yellow', 'fever', 'vaccine', 'viraemia', '71', '95', 'ci', '6', '91', 'volunteer', 'netherlands', '5arts', 'rjw', 'moorlag', 'novakovic', 'b', 'et', 'al', 'bcg', 'vaccination', 'protect', 'experimental', 'viral', 'infection', 'human', 'induction', 'cytokine', 'associate', 'train', 'immunity', 'cell', 'host', 'microbe', '2018', '23', '89', '100', 'e5google', 'scholar', 'markedly', 'reduce', 'severity', 'mengovirus', 'encephalomyocarditis', 'virus', 'infection', 'two', 'study', 'mouse', '6old', 'lj', 'benacerraf', 'b', 'clarke', 'da', 'carswell', 'ea', 'stockert', 'e', 'role', 'reticuloendothelial', 'system', 'host', 'reaction', 'neoplasia', 'cancer', 're', '1961', '21', '1281', '1300google', 'scholar', '7floc', 'h', 'f', 'werner', 'gh', 'increase', 'resistance', 'virus', 'infection', 'mouse', 'inoculate', 'bcg', 'bacillus', 'calmette', 'gu', 'rin', 'ann', 'immunol', '1976', '127', '173', '186google', 'scholarmany', 'mechanism', 'underlie', 'beneficial', 'target', 'effect', 'bcg', 'vaccine', 'understand', 'bcg', 'vaccine', 'live', 'vaccine', 'induce', 'metabolic', 'epigenetic', 'change', 'enhance', 'innate', 'immune', 'response', 'subsequent', 'infection', 'process', 'term', 'train', 'immunity', '8netea', 'mg', 'dominguez', 'andres', 'j', 'barreiro', 'lb', 'et', 'al', 'define', 'train', 'immunity', 'role', 'health', 'disease', 'nat', 'rev', 'immunol', '2020', 'publish', 'online', 'march', '4', 'doi', '10', '1038', 's41577', '020', '0285', '6google', 'scholar', 'bcg', 'vaccine', 'might', 'therefore', 'reduce', 'viraemia', 'sars', 'cov', '2', 'exposure', 'consequent', 'le', 'severe', 'covid', '19', 'rapid', 'recovery', 'randomise', 'control', 'trial', 'underway', 'netherlands', 'australia', 'ass', 'whether', 'bcg', 'danish', 'reduce', 'incidence', 'severity', 'covid', '19', 'health', 'care', 'worker', 'effect', 'time', 'away', 'work', 'nct04327206', 'nct04328441', 'possible', 'bcg', 'tokyo', 'would', 'preferable', 'bcg', 'danish', '9ritz', 'n', 'hanekom', 'wa', 'robin', 'browne', 'r', 'britton', 'wj', 'curtis', 'n', 'influence', 'bcg', 'vaccine', 'strain', 'immune', 'response', 'protection', 'tuberculosis', 'fems', 'microbiol', 'rev', '2008', '32', '821', '841google', 'scholaruntil', 'trial', 'complete', 'four', 'main', 'reason', 'important', 'adhere', 'recommendation', 'bcg', 'vaccine', 'use', 'covid', '19', 'randomise', 'control', 'trial', '10whobacille', 'calmette', 'gu', 'rin', 'bcg', 'vaccination', 'covid', '19', 'http', 'www', 'int', 'news', 'room', 'commentary', 'detail', 'bacille', 'calmette', 'gu', 'c3', 'a9rin', 'bcg', 'vaccination', 'covid', '19date', 'april', '12', '2020date', 'access', 'april', '29', '2020google', 'scholar', 'first', 'bcg', 'vaccine', 'already', 'short', 'supply', 'indiscriminate', 'use', 'could', 'jeopardise', 'supply', 'need', 'protect', 'child', 'tuberculosis', 'high', 'risk', 'area', 'second', 'whether', 'bcg', 'effective', 'remain', 'unknown', 'find', 'ecological', 'study', 'suggest', 'le', 'covid', '19', 'country', 'routine', 'bcg', 'immunisation', 'weak', 'evidence', 'base', 'population', 'rather', 'individual', 'data', 'prone', 'confound', '11faust', 'l', 'huddart', 'maclean', 'e', 'svadzian', 'universal', 'bcg', 'vaccination', 'protection', 'covid', '19', 'critique', 'ecological', 'study', 'http', 'naturemicrobiologycommunity', 'nature', 'com', 'user', '36050', 'emily', 'maclean', 'post', '64892', 'universal', 'bcg', 'vaccination', 'protection', 'covid', '19', 'critique', 'ecological', 'studydate', 'april', '1', '2020date', 'access', 'april', '5', '2020google', 'scholar', 'also', 'unlikely', 'bcg', 'vaccine', 'give', 'decade', 'ago', 'childhood', 'ameliorate', 'covid', '19', 'one', 'reason', 'beneficial', 'target', 'effect', 'bcg', 'vaccine', 'might', 'alter', 'subsequent', 'administration', 'different', 'vaccine', '1pollard', 'aj', 'finn', 'curtis', 'n', 'non', 'specific', 'effect', 'vaccine', 'plausible', 'potentially', 'important', 'implication', 'uncertain', 'arch', 'dis', 'child', '2017', '102', '1077', '1081google', 'scholar', 'third', 'bcg', 'vaccine', 'effective', 'covid', '19', 'bcg', 'vaccination', 'could', 'engender', 'false', 'sense', 'security', 'fourth', 'careful', 'safety', 'monitor', 'randomise', 'trial', 'need', 'guard', 'remote', 'possibility', 'regulation', 'immunity', 'bcg', 'exacerbate', 'covid', '19', 'minority', 'patient', 'severe', 'disease', 'bcg', 'vaccine', 'another', 'inducer', 'train', 'immunity', 'provide', 'non', 'specific', 'protection', 'bridge', 'gap', 'disease', 'specific', 'vaccine', 'develop', 'would', 'important', 'tool', 'response', 'covid', '19', 'future', 'pandemic', 'nc', 'lead', 'investigator', 'brace', 'trial', 'nct04327206', 'mgn', 'one', 'lead', 'investigator', 'bcg', 'corona', 'trial', 'nct04328441', 'tag', 'director', 'general', 'declare', 'compete', 'interest']",
,10.1016/j.ando.2020.04.005N/A10.1016/S0140-6736(20)31026-6,DOI:10.1016/j.ando.2020.04.005N/AN/A,"2020-04-2123 April April 30, 2020",ELSEVIEREMALANCET,Renin-angiotensin-aldosterone system and COVID-19 infectionPublic-health advice during COVID-19 pandemicA COVID-19 conference at AIDS 2020: Virtual,Annales d'EndocrinologieUpdateComment,"['renin', 'angiotensin', 'aldosterone', 'system', 'covid', '19', 'infectionpublic', 'health', 'advice', 'covid', '19', 'pandemica', 'covid', '19', 'conference', 'aid', '2020', 'virtual']",N/A,N/A
"N/A (Too many requests)EMA participated in the global regulators’ meeting on COVID-19-related policy approaches and regulatory flexibility on Thursday, 16 April, under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). Participants discussed high-level policy issues and regulatory challenges related to the rapid development of potential COVID-19 treatments and vaccines and the continued availability of medicines during the pandemic, in particular those used in intensive care. The meeting was the first of a series of bi-weekly meetings organised by ICMRA to allow medicine regulators worldwide to exchange information and build synergies for expediting COVID-19 medicine and vaccine development and approval and avoiding medicine shortages. EMA will chair every other meeting.Care providers are adopting virtual consultations to mitigate the risks associated with coronavirus disease 2019 (COVID-19). Remote shared care delivery is one such model, which enables multiple patients to be seen at once, via virtual platforms. Outside of clinical medicine, use of remote shared service delivery has rapidly increased—eg, in education, where instructors with no prior online teaching experience have been quick to transition.Clinicians can follow suit. In the USA, the Cleveland Clinic has offered in-person shared medical appointments (SMAs) since 1999, in which patients with similar conditions meet with a clinician simultaneously and each receives one-on-one attention. The SMA format allows patients to learn about their disease from both the clinician and peers. In India, Aravind Eye Hospital has successfully trialled SMAs for patients with glaucoma.1Venkatesh R Srinivasan K Sonmez N Buell R Ramdas K Shared medical appointments in glaucoma management at a tertiary care eye hospital—a randomised trial. Association for Research in Vision and Ophthalmology,
        Baltimore, MD, USAMay 7–11, 2017Google ScholarPeople who provide SMAs often report improved outcomes and productivity gains through eliminating repetition of common advice;2Jones T Darzi A Egger G Ickovics J et al.A systems approach to embedding group consultations in the NHS.Future Healthc J. 2019; 6: 8-16Google Scholar however, acceptance of SMAs has been limited by inertia among patients and clinicians.3Ramdas K Darzi A Adopting innovations in care delivery—the case of shared medical appointments.N Engl J Med. 2017; 376: 1105-1107Google Scholar In the current COVID-19 pandemic, embracing virtual SMAs has potential to enhance provider capacity while mitigating transmission risks and enabling privacy: identity can be withheld, voices disguised, and patient video made visible only to the clinician.Providers experienced in both SMAs and telehealth can lead the way. The Cleveland Clinic offers virtual SMAs and is rapidly expanding their use.4Shibuya K Pantalone KM Burguera B Virtual shared medical appointments: a novel tool to treat obesity.Endocr Pract. 2018; 24: 1108-1109Google Scholar In India, Aravind Eye Hospital has provided telemedical appointments since 2004,5Delana K Deo S Ramdas K Babu G Ravilla T Multichannel delivery in healthcare: the impact of telemedicine centers in southern India.SSRN. 2019;  (published online Jan 8.) (preprint)https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3505318Google Scholar group counselling since 1980, and is now considering opportunities to combine these models.Through remote shared care delivery, specialists can efficiently advise many people facing cancellation of essential scheduled services. Clinicians can virtually monitor patients in many rooms (eg, in hospitals or in hotels converted into temporary field hospitals), remotely counsel infection-free patients on COVID-19 implications for specific chronic diseases (eg, in apartment building lobbies), or counsel people in their homes through loudspeaker-equipped vehicles (eg, in densely populated areas).Remote shared care can help address the backlog of consultations building up because of cancellation of non-urgent services. Routine care of people with physical or mental chronic diseases, and of pregnant women, which is more readily feasible through virtual SMAs, will help prevent future clinical events that require hospitalisation (figure). The shared care format enables patients to spend more time with their clinician and also to interact with one another, both of which can be calming in the current context of social isolation.FigureHospital bed demand and supply for patients with COVID-19 and chronic diseases under in-person care, remote 1:1 consultations, and remote shared care delivery scenariosView Large
                                            Image
                                        Figure ViewerDownload (PPT)Unavailability of high-quality electronic medical records and remote monitoring equipment prevent certain types of virtual interactions—eg, diagnosing need for surgery. Universal barriers to providing virtual care include clinician acceptance (affected by a reduced ability to examine and test patients), patient acceptance, and insurance coverage. However, clinician training is being developed by National Health Service (NHS) England, NHS Improvement, and by the British Society of Lifestyle Medicine.Technology firms can facilitate adoption of virtual SMAs by enhancing features around privacy and monitoring. The success of telehealth is already apparent in the COVID-19 pandemic. Looking ahead, both providers and patients must adjust their expectations and embrace remote shared care.AR is an honorary consultant surgeon at Imperial College Healthcare NHS Trust and the Royal Marsden Hospital; non-executive director of NHS England and Improvement; co-director of the Institute of Global Health Innovation; chair of the Accelerated Access Collaborative; and co-director of the Cancer Research UK Convergence Science Centre at the Institute of Cancer Research and Imperial College London.We thank London Business School for providing Research and Materials Development funding in support of this research. Infrastructure support for this research was provided by the National Institute of Health Research Imperial Biomedical Research Centre.",10.1016/j.jaci.2020.04.029N/A10.1016/S2589-7500(20)30101-1,DOI:10.1016/j.jaci.2020.04.029N/AN/A,"2020-04-2921 April April 30, 2020",ELSEVIEREMALANCET,Type I IFN immunoprofiling in COVID-19 patientsInternational Coalition of Medicines Regulatory Authorities (ICMRA)Remote shared care delivery: a virtual response to COVID-19,Journal of Allergy and Clinical ImmunologyUpdateCorrespondence,"['type', 'ifn', 'immunoprofiling', 'covid', '19', 'patientsinternational', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'remote', 'share', 'care', 'delivery', 'virtual', 'response', 'covid', '19']","['n', 'many', 'request', 'ema', 'participate', 'global', 'regulator', 'meet', 'covid', '19', 'relate', 'policy', 'approach', 'regulatory', 'flexibility', 'thursday', '16', 'april', 'umbrella', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'participant', 'discuss', 'high', 'level', 'policy', 'issue', 'regulatory', 'challenge', 'relate', 'rapid', 'development', 'potential', 'covid', '19', 'treatment', 'vaccine', 'continue', 'availability', 'medicine', 'pandemic', 'particular', 'use', 'intensive', 'care', 'meet', 'first', 'series', 'bi', 'weekly', 'meet', 'organise', 'icmra', 'allow', 'medicine', 'regulator', 'worldwide', 'exchange', 'information', 'build', 'synergy', 'expedite', 'covid', '19', 'medicine', 'vaccine', 'development', 'approval', 'avoid', 'medicine', 'shortage', 'ema', 'chair', 'every', 'meet', 'care', 'provider', 'adopt', 'virtual', 'consultation', 'mitigate', 'risk', 'associate', 'coronavirus', 'disease', '2019', 'covid', '19', 'remote', 'share', 'care', 'delivery', 'one', 'model', 'enable', 'multiple', 'patient', 'see', 'via', 'virtual', 'platform', 'outside', 'clinical', 'medicine', 'use', 'remote', 'share', 'service', 'delivery', 'rapidly', 'increase', 'eg', 'education', 'instructor', 'prior', 'online', 'teach', 'experience', 'quick', 'transition', 'clinician', 'follow', 'suit', 'usa', 'cleveland', 'clinic', 'offer', 'person', 'share', 'medical', 'appointment', 'smas', 'since', '1999', 'patient', 'similar', 'condition', 'meet', 'clinician', 'simultaneously', 'receive', 'one', 'one', 'attention', 'sma', 'format', 'allow', 'patient', 'learn', 'disease', 'clinician', 'peer', 'india', 'aravind', 'eye', 'hospital', 'successfully', 'trialled', 'smas', 'patient', 'glaucoma', '1venkatesh', 'r', 'srinivasan', 'k', 'sonmez', 'n', 'buell', 'r', 'ramdas', 'k', 'share', 'medical', 'appointment', 'glaucoma', 'management', 'tertiary', 'care', 'eye', 'hospital', 'randomise', 'trial', 'association', 'research', 'vision', 'ophthalmology', 'baltimore', 'md', 'usamay', '7', '11', '2017google', 'scholarpeople', 'provide', 'smas', 'often', 'report', 'improve', 'outcome', 'productivity', 'gain', 'eliminate', 'repetition', 'common', 'advice', '2jones', 'darzi', 'egger', 'g', 'ickovics', 'j', 'et', 'al', 'system', 'approach', 'embed', 'group', 'consultation', 'nh', 'future', 'healthc', 'j', '2019', '6', '8', '16google', 'scholar', 'however', 'acceptance', 'smas', 'limit', 'inertia', 'among', 'patient', 'clinician', '3ramdas', 'k', 'darzi', 'adopt', 'innovation', 'care', 'delivery', 'case', 'share', 'medical', 'appointment', 'n', 'engl', 'j', 'med', '2017', '376', '1105', '1107google', 'scholar', 'current', 'covid', '19', 'pandemic', 'embrace', 'virtual', 'smas', 'potential', 'enhance', 'provider', 'capacity', 'mitigate', 'transmission', 'risk', 'enable', 'privacy', 'identity', 'withhold', 'voice', 'disguise', 'patient', 'video', 'make', 'visible', 'clinician', 'provider', 'experience', 'smas', 'telehealth', 'lead', 'way', 'cleveland', 'clinic', 'offer', 'virtual', 'smas', 'rapidly', 'expand', 'use', '4shibuya', 'k', 'pantalone', 'km', 'burguera', 'b', 'virtual', 'share', 'medical', 'appointment', 'novel', 'tool', 'treat', 'obesity', 'endocr', 'pract', '2018', '24', '1108', '1109google', 'scholar', 'india', 'aravind', 'eye', 'hospital', 'provide', 'telemedical', 'appointment', 'since', '2004', '5delana', 'k', 'deo', 'ramdas', 'k', 'babu', 'g', 'ravilla', 'multichannel', 'delivery', 'healthcare', 'impact', 'telemedicine', 'center', 'southern', 'india', 'ssrn', '2019', 'publish', 'online', 'jan', '8', 'preprint', 'http', 'paper', 'ssrn', 'com', 'sol3', 'paper', 'cfm', 'abstract', 'id', '3505318google', 'scholar', 'group', 'counsel', 'since', '1980', 'consider', 'opportunity', 'combine', 'model', 'remote', 'share', 'care', 'delivery', 'specialist', 'efficiently', 'advise', 'many', 'people', 'face', 'cancellation', 'essential', 'schedule', 'service', 'clinician', 'virtually', 'monitor', 'patient', 'many', 'room', 'eg', 'hospital', 'hotel', 'convert', 'temporary', 'field', 'hospital', 'remotely', 'counsel', 'infection', 'free', 'patient', 'covid', '19', 'implication', 'specific', 'chronic', 'disease', 'eg', 'apartment', 'build', 'lobby', 'counsel', 'people', 'home', 'loudspeaker', 'equip', 'vehicle', 'eg', 'densely', 'populate', 'area', 'remote', 'share', 'care', 'help', 'address', 'backlog', 'consultation', 'build', 'cancellation', 'non', 'urgent', 'service', 'routine', 'care', 'people', 'physical', 'mental', 'chronic', 'disease', 'pregnant', 'woman', 'readily', 'feasible', 'virtual', 'smas', 'help', 'prevent', 'future', 'clinical', 'event', 'require', 'hospitalisation', 'figure', 'share', 'care', 'format', 'enable', 'patient', 'spend', 'time', 'clinician', 'also', 'interact', 'one', 'another', 'calm', 'current', 'context', 'social', 'isolation', 'figurehospital', 'bed', 'demand', 'supply', 'patient', 'covid', '19', 'chronic', 'disease', 'person', 'care', 'remote', '1', '1', 'consultation', 'remote', 'share', 'care', 'delivery', 'scenariosview', 'large', 'image', 'figure', 'viewerdownload', 'ppt', 'unavailability', 'high', 'quality', 'electronic', 'medical', 'record', 'remote', 'monitor', 'equipment', 'prevent', 'certain', 'type', 'virtual', 'interaction', 'eg', 'diagnose', 'need', 'surgery', 'universal', 'barrier', 'provide', 'virtual', 'care', 'include', 'clinician', 'acceptance', 'affect', 'reduce', 'ability', 'examine', 'test', 'patient', 'patient', 'acceptance', 'insurance', 'coverage', 'however', 'clinician', 'train', 'develop', 'national', 'health', 'service', 'nh', 'england', 'nh', 'improvement', 'british', 'society', 'lifestyle', 'medicine', 'technology', 'firm', 'facilitate', 'adoption', 'virtual', 'smas', 'enhance', 'feature', 'around', 'privacy', 'monitor', 'success', 'telehealth', 'already', 'apparent', 'covid', '19', 'pandemic', 'look', 'ahead', 'provider', 'patient', 'must', 'adjust', 'expectation', 'embrace', 'remote', 'share', 'care', 'ar', 'honorary', 'consultant', 'surgeon', 'imperial', 'college', 'healthcare', 'nh', 'trust', 'royal', 'marsden', 'hospital', 'non', 'executive', 'director', 'nh', 'england', 'improvement', 'co', 'director', 'institute', 'global', 'health', 'innovation', 'chair', 'accelerate', 'access', 'collaborative', 'co', 'director', 'cancer', 'research', 'uk', 'convergence', 'science', 'centre', 'institute', 'cancer', 'research', 'imperial', 'college', 'london', 'thank', 'london', 'business', 'school', 'provide', 'research', 'material', 'development', 'fund', 'support', 'research', 'infrastructure', 'support', 'research', 'provide', 'national', 'institute', 'health', 'research', 'imperial', 'biomedical', 'research', 'centre']",
"N/A (Too many requests)EMA announced that it had launched, together with EU Member States and the pharmaceutical industry, an enhanced fast-track monitoring system to help prevent and mitigate supply issues with crucial medicines used for treating COVID-19 patients. Initially, the system will focus on medicines used in intensive care, which are in greatest demand, before extending to a broader range of medicines. The monitoring system, which involves each pharmaceutical company appointing an industry single point of contact (iSPOC), was set up by the EU Executive Steering Group on Shortages of Medicines Caused by Major Events in cooperation with pharmaceutical companies in the EU.In criticising Nicaragua's response to the coronavirus disease 2019 (COVID-19) pandemic, Thais P Salazar Mather and colleagues1Mather TPS Marin BG Perez GM et al.Love in the time of COVID-19: negligence in the Nicaraguan response.Lancet Glob Health. 2020;  (published online April 6.)https://doi.org/10.1016/S2214-109X(20)30131-5Google Scholar fail to note that the country has the lowest level of infection in the Americas, with (as of April 22, 2020) ten cases of COVID-19. They ignore the Nicaraguan Government's measures to achieve this low number and the dilemma, recognised by Oxfam,2Oxfam InternationalHalf a billion people could be pushed into poverty by coronavirus, warns Oxfam.https://www.oxfam.org/en/press-releases/half-billion-people-could-be-pushed-poverty-coronavirus-warns-oxfamDate: April 9, 2020Date accessed: April 23, 2020Google Scholar that faces resource-limited countries in deciding when to implement physical distancing.Nicaragua has had health checks at its borders for months, far sooner than in the USA, and these checks are followed up with phone calls and house visits. Two lengthy and porous land frontiers make keeping Nicaragua's borders open preferable, to minimise informal crossings that make health checks impossible. Community-based health programmes in Nicaragua3World BankStrengthening the family and community health care model in Nicaragua.https://www.worldbank.org/en/results/2017/04/11/strengthening-the-family-and-community-health-care-model-in-nicaraguaDate: April 11, 2017Date accessed: April 23, 2020Google Scholar mean that most households have been visited three times by health advisers telling people how to combat COVID-19.4Cruz I Nicaragua records more than 3 million visits to families.https://www.tn8.tv/politica/502764-nicaragua-contabiliza-3-millones-visitas-familias/Date: April 17, 2020Date accessed: April 23, 2020Google Scholar 19 hospitals have been identified to receive individuals with COVID-19, and 37 000 health workers and 250 000 volunteers have been trained.All confirmed COVID-19 cases in Nicaragua have been travellers from abroad or their immediate contacts;5Nicaraguan Ministry of Health (MINSA)Nota de prensa ministerio del poder ciudadano para la salud. MINSA,
        ManaguaApril 21, 2020Google Scholar no community transmission has been judged to have taken place so far and is the reason wider measures have not yet been implemented. If self-isolation becomes necessary, it will carry a massive cost; most people need to go to work daily to eat. No reliable mechanism exists to distribute subsidies, nor can small resource-limited countries borrow money with impunity to pay for such support. Many people in Nicaragua live in cramped houses in densely populated neighbourhoods, making physical distancing difficult.Mather and colleagues cite the contrasting policies of El Salvador and Honduras. In El Salvador, President Nayib Bukele has told people to self-isolate, offering a subsidy of US$300 per family that led to massive unregulated queues outside government offices. The Los Angeles Times reported on April 7, 2020, that the lockdown in El Salvador is enforced by gangs with baseball bats.6Linthicum K O'Toole M Renderos A In El Salvador, gangs are enforcing the coronavirus lockdown with baseball bats.https://www.latimes.com/world-nation/story/2020-04-07/el-salvador-coronavirus-homicides-bukeleDate: April 7, 2020Date accessed: April 22, 2020Google Scholar In Honduras, a national curfew has led to police violence, more than 1000 arrests, and almost 900 vehicles being confiscated, according to human rights group COFADEH (Committee of Relatives of the Disappeared in Honduras).7DefensoresReport: human rights crisis during the Covid-19 pandemic.https://defensoresenlinea.com/informe-crisis-de-derechos-humanos-durante-la-pandemia-covid-19/Date: April 2, 2020Date accessed: April 22, 2020Google Scholar Despite these actions, both countries have much higher infection levels than does Nicaragua.Accusing the Nicaraguan Government of an erratic response to the epidemic, “violating the human rights of its citizens”, is both inaccurate and unfair. The government is genuinely attempting to balance the fight against COVID-19 with the economic needs of the population. To impose an untimely lockdown would not only cause huge resentment and hardship but could be counterproductive. Mather and colleagues should address these dilemmas, not omit to mention them.I declare no competing interests.Love in the time of COVID-19: negligence in the Nicaraguan responseFull-TextPDFOpen AccessNicaragua's response to COVID-19 – Authors' replyFull-TextPDFOpen Access",10.1016/j.therap.2020.04.004N/A10.1016/S2214-109X(20)30218-7,DOI:10.1016/j.therap.2020.04.004N/AN/A,"2020-04-2321 April April 30, 2020",ELSEVIEREMALANCET,THERAP–COVID-19Availability of medicines during COVID-19 pandemicNicaragua's response to COVID-19,TherapiesUpdateCorrespondence,"['therap', 'covid', '19availability', 'medicine', 'covid', '19', 'pandemicnicaragua', 'response', 'covid', '19']","['n', 'many', 'request', 'ema', 'announce', 'launch', 'together', 'eu', 'member', 'state', 'pharmaceutical', 'industry', 'enhance', 'fast', 'track', 'monitor', 'system', 'help', 'prevent', 'mitigate', 'supply', 'issue', 'crucial', 'medicine', 'use', 'treat', 'covid', '19', 'patient', 'initially', 'system', 'focus', 'medicine', 'use', 'intensive', 'care', 'greatest', 'demand', 'extend', 'broader', 'range', 'medicine', 'monitor', 'system', 'involve', 'pharmaceutical', 'company', 'appoint', 'industry', 'single', 'point', 'contact', 'ispoc', 'set', 'eu', 'executive', 'steer', 'group', 'shortage', 'medicine', 'cause', 'major', 'event', 'cooperation', 'pharmaceutical', 'company', 'eu', 'criticise', 'nicaragua', 'response', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', 'thai', 'p', 'salazar', 'mather', 'colleagues1mather', 'tps', 'marin', 'bg', 'perez', 'gm', 'et', 'al', 'love', 'time', 'covid', '19', 'negligence', 'nicaraguan', 'response', 'lancet', 'glob', 'health', '2020', 'publish', 'online', 'april', '6', 'http', 'doi', 'org', '10', '1016', 's2214', '109x', '20', '30131', '5google', 'scholar', 'fail', 'note', 'country', 'lowest', 'level', 'infection', 'america', 'april', '22', '2020', 'ten', 'case', 'covid', '19', 'ignore', 'nicaraguan', 'government', 'measure', 'achieve', 'low', 'number', 'dilemma', 'recognise', 'oxfam', '2oxfam', 'internationalhalf', 'billion', 'people', 'could', 'push', 'poverty', 'coronavirus', 'warn', 'oxfam', 'http', 'www', 'oxfam', 'org', 'en', 'press', 'release', 'half', 'billion', 'people', 'could', 'push', 'poverty', 'coronavirus', 'warn', 'oxfamdate', 'april', '9', '2020date', 'access', 'april', '23', '2020google', 'scholar', 'face', 'resource', 'limit', 'country', 'decide', 'implement', 'physical', 'distance', 'nicaragua', 'health', 'check', 'border', 'month', 'far', 'sooner', 'usa', 'check', 'follow', 'phone', 'call', 'house', 'visit', 'two', 'lengthy', 'porous', 'land', 'frontier', 'make', 'keep', 'nicaragua', 'border', 'open', 'preferable', 'minimise', 'informal', 'cross', 'make', 'health', 'check', 'impossible', 'community', 'base', 'health', 'programme', 'nicaragua3world', 'bankstrengthening', 'family', 'community', 'health', 'care', 'model', 'nicaragua', 'http', 'www', 'worldbank', 'org', 'en', 'result', '2017', '04', '11', 'strengthen', 'family', 'community', 'health', 'care', 'model', 'nicaraguadate', 'april', '11', '2017date', 'access', 'april', '23', '2020google', 'scholar', 'mean', 'household', 'visit', 'three', 'time', 'health', 'adviser', 'tell', 'people', 'combat', 'covid', '19', '4cruz', 'nicaragua', 'record', '3', 'million', 'visit', 'family', 'http', 'www', 'tn8', 'tv', 'politica', '502764', 'nicaragua', 'contabiliza', '3', 'millones', 'visitas', 'familias', 'date', 'april', '17', '2020date', 'access', 'april', '23', '2020google', 'scholar', '19', 'hospital', 'identify', 'receive', 'individual', 'covid', '19', '37', '000', 'health', 'worker', '250', '000', 'volunteer', 'train', 'confirm', 'covid', '19', 'case', 'nicaragua', 'traveller', 'abroad', 'immediate', 'contact', '5nicaraguan', 'ministry', 'health', 'minsa', 'nota', 'de', 'prensa', 'ministerio', 'del', 'poder', 'ciudadano', 'para', 'la', 'salud', 'minsa', 'managuaapril', '21', '2020google', 'scholar', 'community', 'transmission', 'judge', 'take', 'place', 'far', 'reason', 'wider', 'measure', 'yet', 'implement', 'self', 'isolation', 'become', 'necessary', 'carry', 'massive', 'cost', 'people', 'need', 'go', 'work', 'daily', 'eat', 'reliable', 'mechanism', 'exist', 'distribute', 'subsidy', 'small', 'resource', 'limit', 'country', 'borrow', 'money', 'impunity', 'pay', 'support', 'many', 'people', 'nicaragua', 'live', 'cramp', 'house', 'densely', 'populate', 'neighbourhood', 'make', 'physical', 'distance', 'difficult', 'mather', 'colleague', 'cite', 'contrast', 'policy', 'el', 'salvador', 'honduras', 'el', 'salvador', 'president', 'nayib', 'bukele', 'tell', 'people', 'self', 'isolate', 'offer', 'subsidy', 'u', '300', 'per', 'family', 'lead', 'massive', 'unregulated', 'queue', 'outside', 'government', 'office', 'los', 'angeles', 'time', 'report', 'april', '7', '2020', 'lockdown', 'el', 'salvador', 'enforce', 'gang', 'baseball', 'bat', '6linthicum', 'k', 'toole', 'renderos', 'el', 'salvador', 'gang', 'enforce', 'coronavirus', 'lockdown', 'baseball', 'bat', 'http', 'www', 'latimes', 'com', 'world', 'nation', 'story', '2020', '04', '07', 'el', 'salvador', 'coronavirus', 'homicide', 'bukeledate', 'april', '7', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'honduras', 'national', 'curfew', 'lead', 'police', 'violence', '1000', 'arrest', 'almost', '900', 'vehicle', 'confiscate', 'accord', 'human', 'right', 'group', 'cofadeh', 'committee', 'relative', 'disappear', 'honduras', '7defensoresreport', 'human', 'right', 'crisis', 'covid', '19', 'pandemic', 'http', 'defensoresenlinea', 'com', 'informe', 'crisis', 'de', 'derechos', 'humanos', 'durante', 'la', 'pandemia', 'covid', '19', 'date', 'april', '2', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'despite', 'action', 'country', 'much', 'higher', 'infection', 'level', 'nicaragua', 'accuse', 'nicaraguan', 'government', 'erratic', 'response', 'epidemic', 'violate', 'human', 'right', 'citizen', 'inaccurate', 'unfair', 'government', 'genuinely', 'attempt', 'balance', 'fight', 'covid', '19', 'economic', 'need', 'population', 'impose', 'untimely', 'lockdown', 'would', 'cause', 'huge', 'resentment', 'hardship', 'could', 'counterproductive', 'mather', 'colleague', 'address', 'dilemma', 'omit', 'mention', 'declare', 'compete', 'interest', 'love', 'time', 'covid', '19', 'negligence', 'nicaraguan', 'responsefull', 'textpdfopen', 'accessnicaragua', 'response', 'covid', '19', 'author', 'replyfull', 'textpdfopen', 'access']",
"N/A (Too many requests)EMA decided to continue holding its committee and working-party meetings virtually until the end of May 2020. Stakeholder events planned for May will either be postponed or held virtually. Most EMA staff are also continuing to work remotely until the end of May.In challenging our observations of the Nicaraguan Government's failure to confront the coronavirus disease 2019 (COVID-19) pandemic,1Mather TPS Gallo Marin B Medina Perez G et al.Love in the time of COVID-19: negligence in the Nicaraguan response.Lancet Glob Health. 2020;  (published online April 6.)https://doi.org/10.1016/S2214-109X(20)30131-5Google Scholar John Perry does not address key issues.First, while proposing reasons why the Nicaraguan Government has not promoted physical distancing, Perry offers no explanation for why the government has encouraged mass gatherings since the pandemic started. The ability to physically distance is certainly a privilege, and people from low-income and middle-income countries face starker challenges to adopt these measures. However, repeatedly encouraging mass gatherings when science supports banning large group meetings as a basic preventive strategy to reduce the risk of infection in the context of a global pandemic is troublesome.2Nicola M O'Neill N Sohrabi C Khan M Agha M Agha R Evidence based management guideline for the COVID-19 pandemic: review article.Int J Surg. 2020;  (published online April 11.)DOI:10.1016/j.ijsu.2020.04.001Google ScholarSecond, Perry suggests that, despite the absence of physical distancing measures, Nicaragua has the lowest infection rate in the Americas. However, the Nicaraguan Government has not revealed how many tests it has done.3Aburto WM Regime is not accountable for Covid-19 test, and requests CABEI US $13 million.https://confidencial.com.ni/regimen-no-rinde-cuentas-sobre-test-covid-19-y-pide-al-bcie-us-13-millones/Date: April 12, 2020Date accessed: April 22, 2020Google Scholar It is, therefore, impossible to know the real number of cases, much less make comparisons across countries.Our concerns are widely shared by leading voices in the areas of public health and human rights.4Tucker D Nicaragua: government increases risk of COVID-19 infection in a country already devastated by two years of crisis.https://www.amnesty.org/en/latest/news/2020/04/nicaragua-gobierno-aumenta-riesgo-contagio-covid19/Date: April 16, 2020Date accessed: April 22, 2020Google Scholar,  5Human Rights WatchNicaragua: reckless COVID-19 response—calls for mass gatherings; no quarantine or travel restrictions.https://www.hrw.org/news/2020/04/10/nicaragua-reckless-covid-19-responseDate: April 10, 2020Date accessed: April 22, 2020Google Scholar,  6Padgett T PAHO warns Latin America – especially Nicaragua – coronavirus ‘accelerating rapidly’.https://www.wlrn.org/post/paho-warns-latin-america-especially-nicaragua-coronavirus-accelerating-rapidly#stream/0Date: April 7, 2020Date accessed: April 22, 2020Google Scholar,  7Inter-American Commission on Human RightsIACHR and its REDESCA express serious concern about the human rights situation in the context of the response to the COVID-19 pandemic in Nicaragua.http://www.oas.org/es/cidh/prensa/comunicados/2020/072.aspDate: April 8, 2020Date accessed: April 22, 2020Google Scholar Since publication of our Correspondence on April 6, 2020, the Pan American Health Organization6Padgett T PAHO warns Latin America – especially Nicaragua – coronavirus ‘accelerating rapidly’.https://www.wlrn.org/post/paho-warns-latin-america-especially-nicaragua-coronavirus-accelerating-rapidly#stream/0Date: April 7, 2020Date accessed: April 22, 2020Google Scholar stated worries about the absence of physical distancing, convening of mass gatherings, testing, reporting of cases, and inadequate infection prevention and control. Both Human Rights Watch5Human Rights WatchNicaragua: reckless COVID-19 response—calls for mass gatherings; no quarantine or travel restrictions.https://www.hrw.org/news/2020/04/10/nicaragua-reckless-covid-19-responseDate: April 10, 2020Date accessed: April 22, 2020Google Scholar and the Inter-American Commission on Human Rights7Inter-American Commission on Human RightsIACHR and its REDESCA express serious concern about the human rights situation in the context of the response to the COVID-19 pandemic in Nicaragua.http://www.oas.org/es/cidh/prensa/comunicados/2020/072.aspDate: April 8, 2020Date accessed: April 22, 2020Google Scholar have expressed concern for the human rights of the Nicaraguan people in the context of the government's response to the pandemic. Amnesty International puts the problem thusly: “The Nicaraguan authorities' response to the serious threat posed by COVID-19 shows once again that the Ortega administration is not taking any responsibility for the human rights of the Nicaraguan people, leaving them completely vulnerable.”4Tucker D Nicaragua: government increases risk of COVID-19 infection in a country already devastated by two years of crisis.https://www.amnesty.org/en/latest/news/2020/04/nicaragua-gobierno-aumenta-riesgo-contagio-covid19/Date: April 16, 2020Date accessed: April 22, 2020Google ScholarWe declare no competing interests.Love in the time of COVID-19: negligence in the Nicaraguan responseFull-TextPDFOpen AccessNicaragua's response to COVID-19Full-TextPDFOpen Access",10.1016/j.ijid.2020.04.061N/A10.1016/S2214-109X(20)30220-5,DOI:10.1016/j.ijid.2020.04.061N/AN/A,"2020-04-2521 April April 30, 2020",ELSEVIEREMALANCET,Mild versus severe COVID-19: laboratory markersEMA’s governance during COVID-19 pandemicNicaragua's response to COVID-19 – Authors' reply,International Journal of Infectious DiseasesUpdateCorrespondence,"['mild', 'versus', 'severe', 'covid', '19', 'laboratory', 'markersema', 'governance', 'covid', '19', 'pandemicnicaragua', 'response', 'covid', '19', 'author', 'reply']","['n', 'many', 'request', 'ema', 'decide', 'continue', 'hold', 'committee', 'work', 'party', 'meet', 'virtually', 'end', 'may', '2020', 'stakeholder', 'event', 'plan', 'may', 'either', 'postpone', 'hold', 'virtually', 'ema', 'staff', 'also', 'continue', 'work', 'remotely', 'end', 'may', 'challenge', 'observation', 'nicaraguan', 'government', 'failure', 'confront', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', '1mather', 'tps', 'gallo', 'marin', 'b', 'medina', 'perez', 'g', 'et', 'al', 'love', 'time', 'covid', '19', 'negligence', 'nicaraguan', 'response', 'lancet', 'glob', 'health', '2020', 'publish', 'online', 'april', '6', 'http', 'doi', 'org', '10', '1016', 's2214', '109x', '20', '30131', '5google', 'scholar', 'john', 'perry', 'address', 'key', 'issue', 'first', 'propose', 'reason', 'nicaraguan', 'government', 'promote', 'physical', 'distance', 'perry', 'offer', 'explanation', 'government', 'encourage', 'mass', 'gather', 'since', 'pandemic', 'start', 'ability', 'physically', 'distance', 'certainly', 'privilege', 'people', 'low', 'income', 'middle', 'income', 'country', 'face', 'starker', 'challenge', 'adopt', 'measure', 'however', 'repeatedly', 'encourage', 'mass', 'gather', 'science', 'support', 'ban', 'large', 'group', 'meet', 'basic', 'preventive', 'strategy', 'reduce', 'risk', 'infection', 'context', 'global', 'pandemic', 'troublesome', '2nicola', 'neill', 'n', 'sohrabi', 'c', 'khan', 'agha', 'agha', 'r', 'evidence', 'base', 'management', 'guideline', 'covid', '19', 'pandemic', 'review', 'article', 'int', 'j', 'surg', '2020', 'publish', 'online', 'april', '11', 'doi', '10', '1016', 'j', 'ijsu', '2020', '04', '001google', 'scholarsecond', 'perry', 'suggest', 'despite', 'absence', 'physical', 'distance', 'measure', 'nicaragua', 'lowest', 'infection', 'rate', 'america', 'however', 'nicaraguan', 'government', 'reveal', 'many', 'test', 'do', '3aburto', 'wm', 'regime', 'accountable', 'covid', '19', 'test', 'request', 'cabei', 'u', '13', 'million', 'http', 'confidencial', 'com', 'ni', 'regimen', 'rinde', 'cuentas', 'sobre', 'test', 'covid', '19', 'pide', 'al', 'bcie', 'u', '13', 'millones', 'date', 'april', '12', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'therefore', 'impossible', 'know', 'real', 'number', 'case', 'much', 'le', 'make', 'comparison', 'across', 'country', 'concern', 'widely', 'share', 'lead', 'voice', 'area', 'public', 'health', 'human', 'right', '4tucker', 'nicaragua', 'government', 'increase', 'risk', 'covid', '19', 'infection', 'country', 'already', 'devastate', 'two', 'year', 'crisis', 'http', 'www', 'amnesty', 'org', 'en', 'latest', 'news', '2020', '04', 'nicaragua', 'gobierno', 'aumenta', 'riesgo', 'contagio', 'covid19', 'date', 'april', '16', '2020date', 'access', 'april', '22', '2020google', 'scholar', '5human', 'right', 'watchnicaragua', 'reckless', 'covid', '19', 'response', 'call', 'mass', 'gather', 'quarantine', 'travel', 'restriction', 'http', 'www', 'hrw', 'org', 'news', '2020', '04', '10', 'nicaragua', 'reckless', 'covid', '19', 'responsedate', 'april', '10', '2020date', 'access', 'april', '22', '2020google', 'scholar', '6padgett', 'paho', 'warn', 'latin', 'america', 'especially', 'nicaragua', 'coronavirus', 'accelerate', 'rapidly', 'http', 'www', 'wlrn', 'org', 'post', 'paho', 'warn', 'latin', 'america', 'especially', 'nicaragua', 'coronavirus', 'accelerate', 'rapidly', 'stream', '0date', 'april', '7', '2020date', 'access', 'april', '22', '2020google', 'scholar', '7inter', 'american', 'commission', 'human', 'rightsiachr', 'redesca', 'express', 'serious', 'concern', 'human', 'right', 'situation', 'context', 'response', 'covid', '19', 'pandemic', 'nicaragua', 'http', 'www', 'oas', 'org', 'e', 'cidh', 'prensa', 'comunicados', '2020', '072', 'aspdate', 'april', '8', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'since', 'publication', 'correspondence', 'april', '6', '2020', 'pan', 'american', 'health', 'organization6padgett', 'paho', 'warn', 'latin', 'america', 'especially', 'nicaragua', 'coronavirus', 'accelerate', 'rapidly', 'http', 'www', 'wlrn', 'org', 'post', 'paho', 'warn', 'latin', 'america', 'especially', 'nicaragua', 'coronavirus', 'accelerate', 'rapidly', 'stream', '0date', 'april', '7', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'state', 'worry', 'absence', 'physical', 'distance', 'convene', 'mass', 'gather', 'test', 'report', 'case', 'inadequate', 'infection', 'prevention', 'control', 'human', 'right', 'watch5human', 'right', 'watchnicaragua', 'reckless', 'covid', '19', 'response', 'call', 'mass', 'gather', 'quarantine', 'travel', 'restriction', 'http', 'www', 'hrw', 'org', 'news', '2020', '04', '10', 'nicaragua', 'reckless', 'covid', '19', 'responsedate', 'april', '10', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'inter', 'american', 'commission', 'human', 'rights7inter', 'american', 'commission', 'human', 'rightsiachr', 'redesca', 'express', 'serious', 'concern', 'human', 'right', 'situation', 'context', 'response', 'covid', '19', 'pandemic', 'nicaragua', 'http', 'www', 'oas', 'org', 'e', 'cidh', 'prensa', 'comunicados', '2020', '072', 'aspdate', 'april', '8', '2020date', 'access', 'april', '22', '2020google', 'scholar', 'express', 'concern', 'human', 'right', 'nicaraguan', 'people', 'context', 'government', 'response', 'pandemic', 'amnesty', 'international', 'put', 'problem', 'thusly', 'nicaraguan', 'authority', 'response', 'serious', 'threat', 'pose', 'covid', '19', 'show', 'ortega', 'administration', 'take', 'responsibility', 'human', 'right', 'nicaraguan', 'people', 'leave', 'completely', 'vulnerable', '4tucker', 'nicaragua', 'government', 'increase', 'risk', 'covid', '19', 'infection', 'country', 'already', 'devastate', 'two', 'year', 'crisis', 'http', 'www', 'amnesty', 'org', 'en', 'latest', 'news', '2020', '04', 'nicaragua', 'gobierno', 'aumenta', 'riesgo', 'contagio', 'covid19', 'date', 'april', '16', '2020date', 'access', 'april', '22', '2020google', 'scholarwe', 'declare', 'compete', 'interest', 'love', 'time', 'covid', '19', 'negligence', 'nicaraguan', 'responsefull', 'textpdfopen', 'accessnicaragua', 'response', 'covid', '19full', 'textpdfopen', 'access']",
,10.1016/j.scitotenv.2020.139115N/A10.1016/S2214-109X(20)30129-7,DOI:10.1016/j.scitotenv.2020.139115N/AN/A,"2020-05-0120 April April 30, 2020",ELSEVIEREMALANCET,Asymmetric nexus between temperature and COVID-19 in the top ten affected provinces of China: A current application of quantile-on-quantile approachGuidance for medicine developers and companies on COVID-19Feasibility of controlling COVID-19,Science of The Total EnvironmentUpdateCorrespondence,"['asymmetric', 'nexus', 'temperature', 'covid', '19', 'top', 'ten', 'affect', 'province', 'china', 'current', 'application', 'quantile', 'quantile', 'approachguidance', 'medicine', 'developer', 'company', 'covid', '19feasibility', 'control', 'covid', '19']",N/A,N/A
,10.1016/j.numecd.2020.04.013N/A10.1016/S2214-109X(20)30128-5,DOI:10.1016/j.numecd.2020.04.013N/AN/A,"2020-04-1820 April April 30, 2020",ELSEVIEREMALANCET,Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19Availability of medicines during COVID-19 pandemicFeasibility of controlling COVID-19 – Authors' reply,"Nutrition, Metabolism and Cardiovascular DiseasesUpdateCorrespondence","['cardiovascular', 'disease', 'potentially', 'contribute', 'progression', 'poor', 'prognosis', 'covid', '19availability', 'medicine', 'covid', '19', 'pandemicfeasibility', 'control', 'covid', '19', 'author', 'reply']",N/A,N/A
"N/A (Too many requests)The International Coalition of Medicines Regulatory Authorities published a report summarising the third global regulatory workshop on the use of observational studies and real-world data in generating robust evidence on the safety and efficacy of COVID-19 vaccines and treatments. The report provides a snapshot of ongoing and planned observational studies, platforms and registries in various countries and regions around the world. EMA co-chaired the meeting with Health Canada.As of April 24, 2020, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to over 2·7 million confirmed cases, and 190 000 reported deaths worldwide. To reduce the transmission and mortality of this newly emerging infection, countries have needed to make rapid policy decisions on the basis of scarce early data with many uncertainties.In the early stages of pandemics, mathematical models can provide valuable insights into transmission dynamics, help to predict disease spread, and evaluate control measures.1Fitzpatrick MC Bauch CT Townsend JP Galvani AP Modelling microbial infection to address global health challenges.Nat Microbiol. 2019; 4: 1612-1619Google Scholar However, models are only valid within the limits of the parameters examined. As reliable parameter estimates are rarely available early in a new pandemic, best-guess estimates are used, which need to be constantly reviewed as new real-world data emerge. Estimating how sensitive the model is to changes in its parameters can provide useful information about validity when parameters are uncertain. Interpreting models without considering these factors can lead to flawed inferences, which can have far-reaching effects when they inform public health policy.We illustrate the potential impact that flawed model inferences can have on public health policy with the model described in The Lancet Global Health by Joel Hellewell and colleagues,2Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google Scholar which is part of the scientific evidence informing the UK Government's response to coronavirus disease 2019 (COVID-19).3UK GovernmentScientific Advisory Group for Emergencies (SAGE): coronavirus (COVID-19) response.https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-responseDate: 2020Date accessed: April 4, 2020Google Scholar On March 12, 2020, the UK Government decided to cease community testing and contact tracing, claiming that the scientific evidence did not support these strategies, as the UK had entered the so-called delay phase of the epidemic. These actions were consistent with the conclusions of Hellewell and colleagues that these measures were unlikely to be able to bring the epidemic under control in under 12 weeks: “In most plausible outbreak scenarios, case isolation and contact tracing alone is insufficient to control outbreaks, and in some scenarios even near perfect contact tracing will still be insufficient, and further interventions would be required to achieve control.”2Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google ScholarA key parameter of the model was the delay between a case becoming symptomatic and being isolated.2Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google Scholar Two median delays were modelled—3·83 days (short) and 8·09 days (long)—on the basis of data from the SARS-CoV epidemic, and an empirical distribution calculated from the early phase of the SARS-CoV-2 outbreak in Wuhan.2Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google Scholar However, by this time, several rapid tests with a turnaround time of less than 4 h had been developed internationally, with some having received relevant regulatory approvals.4Sheridan C Coronavirus and the race to distribute reliable diagnostics.https://www.nature.com/articles/d41587-020-00002-2Date: Feb 19, 2020Date accessed: April 4, 2020Google Scholar Soon after, South Korea and Singapore began drive-through testing and had developed the capacity to test rapidly and deliver results within a single day, making a 1-day delay scenario plausible.5Bedingfield W What the world can learn from South Korea's coronavirus strategy.https://www.wired.co.uk/article/south-korea-coronavirusDate: March 21, 2020Date accessed: April 4, 2020Google Scholar,  6Edward D How South Korea created the world's most ambitious coronavirus testing programme.https://www.itv.com/news/2020-03-31/how-south-korea-created-the-world-s-most-ambitious-coronavirus-testing-programmeDate: March 31, 2020Date accessed: April 4, 2020Google Scholar Indeed, recent models examining interventions for COVID-19 control in Singapore have assumed a 1-day delay between symptom onset and quarantine.7Koo JR Cook AR Park M et al.Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.Lancet Infect Dis. 2020;  (published online March 23.)https://doi.org/10.1016/S1473-3099(20)30162-6Google ScholarWe find that inferences of the model from Hellewell and colleagues2Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google Scholar are very sensitive to the parameter of onset-to-isolation delay (appendix). Using the authors' original code, we demonstrate that when the delay is changed to a median of 1 day, the model predicts the probability of controlling the epidemic within 12 weeks to be more than 80%, with 30–60% (ie, considerably less than near perfect) contact tracing (depending on the proportion of pre-symptomatic cases at a given time). These results suggest that rapid testing, contact tracing, and isolation could be effective strategies to control transmission.At the time that the UK Government decided to cease community testing, real-world data from several other countries were pointing to the effectiveness of testing and contact tracing, potentially at odds with the evidence that the government was following. On March 12, 2020 (16 days after the tenth SARS-CoV-2 death in both South Korea and Italy), South Korea had 66 reported deaths compared with Italy's 827 (appendix). The epidemic trajectories in South Korea, Japan, Taiwan, and Singapore have been vastly different from most European countries, with far fewer deaths (appendix). Although multiple aspects of the populations and systems of these countries could have contributed to these differences, one key commonality is the early adoption of an approach focused on testing, isolation, and contact tracing in the countries with slower trajectories. Indeed, many of these countries did not institute nationwide lockdown measures at all or until much later, after the curve had flattened, potentially indicating the impact of case detection-based strategies on transmission (appendix). These detection-based strategies might have allowed the countries to control transmission without stringent lockdown measures and school closures, thus avoiding the disruption that these entail. Instead, they were able to implement targeted restrictions in response to observed outbreaks (eg, church closures in South Korea).8Shim E Tariq A Choi W Lee Y Chowell G Transmission potential and severity of COVID-19 in South Korea.Int J Infect Dis. 2020;  (published online March 18.)DOI:10.1016/j.ijid.2020.03.031Google Scholar By contrast, many European countries have had to impose lockdowns much earlier in the timeline of their epidemics (appendix).Empirical, real-world data must be considered alongside mathematical models when devising pandemic responses. Models are fallible and scientists and policy makers must be mindful that an over-reliance on models, and a lack of caution in interpreting them, could be a costly exercise.We declare no competing interests.
                                            Download .pdf (.4
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendixFeasibility of controlling COVID-19 outbreaks by isolation of cases and contactsFull-TextPDFOpen AccessOn the fallibility of simulation models in informing pandemic responses – Authors' replyFull-TextPDFOpen Access",10.1016/j.bbi.2020.04.077N/A10.1016/S2214-109X(20)30219-9,DOI:10.1016/j.bbi.2020.04.077N/AN/A,"2020-04-2816 April April 30, 2020",ELSEVIEREMALANCET,COVID-19 presenting as strokeInternational Coalition of Medicines Regulatory Authorities (ICMRA)On the fallibility of simulation models in informing pandemic responses,"Brain, Behavior, and ImmunityUpdateCorrespondence","['covid', '19', 'present', 'strokeinternational', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'fallibility', 'simulation', 'model', 'inform', 'pandemic', 'response']","['n', 'many', 'request', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'publish', 'report', 'summarise', 'third', 'global', 'regulatory', 'workshop', 'use', 'observational', 'study', 'real', 'world', 'data', 'generate', 'robust', 'evidence', 'safety', 'efficacy', 'covid', '19', 'vaccine', 'treatment', 'report', 'provide', 'snapshot', 'ongoing', 'plan', 'observational', 'study', 'platform', 'registry', 'various', 'country', 'region', 'around', 'world', 'ema', 'co', 'chair', 'meet', 'health', 'canada', 'april', '24', '2020', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'pandemic', 'lead', '2', '7', 'million', 'confirm', 'case', '190', '000', 'report', 'death', 'worldwide', 'reduce', 'transmission', 'mortality', 'newly', 'emerge', 'infection', 'country', 'need', 'make', 'rapid', 'policy', 'decision', 'basis', 'scarce', 'early', 'data', 'many', 'uncertainty', 'early', 'stage', 'pandemic', 'mathematical', 'model', 'provide', 'valuable', 'insight', 'transmission', 'dynamic', 'help', 'predict', 'disease', 'spread', 'evaluate', 'control', 'measure', '1fitzpatrick', 'mc', 'bauch', 'ct', 'townsend', 'jp', 'galvani', 'ap', 'model', 'microbial', 'infection', 'address', 'global', 'health', 'challenge', 'nat', 'microbiol', '2019', '4', '1612', '1619google', 'scholar', 'however', 'model', 'valid', 'within', 'limit', 'parameter', 'examine', 'reliable', 'parameter', 'estimate', 'rarely', 'available', 'early', 'new', 'pandemic', 'best', 'guess', 'estimate', 'use', 'need', 'constantly', 'review', 'new', 'real', 'world', 'data', 'emerge', 'estimate', 'sensitive', 'model', 'change', 'parameter', 'provide', 'useful', 'information', 'validity', 'parameter', 'uncertain', 'interpret', 'model', 'without', 'consider', 'factor', 'lead', 'flaw', 'inference', 'far', 'reach', 'effect', 'inform', 'public', 'health', 'policy', 'illustrate', 'potential', 'impact', 'flaw', 'model', 'inference', 'public', 'health', 'policy', 'model', 'describe', 'lancet', 'global', 'health', 'joel', 'hellewell', 'colleague', '2hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholar', 'part', 'scientific', 'evidence', 'inform', 'uk', 'government', 'response', 'coronavirus', 'disease', '2019', 'covid', '19', '3uk', 'governmentscientific', 'advisory', 'group', 'emergency', 'sage', 'coronavirus', 'covid', '19', 'response', 'http', 'www', 'gov', 'uk', 'government', 'group', 'scientific', 'advisory', 'group', 'emergency', 'sage', 'coronavirus', 'covid', '19', 'responsedate', '2020date', 'access', 'april', '4', '2020google', 'scholar', 'march', '12', '2020', 'uk', 'government', 'decide', 'cease', 'community', 'test', 'contact', 'trace', 'claim', 'scientific', 'evidence', 'support', 'strategy', 'uk', 'enter', 'call', 'delay', 'phase', 'epidemic', 'action', 'consistent', 'conclusion', 'hellewell', 'colleague', 'measure', 'unlikely', 'able', 'bring', 'epidemic', 'control', '12', 'week', 'plausible', 'outbreak', 'scenario', 'case', 'isolation', 'contact', 'trace', 'alone', 'insufficient', 'control', 'outbreak', 'scenario', 'even', 'near', 'perfect', 'contact', 'trace', 'still', 'insufficient', 'intervention', 'would', 'require', 'achieve', 'control', '2hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholara', 'key', 'parameter', 'model', 'delay', 'case', 'become', 'symptomatic', 'isolate', '2hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholar', 'two', 'median', 'delay', 'model', '3', '83', 'day', 'short', '8', '09', 'day', 'long', 'basis', 'data', 'sars', 'cov', 'epidemic', 'empirical', 'distribution', 'calculate', 'early', 'phase', 'sars', 'cov', '2', 'outbreak', 'wuhan', '2hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholar', 'however', 'time', 'several', 'rapid', 'test', 'turnaround', 'time', 'le', '4', 'h', 'develop', 'internationally', 'receive', 'relevant', 'regulatory', 'approval', '4sheridan', 'c', 'coronavirus', 'race', 'distribute', 'reliable', 'diagnostics', 'http', 'www', 'nature', 'com', 'article', 'd41587', '020', '00002', '2date', 'feb', '19', '2020date', 'access', 'april', '4', '2020google', 'scholar', 'soon', 'south', 'korea', 'singapore', 'begin', 'drive', 'test', 'develop', 'capacity', 'test', 'rapidly', 'deliver', 'result', 'within', 'single', 'day', 'make', '1', 'day', 'delay', 'scenario', 'plausible', '5bedingfield', 'w', 'world', 'learn', 'south', 'korea', 'coronavirus', 'strategy', 'http', 'www', 'wire', 'co', 'uk', 'article', 'south', 'korea', 'coronavirusdate', 'march', '21', '2020date', 'access', 'april', '4', '2020google', 'scholar', '6edward', 'south', 'korea', 'create', 'world', 'ambitious', 'coronavirus', 'test', 'programme', 'http', 'www', 'itv', 'com', 'news', '2020', '03', '31', 'south', 'korea', 'create', 'world', 'ambitious', 'coronavirus', 'test', 'programmedate', 'march', '31', '2020date', 'access', 'april', '4', '2020google', 'scholar', 'indeed', 'recent', 'model', 'examine', 'intervention', 'covid', '19', 'control', 'singapore', 'assume', '1', 'day', 'delay', 'symptom', 'onset', 'quarantine', '7koo', 'jr', 'cook', 'ar', 'park', 'et', 'al', 'intervention', 'mitigate', 'early', 'spread', 'sars', 'cov', '2', 'singapore', 'model', 'study', 'lancet', 'infect', 'dis', '2020', 'publish', 'online', 'march', '23', 'http', 'doi', 'org', '10', '1016', 's1473', '3099', '20', '30162', '6google', 'scholarwe', 'find', 'inference', 'model', 'hellewell', 'colleagues2hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholar', 'sensitive', 'parameter', 'onset', 'isolation', 'delay', 'appendix', 'use', 'author', 'original', 'code', 'demonstrate', 'delay', 'change', 'median', '1', 'day', 'model', 'predict', 'probability', 'control', 'epidemic', 'within', '12', 'week', '80', '30', '60', 'ie', 'considerably', 'le', 'near', 'perfect', 'contact', 'trace', 'depend', 'proportion', 'pre', 'symptomatic', 'case', 'give', 'time', 'result', 'suggest', 'rapid', 'test', 'contact', 'trace', 'isolation', 'could', 'effective', 'strategy', 'control', 'transmission', 'time', 'uk', 'government', 'decide', 'cease', 'community', 'test', 'real', 'world', 'data', 'several', 'country', 'point', 'effectiveness', 'test', 'contact', 'trace', 'potentially', 'odds', 'evidence', 'government', 'follow', 'march', '12', '2020', '16', 'day', 'tenth', 'sars', 'cov', '2', 'death', 'south', 'korea', 'italy', 'south', 'korea', '66', 'report', 'death', 'compare', 'italy', '827', 'appendix', 'epidemic', 'trajectory', 'south', 'korea', 'japan', 'taiwan', 'singapore', 'vastly', 'different', 'european', 'country', 'far', 'fewer', 'death', 'appendix', 'although', 'multiple', 'aspect', 'population', 'system', 'country', 'could', 'contribute', 'difference', 'one', 'key', 'commonality', 'early', 'adoption', 'approach', 'focus', 'test', 'isolation', 'contact', 'trace', 'country', 'slower', 'trajectory', 'indeed', 'many', 'country', 'institute', 'nationwide', 'lockdown', 'measure', 'much', 'later', 'curve', 'flatten', 'potentially', 'indicate', 'impact', 'case', 'detection', 'base', 'strategy', 'transmission', 'appendix', 'detection', 'base', 'strategy', 'might', 'allow', 'country', 'control', 'transmission', 'without', 'stringent', 'lockdown', 'measure', 'school', 'closure', 'thus', 'avoid', 'disruption', 'entail', 'instead', 'able', 'implement', 'target', 'restriction', 'response', 'observe', 'outbreak', 'eg', 'church', 'closure', 'south', 'korea', '8shim', 'e', 'tariq', 'choi', 'w', 'lee', 'chowell', 'g', 'transmission', 'potential', 'severity', 'covid', '19', 'south', 'korea', 'int', 'j', 'infect', 'dis', '2020', 'publish', 'online', 'march', '18', 'doi', '10', '1016', 'j', 'ijid', '2020', '03', '031google', 'scholar', 'contrast', 'many', 'european', 'country', 'impose', 'lockdown', 'much', 'earlier', 'timeline', 'epidemic', 'appendix', 'empirical', 'real', 'world', 'data', 'must', 'consider', 'alongside', 'mathematical', 'model', 'devise', 'pandemic', 'response', 'model', 'fallible', 'scientist', 'policy', 'maker', 'must', 'mindful', 'reliance', 'model', 'lack', 'caution', 'interpret', 'could', 'costly', 'exercise', 'declare', 'compete', 'interest', 'download', 'pdf', '4', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendixfeasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contactsfull', 'textpdfopen', 'accesson', 'fallibility', 'simulation', 'model', 'inform', 'pandemic', 'response', 'author', 'replyfull', 'textpdfopen', 'access']",
"N/A (Too many requests)EMA, the European Commission and the European medicines regulatory network published guidance for companies on adaptations to the regulatory framework to address challenges arising from the COVID-19 pandemic, with a particular focus on crucial medicines for use in COVID-19 patients.We welcome the correspondence from Deepti Gurdasani and Hisham Ziauddeen and agree that models that influence policy should be open to scrutiny, be informed by the best available evidence, and be constantly reviewed as more information and better estimates emerge. For these very reasons, we made the computer code needed to run the model available with the publication. This allows others to run the model using different parameter values when more information becomes available and explore the resulting effects. We are heartened to see that Gurdasani and Ziauddeen have done so.In our Article,1Hellewell J Abbott S Gimma S et al.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.Lancet Glob Health. 2020; 8: e488-e496Google Scholar we evaluated one method through which countries could potentially control coronavirus disease 2019 (COVID-19) outbreaks due to seeding from imported cases: ascertaining the known contacts of symptomatic cases, tracing them, and isolating them upon symptom onset. We did not consider the effects of mass testing or untargeted testing within the wider community and drew no conclusions on their use.Gurdasani and Ziauddeen quote a conclusion of our study, namely that achieving control using contact tracing and isolation alone was unlikely to bring the outbreak under control. Unfortunately, they did not include the second half of our paper's concluding statement in their quote: “Rapid and effective contact tracing can reduce the initial number of cases, which would make the outbreak easier to control overall. Effective contact tracing and isolation could contribute to reducing the overall size of an outbreak or bringing it under control over a longer time period.” These conclusions do not promote the complete abandonment of case isolation and contact tracing efforts, as the authors suggest. Instead, they point to the long-term benefits of such measures in reducing overall transmission.As Gurdasani and Ziauddeen note, the model parameter for the delay from onset to isolation plays a crucial role in determining the probability of controlling the outbreak within 12 weeks. At least some of this delay will be mitigated by the speed at which testing can return results, and we agree that the availability of rapid tests with high sensitivity could play a key role here, as could other technologies. In the manuscript our short delay of 3·4 days was based on empirical data of delay from onset to hospitalisation during the late stages of the 2003 severe acute respiratory syndrome (SARS) outbreak in Hong Kong.2Donnelly CA Ghani AC Leung GM et al.Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.Lancet. 2003; 361: 1761-1766Google Scholar Early studies of SARS coronavirus 2 (SARS-CoV-2) suggested similar delays; a delay of 4·6 days from onset to isolation was reported from symptom-based surveillance in Shenzhen,3Bi Q Wu Y Mei S et al.Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts.medRxiv. 2020;  (published online March 27.) (preprint).DOI: 10.1101/2020.03.03.20028423Google Scholar and in Singapore the average delay from onset to isolation for local cases was 3 days by the end of February, 2020.4Ng Y Li Z Chua YX Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore—January 2–February 29, 2020.MMWR Morb Mortal Wkly Rep. 2020; 69: 307-311Google Scholar Other new information has emerged about the natural history of SARS-CoV-2, suggesting our baseline assumption of 15% pre-symptomatic transmission was optimistic; one recent estimate suggests around 45% in the presence of active case-finding.5He X Lau EHY Wu P et al.Temporal dynamics in viral shedding and transmissibility of COVID-19.Nat Med. 2020;  (published online April 15.)DOI:10.1038/s41591-020-0869-5Google Scholar We also assumed 0% or 10% of cases were subclinical, whereas newer studies suggest the percentage is higher.We would advise the authors to be cautious about presenting the probability of controlling an outbreak as a standalone metric to describe the feasibility of contact tracing and isolation. Our model assumes that a health-care system has unlimited capacity to perform contact tracing but, as we show in figure 5 of the Article, some scenarios require the tracing of a considerable number of contacts per week. Governments and public health agencies will have to consider what scale of contact-tracing effort is logistically possible. In the USA, for example, an estimated 100 000 new contact-tracing workers would be needed to manage future COVID-19 epidemics.6Watson C Cicero A Blumenstock J Fraser M A national plan to enable comprehensive COVID-19 case finding and contact tracing in the US.https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/a-national-plan-to-enable-comprehensive-COVID-19-case-finding-and-contact-tracing-in-the-US.pdf?stream=topDate: April 10, 2020Date accessed: April 21, 2020Google ScholarWe agree with Gurdasani and Ziauddeen that there is a pressing need to disentangle the effectiveness of the varied responses to COVID-19 outbreaks around the world. As the authors state, the response in South Korea, which has so far managed to keep mortality low, involved a strong component of contact tracing and testing. However, in line with our original conclusion that this measure might not be sufficient to contain COVID-19 outbreaks on its own, many other strategies have been implemented in South Korea, including the closure of schools, kindergartens, community centres, and universities, and mandatory quarantines enforced by GPS-based mobile phone applications.7Cha V Kim D A timeline of South Korea's Response to COVID-19.https://www.csis.org/analysis/timeline-south-koreas-response-covid-19Date: March 27, 2020Date accessed: April 21, 2020Google Scholar Nevertheless, we agree that contact tracing and isolation will probably play a major part in future strategies to combat the pandemic, and we firmly reject the notion that we recommended its abandonment.For the code for the model from Hellewell and colleagues see https://github.com/cmmid/ringbpFor the code for the model from Hellewell and colleagues see https://github.com/cmmid/ringbpWe declare no competing interests.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contactsFull-TextPDFOpen AccessOn the fallibility of simulation models in informing pandemic responsesFull-TextPDFOpen Access",10.1016/j.oraloncology.2020.104741N/A10.1016/S2214-109X(20)30217-5,DOI:10.1016/j.oraloncology.2020.104741N/AN/A,"2020-04-2810 April April 30, 2020",ELSEVIEREMALANCET,What Dentists Need to Know about COVID-19Availability of medicines during COVID-19 pandemicOn the fallibility of simulation models in informing pandemic responses – Authors' reply,Oral OncologyUpdateCorrespondence,"['dentist', 'need', 'know', 'covid', '19availability', 'medicine', 'covid', '19', 'pandemicon', 'fallibility', 'simulation', 'model', 'inform', 'pandemic', 'response', 'author', 'reply']","['n', 'many', 'request', 'ema', 'european', 'commission', 'european', 'medicine', 'regulatory', 'network', 'publish', 'guidance', 'company', 'adaptation', 'regulatory', 'framework', 'address', 'challenge', 'arise', 'covid', '19', 'pandemic', 'particular', 'focus', 'crucial', 'medicine', 'use', 'covid', '19', 'patient', 'welcome', 'correspondence', 'deepti', 'gurdasani', 'hisham', 'ziauddeen', 'agree', 'model', 'influence', 'policy', 'open', 'scrutiny', 'inform', 'best', 'available', 'evidence', 'constantly', 'review', 'information', 'better', 'estimate', 'emerge', 'reason', 'make', 'computer', 'code', 'need', 'run', 'model', 'available', 'publication', 'allow', 'others', 'run', 'model', 'use', 'different', 'parameter', 'value', 'information', 'become', 'available', 'explore', 'result', 'effect', 'hearten', 'see', 'gurdasani', 'ziauddeen', 'do', 'article', '1hellewell', 'j', 'abbott', 'gimma', 'et', 'al', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contact', 'lancet', 'glob', 'health', '2020', '8', 'e488', 'e496google', 'scholar', 'evaluate', 'one', 'method', 'country', 'could', 'potentially', 'control', 'coronavirus', 'disease', '2019', 'covid', '19', 'outbreak', 'due', 'seed', 'import', 'case', 'ascertain', 'know', 'contact', 'symptomatic', 'case', 'trace', 'isolate', 'upon', 'symptom', 'onset', 'consider', 'effect', 'mass', 'test', 'untargeted', 'test', 'within', 'wider', 'community', 'draw', 'conclusion', 'use', 'gurdasani', 'ziauddeen', 'quote', 'conclusion', 'study', 'namely', 'achieve', 'control', 'use', 'contact', 'trace', 'isolation', 'alone', 'unlikely', 'bring', 'outbreak', 'control', 'unfortunately', 'include', 'second', 'half', 'paper', 'conclude', 'statement', 'quote', 'rapid', 'effective', 'contact', 'trace', 'reduce', 'initial', 'number', 'case', 'would', 'make', 'outbreak', 'easier', 'control', 'overall', 'effective', 'contact', 'trace', 'isolation', 'could', 'contribute', 'reduce', 'overall', 'size', 'outbreak', 'bring', 'control', 'longer', 'time', 'period', 'conclusion', 'promote', 'complete', 'abandonment', 'case', 'isolation', 'contact', 'trace', 'effort', 'author', 'suggest', 'instead', 'point', 'long', 'term', 'benefit', 'measure', 'reduce', 'overall', 'transmission', 'gurdasani', 'ziauddeen', 'note', 'model', 'parameter', 'delay', 'onset', 'isolation', 'play', 'crucial', 'role', 'determine', 'probability', 'control', 'outbreak', 'within', '12', 'week', 'least', 'delay', 'mitigate', 'speed', 'test', 'return', 'result', 'agree', 'availability', 'rapid', 'test', 'high', 'sensitivity', 'could', 'play', 'key', 'role', 'could', 'technology', 'manuscript', 'short', 'delay', '3', '4', 'day', 'base', 'empirical', 'data', 'delay', 'onset', 'hospitalisation', 'late', 'stage', '2003', 'severe', 'acute', 'respiratory', 'syndrome', 'sars', 'outbreak', 'hong', 'kong', '2donnelly', 'ca', 'ghani', 'ac', 'leung', 'gm', 'et', 'al', 'epidemiological', 'determinant', 'spread', 'causal', 'agent', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'kong', 'lancet', '2003', '361', '1761', '1766google', 'scholar', 'early', 'study', 'sars', 'coronavirus', '2', 'sars', 'cov', '2', 'suggest', 'similar', 'delay', 'delay', '4', '6', 'day', 'onset', 'isolation', 'report', 'symptom', 'base', 'surveillance', 'shenzhen', '3bi', 'q', 'wu', 'mei', 'et', 'al', 'epidemiology', 'transmission', 'covid', '19', 'shenzhen', 'china', 'analysis', '391', 'case', '1', '286', 'close', 'contact', 'medrxiv', '2020', 'publish', 'online', 'march', '27', 'preprint', 'doi', '10', '1101', '2020', '03', '03', '20028423google', 'scholar', 'singapore', 'average', 'delay', 'onset', 'isolation', 'local', 'case', '3', 'day', 'end', 'february', '2020', '4ng', 'li', 'z', 'chua', 'yx', 'evaluation', 'effectiveness', 'surveillance', 'containment', 'measure', 'first', '100', 'patient', 'covid', '19', 'singapore', 'january', '2', 'february', '29', '2020', 'mmwr', 'morb', 'mortal', 'wkly', 'rep', '2020', '69', '307', '311google', 'scholar', 'new', 'information', 'emerge', 'natural', 'history', 'sars', 'cov', '2', 'suggest', 'baseline', 'assumption', '15', 'pre', 'symptomatic', 'transmission', 'optimistic', 'one', 'recent', 'estimate', 'suggest', 'around', '45', 'presence', 'active', 'case', 'find', '5he', 'x', 'lau', 'ehy', 'wu', 'p', 'et', 'al', 'temporal', 'dynamic', 'viral', 'shed', 'transmissibility', 'covid', '19', 'nat', 'med', '2020', 'publish', 'online', 'april', '15', 'doi', '10', '1038', 's41591', '020', '0869', '5google', 'scholar', 'also', 'assume', '0', '10', 'case', 'subclinical', 'whereas', 'newer', 'study', 'suggest', 'percentage', 'higher', 'would', 'advise', 'author', 'cautious', 'present', 'probability', 'control', 'outbreak', 'standalone', 'metric', 'describe', 'feasibility', 'contact', 'trace', 'isolation', 'model', 'assume', 'health', 'care', 'system', 'unlimited', 'capacity', 'perform', 'contact', 'trace', 'show', 'figure', '5', 'article', 'scenario', 'require', 'trace', 'considerable', 'number', 'contact', 'per', 'week', 'government', 'public', 'health', 'agency', 'consider', 'scale', 'contact', 'trace', 'effort', 'logistically', 'possible', 'usa', 'example', 'estimate', '100', '000', 'new', 'contact', 'trace', 'worker', 'would', 'need', 'manage', 'future', 'covid', '19', 'epidemic', '6watson', 'c', 'cicero', 'blumenstock', 'j', 'fraser', 'national', 'plan', 'enable', 'comprehensive', 'covid', '19', 'case', 'find', 'contact', 'trace', 'u', 'http', 'www', 'centerforhealthsecurity', 'org', 'work', 'pub', 'archive', 'pub', 'pdfs', '2020', 'national', 'plan', 'enable', 'comprehensive', 'covid', '19', 'case', 'find', 'contact', 'trace', 'u', 'pdf', 'stream', 'topdate', 'april', '10', '2020date', 'access', 'april', '21', '2020google', 'scholarwe', 'agree', 'gurdasani', 'ziauddeen', 'press', 'need', 'disentangle', 'effectiveness', 'vary', 'response', 'covid', '19', 'outbreak', 'around', 'world', 'author', 'state', 'response', 'south', 'korea', 'far', 'manage', 'keep', 'mortality', 'low', 'involve', 'strong', 'component', 'contact', 'trace', 'test', 'however', 'line', 'original', 'conclusion', 'measure', 'might', 'sufficient', 'contain', 'covid', '19', 'outbreak', 'many', 'strategy', 'implement', 'south', 'korea', 'include', 'closure', 'school', 'kindergarten', 'community', 'centre', 'university', 'mandatory', 'quarantine', 'enforce', 'gps', 'base', 'mobile', 'phone', 'application', '7cha', 'v', 'kim', 'timeline', 'south', 'korea', 'response', 'covid', '19', 'http', 'www', 'csis', 'org', 'analysis', 'timeline', 'south', 'korea', 'response', 'covid', '19date', 'march', '27', '2020date', 'access', 'april', '21', '2020google', 'scholar', 'nevertheless', 'agree', 'contact', 'trace', 'isolation', 'probably', 'play', 'major', 'part', 'future', 'strategy', 'combat', 'pandemic', 'firmly', 'reject', 'notion', 'recommend', 'abandonment', 'code', 'model', 'hellewell', 'colleague', 'see', 'http', 'github', 'com', 'cmmid', 'ringbpfor', 'code', 'model', 'hellewell', 'colleague', 'see', 'http', 'github', 'com', 'cmmid', 'ringbpwe', 'declare', 'compete', 'interest', 'feasibility', 'control', 'covid', '19', 'outbreak', 'isolation', 'case', 'contactsfull', 'textpdfopen', 'accesson', 'fallibility', 'simulation', 'model', 'inform', 'pandemic', 'responsesfull', 'textpdfopen', 'access']",
"N/A (Too many requests)EMA provided an update on the measures EU authorities are putting place to support the continued availability of medicines during the pandemic. This covers the enhanced monitoring system for supply issues with crucial medicines for the treatment of COVID-19 and the guidance currently under development on the regulatory rules that could be applied with greater flexibility to help secure their continued supply.Studies have shown that some patients with coronavirus disease 2019 (COVID-19) and acute hypoxaemic respiratory failure have preserved lung compliance, suggesting that processes other than alveolar damage might be involved in hypoxaemia related to COVID-19 pneumonia.1Gattinoni L Coppola S Cressoni M Busana M Rossi S Chiumello D Covid-19 does not lead to a “typical” acute respiratory distress syndrome.Am J Respir Crit Care Med. 2020;  (published online March 30.)DOI:10.1164/rccm.202003-0817LEGoogle Scholar The typical imaging features of COVID-19 pneumonia, including peripheral ground-glass opacities with or without consolidation, are also non-specific and can be seen in many other diseases.2Bernheim A Mei X Huang M et al.Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection.Radiology. 2020;  (published online Feb 20.)DOI:10.1148/radiol.2020200463Google Scholar There has been increasing attention on microvascular thrombi as a possible explanation for the severe hypoxaemia related to COVID-19.3Klok FA Kruip MJHA van der Meer NJM et al.Incidence of thrombotic complications in critically ill ICU patients with COVID-19.Thromb Res. 2020;  (published online April 10.)DOI:10.1016/j.thromres.2020.04.013Google Scholar,  4Zhou F Yu T Du R et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020; 395: 1054-1062Google ScholarDual-energy CT imaging can be used to characterise lung perfusion and is done as part of the standard protocol for imaging pulmonary embolism at our institution. Three patients with COVID-19, as confirmed by nasopharyngeal RT-PCR at our hospital, who did not have a history of smoking, asthma, chronic obstructive pulmonary disease, or other pulmonary conditions, underwent dual-energy CT imaging for elevated concentrations of D-dimer (>1000 ng/mL) and clinical suspicion of pulmonary emboli. Although no pulmonary emboli were observed in these individuals, we noted striking perfusion abnormalities that have not been previously described; in retrospect, at least nine other COVID-19 cases also shared these findings. In addition to the typical CT features of COVID-19 pneumonia,2Bernheim A Mei X Huang M et al.Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection.Radiology. 2020;  (published online Feb 20.)DOI:10.1148/radiol.2020200463Google Scholar we observed considerable proximal and distal pulmonary vessel dilatation and tortuosity, predominately within, or surrounding, areas of lung opacities. Here, we present the first published images from dual-energy CT imaging of COVID-19 pneumonia that show profound vascular and perfusion abnormalities (figure; appendix).FigureDual-energy CT in a patient with COVID-19 pneumonia without evidence of pulmonary emboliShow full captionPatient 1, an 87-year-old woman with a history of fever and cough for 5 days, was found on the floor of her nursing home. On admission to hospital, the patient required a non-rebreather mask with a flow rate of 15 L/min to maintain an oxygen saturation of 85%; intubation was not pursued as the patient's status was comfort measures only. (A) There is a large area of peripheral ground-glass opacity and consolidation within the right upper lobe and smaller ground-glass opacity in the posterior left upper lobe (green arrowheads), which are accompanied by dilated subsegmental vessels proximal to, and within, the opacities (green arrows). (B) The accompanying image of pulmonary blood volume shows corresponding wedge-shaped areas of decreased perfusion within the upper lobes, with a peripheral halo of higher perfusion (green arrows). COVID-19=coronavirus disease 2019.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Patient 1, an 87-year-old woman with a history of fever and cough for 5 days, was found on the floor of her nursing home. On admission to hospital, the patient required a non-rebreather mask with a flow rate of 15 L/min to maintain an oxygen saturation of 85%; intubation was not pursued as the patient's status was comfort measures only. (A) There is a large area of peripheral ground-glass opacity and consolidation within the right upper lobe and smaller ground-glass opacity in the posterior left upper lobe (green arrowheads), which are accompanied by dilated subsegmental vessels proximal to, and within, the opacities (green arrows). (B) The accompanying image of pulmonary blood volume shows corresponding wedge-shaped areas of decreased perfusion within the upper lobes, with a peripheral halo of higher perfusion (green arrows). COVID-19=coronavirus disease 2019.Three major findings from dual-energy CT were observed on the images of pulmonary blood volume perfusion: preferentially increased perfusion of the lungs proximal to areas of lung opacity, decreased areas of peripheral perfusion corresponding to peripheral lung opacities, and a halo of increased perfusion surrounding peripheral areas of consolidation. The observed pulmonary vascular dilation might be due to relative failure of normal, physiological hypoxic pulmonary vasoconstriction in the setting of overactivation of a regional vasodilatation cascade as part of a dysfunctional and diffuse inflammatory process. Additionally, the mosaic perfusion pattern did not correspond to findings of bronchial wall thickening or secretions, making airway disease as the main underlying cause of hypoxaemia unlikely. Therefore, these perfusion abnormalities, combined with the pulmonary vascular dilation we observed, are suggestive of intrapulmonary shunting toward areas where gas exchange is impaired, resulting in a worsening ventilation–perfusion mismatch and clinical hypoxia. Although peripheral opacities with hypoperfusion can be seen in pulmonary infarction, no pulmonary emboli were observed in any of the studies, and segmental increased perfusion to areas of infarction would be very atypical. Furthermore, a peripheral halo of increased perfusion has not been described in pulmonary infarction, but has been described once previously in a case of bacterial pneumonia.5Otrakji A Digumarthy SR Lo Gullo R Flores EJ Shepard JA Kalra MK Dual-energy CT: spectrum of thoracic abnormalities.Radiographics. 2016; 36: 38-52Google Scholar However, blood and sputum cultures were negative in the three patients with COVID-19 at our hospital and did not suggest bacterial coinfection. It might be possible that the inflammatory response to COVID-19 resembles more of a bacterial infection than a viral infection. Overall, the combination of these imaging findings is novel for COVID-19 pneumonia.Treatment for acute respiratory failure in patients with COVID-19 is challenging in part because of little understanding of the underlying pathophysiology. Our findings are atypical for acute respiratory distress syndrome or thrombotic vascular disease and point to a possible central role for previously underappreciated pulmonary vascular shunting. More detailed assessments of vascular and perfusion changes in patients with COVID-19 are urgently needed.BPL reports royalties from Elsevier as a textbook author and editor, outside the submitted work. AW reports personal fees from Bayer Pharmaceuticals, outside the submitted work. All other authors declare no competing interests.
                                            Download .pdf (.16
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendix",10.1016/j.bbih.2020.100064N/A10.1016/S1473-3099(20)30367-4,DOI:10.1016/j.bbih.2020.100064N/AN/A,"2020-03-2910 April April 30, 2020",ELSEVIEREMALANCET,Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19Availability of medicines during COVID-19 pandemicHypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT,"Brain, Behavior, & Immunity - HealthUpdateCorrespondence","['knowledge', 'attitude', 'medical', 'staff', 'chinese', 'psychiatric', 'hospital', 'regard', 'covid', '19availability', 'medicine', 'covid', '19', 'pandemichypoxaemia', 'relate', 'covid', '19', 'vascular', 'perfusion', 'abnormality', 'dual', 'energy', 'ct']","['n', 'many', 'request', 'ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', 'cover', 'enhance', 'monitor', 'system', 'supply', 'issue', 'crucial', 'medicine', 'treatment', 'covid', '19', 'guidance', 'currently', 'development', 'regulatory', 'rule', 'could', 'apply', 'greater', 'flexibility', 'help', 'secure', 'continue', 'supply', 'study', 'show', 'patient', 'coronavirus', 'disease', '2019', 'covid', '19', 'acute', 'hypoxaemic', 'respiratory', 'failure', 'preserve', 'lung', 'compliance', 'suggest', 'process', 'alveolar', 'damage', 'might', 'involve', 'hypoxaemia', 'relate', 'covid', '19', 'pneumonia', '1gattinoni', 'l', 'coppola', 'cressoni', 'busana', 'rossi', 'chiumello', 'covid', '19', 'lead', 'typical', 'acute', 'respiratory', 'distress', 'syndrome', 'j', 'respir', 'crit', 'care', 'med', '2020', 'publish', 'online', 'march', '30', 'doi', '10', '1164', 'rccm', '202003', '0817legoogle', 'scholar', 'typical', 'image', 'feature', 'covid', '19', 'pneumonia', 'include', 'peripheral', 'grind', 'glass', 'opacity', 'without', 'consolidation', 'also', 'non', 'specific', 'see', 'many', 'disease', '2bernheim', 'mei', 'x', 'huang', 'et', 'al', 'chest', 'ct', 'find', 'coronavirus', 'disease', '19', 'covid', '19', 'relationship', 'duration', 'infection', 'radiology', '2020', 'publish', 'online', 'feb', '20', 'doi', '10', '1148', 'radiol', '2020200463google', 'scholar', 'increase', 'attention', 'microvascular', 'thrombus', 'possible', 'explanation', 'severe', 'hypoxaemia', 'relate', 'covid', '19', '3klok', 'fa', 'kruip', 'mjha', 'van', 'der', 'meer', 'njm', 'et', 'al', 'incidence', 'thrombotic', 'complication', 'critically', 'ill', 'icu', 'patient', 'covid', '19', 'thromb', 're', '2020', 'publish', 'online', 'april', '10', 'doi', '10', '1016', 'j', 'thromres', '2020', '04', '013google', 'scholar', '4zhou', 'f', 'yu', 'du', 'r', 'et', 'al', 'clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid', '19', 'wuhan', 'china', 'retrospective', 'cohort', 'study', 'lancet', '2020', '395', '1054', '1062google', 'scholardual', 'energy', 'ct', 'image', 'use', 'characterise', 'lung', 'perfusion', 'do', 'part', 'standard', 'protocol', 'image', 'pulmonary', 'embolism', 'institution', 'three', 'patient', 'covid', '19', 'confirm', 'nasopharyngeal', 'rt', 'pcr', 'hospital', 'history', 'smoke', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', 'pulmonary', 'condition', 'undergo', 'dual', 'energy', 'ct', 'image', 'elevate', 'concentration', 'dimer', '1000', 'ng', 'ml', 'clinical', 'suspicion', 'pulmonary', 'embolus', 'although', 'pulmonary', 'embolus', 'observe', 'individual', 'note', 'strike', 'perfusion', 'abnormality', 'previously', 'describe', 'retrospect', 'least', 'nine', 'covid', '19', 'case', 'also', 'share', 'find', 'addition', 'typical', 'ct', 'feature', 'covid', '19', 'pneumonia', '2bernheim', 'mei', 'x', 'huang', 'et', 'al', 'chest', 'ct', 'find', 'coronavirus', 'disease', '19', 'covid', '19', 'relationship', 'duration', 'infection', 'radiology', '2020', 'publish', 'online', 'feb', '20', 'doi', '10', '1148', 'radiol', '2020200463google', 'scholar', 'observe', 'considerable', 'proximal', 'distal', 'pulmonary', 'vessel', 'dilatation', 'tortuosity', 'predominately', 'within', 'surround', 'area', 'lung', 'opacity', 'present', 'first', 'publish', 'image', 'dual', 'energy', 'ct', 'image', 'covid', '19', 'pneumonia', 'show', 'profound', 'vascular', 'perfusion', 'abnormality', 'figure', 'appendix', 'figuredual', 'energy', 'ct', 'patient', 'covid', '19', 'pneumonia', 'without', 'evidence', 'pulmonary', 'embolishow', 'full', 'captionpatient', '1', '87', 'year', 'old', 'woman', 'history', 'fever', 'cough', '5', 'day', 'find', 'floor', 'nurse', 'home', 'admission', 'hospital', 'patient', 'require', 'non', 'rebreather', 'mask', 'flow', 'rate', '15', 'l', 'min', 'maintain', 'oxygen', 'saturation', '85', 'intubation', 'pursue', 'patient', 'status', 'comfort', 'measure', 'large', 'area', 'peripheral', 'grind', 'glass', 'opacity', 'consolidation', 'within', 'right', 'upper', 'lobe', 'smaller', 'grind', 'glass', 'opacity', 'posterior', 'leave', 'upper', 'lobe', 'green', 'arrowhead', 'accompany', 'dilate', 'subsegmental', 'vessel', 'proximal', 'within', 'opacity', 'green', 'arrow', 'b', 'accompany', 'image', 'pulmonary', 'blood', 'volume', 'show', 'correspond', 'wedge', 'shape', 'area', 'decrease', 'perfusion', 'within', 'upper', 'lobe', 'peripheral', 'halo', 'higher', 'perfusion', 'green', 'arrow', 'covid', '19', 'coronavirus', 'disease', '2019', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'patient', '1', '87', 'year', 'old', 'woman', 'history', 'fever', 'cough', '5', 'day', 'find', 'floor', 'nurse', 'home', 'admission', 'hospital', 'patient', 'require', 'non', 'rebreather', 'mask', 'flow', 'rate', '15', 'l', 'min', 'maintain', 'oxygen', 'saturation', '85', 'intubation', 'pursue', 'patient', 'status', 'comfort', 'measure', 'large', 'area', 'peripheral', 'grind', 'glass', 'opacity', 'consolidation', 'within', 'right', 'upper', 'lobe', 'smaller', 'grind', 'glass', 'opacity', 'posterior', 'leave', 'upper', 'lobe', 'green', 'arrowhead', 'accompany', 'dilate', 'subsegmental', 'vessel', 'proximal', 'within', 'opacity', 'green', 'arrow', 'b', 'accompany', 'image', 'pulmonary', 'blood', 'volume', 'show', 'correspond', 'wedge', 'shape', 'area', 'decrease', 'perfusion', 'within', 'upper', 'lobe', 'peripheral', 'halo', 'higher', 'perfusion', 'green', 'arrow', 'covid', '19', 'coronavirus', 'disease', '2019', 'three', 'major', 'find', 'dual', 'energy', 'ct', 'observe', 'image', 'pulmonary', 'blood', 'volume', 'perfusion', 'preferentially', 'increase', 'perfusion', 'lung', 'proximal', 'area', 'lung', 'opacity', 'decrease', 'area', 'peripheral', 'perfusion', 'correspond', 'peripheral', 'lung', 'opacity', 'halo', 'increase', 'perfusion', 'surround', 'peripheral', 'area', 'consolidation', 'observe', 'pulmonary', 'vascular', 'dilation', 'might', 'due', 'relative', 'failure', 'normal', 'physiological', 'hypoxic', 'pulmonary', 'vasoconstriction', 'set', 'overactivation', 'regional', 'vasodilatation', 'cascade', 'part', 'dysfunctional', 'diffuse', 'inflammatory', 'process', 'additionally', 'mosaic', 'perfusion', 'pattern', 'correspond', 'find', 'bronchial', 'wall', 'thicken', 'secretion', 'make', 'airway', 'disease', 'main', 'underlie', 'cause', 'hypoxaemia', 'unlikely', 'therefore', 'perfusion', 'abnormality', 'combine', 'pulmonary', 'vascular', 'dilation', 'observe', 'suggestive', 'intrapulmonary', 'shunt', 'toward', 'area', 'gas', 'exchange', 'impair', 'result', 'worsen', 'ventilation', 'perfusion', 'mismatch', 'clinical', 'hypoxia', 'although', 'peripheral', 'opacity', 'hypoperfusion', 'see', 'pulmonary', 'infarction', 'pulmonary', 'embolus', 'observe', 'study', 'segmental', 'increase', 'perfusion', 'area', 'infarction', 'would', 'atypical', 'furthermore', 'peripheral', 'halo', 'increase', 'perfusion', 'describe', 'pulmonary', 'infarction', 'describe', 'previously', 'case', 'bacterial', 'pneumonia', '5otrakji', 'digumarthy', 'sr', 'lo', 'gullo', 'r', 'flores', 'ej', 'shepard', 'ja', 'kalra', 'mk', 'dual', 'energy', 'ct', 'spectrum', 'thoracic', 'abnormality', 'radiographics', '2016', '36', '38', '52google', 'scholar', 'however', 'blood', 'sputum', 'culture', 'negative', 'three', 'patient', 'covid', '19', 'hospital', 'suggest', 'bacterial', 'coinfection', 'might', 'possible', 'inflammatory', 'response', 'covid', '19', 'resemble', 'bacterial', 'infection', 'viral', 'infection', 'overall', 'combination', 'image', 'find', 'novel', 'covid', '19', 'pneumonia', 'treatment', 'acute', 'respiratory', 'failure', 'patient', 'covid', '19', 'challenge', 'part', 'little', 'understand', 'underlie', 'pathophysiology', 'find', 'atypical', 'acute', 'respiratory', 'distress', 'syndrome', 'thrombotic', 'vascular', 'disease', 'point', 'possible', 'central', 'role', 'previously', 'underappreciated', 'pulmonary', 'vascular', 'shunt', 'detail', 'assessment', 'vascular', 'perfusion', 'change', 'patient', 'covid', '19', 'urgently', 'need', 'bpl', 'report', 'royalty', 'elsevier', 'textbook', 'author', 'editor', 'outside', 'submit', 'work', 'aw', 'report', 'personal', 'fee', 'bayer', 'pharmaceutical', 'outside', 'submit', 'work', 'author', 'declare', 'compete', 'interest', 'download', 'pdf', '16', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendix']",
"N/A (Too many requests)EMA published the 


mandate of its COVID-19 EMA pandemic Task Force (COVID-ETF).

 The Task Force is helping EU Member States and the European Commission to take quick and coordinated regulatory action on the development, authorisation and safety monitoring of treatments and vaccines intended for the treatment and prevention of COVID-19.The entire landscape of cancer management in primary care, from case identification to the management of people living with and beyond cancer, is evolving rapidly in the face of the coronavirus disease 2019 (COVID-19) pandemic.1The Lancet OncologyCOVID-19: global consequences for oncology.Lancet Oncol. 2020; 21: 467Google Scholar In a climate of fear and mandated avoidance of all but essential clinical services, delays in patient, population, and health-care system responses to suspected cancer symptoms seem inevitable.Screening, case identification, and referral in symptomatic cancer diagnosis have all been affected by the COVID-19 pandemic. UK national cancer screening programmes—accounting for approximately 5% of all cancer diagnoses each year—have been suspended.2National Cancer Registration and Analysis ServiceRoutes to diagnosis.http://www.ncin.org.uk/publications/routes_to_diagnosisDate accessed: March 30, 2020Google Scholar Consequently, early diagnoses from screening will be delayed and symptom-based diagnosis of cancer will become more important.3Hamilton W Walter FM Rubin G Neal RD Improving early diagnosis of symptomatic cancer.Nat Rev Clin Oncol. 2016; 13: 740-749Google Scholar Unfortunately, postponing screening sends a message to the public and primary care that cancer can wait.Timely presentation to primary care of patients with symptoms is driven by a combination of appraising symptoms as warranting attention, perceived or actual ability to consult a health-care professional, perceived consequences of seeking help, and priority over competing goals.4Scott SE Walter FM Webster A Sutton S Emery J The model of pathways to treatment: conceptualization and integration with existing theory.Br J Health Psychol. 2013; 18: 45-65Google Scholar It is probable that patients with well recognised red flag symptoms, such as a new lump or rectal bleeding, will continue to present to primary care. With COVID-19 at the forefront, however, vague cancer symptoms such as fatigue, change in bowel habit, and weight loss might be dismissed by the patient as trivial.5Whitaker KL Scott SE Winstanley K Macleod U Wardle J Attributions of cancer ‘alarm’ symptoms in a community sample.PLoS One. 2014; 9: 1-17Google Scholar Respiratory symptoms, including persistent cough, might be attributed to COVID-19 and not acted on. Patients might be reluctant to present because of fear of interacting with others, limited capacity to use video or teleconsultations, and concerns about wasting the doctor's time.6Forbes LJL Simon AE Warburton F et al.Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?.Brit J Cancer. 2013; 108: 292-300Google Scholar,  7Llanwarne N Newbould J Burt J Campbell JL Roland M Wasting the doctor's time? A video-elicitation study with patients in primary care.Soc Sci Med. 2017; 176: 113-122Google ScholarFor family doctors, the COVID-19 pandemic is affecting all aspects of normal working life, including a reduced workforce due to illness and self-isolation, and the reduced availability of appointments and investigations in primary and secondary care. The huge shift to telephone triage and video consultations might result in missed cues, reduced examination findings, and loss of the clinician's gut feeling. Remote consulting might also be less suited to vulnerable patients and individuals from low socioeconomic backgrounds than to patients from high socioeconomic settings, compounding inequalities already apparent in early cancer diagnosis.8Public Health EnglandCOVID-19: Guidance for health professionals.https://www.gov.uk/government/collections/wuhan-novel-coronavirusDate: April 23, 2020Date accessed: April 25, 2020Google Scholar If patients with cancer symptoms do present to primary care, there is no consensus on how they should be managed during the pandemic, or safety-netted. When patients are referred, they are likely to be triaged or delayed.9Public Health EnglandClinical guide for the management of noncoronavirus patients requiring acute treatment: cancer.https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-acute-treatment-cancer-23-march-2020.pdfDate: March 23, 2020Date accessed: March 30, 2020Google Scholar For example, the cancellation of all but emergency endoscopy will inevitably prolong the time to diagnosis of gastrointestinal cancers.Management and follow-up of patients with cancer is also affected by the COVID-19 pandemic. Many patients with cancer, especially those undergoing chemotherapy, radical radiotherapy, and immunotherapy, are at greater risk from the symptoms and sequelae of COVID-19. The National Health Service guidelines state that patients will want to discuss whether the benefits of continuing active cancer treatment outweigh the risks of potentially being seriously unwell if they contract COVID-19, which is a role that could well fall to primary care.9Public Health EnglandClinical guide for the management of noncoronavirus patients requiring acute treatment: cancer.https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-acute-treatment-cancer-23-march-2020.pdfDate: March 23, 2020Date accessed: March 30, 2020Google Scholar The UK cancer charity Macmillan Cancer Support reports that a quarter of calls to its support line are from patients with cancer who are anxious about COVID-19.10Extance A Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?.BMJ. 2020; 368m1174Google Scholar Although cancer charities provide a vital support role, primary care needs to support the physical and mental health of patients for whom potentially lifesaving cancer treatments are being postponed.Cancer treatments are a priority in the health-care system, but as health-care become increasingly occupied with caring for patients with COVID-19, these patients will inevitably take precedence. Patients needing immediate care are receiving treatment, but when possible, treatments will be delayed. Guidance to help make these difficult decisions might be variable, inconsistent, and hurried, with the inevitable risk to patient outcomes. In this situation, the psychological effect on patients and clinical staff will be enormous.The COVID-19 pandemic has implications for primary care and the crisis has highlighted potential solutions for dealing with future global health threats. Although these are unprecedented times, it is probable that the use of remote consultations will grow. Increased flexibility in accessing health care might serve to advantage some population groups, but risks disadvantaging others. If done well, remote consulting could benefit previously underserved patient populations (ie, individuals living in remote areas).Behavioural interventions to encourage the timely symptomatic diagnosis of cancer are important. Public awareness campaigns should signal that early help-seeking is welcome and legitimate, and might use social media and community networks that have grown in response to COVID-19. Clinicians should be aware of so-called diagnostic overshadowing from COVID-19 and remember that patients might have markedly delayed presentation already and need additional support navigating the next steps in terms of their referral and safety-netting.If cancer is suspected, clinicians should not be deterred from referring patients urgently because of COVID-19 or other future global health threats. However, health-care professionals might have to accept triage and risk stratification of patients with potentially serious disease. Biomarker and machine-learning approaches might support prioritisation of patients who are at greatest risk, diverting health-care resources towards managing patients who are seriously ill.When patients are diagnosed with cancer, or are living with or beyond cancer, providers of primary care might have to accept enhanced roles in supporting decisions on cancer treatment, palliative care, and advanced planning around resuscitation and preferred places of care.When normal service resumes at a population and health-service level, there will be a huge backlog of patients with potential cancer symptoms needing urgent assessment. Planning for recovery should commence as soon as possible.View Large
                                            Image
                                        
                                Copyright
                                © 2020 Bacho/shutterstock.comView Large
                                            Image
                                        
                                Copyright
                                © 2020 Bacho/shutterstock.comWe declare no competing interests. This research is linked to the CanTest Collaborative, which is funded by Cancer Research UK (C8640/A23385), of which RDN is an associate director and SES is a co-investigator. It also comes under the auspices of the Health and Care Research Wales funded Primary and Emergency Care Research Centre (517195) and Wales Cancer Research Centre (517190), in which KB is co-investigator and collaborator.Safeguarding cancer care in a post-COVID-19 worldFull-TextPDFFewer cancer diagnoses during the COVID-19 epidemic in the NetherlandsFull-TextPDF",10.1016/j.mehy.2020.109762N/A10.1016/S1470-2045(20)30242-4,DOI:10.1016/j.mehy.2020.109762N/AN/A,"2020-04-229 April April 30, 2020",ELSEVIEREMALANCET,The Powerful Immune System Against Powerful COVID-19: A HypothesisEMA’s governance during COVID-19 pandemicImpact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care,Medical HypothesesUpdateComment,"['powerful', 'immune', 'system', 'powerful', 'covid', '19', 'hypothesisema', 'governance', 'covid', '19', 'pandemicimpact', 'covid', '19', 'pandemic', 'symptomatic', 'diagnosis', 'cancer', 'view', 'primary', 'care']","['n', 'many', 'request', 'ema', 'publish', 'mandate', 'covid', '19', 'ema', 'pandemic', 'task', 'force', 'covid', 'etf', 'task', 'force', 'help', 'eu', 'member', 'state', 'european', 'commission', 'take', 'quick', 'coordinate', 'regulatory', 'action', 'development', 'authorisation', 'safety', 'monitor', 'treatment', 'vaccine', 'intend', 'treatment', 'prevention', 'covid', '19', 'entire', 'landscape', 'cancer', 'management', 'primary', 'care', 'case', 'identification', 'management', 'people', 'live', 'beyond', 'cancer', 'evolve', 'rapidly', 'face', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', '1the', 'lancet', 'oncologycovid', '19', 'global', 'consequence', 'oncology', 'lancet', 'oncol', '2020', '21', '467google', 'scholar', 'climate', 'fear', 'mandate', 'avoidance', 'essential', 'clinical', 'service', 'delay', 'patient', 'population', 'health', 'care', 'system', 'response', 'suspect', 'cancer', 'symptom', 'seem', 'inevitable', 'screen', 'case', 'identification', 'referral', 'symptomatic', 'cancer', 'diagnosis', 'affect', 'covid', '19', 'pandemic', 'uk', 'national', 'cancer', 'screen', 'programme', 'account', 'approximately', '5', 'cancer', 'diagnosis', 'year', 'suspend', '2national', 'cancer', 'registration', 'analysis', 'serviceroutes', 'diagnosis', 'http', 'www', 'ncin', 'org', 'uk', 'publication', 'route', 'diagnosisdate', 'access', 'march', '30', '2020google', 'scholar', 'consequently', 'early', 'diagnosis', 'screen', 'delay', 'symptom', 'base', 'diagnosis', 'cancer', 'become', 'important', '3hamilton', 'w', 'walter', 'fm', 'rubin', 'g', 'neal', 'rd', 'improve', 'early', 'diagnosis', 'symptomatic', 'cancer', 'nat', 'rev', 'clin', 'oncol', '2016', '13', '740', '749google', 'scholar', 'unfortunately', 'postpone', 'screen', 'send', 'message', 'public', 'primary', 'care', 'cancer', 'wait', 'timely', 'presentation', 'primary', 'care', 'patient', 'symptom', 'drive', 'combination', 'appraise', 'symptom', 'warrant', 'attention', 'perceive', 'actual', 'ability', 'consult', 'health', 'care', 'professional', 'perceive', 'consequence', 'seek', 'help', 'priority', 'compete', 'goal', '4scott', 'se', 'walter', 'fm', 'webster', 'sutton', 'emery', 'j', 'model', 'pathway', 'treatment', 'conceptualization', 'integration', 'exist', 'theory', 'br', 'j', 'health', 'psychol', '2013', '18', '45', '65google', 'scholar', 'probable', 'patient', 'well', 'recognise', 'red', 'flag', 'symptom', 'new', 'lump', 'rectal', 'bleed', 'continue', 'present', 'primary', 'care', 'covid', '19', 'forefront', 'however', 'vague', 'cancer', 'symptom', 'fatigue', 'change', 'bowel', 'habit', 'weight', 'loss', 'might', 'dismiss', 'patient', 'trivial', '5whitaker', 'kl', 'scott', 'se', 'winstanley', 'k', 'macleod', 'u', 'wardle', 'j', 'attribution', 'cancer', 'alarm', 'symptom', 'community', 'sample', 'plo', 'one', '2014', '9', '1', '17google', 'scholar', 'respiratory', 'symptom', 'include', 'persistent', 'cough', 'might', 'attribute', 'covid', '19', 'act', 'patient', 'might', 'reluctant', 'present', 'fear', 'interact', 'others', 'limit', 'capacity', 'use', 'video', 'teleconsultations', 'concern', 'waste', 'doctor', 'time', '6forbes', 'ljl', 'simon', 'ae', 'warburton', 'f', 'et', 'al', 'difference', 'cancer', 'awareness', 'belief', 'australia', 'canada', 'denmark', 'norway', 'sweden', 'uk', 'international', 'cancer', 'benchmarking', 'partnership', 'contribute', 'difference', 'cancer', 'survival', 'brit', 'j', 'cancer', '2013', '108', '292', '300google', 'scholar', '7llanwarne', 'n', 'newbould', 'j', 'burt', 'j', 'campbell', 'jl', 'roland', 'waste', 'doctor', 'time', 'video', 'elicitation', 'study', 'patient', 'primary', 'care', 'soc', 'sci', 'med', '2017', '176', '113', '122google', 'scholarfor', 'family', 'doctor', 'covid', '19', 'pandemic', 'affect', 'aspect', 'normal', 'work', 'life', 'include', 'reduce', 'workforce', 'due', 'illness', 'self', 'isolation', 'reduce', 'availability', 'appointment', 'investigation', 'primary', 'secondary', 'care', 'huge', 'shift', 'telephone', 'triage', 'video', 'consultation', 'might', 'result', 'miss', 'cue', 'reduce', 'examination', 'find', 'loss', 'clinician', 'gut', 'feel', 'remote', 'consult', 'might', 'also', 'le', 'suit', 'vulnerable', 'patient', 'individual', 'low', 'socioeconomic', 'background', 'patient', 'high', 'socioeconomic', 'set', 'compound', 'inequality', 'already', 'apparent', 'early', 'cancer', 'diagnosis', '8public', 'health', 'englandcovid', '19', 'guidance', 'health', 'professional', 'http', 'www', 'gov', 'uk', 'government', 'collection', 'wuhan', 'novel', 'coronavirusdate', 'april', '23', '2020date', 'access', 'april', '25', '2020google', 'scholar', 'patient', 'cancer', 'symptom', 'present', 'primary', 'care', 'consensus', 'manage', 'pandemic', 'safety', 'net', 'patient', 'refer', 'likely', 'triaged', 'delay', '9public', 'health', 'englandclinical', 'guide', 'management', 'noncoronavirus', 'patient', 'require', 'acute', 'treatment', 'cancer', 'http', 'www', 'england', 'nh', 'uk', 'coronavirus', 'wp', 'content', 'upload', 'site', '52', '2020', '03', 'specialty', 'guide', 'acute', 'treatment', 'cancer', '23', 'march', '2020', 'pdfdate', 'march', '23', '2020date', 'access', 'march', '30', '2020google', 'scholar', 'example', 'cancellation', 'emergency', 'endoscopy', 'inevitably', 'prolong', 'time', 'diagnosis', 'gastrointestinal', 'cancer', 'management', 'follow', 'patient', 'cancer', 'also', 'affect', 'covid', '19', 'pandemic', 'many', 'patient', 'cancer', 'especially', 'undergo', 'chemotherapy', 'radical', 'radiotherapy', 'immunotherapy', 'greater', 'risk', 'symptom', 'sequela', 'covid', '19', 'national', 'health', 'service', 'guideline', 'state', 'patient', 'want', 'discus', 'whether', 'benefit', 'continue', 'active', 'cancer', 'treatment', 'outweigh', 'risk', 'potentially', 'seriously', 'unwell', 'contract', 'covid', '19', 'role', 'could', 'well', 'fall', 'primary', 'care', '9public', 'health', 'englandclinical', 'guide', 'management', 'noncoronavirus', 'patient', 'require', 'acute', 'treatment', 'cancer', 'http', 'www', 'england', 'nh', 'uk', 'coronavirus', 'wp', 'content', 'upload', 'site', '52', '2020', '03', 'specialty', 'guide', 'acute', 'treatment', 'cancer', '23', 'march', '2020', 'pdfdate', 'march', '23', '2020date', 'access', 'march', '30', '2020google', 'scholar', 'uk', 'cancer', 'charity', 'macmillan', 'cancer', 'support', 'report', 'quarter', 'call', 'support', 'line', 'patient', 'cancer', 'anxious', 'covid', '19', '10extance', 'covid', '19', 'long', 'term', 'condition', 'cancer', 'diabetes', 'chronic', 'kidney', 'disease', 'bmj', '2020', '368m1174google', 'scholar', 'although', 'cancer', 'charity', 'provide', 'vital', 'support', 'role', 'primary', 'care', 'need', 'support', 'physical', 'mental', 'health', 'patient', 'potentially', 'lifesaving', 'cancer', 'treatment', 'postpone', 'cancer', 'treatment', 'priority', 'health', 'care', 'system', 'health', 'care', 'become', 'increasingly', 'occupy', 'care', 'patient', 'covid', '19', 'patient', 'inevitably', 'take', 'precedence', 'patient', 'need', 'immediate', 'care', 'receive', 'treatment', 'possible', 'treatment', 'delay', 'guidance', 'help', 'make', 'difficult', 'decision', 'might', 'variable', 'inconsistent', 'hurry', 'inevitable', 'risk', 'patient', 'outcome', 'situation', 'psychological', 'effect', 'patient', 'clinical', 'staff', 'enormous', 'covid', '19', 'pandemic', 'implication', 'primary', 'care', 'crisis', 'highlight', 'potential', 'solution', 'deal', 'future', 'global', 'health', 'threat', 'although', 'unprecedented', 'time', 'probable', 'use', 'remote', 'consultation', 'grow', 'increase', 'flexibility', 'access', 'health', 'care', 'might', 'serve', 'advantage', 'population', 'group', 'risk', 'disadvantage', 'others', 'do', 'well', 'remote', 'consult', 'could', 'benefit', 'previously', 'underserved', 'patient', 'population', 'ie', 'individual', 'live', 'remote', 'area', 'behavioural', 'intervention', 'encourage', 'timely', 'symptomatic', 'diagnosis', 'cancer', 'important', 'public', 'awareness', 'campaign', 'signal', 'early', 'help', 'seek', 'welcome', 'legitimate', 'might', 'use', 'social', 'medium', 'community', 'network', 'grow', 'response', 'covid', '19', 'clinician', 'aware', 'call', 'diagnostic', 'overshadow', 'covid', '19', 'remember', 'patient', 'might', 'markedly', 'delay', 'presentation', 'already', 'need', 'additional', 'support', 'navigate', 'next', 'step', 'term', 'referral', 'safety', 'net', 'cancer', 'suspect', 'clinician', 'deter', 'refer', 'patient', 'urgently', 'covid', '19', 'future', 'global', 'health', 'threat', 'however', 'health', 'care', 'professional', 'might', 'accept', 'triage', 'risk', 'stratification', 'patient', 'potentially', 'serious', 'disease', 'biomarker', 'machine', 'learn', 'approach', 'might', 'support', 'prioritisation', 'patient', 'greatest', 'risk', 'divert', 'health', 'care', 'resource', 'towards', 'manage', 'patient', 'seriously', 'ill', 'patient', 'diagnose', 'cancer', 'live', 'beyond', 'cancer', 'provider', 'primary', 'care', 'might', 'accept', 'enhance', 'role', 'support', 'decision', 'cancer', 'treatment', 'palliative', 'care', 'advance', 'plan', 'around', 'resuscitation', 'prefer', 'place', 'care', 'normal', 'service', 'resume', 'population', 'health', 'service', 'level', 'huge', 'backlog', 'patient', 'potential', 'cancer', 'symptom', 'need', 'urgent', 'assessment', 'plan', 'recovery', 'commence', 'soon', 'possible', 'view', 'large', 'image', 'copyright', '2020', 'bacho', 'shutterstock', 'comview', 'large', 'image', 'copyright', '2020', 'bacho', 'shutterstock', 'comwe', 'declare', 'compete', 'interest', 'research', 'link', 'cantest', 'collaborative', 'fund', 'cancer', 'research', 'uk', 'c8640', 'a23385', 'rdn', 'associate', 'director', 's', 'co', 'investigator', 'also', 'come', 'auspex', 'health', 'care', 'research', 'wale', 'fund', 'primary', 'emergency', 'care', 'research', 'centre', '517195', 'wale', 'cancer', 'research', 'centre', '517190', 'kb', 'co', 'investigator', 'collaborator', 'safeguard', 'cancer', 'care', 'post', 'covid', '19', 'worldfull', 'textpdffewer', 'cancer', 'diagnosis', 'covid', '19', 'epidemic', 'netherlandsfull', 'textpdf']",
"N/A (Too many requests)The International Coalition of Medicines Regulatory Authorities published the report summarising the second global regulatory workshop on COVID-19 medicine development held on Thursday 2 April. The report stresses the need for robust evidence to show which potential treatments work. EMA co-chaired the meeting.The dreadful consequences of coronavirus disease 2019 (COVID-19) put an unprecedented pressure on health-care services across the globe.1Rosenbaum L The untold toll - the pandemic's effects on patients without Covid-19.N Engl J Med. 2020;  (published online April 17.)DOI:10.1056/NEJMms2009984Google Scholar The Netherlands, a country with 17·4 million inhabitants that provides its citizens with universal access to essential health-care services—with the general practitioner as the gatekeeper to secondary care—is no exception in this regard.The first patient with COVID-19 in the Netherlands was confirmed on Feb 27, 2020, in the southern part of the country.2Government of the NetherlandsMan diagnosed with coronavirus (COVID-19) in the Netherlands.https://www.government.nl/latest/news/2020/02/27/man-diagnosed-with-coronavirus-covid-19-in-the-netherlandsDate: Feb 27, 2020Date accessed: April 23, 2020Google Scholar Thereafter, the disease spread rapidly throughout the country. Subsequently, strict social distancing policies were implemented by the Dutch government as of March 15, 2020, to mitigate the spread of COVID-19.3Government of the NetherlandsNew measures to stop spread of coronavirus in the Netherlands.https://www.government.nl/latest/news/2020/03/12/new-measures-to-stop-spread-of-coronavirus-in-the-netherlandsDate: March 12, 2020Date accessed: April 23, 2020Google Scholar,  4Government of the NetherlandsCOVID-19: additional measures in schools, the hospitality sector and sport.https://www.government.nl/latest/news/2020/03/15/additional-measures-in-schools-the-hospitality-sector-and-sportDate: March 15, 2020Date accessed: April 23, 2020Google ScholarThe mayhem caused by COVID-19 has brought about substantial changes in cancer diagnosis in the Netherlands. Data from the nationwide Netherlands Cancer Registry in the period between Feb 24, 2020, and April 12, 2020—which are based on initial case ascertainment through pathological cancer notifications from the Nationwide Network of Histopathology and Cytopathology—show that there is a notable decrease in cancer diagnoses when compared with the period before the COVID-19 outbreak. This effect was most pronounced for skin cancers (figure) and observed across all age groups and geographical regions, and almost all cancer sites (appendix). Several arguments might explain this decrease. First, individuals with potential, non-specific symptoms of cancer might have barriers to consulting a general practitioner, including moral concerns about wasting the general practitioner's time for non-COVID-19-related symptoms, assumptions about insufficient capacity for essential non-COVID-19-related health-care services, and anxiety about acquiring COVID-19 in a health-care setting. Second, most of the general practitioner consultations for non-acute issues are transitioned to telehealth. A general practitioner might, therefore, postpone initial investigations for symptoms that do not immediately hint towards a potential cancer diagnosis, resulting in delayed or postponed hospital referrals. Third, hospitals might have postponed diagnostic evaluation or have longer turnaround times for diagnostic evaluation because many hospital-based resources are being allocated to tackle COVID-19. Lastly, national screening programmes for breast, colorectal, and cervical cancer are temporarily halted as of March 16, 2020, to alleviate the demand on the health-care system due to COVID-19. The effect of this pause in cancer diagnosis might be more pronounced after extended periods of follow-up. However, this effect might be less notable for cervical cancer because screening aims to identify precancerous lesions. Collectively, fewer cancer diagnoses in the COVID-19 era will result from patient, doctor, and system factors.5Dobson CM Russell AJ Rubin GP Patient delay in cancer diagnosis: what do we really mean and can we be more specific?.BMC Health Serv Res. 2014; 14: 387Google ScholarFigureNumber of cancer diagnoses by week in the Netherlands in the period between Jan 6, 2020 (calendar week 2) and April 12, 2020 (calendar week 15)Show full captionBasal cell carcinoma of the skin is not included in the statistics. The point estimates for the change in cancer diagnoses per calendar week are based on the mean total number of cancer diagnoses in the calendar weeks from 2 to 8; that is, the period before the COVID-19 outbreak in the Netherlands. Approximately 3400 malignancies were notified per week to the Netherlands Cancer Registry in the calendar weeks from 2 to 8. Of note, these figures do not yet include cases diagnosed in one of the 74 hospitals in the Netherlands. COVID-19=coronavirus disease 2019.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Basal cell carcinoma of the skin is not included in the statistics. The point estimates for the change in cancer diagnoses per calendar week are based on the mean total number of cancer diagnoses in the calendar weeks from 2 to 8; that is, the period before the COVID-19 outbreak in the Netherlands. Approximately 3400 malignancies were notified per week to the Netherlands Cancer Registry in the calendar weeks from 2 to 8. Of note, these figures do not yet include cases diagnosed in one of the 74 hospitals in the Netherlands. COVID-19=coronavirus disease 2019.The upsetting findings of fewer cancer diagnoses were initially disseminated among the Dutch community on April 2, 2020, and again on April 15, 2020, by the Netherlands Comprehensive Cancer Organisation—which hosts the Netherlands Cancer Registry—to create awareness of this issue. The aims of this dissemination were multifold. First, individuals were encouraged to consult their general practitioner whenever symptoms continued to be troublesome. Second, general practitioners were encouraged to refer patients with suspected cancer to oncology specialists. Third, an appeal was made to restart national cancer screening programmes. Lastly, misconceptions were eliminated about a heightened risk of contracting COVID-19 in a health-care setting because of inadequate policies for infection control at the institutional level and resource constraints in the delivery of essential oncological care.There is cause for cautious optimism that the initial dissemination to the public resulted in the gradual restart of various non-acute aspects of oncological care and more proactive health-seeking behaviours of individuals, reflected in an increase in cancer diagnoses in calendar week 15 (figure). Notwithstanding, priorities for cancer care amid the COVID-19 pandemic will be meticulously triaged on the basis of a multitude of factors that are outside the scope of this Comment. General frameworks to inform cancer treatment decisions during the COVID-19 pandemic are discussed elsewhere.6Hanna TP Evans GA Booth CM Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.Nat Rev Clin Oncol. 2020; 17: 268-270Google Scholar,  7Schrag D Hershman DL Basch E Oncology practice during the COVID-19 pandemic.JAMA. 2020;  (published online April 13.)DOI:10.1001/jama.2020.6236Google Scholar,  8Marron JM Joffe S Jagsi R Spence RA Hlubocky FJ Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID19 pandemic.J Clin Oncol. 2020;  (published online April 9.)DOI:10.1200/JCO.20.00960Google Scholar,  9van de Haar J Hoes LR Coles CE et al.Caring for patients with cancer in the COVID-19 era.Nat Med. 2020;  (published online April 16.)DOI:10.1038/s41591-020-0874-8Google Scholar It does merit brief acknowledgment that the effect of a reasonable delay in the management of particular low-risk malignancies (eg, many skin cancers) will only marginally affect the quantity and quality of life. Conversely, the treatment for potentially curable cancers with an imminent risk of early death (eg, acute leukaemias) cannot be safely postponed.The data discussed here support the National Oncology Taskforce and the National Coordination Centre for Patient Distribution to safeguard optimal patient access to essential oncological care throughout all hospitals in the Netherlands. The Netherlands Cancer Registry will, in due course, complete the registration of current and new cases via retrospective medical records review. These more detailed data—including various patient (eg, COVID-19 positivity), tumour, and treatment characteristics, and follow-up—will ultimately establish the effect of the COVID-19 outbreak on oncological care in the Netherlands. This information can also guide the public, policymakers, and physicians in the future whenever an outbreak of a similar magnitude occurs.RHAV reports grants from Bristol-Myers Squibb and Roche, outside the submitted work. All other authors declare no competing interests.We thank Maaike van der Aa, Mieke Aarts, Katja Aben, Amanda Bos, Boukje van Dijk, Vincent Ho, and Jan Maarten van der Zwan from the Netherlands Comprehensive Cancer Organisation, Elisabeth de Vries from the University Medical Centre Groningen, Ivo Smeele from the Dutch College of General Practitioners, and the National Institute for Public Health and the Environment – Centre for Population Screening for providing feedback on an earlier draft of this Comment.
                                            Download .pdf (.18
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendixSafeguarding cancer care in a post-COVID-19 worldFull-TextPDFImpact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary careFull-TextPDF",10.1016/j.clinimag.2020.04.023N/A10.1016/S1470-2045(20)30265-5,DOI:10.1016/j.clinimag.2020.04.023N/AN/A,"2020-04-249 April April 30, 2020",ELSEVIEREMALANCET,COVID-19 pneumonia patient without clear epidemiological history outside Wuhan: An analysis of the radiographic and clinical featuresInternational Coalition of Medicines Regulatory Authorities (ICMRA)Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands,Clinical ImagingUpdateComment,"['covid', '19', 'pneumonia', 'patient', 'without', 'clear', 'epidemiological', 'history', 'outside', 'wuhan', 'analysis', 'radiographic', 'clinical', 'featuresinternational', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'fewer', 'cancer', 'diagnosis', 'covid', '19', 'epidemic', 'netherlands']","['n', 'many', 'request', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'publish', 'report', 'summarise', 'second', 'global', 'regulatory', 'workshop', 'covid', '19', 'medicine', 'development', 'hold', 'thursday', '2', 'april', 'report', 'stress', 'need', 'robust', 'evidence', 'show', 'potential', 'treatment', 'work', 'ema', 'co', 'chair', 'meet', 'dreadful', 'consequence', 'coronavirus', 'disease', '2019', 'covid', '19', 'put', 'unprecedented', 'pressure', 'health', 'care', 'service', 'across', 'globe', '1rosenbaum', 'l', 'untold', 'toll', 'pandemic', 'effect', 'patient', 'without', 'covid', '19', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'april', '17', 'doi', '10', '1056', 'nejmms2009984google', 'scholar', 'netherlands', 'country', '17', '4', 'million', 'inhabitant', 'provide', 'citizen', 'universal', 'access', 'essential', 'health', 'care', 'service', 'general', 'practitioner', 'gatekeeper', 'secondary', 'care', 'exception', 'regard', 'first', 'patient', 'covid', '19', 'netherlands', 'confirm', 'feb', '27', '2020', 'southern', 'part', 'country', '2government', 'netherlandsman', 'diagnose', 'coronavirus', 'covid', '19', 'netherlands', 'http', 'www', 'government', 'nl', 'latest', 'news', '2020', '02', '27', 'man', 'diagnose', 'coronavirus', 'covid', '19', 'netherlandsdate', 'feb', '27', '2020date', 'access', 'april', '23', '2020google', 'scholar', 'thereafter', 'disease', 'spread', 'rapidly', 'throughout', 'country', 'subsequently', 'strict', 'social', 'distance', 'policy', 'implement', 'dutch', 'government', 'march', '15', '2020', 'mitigate', 'spread', 'covid', '19', '3government', 'netherlandsnew', 'measure', 'stop', 'spread', 'coronavirus', 'netherlands', 'http', 'www', 'government', 'nl', 'latest', 'news', '2020', '03', '12', 'new', 'measure', 'stop', 'spread', 'coronavirus', 'netherlandsdate', 'march', '12', '2020date', 'access', 'april', '23', '2020google', 'scholar', '4government', 'netherlandscovid', '19', 'additional', 'measure', 'school', 'hospitality', 'sector', 'sport', 'http', 'www', 'government', 'nl', 'latest', 'news', '2020', '03', '15', 'additional', 'measure', 'school', 'hospitality', 'sector', 'sportdate', 'march', '15', '2020date', 'access', 'april', '23', '2020google', 'scholarthe', 'mayhem', 'cause', 'covid', '19', 'bring', 'substantial', 'change', 'cancer', 'diagnosis', 'netherlands', 'data', 'nationwide', 'netherlands', 'cancer', 'registry', 'period', 'feb', '24', '2020', 'april', '12', '2020', 'base', 'initial', 'case', 'ascertainment', 'pathological', 'cancer', 'notification', 'nationwide', 'network', 'histopathology', 'cytopathology', 'show', 'notable', 'decrease', 'cancer', 'diagnosis', 'compare', 'period', 'covid', '19', 'outbreak', 'effect', 'pronounce', 'skin', 'cancer', 'figure', 'observe', 'across', 'age', 'group', 'geographical', 'region', 'almost', 'cancer', 'site', 'appendix', 'several', 'argument', 'might', 'explain', 'decrease', 'first', 'individual', 'potential', 'non', 'specific', 'symptom', 'cancer', 'might', 'barrier', 'consult', 'general', 'practitioner', 'include', 'moral', 'concern', 'waste', 'general', 'practitioner', 'time', 'non', 'covid', '19', 'relate', 'symptom', 'assumption', 'insufficient', 'capacity', 'essential', 'non', 'covid', '19', 'relate', 'health', 'care', 'service', 'anxiety', 'acquire', 'covid', '19', 'health', 'care', 'set', 'second', 'general', 'practitioner', 'consultation', 'non', 'acute', 'issue', 'transition', 'telehealth', 'general', 'practitioner', 'might', 'therefore', 'postpone', 'initial', 'investigation', 'symptom', 'immediately', 'hint', 'towards', 'potential', 'cancer', 'diagnosis', 'result', 'delay', 'postpone', 'hospital', 'referral', 'third', 'hospital', 'might', 'postpone', 'diagnostic', 'evaluation', 'longer', 'turnaround', 'time', 'diagnostic', 'evaluation', 'many', 'hospital', 'base', 'resource', 'allocate', 'tackle', 'covid', '19', 'lastly', 'national', 'screen', 'programme', 'breast', 'colorectal', 'cervical', 'cancer', 'temporarily', 'halt', 'march', '16', '2020', 'alleviate', 'demand', 'health', 'care', 'system', 'due', 'covid', '19', 'effect', 'pause', 'cancer', 'diagnosis', 'might', 'pronounce', 'extend', 'period', 'follow', 'however', 'effect', 'might', 'le', 'notable', 'cervical', 'cancer', 'screen', 'aim', 'identify', 'precancerous', 'lesion', 'collectively', 'fewer', 'cancer', 'diagnosis', 'covid', '19', 'era', 'result', 'patient', 'doctor', 'system', 'factor', '5dobson', 'cm', 'russell', 'aj', 'rubin', 'gp', 'patient', 'delay', 'cancer', 'diagnosis', 'really', 'mean', 'specific', 'bmc', 'health', 'serv', 're', '2014', '14', '387google', 'scholarfigurenumber', 'cancer', 'diagnosis', 'week', 'netherlands', 'period', 'jan', '6', '2020', 'calendar', 'week', '2', 'april', '12', '2020', 'calendar', 'week', '15', 'show', 'full', 'captionbasal', 'cell', 'carcinoma', 'skin', 'include', 'statistic', 'point', 'estimate', 'change', 'cancer', 'diagnosis', 'per', 'calendar', 'week', 'base', 'mean', 'total', 'number', 'cancer', 'diagnosis', 'calendar', 'week', '2', '8', 'period', 'covid', '19', 'outbreak', 'netherlands', 'approximately', '3400', 'malignancy', 'notify', 'per', 'week', 'netherlands', 'cancer', 'registry', 'calendar', 'week', '2', '8', 'note', 'figure', 'yet', 'include', 'case', 'diagnose', 'one', '74', 'hospital', 'netherlands', 'covid', '19', 'coronavirus', 'disease', '2019', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'basal', 'cell', 'carcinoma', 'skin', 'include', 'statistic', 'point', 'estimate', 'change', 'cancer', 'diagnosis', 'per', 'calendar', 'week', 'base', 'mean', 'total', 'number', 'cancer', 'diagnosis', 'calendar', 'week', '2', '8', 'period', 'covid', '19', 'outbreak', 'netherlands', 'approximately', '3400', 'malignancy', 'notify', 'per', 'week', 'netherlands', 'cancer', 'registry', 'calendar', 'week', '2', '8', 'note', 'figure', 'yet', 'include', 'case', 'diagnose', 'one', '74', 'hospital', 'netherlands', 'covid', '19', 'coronavirus', 'disease', '2019', 'upset', 'find', 'fewer', 'cancer', 'diagnosis', 'initially', 'disseminate', 'among', 'dutch', 'community', 'april', '2', '2020', 'april', '15', '2020', 'netherlands', 'comprehensive', 'cancer', 'organisation', 'host', 'netherlands', 'cancer', 'registry', 'create', 'awareness', 'issue', 'aim', 'dissemination', 'multifold', 'first', 'individual', 'encourage', 'consult', 'general', 'practitioner', 'whenever', 'symptom', 'continue', 'troublesome', 'second', 'general', 'practitioner', 'encourage', 'refer', 'patient', 'suspect', 'cancer', 'oncology', 'specialist', 'third', 'appeal', 'make', 'restart', 'national', 'cancer', 'screen', 'programme', 'lastly', 'misconception', 'eliminate', 'heighten', 'risk', 'contract', 'covid', '19', 'health', 'care', 'set', 'inadequate', 'policy', 'infection', 'control', 'institutional', 'level', 'resource', 'constraint', 'delivery', 'essential', 'oncological', 'care', 'cause', 'cautious', 'optimism', 'initial', 'dissemination', 'public', 'result', 'gradual', 'restart', 'various', 'non', 'acute', 'aspect', 'oncological', 'care', 'proactive', 'health', 'seek', 'behaviour', 'individual', 'reflect', 'increase', 'cancer', 'diagnosis', 'calendar', 'week', '15', 'figure', 'notwithstanding', 'priority', 'cancer', 'care', 'amid', 'covid', '19', 'pandemic', 'meticulously', 'triaged', 'basis', 'multitude', 'factor', 'outside', 'scope', 'comment', 'general', 'framework', 'inform', 'cancer', 'treatment', 'decision', 'covid', '19', 'pandemic', 'discuss', 'elsewhere', '6hanna', 'tp', 'evans', 'ga', 'booth', 'cm', 'cancer', 'covid', '19', 'precautionary', 'principle', 'prioritize', 'treatment', 'global', 'pandemic', 'nat', 'rev', 'clin', 'oncol', '2020', '17', '268', '270google', 'scholar', '7schrag', 'hershman', 'dl', 'basch', 'e', 'oncology', 'practice', 'covid', '19', 'pandemic', 'jama', '2020', 'publish', 'online', 'april', '13', 'doi', '10', '1001', 'jama', '2020', '6236google', 'scholar', '8marron', 'jm', 'joffe', 'jagsi', 'r', 'spence', 'ra', 'hlubocky', 'fj', 'ethic', 'resource', 'scarcity', 'asco', 'recommendation', 'oncology', 'community', 'covid19', 'pandemic', 'j', 'clin', 'oncol', '2020', 'publish', 'online', 'april', '9', 'doi', '10', '1200', 'jco', '20', '00960google', 'scholar', '9van', 'de', 'haar', 'j', 'hoe', 'lr', 'cole', 'ce', 'et', 'al', 'care', 'patient', 'cancer', 'covid', '19', 'era', 'nat', 'med', '2020', 'publish', 'online', 'april', '16', 'doi', '10', '1038', 's41591', '020', '0874', '8google', 'scholar', 'merit', 'brief', 'acknowledgment', 'effect', 'reasonable', 'delay', 'management', 'particular', 'low', 'risk', 'malignancy', 'eg', 'many', 'skin', 'cancer', 'marginally', 'affect', 'quantity', 'quality', 'life', 'conversely', 'treatment', 'potentially', 'curable', 'cancer', 'imminent', 'risk', 'early', 'death', 'eg', 'acute', 'leukaemia', 'safely', 'postpone', 'data', 'discuss', 'support', 'national', 'oncology', 'taskforce', 'national', 'coordination', 'centre', 'patient', 'distribution', 'safeguard', 'optimal', 'patient', 'access', 'essential', 'oncological', 'care', 'throughout', 'hospital', 'netherlands', 'netherlands', 'cancer', 'registry', 'due', 'course', 'complete', 'registration', 'current', 'new', 'case', 'via', 'retrospective', 'medical', 'record', 'review', 'detail', 'data', 'include', 'various', 'patient', 'eg', 'covid', '19', 'positivity', 'tumour', 'treatment', 'characteristic', 'follow', 'ultimately', 'establish', 'effect', 'covid', '19', 'outbreak', 'oncological', 'care', 'netherlands', 'information', 'also', 'guide', 'public', 'policymakers', 'physician', 'future', 'whenever', 'outbreak', 'similar', 'magnitude', 'occur', 'rhav', 'report', 'grant', 'bristol', 'myers', 'squibb', 'roche', 'outside', 'submit', 'work', 'author', 'declare', 'compete', 'interest', 'thank', 'maaike', 'van', 'der', 'aa', 'mieke', 'aarts', 'katja', 'aben', 'amanda', 'bos', 'boukje', 'van', 'dijk', 'vincent', 'ho', 'jan', 'maarten', 'van', 'der', 'zwan', 'netherlands', 'comprehensive', 'cancer', 'organisation', 'elisabeth', 'de', 'vries', 'university', 'medical', 'centre', 'groningen', 'ivo', 'smeele', 'dutch', 'college', 'general', 'practitioner', 'national', 'institute', 'public', 'health', 'environment', 'centre', 'population', 'screen', 'provide', 'feedback', 'earlier', 'draft', 'comment', 'download', 'pdf', '18', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendixsafeguarding', 'cancer', 'care', 'post', 'covid', '19', 'worldfull', 'textpdfimpact', 'covid', '19', 'pandemic', 'symptomatic', 'diagnosis', 'cancer', 'view', 'primary', 'carefull', 'textpdf']",
"N/A (Too many requests)EMA and Health Canada jointly chaired the third global regulatory workshop on Monday 6 April under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The participants discussed how data generated during clinical practice in the treatment of COVID-19 could complement evidence from clinical trials of potential COVID-19 treatments and vaccines.Italy was the first European country to encounter the effects of the coronavirus disease 2019 (COVID-19) pandemic.1Li C Romagnani P von Brunn A Hans-Joachim A SARS-CoV-2 and Europe: timing of containment measures for outbreak control.Infection. 2020;  (published online April 9.)DOI:10.1007/s15010-020-01420-9Google Scholar For people with multiple sclerosis, the situation carries additional reasons for concern. Although emerging work suggests that some coexisting diseases, such as hypertension, might increase the severity of the COVID-19 infection, how less common conditions, such as multiple sclerosis, effect COVID-19 outcomes is still uncertain. Furthermore, immunosuppressive therapies, the mainstay of treatment for multiple sclerosis, might confer additional risks or, on the contrary, confer some protection. Therefore, collecting information to evaluate the relationship between multiple sclerosis and COVID-19 and implement immediate and appropriate protective strategies is crucial. Less crucial, but equally as important, are questions about the long-term effect of this pandemic on psychiatric comorbidities, such as depression and anxiety (common comorbidities in multiple sclerosis), the patient–physician relationship, the spread of scientific information, the development of new models of care, and the role of patients and patient organisations in the community.The Italian Multiple Sclerosis Society (AISM), the Italian Multiple Sclerosis Foundation (FISM), and the Multiple Sclerosis Study Group of the Italian Neurological Society have set up a programme to help with these crucial elements in the response to COVID-19 in patients with multiple sclerosis. The programme was developed according to suggestions received from a group of neurologists, including health-care workers on the front-line and representatives of the AISM and the FISM. Further initiatives of the programme will also consider the results of an online survey made by the AISM and the FISM aimed at understanding the most pressing needs of people with multiple sclerosis during this pandemic.Here we report the results of the pilot phase of an investigation of COVID-19 among people with multiple sclerosis, based on a core set of data collected from treatment providers through a specifically designed web-based case report form. The core data set includes clinical and demographic characteristics, and information on disease-modifying therapies. To be included, patients had to have symptoms and signs of COVID-19 infection, with or without a positive test (RT-PCR on nasal and pharyngeal swabs).On March 14, 2020, we sent the case report form to more than 200 Italian neurologists from about 90 multiple sclerosis centres across Italy. As of April 7, 2020, we have collected data on 232 patients from 38 centres, 57 of whom tested positive for COVID-19 and 175 of whom had suspected COVID-19 symptoms but did not have a positive test (appendix p 1). Mean follow-up was 12·6 days (SD 7·4).The severity of COVID-19 infection in 232 patients was classified as mild (no pneumonia or mild pneumonia) in 223 (96%), severe (shortness of breath, respiratory rates ≥30 breaths per min, blood oxygen saturation ≤93%, PaO2:FiO2 <300 mmHg/%, and an increase in lung infiltrates of >50% within 24–48 h) in four (2%), and critical (respiratory failure, septic shock, and multiple organ dysfunction or failure) in six (3%).2Chinese Center for Disease Control and PreventionThe epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145-151Google Scholar Of the six critical patients, one recovered and five died; all had a positive swab (appendix p 2). 21 patients had undergone a 5-day course of methylprednisolone within 3 months before the onset of COVID-19.These results appear to be slightly reassuring and do not seem to contradict guidelines that we and others had already issued on the management of multiple sclerosis treatments in the time of the COVID-19 pandemic.3Multiple Sclerosis International FederationGlobal COVID-19 advice for people with MS.http://www.msif.org/wp-content/uploads/2020/03/MSIF-Global-advice-on-COVID-19-for-people-with-MS.docx-1.pdfDate: March, 2020Date accessed: April 23, 2020Google Scholar These data must be considered only preliminary, however, and there is not enough information to speculate about any susceptibility to protection from COVID-19 afforded by disease-modifying therapies. The same is true for the effect of comorbidities, sex, and other medications (beyond just the disease-modifying therapies) that patients with multiple sclerosis might be taking.We will continue to monitor these patients throughout the duration of the pandemic. When a system to record all patients with multiple sclerosis positive for COVID-19 is implemented, more data on the prevalence of these cases can be gathered.Our web-based platform for data collection is available to all colleagues interested in collecting this type of data. Through procedures that are currently being defined, we also aim to make the raw consolidated data from this web-based case report form open access.MPS reports personal fees from Biogen, Merck, Teva, Novartis, Sanofi Genzyme, Roche, GeNeuro, and Medday, outside the submitted work. The Italian Study Group on COVID-19 infection in multiple sclerosis thanks Roche for donating the web-based platform for data collection. The study was approved by the Regional Ethics Committee of Liguria (n 130/2020 – DB id 10433). There is no prominent authorship and MPS is acting as the corresponding author on behalf of the Italian Study Group on COVID-19 infection in multiple sclerosis.
                                            Download .pdf (.63
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendix",10.1016/j.jcv.2020.104379N/A10.1016/S1474-4422(20)30147-2,DOI:10.1016/j.jcv.2020.104379N/AN/A,"2020-04-227 April April 30, 2020",ELSEVIEREMALANCET,COVID-19 in Vietnam: A lesson of pre-preparationInternational Coalition of Medicines Regulatory Authorities (ICMRA)An Italian programme for COVID-19 infection in multiple sclerosis,Journal of Clinical VirologyUpdateCorrespondence,"['covid', '19', 'vietnam', 'lesson', 'pre', 'preparationinternational', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'italian', 'programme', 'covid', '19', 'infection', 'multiple', 'sclerosis']","['n', 'many', 'request', 'ema', 'health', 'canada', 'jointly', 'chair', 'third', 'global', 'regulatory', 'workshop', 'monday', '6', 'april', 'umbrella', 'international', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'participant', 'discuss', 'data', 'generate', 'clinical', 'practice', 'treatment', 'covid', '19', 'could', 'complement', 'evidence', 'clinical', 'trial', 'potential', 'covid', '19', 'treatment', 'vaccine', 'italy', 'first', 'european', 'country', 'encounter', 'effect', 'coronavirus', 'disease', '2019', 'covid', '19', 'pandemic', '1li', 'c', 'romagnani', 'p', 'von', 'brunn', 'han', 'joachim', 'sars', 'cov', '2', 'europe', 'time', 'containment', 'measure', 'outbreak', 'control', 'infection', '2020', 'publish', 'online', 'april', '9', 'doi', '10', '1007', 's15010', '020', '01420', '9google', 'scholar', 'people', 'multiple', 'sclerosis', 'situation', 'carry', 'additional', 'reason', 'concern', 'although', 'emerge', 'work', 'suggest', 'coexist', 'disease', 'hypertension', 'might', 'increase', 'severity', 'covid', '19', 'infection', 'le', 'common', 'condition', 'multiple', 'sclerosis', 'effect', 'covid', '19', 'outcome', 'still', 'uncertain', 'furthermore', 'immunosuppressive', 'therapy', 'mainstay', 'treatment', 'multiple', 'sclerosis', 'might', 'confer', 'additional', 'risk', 'contrary', 'confer', 'protection', 'therefore', 'collect', 'information', 'evaluate', 'relationship', 'multiple', 'sclerosis', 'covid', '19', 'implement', 'immediate', 'appropriate', 'protective', 'strategy', 'crucial', 'le', 'crucial', 'equally', 'important', 'question', 'long', 'term', 'effect', 'pandemic', 'psychiatric', 'comorbidities', 'depression', 'anxiety', 'common', 'comorbidities', 'multiple', 'sclerosis', 'patient', 'physician', 'relationship', 'spread', 'scientific', 'information', 'development', 'new', 'model', 'care', 'role', 'patient', 'patient', 'organisation', 'community', 'italian', 'multiple', 'sclerosis', 'society', 'aism', 'italian', 'multiple', 'sclerosis', 'foundation', 'fism', 'multiple', 'sclerosis', 'study', 'group', 'italian', 'neurological', 'society', 'set', 'programme', 'help', 'crucial', 'element', 'response', 'covid', '19', 'patient', 'multiple', 'sclerosis', 'programme', 'develop', 'accord', 'suggestion', 'receive', 'group', 'neurologist', 'include', 'health', 'care', 'worker', 'front', 'line', 'representative', 'aism', 'fism', 'initiative', 'programme', 'also', 'consider', 'result', 'online', 'survey', 'make', 'aism', 'fism', 'aim', 'understand', 'press', 'need', 'people', 'multiple', 'sclerosis', 'pandemic', 'report', 'result', 'pilot', 'phase', 'investigation', 'covid', '19', 'among', 'people', 'multiple', 'sclerosis', 'base', 'core', 'set', 'data', 'collect', 'treatment', 'provider', 'specifically', 'design', 'web', 'base', 'case', 'report', 'form', 'core', 'data', 'set', 'include', 'clinical', 'demographic', 'characteristic', 'information', 'disease', 'modify', 'therapy', 'include', 'patient', 'symptom', 'sign', 'covid', '19', 'infection', 'without', 'positive', 'test', 'rt', 'pcr', 'nasal', 'pharyngeal', 'swab', 'march', '14', '2020', 'send', 'case', 'report', 'form', '200', 'italian', 'neurologist', '90', 'multiple', 'sclerosis', 'centre', 'across', 'italy', 'april', '7', '2020', 'collect', 'data', '232', 'patient', '38', 'centre', '57', 'test', 'positive', 'covid', '19', '175', 'suspect', 'covid', '19', 'symptom', 'positive', 'test', 'appendix', 'p', '1', 'mean', 'follow', '12', '6', 'day', 'sd', '7', '4', 'severity', 'covid', '19', 'infection', '232', 'patient', 'classify', 'mild', 'pneumonia', 'mild', 'pneumonia', '223', '96', 'severe', 'shortness', 'breath', 'respiratory', 'rate', '30', 'breath', 'per', 'min', 'blood', 'oxygen', 'saturation', '93', 'pao2', 'fio2', '300', 'mmhg', 'increase', 'lung', 'infiltrate', '50', 'within', '24', '48', 'h', 'four', '2', 'critical', 'respiratory', 'failure', 'septic', 'shock', 'multiple', 'organ', 'dysfunction', 'failure', 'six', '3', '2chinese', 'center', 'disease', 'control', 'preventionthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', 'covid', '19', 'china', 'zhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '2020', '41', '145', '151google', 'scholar', 'six', 'critical', 'patient', 'one', 'recover', 'five', 'die', 'positive', 'swab', 'appendix', 'p', '2', '21', 'patient', 'undergo', '5', 'day', 'course', 'methylprednisolone', 'within', '3', 'month', 'onset', 'covid', '19', 'result', 'appear', 'slightly', 'reassure', 'seem', 'contradict', 'guideline', 'others', 'already', 'issue', 'management', 'multiple', 'sclerosis', 'treatment', 'time', 'covid', '19', 'pandemic', '3multiple', 'sclerosis', 'international', 'federationglobal', 'covid', '19', 'advice', 'people', 'm', 'http', 'www', 'msif', 'org', 'wp', 'content', 'upload', '2020', '03', 'msif', 'global', 'advice', 'covid', '19', 'people', 'm', 'docx', '1', 'pdfdate', 'march', '2020date', 'access', 'april', '23', '2020google', 'scholar', 'data', 'must', 'consider', 'preliminary', 'however', 'enough', 'information', 'speculate', 'susceptibility', 'protection', 'covid', '19', 'afford', 'disease', 'modify', 'therapy', 'true', 'effect', 'comorbidities', 'sex', 'medication', 'beyond', 'disease', 'modify', 'therapy', 'patient', 'multiple', 'sclerosis', 'might', 'take', 'continue', 'monitor', 'patient', 'throughout', 'duration', 'pandemic', 'system', 'record', 'patient', 'multiple', 'sclerosis', 'positive', 'covid', '19', 'implement', 'data', 'prevalence', 'case', 'gather', 'web', 'base', 'platform', 'data', 'collection', 'available', 'colleague', 'interest', 'collect', 'type', 'data', 'procedure', 'currently', 'define', 'also', 'aim', 'make', 'raw', 'consolidate', 'data', 'web', 'base', 'case', 'report', 'form', 'open', 'access', 'mp', 'report', 'personal', 'fee', 'biogen', 'merck', 'teva', 'novartis', 'sanofi', 'genzyme', 'roche', 'geneuro', 'medday', 'outside', 'submit', 'work', 'italian', 'study', 'group', 'covid', '19', 'infection', 'multiple', 'sclerosis', 'thank', 'roche', 'donate', 'web', 'base', 'platform', 'data', 'collection', 'study', 'approve', 'regional', 'ethic', 'committee', 'liguria', 'n', '130', '2020', 'db', 'id', '10433', 'prominent', 'authorship', 'mp', 'act', 'correspond', 'author', 'behalf', 'italian', 'study', 'group', 'covid', '19', 'infection', 'multiple', 'sclerosis', 'download', 'pdf', '63', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendix']",
"N/A (Too many requests)EMA announced that essential work to combat the COVID-19 pandemic would continue during the Agency’s Easter break from 9 to 13 April 2020.In The Lancet, Yeming Wang and colleagues1Wang Y Zhang D Du G et al.Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet. 2020;  (published online April 29.)https://doi.org/10.1016/S0140-6736(20)31022-9Google Scholar report a randomised trial of remdesivir (200 mg on day 1 followed by 100 mg on days 2–10, in single daily infusions) versus placebo for adults with severe coronavirus disease 2019 (COVID-19) in ten hospitals in Wuhan, China. The authors report on 236 patients (140 [59%] men and 96 [41%] women; median age 65 years [IQR 56–71]), with inconclusive findings on the primary outcome of time to clinical improvement, defined as a two-point improvement on a 6-point ordinal scale,2WHOCOVID-19 therapeutic trial synopsis. World Health Organization,
        GenevaFeb 18, 2020https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdfDate accessed: April 25, 2020Google Scholar a hazard ratio of 1·23 (95% CI 0·87–1·75; favouring remdesivir), and median observation times of 21 days (IQR 13–28) in the remdesivir group versus 23 days (15–28) in the placebo group (a non-significant difference).The study was well designed—a double-blind, placebo-controlled, multicentre, randomised trial—and well conducted, with high protocol adherence and no loss to follow up. Randomised evidence was needed following high-profile publications on the first US COVID-19 case3Holshue ML DeBolt C Lindquist S et al.First case of 2019 novel coronavirus in the United States.N Engl J Med. 2020; 382: 929-936Google Scholar and the subsequent compassionate use of remdesivir in a 53-patient case series,4Grein J Ohmagari N Shin D et al.Compassionate use of remdesivir for patients with severe COVID-19.N Engl J Med. 2020;  (published online April 10.)DOI:10.1056/NEJMoa2007016Google Scholar which, coupled with in-vitro and animal model evidence, had generated high expectations of remdesivir efficacy.Promising signals from observational data must be rigorously confirmed or refuted in high-quality randomised trials—particularly given that for COVID-19 no proven safe and effective treatments yet exist. Ideally, efficacy-based trials, including proof-of-mechanism studies, should precede larger pragmatic effectiveness trials.5Ford I Norrie J Pragmatic Trials.N Engl J Med. 2016; 375: 454-463Google Scholar That is additionally challenging in a pandemic, and the temptation to lower the threshold of convincing evidence must be resisted, because adopting ineffective and potentially unsafe interventions risks only harm without worthwhile benefit, while making it even harder to undertake trials to find truly effective and safe interventions. We have already seen other drugs, repurposed for COVID-19, including hydroxychloroquine6Tang W et al.Hydroxychloroquine in patients with COVID-19: an open-label, randomised, controlled trial.medRxiv. 2020;  (published online April 14.) (preprint).https://www.medrxiv.org/content/10.1101/2020.04.10.20060558v1.full.pdfGoogle Scholar and lopinavir–ritonavir,7Cao B Wang Y Wen D et al.A trial of lopinavir–ritonavir in adults hospitalised with severe COVID-19.N Engl J Med. 2020;  (published March 18.)DOI:10.1056/NEJMoa2001282Google Scholar report disappointing findings so far in randomised trials after early promise.Wang and colleagues' study1Wang Y Zhang D Du G et al.Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet. 2020;  (published online April 29.)https://doi.org/10.1016/S0140-6736(20)31022-9Google Scholar stopped early after 237 of the intended 453 patients were enrolled, because by March 12 there were no further patients meeting eligibility criteria admitted in Wuhan. The study closed on March 29, having begun on Feb 6.Here, stopping early gives an underpowered trial, which taken alone, gives inconclusive findings. The study has not shown a statistically significant finding that confirms a remdesivir treatment benefit of at least the minimally clinically important difference, nor has it ruled such a benefit out. The study sought a treatment effect of hazard ratio (HR) 1·40, translating to reducing median time to clinical improvement to 15 days (remdesivir) versus 21 days (placebo). The observed HR of 1·23 suggests that a benefit, if it exists, might be smaller than anticipated. This study is the first randomised trial of intravenous remdesivir in patients with severe COVID-19, so it is difficult to know what the minimally clinically important difference is.8Cook JA Julious SA Sones W et al.DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.BMJ. 2018; 363k3750Google Scholar That will depend on a complex reckoning of evidence for effectiveness, safety, acceptability, access, and cost. It is possible that even if the 453-patient target was reached, the study would have still been underpowered if a minimally clinically important difference of less than an HR of 1·4 was warranted.However, likewise, a larger benefit might exist, or remdesivir might actually do harm. It is unknown—more data are needed. Fortunately, ClinicalTrials.gov indicates that five randomised trials involving remdesivir are recruiting globally, with one in severe COVID-19 from Gilead (NCT04292899), the drug manufacturer, with a target of 6000 participants; naively, this trial should be adequately powered.In the meantime, how can the findings of Wang and colleagues be interpreted? The statistical reporting is clear, stating that the main findings were not statistically significant and acknowledging that the trial was underpowered (their post-hoc calculation indicated a power of 58% given the 236 participants with available data). However, a trial is not just its primary clinical outcome—there are important data on safety, viral load, and secondary outcomes. 22 (14%) of 158 patients on remdesivir died versus ten (13%) of 78 on placebo, and there was no signal that viral load decreased differentially over time between remdesivir and placebo groups. Furthermore, there were no differential signals on safety. Analyses were very similar under both the intention-to-treat and per-protocol principles.View Large
                                            Image
                                        
                                Copyright
                                © 2020 STR/Getty ImagesView Large
                                            Image
                                        
                                Copyright
                                © 2020 STR/Getty ImagesThe authors also report primary outcome subgroup analyses. Only patients who were 12 days or less from illness onset were eligible overall, so a prespecified subgroup analysis investigated those who started study treatment up to 10 days versus more than 10 days (up to 12 days) from illness onset. Of course, even with an adequately powered study, subgroup analyses are generally not powered (and here, the 2:1 allocation further reduced power). There was no significant interaction of 10 days or less versus more than 10 days—ie, little support statistically of treatment effect moderation by time of initiation. Nor was either the 10 days or less or the more than 10 days within-subgroup treatment effects significant. Nonetheless, the authors give prominence to the 10 days or less subgroup, reporting a non-statistically significant HR of 1·52 (95% CI 0·95 to 2·43), median 18 days (IQR 12 to 28) versus 23 days (15 to 28), and a non-significant reduction in mortality (difference −3·6% [95% CI −16·2 to 8·9]). There was a possible baseline imbalance with 71 (45%) remdesivir patients versus 47 (60%) placebo patients in the 10 days or less subgroup, and possibly more patients with hypertension, diabetes, and coronary heart disease allocated to remdesivir than placebo, making interpretation even more difficult. Subgroup analyses, particularly for phase 3 confirmatory effectiveness trials, have justifiably been criticised9Assmann SF Pocock SJ Enos LE Kasten LE Subgroup analysis and other (mis)uses of baseline data in clinical trials.Lancet. 2000; 355: 1064-1069Google Scholar and even ridiculed.10Sleight P Debate: subgroup analyses in clinical trials: fun to look at—but don't believe them!.Curr Control Trials Cardiovasc Med. 2000; 1: 25-27Google Scholar Giving a subgroup analysis prominence over the primary analysis is unfortunately common. In early phase studies in a pandemic, little is known for certain, and it seems biologically plausible that treating patients earlier could be more effective. Nonetheless, as well as being vigilant against overinterpretation, we need to ensure that hypotheses generated in efficacy-based trials, even in subgroups, are confirmed or refuted in subsequent adequately powered trials or meta-analyses.We have already seen how different interpretations will be put on these results, with the unintended early release of this study's results on the WHO website.11BBCHopes dashed as coronavirus drug remdesivir ‘fails first trial’.www.bbc.co.uk/news/world-52406261Date: April 23, 2020Date accessed: April 25, 2020Google Scholar This underlines how labelling of trials is mistaken as positive or negative—equating a p>0·05 with no evidence of benefit. There has been a welcome discussion of p value limitations recently.12Wasserstein RL Schirm AL Lazar NA Moving to a world beyond “p<0.05”.Am Stat. 2019; 73: 1-19Google Scholar An absence of statistical significance in an underpowered trial means that the findings are inconclusive. The particular challenges of delivering pandemic trials underline the importance of data sharing, allowing rapid curation of relevant datasets for individual patient data meta-analyses.13Simmonds MC Higgins JPT Stewart LA Tierney JF Clarke MJ Thompson SG Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Clin Trials. 2005; 2: 209-217Google Scholar With each individual study at heightened risk of being incomplete, pooling data across possibly several underpowered but high-quality studies looks like our best way to obtain robust insights into what works, safely, and on whom. We eagerly await the ongoing trials.I am employed by University of Edinburgh and by the UK Medical Research Council/National Institutes of Health Research as Chair of the Efficacy and Mechanisms Evaluation Funding Committee.Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialFull-TextPDFOpen Access",10.1016/j.dsx.2020.03.011N/A10.1016/S0140-6736(20)31023-0,DOI:10.1016/j.dsx.2020.03.011N/AN/A,"2020-03-267 April April 29, 2020",ELSEVIEREMALANCET,Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countriesEMA’s governance during COVID-19 pandemicRemdesivir for COVID-19: challenges of underpowered studies,Diabetes & Metabolic Syndrome: Clinical Research & ReviewsUpdateComment,"['chloroquine', 'hydroxychloroquine', 'treatment', 'covid', '19', 'without', 'diabetes', 'systematic', 'search', 'narrative', 'review', 'special', 'reference', 'india', 'develop', 'countriesema', 'governance', 'covid', '19', 'pandemicremdesivir', 'covid', '19', 'challenge', 'underpowered', 'study']","['n', 'many', 'request', 'ema', 'announce', 'essential', 'work', 'combat', 'covid', '19', 'pandemic', 'would', 'continue', 'agency', 'easter', 'break', '9', '13', 'april', '2020', 'lancet', 'yeming', 'wang', 'colleagues1wang', 'zhang', 'du', 'g', 'et', 'al', 'remdesivir', 'adult', 'severe', 'covid', '19', 'randomise', 'double', 'blind', 'placebo', 'control', 'multicentre', 'trial', 'lancet', '2020', 'publish', 'online', 'april', '29', 'http', 'doi', 'org', '10', '1016', 's0140', '6736', '20', '31022', '9google', 'scholar', 'report', 'randomise', 'trial', 'remdesivir', '200', 'mg', 'day', '1', 'follow', '100', 'mg', 'day', '2', '10', 'single', 'daily', 'infusion', 'versus', 'placebo', 'adult', 'severe', 'coronavirus', 'disease', '2019', 'covid', '19', 'ten', 'hospital', 'wuhan', 'china', 'author', 'report', '236', 'patient', '140', '59', 'men', '96', '41', 'woman', 'median', 'age', '65', 'year', 'iqr', '56', '71', 'inconclusive', 'find', 'primary', 'outcome', 'time', 'clinical', 'improvement', 'define', 'two', 'point', 'improvement', '6', 'point', 'ordinal', 'scale', '2whocovid', '19', 'therapeutic', 'trial', 'synopsis', 'world', 'health', 'organization', 'genevafeb', '18', '2020https', 'www', 'int', 'blueprint', 'priority', 'disease', 'key', 'action', 'covid', '19', 'treatment', 'trial', 'design', 'master', 'protocol', 'synopsis', 'final', '18022020', 'pdfdate', 'access', 'april', '25', '2020google', 'scholar', 'hazard', 'ratio', '1', '23', '95', 'ci', '0', '87', '1', '75', 'favour', 'remdesivir', 'median', 'observation', 'time', '21', 'day', 'iqr', '13', '28', 'remdesivir', 'group', 'versus', '23', 'day', '15', '28', 'placebo', 'group', 'non', 'significant', 'difference', 'study', 'well', 'design', 'double', 'blind', 'placebo', 'control', 'multicentre', 'randomise', 'trial', 'well', 'conduct', 'high', 'protocol', 'adherence', 'loss', 'follow', 'randomise', 'evidence', 'need', 'follow', 'high', 'profile', 'publication', 'first', 'u', 'covid', '19', 'case3holshue', 'ml', 'debolt', 'c', 'lindquist', 'et', 'al', 'first', 'case', '2019', 'novel', 'coronavirus', 'unite', 'state', 'n', 'engl', 'j', 'med', '2020', '382', '929', '936google', 'scholar', 'subsequent', 'compassionate', 'use', 'remdesivir', '53', 'patient', 'case', 'series', '4grein', 'j', 'ohmagari', 'n', 'shin', 'et', 'al', 'compassionate', 'use', 'remdesivir', 'patient', 'severe', 'covid', '19', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'april', '10', 'doi', '10', '1056', 'nejmoa2007016google', 'scholar', 'couple', 'vitro', 'animal', 'model', 'evidence', 'generate', 'high', 'expectation', 'remdesivir', 'efficacy', 'promise', 'signal', 'observational', 'data', 'must', 'rigorously', 'confirm', 'refute', 'high', 'quality', 'randomise', 'trial', 'particularly', 'give', 'covid', '19', 'prove', 'safe', 'effective', 'treatment', 'yet', 'exist', 'ideally', 'efficacy', 'base', 'trial', 'include', 'proof', 'mechanism', 'study', 'precede', 'larger', 'pragmatic', 'effectiveness', 'trial', '5ford', 'norrie', 'j', 'pragmatic', 'trial', 'n', 'engl', 'j', 'med', '2016', '375', '454', '463google', 'scholar', 'additionally', 'challenge', 'pandemic', 'temptation', 'lower', 'threshold', 'convince', 'evidence', 'must', 'resist', 'adopt', 'ineffective', 'potentially', 'unsafe', 'intervention', 'risk', 'harm', 'without', 'worthwhile', 'benefit', 'make', 'even', 'harder', 'undertake', 'trial', 'find', 'truly', 'effective', 'safe', 'intervention', 'already', 'see', 'drug', 'repurposed', 'covid', '19', 'include', 'hydroxychloroquine6tang', 'w', 'et', 'al', 'hydroxychloroquine', 'patient', 'covid', '19', 'open', 'label', 'randomise', 'control', 'trial', 'medrxiv', '2020', 'publish', 'online', 'april', '14', 'preprint', 'http', 'www', 'medrxiv', 'org', 'content', '10', '1101', '2020', '04', '10', '20060558v1', 'full', 'pdfgoogle', 'scholar', 'lopinavir', 'ritonavir', '7cao', 'b', 'wang', 'wen', 'et', 'al', 'trial', 'lopinavir', 'ritonavir', 'adult', 'hospitalise', 'severe', 'covid', '19', 'n', 'engl', 'j', 'med', '2020', 'publish', 'march', '18', 'doi', '10', '1056', 'nejmoa2001282google', 'scholar', 'report', 'disappoint', 'find', 'far', 'randomise', 'trial', 'early', 'promise', 'wang', 'colleague', 'study1wang', 'zhang', 'du', 'g', 'et', 'al', 'remdesivir', 'adult', 'severe', 'covid', '19', 'randomise', 'double', 'blind', 'placebo', 'control', 'multicentre', 'trial', 'lancet', '2020', 'publish', 'online', 'april', '29', 'http', 'doi', 'org', '10', '1016', 's0140', '6736', '20', '31022', '9google', 'scholar', 'stop', 'early', '237', 'intend', '453', 'patient', 'enrol', 'march', '12', 'patient', 'meet', 'eligibility', 'criterion', 'admit', 'wuhan', 'study', 'close', 'march', '29', 'begin', 'feb', '6', 'stop', 'early', 'give', 'underpowered', 'trial', 'take', 'alone', 'give', 'inconclusive', 'find', 'study', 'show', 'statistically', 'significant', 'find', 'confirm', 'remdesivir', 'treatment', 'benefit', 'least', 'minimally', 'clinically', 'important', 'difference', 'rule', 'benefit', 'study', 'seek', 'treatment', 'effect', 'hazard', 'ratio', 'hr', '1', '40', 'translate', 'reduce', 'median', 'time', 'clinical', 'improvement', '15', 'day', 'remdesivir', 'versus', '21', 'day', 'placebo', 'observe', 'hr', '1', '23', 'suggest', 'benefit', 'exist', 'might', 'smaller', 'anticipate', 'study', 'first', 'randomise', 'trial', 'intravenous', 'remdesivir', 'patient', 'severe', 'covid', '19', 'difficult', 'know', 'minimally', 'clinically', 'important', 'difference', '8cook', 'ja', 'julious', 'sa', 'sone', 'w', 'et', 'al', 'delta2', 'guidance', 'choose', 'target', 'difference', 'undertake', 'report', 'sample', 'size', 'calculation', 'randomise', 'control', 'trial', 'bmj', '2018', '363k3750google', 'scholar', 'depend', 'complex', 'reckon', 'evidence', 'effectiveness', 'safety', 'acceptability', 'access', 'cost', 'possible', 'even', '453', 'patient', 'target', 'reach', 'study', 'would', 'still', 'underpowered', 'minimally', 'clinically', 'important', 'difference', 'le', 'hr', '1', '4', 'warrant', 'however', 'likewise', 'larger', 'benefit', 'might', 'exist', 'remdesivir', 'might', 'actually', 'harm', 'unknown', 'data', 'need', 'fortunately', 'clinicaltrials', 'gov', 'indicate', 'five', 'randomise', 'trial', 'involve', 'remdesivir', 'recruit', 'globally', 'one', 'severe', 'covid', '19', 'gilead', 'nct04292899', 'drug', 'manufacturer', 'target', '6000', 'participant', 'naively', 'trial', 'adequately', 'power', 'meantime', 'find', 'wang', 'colleague', 'interpret', 'statistical', 'report', 'clear', 'state', 'main', 'find', 'statistically', 'significant', 'acknowledge', 'trial', 'underpowered', 'post', 'hoc', 'calculation', 'indicate', 'power', '58', 'give', '236', 'participant', 'available', 'data', 'however', 'trial', 'primary', 'clinical', 'outcome', 'important', 'data', 'safety', 'viral', 'load', 'secondary', 'outcome', '22', '14', '158', 'patient', 'remdesivir', 'die', 'versus', 'ten', '13', '78', 'placebo', 'signal', 'viral', 'load', 'decrease', 'differentially', 'time', 'remdesivir', 'placebo', 'group', 'furthermore', 'differential', 'signal', 'safety', 'analysis', 'similar', 'intention', 'treat', 'per', 'protocol', 'principle', 'view', 'large', 'image', 'copyright', '2020', 'str', 'getty', 'imagesview', 'large', 'image', 'copyright', '2020', 'str', 'getty', 'imagesthe', 'author', 'also', 'report', 'primary', 'outcome', 'subgroup', 'analysis', 'patient', '12', 'day', 'le', 'illness', 'onset', 'eligible', 'overall', 'prespecified', 'subgroup', 'analysis', 'investigate', 'start', 'study', 'treatment', '10', 'day', 'versus', '10', 'day', '12', 'day', 'illness', 'onset', 'course', 'even', 'adequately', 'power', 'study', 'subgroup', 'analysis', 'generally', 'power', '2', '1', 'allocation', 'reduce', 'power', 'significant', 'interaction', '10', 'day', 'le', 'versus', '10', 'day', 'ie', 'little', 'support', 'statistically', 'treatment', 'effect', 'moderation', 'time', 'initiation', 'either', '10', 'day', 'le', '10', 'day', 'within', 'subgroup', 'treatment', 'effect', 'significant', 'nonetheless', 'author', 'give', 'prominence', '10', 'day', 'le', 'subgroup', 'report', 'non', 'statistically', 'significant', 'hr', '1', '52', '95', 'ci', '0', '95', '2', '43', 'median', '18', 'day', 'iqr', '12', '28', 'versus', '23', 'day', '15', '28', 'non', 'significant', 'reduction', 'mortality', 'difference', '3', '6', '95', 'ci', '16', '2', '8', '9', 'possible', 'baseline', 'imbalance', '71', '45', 'remdesivir', 'patient', 'versus', '47', '60', 'placebo', 'patient', '10', 'day', 'le', 'subgroup', 'possibly', 'patient', 'hypertension', 'diabetes', 'coronary', 'heart', 'disease', 'allocate', 'remdesivir', 'placebo', 'make', 'interpretation', 'even', 'difficult', 'subgroup', 'analysis', 'particularly', 'phase', '3', 'confirmatory', 'effectiveness', 'trial', 'justifiably', 'criticised9assmann', 'sf', 'pocock', 'sj', 'enos', 'le', 'kasten', 'le', 'subgroup', 'analysis', 'mi', 'us', 'baseline', 'data', 'clinical', 'trial', 'lancet', '2000', '355', '1064', '1069google', 'scholar', 'even', 'ridicule', '10sleight', 'p', 'debate', 'subgroup', 'analysis', 'clinical', 'trial', 'fun', 'look', 'believe', 'curr', 'control', 'trial', 'cardiovasc', 'med', '2000', '1', '25', '27google', 'scholar', 'give', 'subgroup', 'analysis', 'prominence', 'primary', 'analysis', 'unfortunately', 'common', 'early', 'phase', 'study', 'pandemic', 'little', 'know', 'certain', 'seem', 'biologically', 'plausible', 'treat', 'patient', 'earlier', 'could', 'effective', 'nonetheless', 'well', 'vigilant', 'overinterpretation', 'need', 'ensure', 'hypothesis', 'generate', 'efficacy', 'base', 'trial', 'even', 'subgroup', 'confirm', 'refute', 'subsequent', 'adequately', 'power', 'trial', 'meta', 'analysis', 'already', 'see', 'different', 'interpretation', 'put', 'result', 'unintended', 'early', 'release', 'study', 'result', 'website', '11bbchopes', 'dash', 'coronavirus', 'drug', 'remdesivir', 'fail', 'first', 'trial', 'www', 'bbc', 'co', 'uk', 'news', 'world', '52406261date', 'april', '23', '2020date', 'access', 'april', '25', '2020google', 'scholar', 'underline', 'label', 'trial', 'mistake', 'positive', 'negative', 'equate', 'p', '0', '05', 'evidence', 'benefit', 'welcome', 'discussion', 'p', 'value', 'limitation', 'recently', '12wasserstein', 'rl', 'schirm', 'al', 'lazar', 'na', 'move', 'world', 'beyond', 'p', '0', '05', 'stat', '2019', '73', '1', '19google', 'scholar', 'absence', 'statistical', 'significance', 'underpowered', 'trial', 'mean', 'find', 'inconclusive', 'particular', 'challenge', 'deliver', 'pandemic', 'trial', 'underline', 'importance', 'data', 'share', 'allow', 'rapid', 'curation', 'relevant', 'datasets', 'individual', 'patient', 'data', 'meta', 'analysis', '13simmonds', 'mc', 'higgins', 'jpt', 'stewart', 'la', 'tierney', 'jf', 'clarke', 'mj', 'thompson', 'sg', 'meta', 'analysis', 'individual', 'patient', 'data', 'randomize', 'trial', 'review', 'method', 'use', 'practice', 'clin', 'trial', '2005', '2', '209', '217google', 'scholar', 'individual', 'study', 'heighten', 'risk', 'incomplete', 'pool', 'data', 'across', 'possibly', 'several', 'underpowered', 'high', 'quality', 'study', 'look', 'like', 'best', 'way', 'obtain', 'robust', 'insight', 'work', 'safely', 'eagerly', 'await', 'ongoing', 'trial', 'employ', 'university', 'edinburgh', 'uk', 'medical', 'research', 'council', 'national', 'institute', 'health', 'research', 'chair', 'efficacy', 'mechanism', 'evaluation', 'fund', 'committee', 'remdesivir', 'adult', 'severe', 'covid', '19', 'randomise', 'double', 'blind', 'placebo', 'control', 'multicentre', 'trialfull', 'textpdfopen', 'access']",
,10.1016/j.jviscsurg.2020.04.011N/A10.1016/S0140-6736(20)31036-9,DOI:10.1016/j.jviscsurg.2020.04.011N/AN/A,"2020-04-186 April May 1, 2020",ELSEVIEREMALANCET,Management of the COVID-19 epidemic by public health establishments - Analysis by the Fédération Hospitalière de FranceAvailability of medicines during COVID-19 pandemicThe COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises,Journal of Visceral SurgeryUpdateCorrespondence,"['management', 'covid', '19', 'epidemic', 'public', 'health', 'establishment', 'analysis', 'f', 'ration', 'hospitali', 'de', 'franceavailability', 'medicine', 'covid', '19', 'pandemicthe', 'covid', '19', 'response', 'vulnerable', 'people', 'place', 'affect', 'conflict', 'humanitarian', 'crisis']",N/A,N/A
"N/A (Too many requests)EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used in compassionate use programmes across Europe when treating COVID-19 patients who are not eligible for inclusion in clinical trials. These recommendations aim to ensure a harmonised approach across EU Member States. They also explain which group of patients may benefit from treatment and provide preliminary information on the medicine’s safety.BackgroundIn the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases.MethodsWe collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2020), and for cases outside of mainland China (from government or ministry of health websites and media reports for 37 countries, as well as Hong Kong and Macau, until Feb 25, 2020). These individual-case data were used to estimate the time between onset of symptoms and outcome (death or discharge from hospital). We next obtained age-stratified estimates of the case fatality ratio by relating the aggregate distribution of cases to the observed cumulative deaths in China, assuming a constant attack rate by age and adjusting for demography and age-based and location-based under-ascertainment. We also estimated the case fatality ratio from individual line-list data on 1334 cases identified outside of mainland China. Using data on the prevalence of PCR-confirmed cases in international residents repatriated from China, we obtained age-stratified estimates of the infection fatality ratio. Furthermore, data on age-stratified severity in a subset of 3665 cases from China were used to estimate the proportion of infected individuals who are likely to require hospitalisation.FindingsUsing data on 24 deaths that occurred in mainland China and 165 recoveries outside of China, we estimated the mean duration from onset of symptoms to death to be 17·8 days (95% credible interval [CrI] 16·9–19·2) and to hospital discharge to be 24·7 days (22·9–28·1). In all laboratory confirmed and clinically diagnosed cases from mainland China (n=70 117), we estimated a crude case fatality ratio (adjusted for censoring) of 3·67% (95% CrI 3·56–3·80). However, after further adjusting for demography and under-ascertainment, we obtained a best estimate of the case fatality ratio in China of 1·38% (1·23–1·53), with substantially higher ratios in older age groups (0·32% [0·27–0·38] in those aged <60 years vs 6·4% [5·7–7·2] in those aged ≥60 years), up to 13·4% (11·2–15·9) in those aged 80 years or older. Estimates of case fatality ratio from international cases stratified by age were consistent with those from China (parametric estimate 1·4% [0·4–3·5] in those aged <60 years [n=360] and 4·5% [1·8–11·1] in those aged ≥60 years [n=151]). Our estimated overall infection fatality ratio for China was 0·66% (0·39–1·33), with an increasing profile with age. Similarly, estimates of the proportion of infected individuals likely to be hospitalised increased with age up to a maximum of 18·4% (11·0–37·6) in those aged 80 years or older.InterpretationThese early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death.FundingUK Medical Research Council.In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases.We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2020), and for cases outside of mainland China (from government or ministry of health websites and media reports for 37 countries, as well as Hong Kong and Macau, until Feb 25, 2020). These individual-case data were used to estimate the time between onset of symptoms and outcome (death or discharge from hospital). We next obtained age-stratified estimates of the case fatality ratio by relating the aggregate distribution of cases to the observed cumulative deaths in China, assuming a constant attack rate by age and adjusting for demography and age-based and location-based under-ascertainment. We also estimated the case fatality ratio from individual line-list data on 1334 cases identified outside of mainland China. Using data on the prevalence of PCR-confirmed cases in international residents repatriated from China, we obtained age-stratified estimates of the infection fatality ratio. Furthermore, data on age-stratified severity in a subset of 3665 cases from China were used to estimate the proportion of infected individuals who are likely to require hospitalisation.Using data on 24 deaths that occurred in mainland China and 165 recoveries outside of China, we estimated the mean duration from onset of symptoms to death to be 17·8 days (95% credible interval [CrI] 16·9–19·2) and to hospital discharge to be 24·7 days (22·9–28·1). In all laboratory confirmed and clinically diagnosed cases from mainland China (n=70 117), we estimated a crude case fatality ratio (adjusted for censoring) of 3·67% (95% CrI 3·56–3·80). However, after further adjusting for demography and under-ascertainment, we obtained a best estimate of the case fatality ratio in China of 1·38% (1·23–1·53), with substantially higher ratios in older age groups (0·32% [0·27–0·38] in those aged <60 years vs 6·4% [5·7–7·2] in those aged ≥60 years), up to 13·4% (11·2–15·9) in those aged 80 years or older. Estimates of case fatality ratio from international cases stratified by age were consistent with those from China (parametric estimate 1·4% [0·4–3·5] in those aged <60 years [n=360] and 4·5% [1·8–11·1] in those aged ≥60 years [n=151]). Our estimated overall infection fatality ratio for China was 0·66% (0·39–1·33), with an increasing profile with age. Similarly, estimates of the proportion of infected individuals likely to be hospitalised increased with age up to a maximum of 18·4% (11·0–37·6) in those aged 80 years or older.These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death.UK Medical Research Council.As of March 25, 2020, 414 179 cases and 18 440 deaths due to coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had been reported worldwide.1WHOCoronavirus disease 2019 (COVID-19) situation report—43.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200303-sitrep-43-covid-19.pdf?sfvrsn=2c21c09c_2Date: March 3, 2020Date accessed: March 5, 2020Google Scholar The epidemic began in mainland China, with a geographical focus in the city of Wuhan, Hubei. However, on Feb 26, 2020, the rate of increase in cases became greater in the rest of the world than inside China. Substantial outbreaks are occurring in Italy (69 176 cases), the USA (51 914 cases), and Iran (24 811 cases), and geographical expansion of the epidemic continues.Clinical studies of hospitalised patients have shown that, at onset of COVID-19, patients frequently show symptoms associated with viral pneumonia, most commonly fever, cough, sore throat, myalgia, and fatigue.2Chan JFW Yuan S Kok KH et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.Lancet. 2020; 395: 514-523Google Scholar,  3Chen N Zhou M Dong X et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395: 507-513Google Scholar,  4Guan WJ Ni ZY Hu Y et al.Clinical characteristics of coronavirus disease 2019 in China.N Engl J Med. 2020;  (published online Feb 28.)DOI:10.1056/NEJMoa2002032Google Scholar,  5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar,  6Li Q Guan X Wu P et al.Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.N Engl J Med. 2020;  (published online Jan 29.)DOI:10.1056/NEJMoa2001316Google Scholar The case definition adopted in China and elsewhere includes further stratification of cases as severe (defined as tachypnoea [≥30 breaths per min], oxygen saturation ≤93% at rest, or PaO2/FiO2 ratio <300 mm Hg) and critical (respiratory failure requiring mechanical ventilation, septic shock, or other organ dysfunction or failure that requires intensive care).7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41 (in Chinese).: 145-151Google Scholar According to the report from the WHO–China Joint Mission on COVID-19, 80% of the 55 924 patients with laboratory-confirmed COVID-19 in China to Feb 20, 2020, had mild-to-moderate disease, including both non-pneumonia and pneumonia cases, while 13·8% developed severe disease and 6·1% developed to a critical stage requiring intensive care.8WHOReport of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19).https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)Date: Feb 28, 2020Date accessed: March 26, 2020Google Scholar In a study of clinical progression in 1099 patients,4Guan WJ Ni ZY Hu Y et al.Clinical characteristics of coronavirus disease 2019 in China.N Engl J Med. 2020;  (published online Feb 28.)DOI:10.1056/NEJMoa2002032Google Scholar those at highest risk for severe disease and death included people over the age of 60 years and those with underlying conditions, including hypertension, diabetes, cardiovascular disease, chronic respiratory disease, and cancer.Research in contextEvidence before this studyWe searched PubMed, medRxiv, bioRxiv, arXiv, SSRN, Research Square, Virological, and Wellcome Open Research for peer-reviewed articles, preprints, and research reports on the severity of coronavirus disease 2019 (COVID-19), using the search terms “coronavirus”, “2019-nCoV”, and similar terms, and “fatality”, up to March 6, 2020. Several studies have estimated the case fatality ratio (the percentage of individuals with symptomatic or confirmed disease who die from the disease) and infection fatality ratio (the percentage of all infected individuals who die from the disease, including those with mild disease) of COVID-19 using a range of different statistical and modelling methods. Studies done solely in hospitalised patients report the highest fatality ratios (8–28%), representing the outcome for the most severely ill patients. Estimates of the population-level case fatality ratio from all case reports are in the range of 2–8%. Estimates of the infection fatality ratio averaged across all age-groups range from 0·2% to 1·6%, while estimates of the infection fatality ratio in the oldest age group (≥80 years) range from 8% to 36%. None of the identified studies had adjusted for differences in the denominator populations to obtain estimates that could be applied across populations. No other studies have estimated the proportion of infected individuals who will require hospitalisation.Added value of this studyBy synthesising data from across a range of surveillance settings, we obtained estimates of the age-stratified case fatality ratio and infection fatality ratio that take into account the different denominator populations in the datasets. Our underlying assumption, that attack rates (ie, the probability of becoming infected) do not vary substantially by age, is consistent with previous studies for respiratory infections. Under this assumption, differences in age patterns among cases in Wuhan versus those elsewhere in China would probably due to under-ascertainment of cases, given the different surveillance systems in place. Our results are consistent with this hypothesis, with cases in Wuhan seen in older individuals, who would have been identified through attendance at hospital, whereas cases elsewhere in China being younger overall, which would be explained by the policy of testing those with a travel history to Wuhan. After correcting for these biases, we found that estimates of the case fatality ratio from China are consistent with those obtained from early international cases. Our age-stratified estimates of the infection fatality ratio can be applied to any demography to give an estimate of the infection fatality ratio in older and younger populations. These estimates can be combined with estimates of the infection attack rate (approximately 80% for an unmitigated epidemic) to give rough projections of scale. Similarly, our estimates of the proportion of infections requiring hospitalisation can be combined with the infection attack rate to forecast health-care requirements.Implications of all the available evidenceOur estimates of the case fatality ratio for COVID-19, although lower than some of the crude estimates made to date, are substantially higher than for recent influenza pandemics (eg, H1N1 influenza in 2009). With the rapid geographical spread observed to date, COVID-19 therefore represents a major global health threat in the coming weeks and months. Our estimate of the proportion of infected individuals requiring hospitalisation, when combined with likely infection attack rates (around 50–80%), show that even the most advanced health-care systems are likely to be overwhelmed. These estimates are therefore crucial to enable countries around the world to best prepare as the global pandemic continues to unfold.Evidence before this studyWe searched PubMed, medRxiv, bioRxiv, arXiv, SSRN, Research Square, Virological, and Wellcome Open Research for peer-reviewed articles, preprints, and research reports on the severity of coronavirus disease 2019 (COVID-19), using the search terms “coronavirus”, “2019-nCoV”, and similar terms, and “fatality”, up to March 6, 2020. Several studies have estimated the case fatality ratio (the percentage of individuals with symptomatic or confirmed disease who die from the disease) and infection fatality ratio (the percentage of all infected individuals who die from the disease, including those with mild disease) of COVID-19 using a range of different statistical and modelling methods. Studies done solely in hospitalised patients report the highest fatality ratios (8–28%), representing the outcome for the most severely ill patients. Estimates of the population-level case fatality ratio from all case reports are in the range of 2–8%. Estimates of the infection fatality ratio averaged across all age-groups range from 0·2% to 1·6%, while estimates of the infection fatality ratio in the oldest age group (≥80 years) range from 8% to 36%. None of the identified studies had adjusted for differences in the denominator populations to obtain estimates that could be applied across populations. No other studies have estimated the proportion of infected individuals who will require hospitalisation.Added value of this studyBy synthesising data from across a range of surveillance settings, we obtained estimates of the age-stratified case fatality ratio and infection fatality ratio that take into account the different denominator populations in the datasets. Our underlying assumption, that attack rates (ie, the probability of becoming infected) do not vary substantially by age, is consistent with previous studies for respiratory infections. Under this assumption, differences in age patterns among cases in Wuhan versus those elsewhere in China would probably due to under-ascertainment of cases, given the different surveillance systems in place. Our results are consistent with this hypothesis, with cases in Wuhan seen in older individuals, who would have been identified through attendance at hospital, whereas cases elsewhere in China being younger overall, which would be explained by the policy of testing those with a travel history to Wuhan. After correcting for these biases, we found that estimates of the case fatality ratio from China are consistent with those obtained from early international cases. Our age-stratified estimates of the infection fatality ratio can be applied to any demography to give an estimate of the infection fatality ratio in older and younger populations. These estimates can be combined with estimates of the infection attack rate (approximately 80% for an unmitigated epidemic) to give rough projections of scale. Similarly, our estimates of the proportion of infections requiring hospitalisation can be combined with the infection attack rate to forecast health-care requirements.Implications of all the available evidenceOur estimates of the case fatality ratio for COVID-19, although lower than some of the crude estimates made to date, are substantially higher than for recent influenza pandemics (eg, H1N1 influenza in 2009). With the rapid geographical spread observed to date, COVID-19 therefore represents a major global health threat in the coming weeks and months. Our estimate of the proportion of infected individuals requiring hospitalisation, when combined with likely infection attack rates (around 50–80%), show that even the most advanced health-care systems are likely to be overwhelmed. These estimates are therefore crucial to enable countries around the world to best prepare as the global pandemic continues to unfold.Assessing the severity of COVID-19 is crucial to determine the appropriateness of mitigation strategies and to enable planning for health-care needs as epidemics unfold. However, crude case fatality ratios obtained by dividing the number of deaths by the number of cases can be misleading.9Garske T Legrand J Donnelly CA et al.Assessing the severity of the novel influenza A/H1N1 pandemic.BMJ. 2009; 339b2840Google Scholar,  10Lipsitch M Donnelly CA Fraser C et al.Potential biases in estimating absolute and relative case-fatality risks during outbreaks.PLoS Negl Trop Dis. 2015; 9e0003846Google Scholar First, there can be a period of 2–3 weeks between a person developing symptoms, the case subsequently being detected and reported, and observation of the final clinical outcome. During a growing epidemic, the final clinical outcome of most of the reported cases is typically unknown. Simply dividing the cumulative reported number of deaths by the cumulative number of reported cases will therefore underestimate the true case fatality ratio early in an epidemic.9Garske T Legrand J Donnelly CA et al.Assessing the severity of the novel influenza A/H1N1 pandemic.BMJ. 2009; 339b2840Google Scholar,  10Lipsitch M Donnelly CA Fraser C et al.Potential biases in estimating absolute and relative case-fatality risks during outbreaks.PLoS Negl Trop Dis. 2015; 9e0003846Google Scholar,  11Ghani AC Donnelly CA Cox DR et al.Methods for estimating the case fatality ratio for a novel, emerging infectious disease.Am J Epidemiol. 2005; 162: 479-486Google Scholar This effect was observed in past epidemics of respiratory pathogens, including severe acute respiratory syndrome (SARS)12Donnelly CA Ghani AC Leung GM et al.Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.Lancet. 2003; 361: 1761-1766Google Scholar and H1N19Garske T Legrand J Donnelly CA et al.Assessing the severity of the novel influenza A/H1N1 pandemic.BMJ. 2009; 339b2840Google Scholar influenza, and as such is widely recognised. Thus, many of the estimates of the case fatality ratio that have been obtained to date for COVID-19 correct for this effect.13Jung S Akhmetzhanov AR Hayashi K et al.Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases.J Clin Med. 2020; 9: E523Google Scholar,  14Mizumoto K Kagaya K Chowell G Yoshida-Nakaadachi-cho U Early epidemiological assessment of the transmission potential and virulence of 2019 novel coronavirus in Wuhan City: China, January–February, 2020.medRxiv. 2020;  (published online March 13.) (preprint).DOI: 10.1101/2020.02.12.20022434Google Scholar,  15Famulare M 2019-nCoV: preliminary estimates of the confirmed-case-fatality-ratio and infection-fatality-ratio, and initial pandemic risk assessment.https://institutefordiseasemodeling.github.io/nCoV-public/analyses/first_adjusted_mortality_estimates_and_risk_assessment/2019-nCoV-preliminary_age_and_time_adjusted_mortality_rates_and_pandemic_risk_assessment.htmlDate: Feb 19, 2020Date accessed: March 26, 2020Google Scholar,  16Wu P Hao X Lau EHY et al.Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.Euro Surveill. 2020; 25: 1-6Google Scholar Additionally, however, during the exponential growth phase of an epidemic, the observed time lags between the onset of symptoms and outcome (recovery or death) are censored, and naive estimates of the observed times from symptom onset to outcome provide biased estimates of the actual distributions. Ignoring this effect tends to bias the estimated case fatality ratio downwards during the early growth phase of an epidemic.Second, surveillance of a newly emerged pathogen is typically biased towards detecting clinically severe cases, especially at the start of an epidemic when diagnostic capacity is low (figure 1). Estimates of the case fatality ratio can thus be biased upwards until the extent of clinically milder disease is determined.9Garske T Legrand J Donnelly CA et al.Assessing the severity of the novel influenza A/H1N1 pandemic.BMJ. 2009; 339b2840Google Scholar Data from the epicentre of the outbreak in Wuhan have primarily been obtained through hospital surveillance and, thus, are likely to represent patients with moderate or severe illness, with atypical pneumonia or acute respiratory distress being used to define suspected cases eligible for testing.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41 (in Chinese).: 145-151Google Scholar In these individuals, clinical outcomes are likely to be more severe, so any estimates of the case fatality ratio will be higher. Elsewhere in mainland China and the rest of the world, countries and administrative regions alert to the risk of infection being imported via travel initially instituted surveillance for COVID-19 with a broader set of clinical criteria for defining a suspected case. These criteria typically included a combination of symptoms (eg, cough and fever) combined with recent travel history to the affected region (Wuhan, or Hubei province)2Chan JFW Yuan S Kok KH et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.Lancet. 2020; 395: 514-523Google Scholar,  17Xu XW Wu XX Jiang XG et al.Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.BMJ. 2020; 368: m606Google Scholar. Such surveillance is likely to detect clinically mild cases but, by initially restricting testing to those with a travel history or link, might have missed other symptomatic cases.Figure 1Spectrum of COVID-19 casesShow full captionAt the top of the pyramid, those meeting the WHO case criteria for severe or critical cases are likely to be identified in the hospital setting, presenting with atypical viral pneumonia. These cases will have been identified in mainland China and among those categorised internationally as local transmission. Many more cases are likely to be symptomatic (ie, with fever, cough, or myalgia), but might not require hospitalisation. These cases will have been identified through links to international travel to high-risk areas and through contact-tracing of contacts of confirmed cases. They might also be identified through population surveillance of, for example, influenza-like illness. The bottom part of the pyramid represents mild (and possibly asymptomatic) cases. These cases might be identified through contact tracing and subsequently via serological testing.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)At the top of the pyramid, those meeting the WHO case criteria for severe or critical cases are likely to be identified in the hospital setting, presenting with atypical viral pneumonia. These cases will have been identified in mainland China and among those categorised internationally as local transmission. Many more cases are likely to be symptomatic (ie, with fever, cough, or myalgia), but might not require hospitalisation. These cases will have been identified through links to international travel to high-risk areas and through contact-tracing of contacts of confirmed cases. They might also be identified through population surveillance of, for example, influenza-like illness. The bottom part of the pyramid represents mild (and possibly asymptomatic) cases. These cases might be identified through contact tracing and subsequently via serological testing.Here we attempt to adjust for these biases in data sources to obtain estimates of the case fatality ratio (proportion of all cases that will eventually lead to death) and infection fatality ratio (the proportion of all infections that will eventually lead to death) using both individual-level case report data and aggregate case and death counts from mainland China, from Hong Kong and Macau, and international case reports. By adjusting for both underlying demography and potential under-ascertainment at different levels of the severity pyramid (figure 1), these estimates should be broadly applicable across a range of settings to inform health planning while more detailed case data accrue.We identified information on the characteristics of 48 patients who died from COVID-19 in Hubei, reported by the National Health Commission and the Hubei Province Health Commission website up to Feb 8, 2020. We recorded the following data elements, where available: sex, age, date of symptom onset, date of hospitalisation, and date of death. Of the 48 cases, neither the date of symptom onset nor the date of report was available for 13 cases. We also removed eight cases with onset before Jan 1, 2020, or death before Jan 21, 2020, and three deaths after Jan 28, 2020, which were the dates consistent with reliable reporting of onset and death in this setting, respectively, considering the onset-to-death times (including early onsets creates a bias towards long onset-to-death times, reflecting under-ascertainment of deaths early on). This left 24 deaths, which we used to estimate the onset-to-death distribution.We collated data on 2010 cases reported in 37 countries and two special administrative regions of China (Hong Kong and Macau), from government or ministry of health websites and media reports, until Feb 25, 2020. We recorded the following information where available: country or administrative region in which the case was detected, whether the infection was acquired in China or abroad, date of travel, date of symptom onset, date of hospitalisation, date of confirmation, date of recovery, and date of death. We used data from 165 recovered individuals with reported recovery dates and reported or imputed onset dates to estimate the onset-to-recovery distribution, after excluding 26 recoveries without appropriate information on dates of recovery, report, or locality. We used data on 1334 international cases to obtain estimates of the case fatality ratio, not including cases without dates of report.Data on 70 117 PCR-confirmed and clinically diagnosed cases by date of onset in Wuhan and elsewhere in China from Jan 1 to Feb 11, 2020, were extracted from the WHO–China Joint Mission report.8WHOReport of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19).https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)Date: Feb 28, 2020Date accessed: March 26, 2020Google Scholar Over this period a total of 1023 deaths were reported across China, with these data available disaggregated into 10-year age bands between 0–9 years and 70–79 years old, and a further age band for those aged 80 years or older.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41 (in Chinese).: 145-151Google Scholar Using collated data on daily reported deaths obtained each day from the National Health Commission regional websites, we estimated that 74% of deaths occurred in Wuhan and the remainder outside Wuhan. Additionally, the most recent available cumulative estimates (March 3, 2020) of 80 304 confirmed cases and 2946 deaths within China were extracted from the WHO COVID-19 Situation Report (number 43).1WHOCoronavirus disease 2019 (COVID-19) situation report—43.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200303-sitrep-43-covid-19.pdf?sfvrsn=2c21c09c_2Date: March 3, 2020Date accessed: March 5, 2020Google ScholarAn earlier preprint of a subset of these cases up to Jan 26, 2020 reported the age distribution of cases categorised by severity for 3665 cases.18Yang Y Lu Q Liu M et al.Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China.medRxiv. 2020;  (published online Feb 21.) (preprint).DOI: 10.1101/2020.02.10.20021675Google Scholar Under the China case definition, a severe case is defined as tachypnoea (≥30 breaths per min) or oxygen saturation 93% or higher at rest, or PaO2/FiO2 ratio less than 300 mm Hg.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41 (in Chinese).: 145-151Google Scholar Assuming severe cases to require hospitalisation (as opposed to all of the patients who were hospitalised in China, some of whom will have been hospitalised to reduce onward transmission), we used the proportion of severe cases by age in these patients to estimate the proportion of cases and infections requiring hospitalisation.Data on infection prevalence in repatriated expatriates returning to their home countries were obtained from government or ministry of health websites and media reports. To match to the incidence reported in Wuhan on Jan 30, 2020, we used data from six flights that departed between Jan 30 and Feb 1, 2020, inclusive.In early February 2020 a cruise liner named the Diamond Princess was quarantined after a disembarked passenger tested positive for the virus. Subsequently all 3711 passengers on board were tested over the next month. We extracted data on the ages of passengers onboard on Feb 5, 2020, the dates of positive test reports, which were available for 657 out of 712 PCR-confirmed cases, and the dates of ten deaths among these cases from the reports of the Japan Ministry of Health, Labour and Welfare19Government of JapanMinistry of Health, Labour and Welfare.https://www.niid.go.jp/niid/en/2019-ncov-e.htmlDate: 2020Date accessed: March 26, 2020Google Scholar and international media.Age-stratified population data for 2018 were obtained from the National Bureau of Statistics of China.20National Bureau of Statistics of ChinaChina statistical yearbook.http://www.stats.gov.cn/tjsj/ndsj/2018/indexeh.htmDate: 2018Date accessed: February 14, 2020Google Scholar According to these data, the population of Wuhan in 2018 was approximately 11 million people.All analyses were done with R software (version 3.6.2), with Bayesian Marko-Chain Monte Carlo via the package drjacoby (version 1.0.0).21Verity R Winskill P drjacoby.https://mrc-ide.github.io/drjacoby/index.htmlDate accessed: March 26, 2020Google Scholar Data and code are available online at GitHub.In estimating time intervals between symptom onset and outcome, it was necessary to account for the fact that, during a growing epidemic, a higher proportion of the cases will have been infected recently (appendix p 7). Therefore, we re-parameterised a gamma model to account for exponential growth using a growth rate of 0·14 per day, obtained from the early case onset data (appendix p 6). Using Bayesian methods, we fitted gamma distributions to the data on time from onset to death and onset to recovery, conditional on having observed the final outcome. Missing onset dates were imputed on the basis of dates of report, where available.Estimates of the distribution of times from onset-to-death were used to project the expected cumulative number of deaths given the onsets observed in Wuhan and outside Wuhan, assuming a uniform attack rate across age groups. Using the age-distribution of the population, we obtained an estimate of the expected number of infections in each age group. Under-ascertainment was estimated in and outside of Wuhan by comparing the number of observed cases by age to this expected distribution, assuming perfect ascertainment in the 50–59 age group as this group had the highest number of detected cases relative to population size. We also did a sensitivity analysis assuming a differential attack rate by age (appendix p 9). For Wuhan, we added scaling to account for further under-ascertainment compared with outside of Wuhan. These steps gave us the expected age-distribution of cases.For a given onset-to-death distribution, we obtained a modelled estimate of the cumulative number of deaths by age under an age-dependent case fatality ratio (fitted relative to the case fatality ratio in the oldest age group, which represented the highest crude case fatality ratio). This estimate was compared with the observed deaths by age using a Poisson likelihood. These data were then jointly fitted alongside the most recent age-aggregated cumulative deaths and cases in mainland China. Given that the numbers of observed cases and deaths have dropped substantially following a peak in late January, the ratio of current cumulative cases to current number of deaths, once corrected for under-ascertainment, should provide a good estimate of the final case fatality ratio.11Ghani AC Donnelly CA Cox DR et al.Methods for estimating the case fatality ratio for a novel, emerging infectious disease.Am J Epidemiol. 2005; 162: 479-486Google ScholarTo estimate the infection fatality ratio we fitted to data on infection prevalence from international Wuhan residents who were repatriated to their home countries. Our age-stratified case fatality ratio and infection fatality ratio model was jointly fitted to the case data and infection prevalence data with use of Bayesian methods, using our previous estimate of the onset-to-death distribution as a prior. Full mathematical details are provided in the appendix (p 8).Assuming a uniform attack rate by age groups, we used the demography-adjusted under-ascertainment rates calculated above to obtain an estimate of the proportion of infected individuals who would require hospitalisation.To independently validate our infection fatality ratio estimate, we analysed data from the outbreak on the Diamond Princess cruise liner taking the dates of reported positive tests as a proxy for onset date. We calculated the expected proportion of deaths observed until March 25, 2020, given the onset times and estimated onset-to-death distribution (appendix p 13).We used parametric and non-parametric methods11Ghani AC Donnelly CA Cox DR et al.Methods for estimating the case fatality ratio for a novel, emerging infectious disease.Am J Epidemiol. 2005; 162: 479-486Google Scholar,  22Griffin J Ghani A CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease. Boston College of Economics.https://ideas.repec.org/c/boc/bocode/s454601.htmlDate: May 7, 2009Date accessed: March 26, 2020Google Scholar to estimate the case fatality ratio in cases reported outside of mainland China using individual-level data. Cases in which the outcome was unknown were treated as censored observations. For parametric and non-parametric analyses, missing onset dates were multiply imputed using information on the onset-to-report distribution, and unreported recoveries were imputed using onset-to-outcome distributions and country summary data. The parametric models were fitted to the data using Bayesian methods (appendix p 12).The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.In the subset of 24 deaths from COVID-19 that occurred in mainland China early in the epidemic, with correction for bias introduced by the growth of the epidemic, we estimated the mean time from onset to death to be 18·8 days (95% credible interval [CrI] 15·7–49·7; figure 2) with a coefficient of variation of 0·45 (95% CrI 0·29–0·54). With the small number of observations in these data and given that they were from early in the epidemic, we could not rule out many deaths occurring with longer times from onset to death, hence the high upper limit of the credible interval. However, given that the epidemic in China has since declined, our posterior estimate of the mean time from onset to death, informed by the analysis of aggregated data from China, is more precise (mean 17·8 days [16·9–19·2]; figure 2).Figure 2Onset-to-death and onset-to-recovery distributionsShow full caption(A) Onset-to-death data from 24 cases in mainland China early in the epidemic. (B) Onset-to-recovery data from 169 cases outside of mainland China. Red lines show the best fit (posterior mode) gamma distributions, uncorrected for epidemic growth, which are biased towards shorter durations. Blue lines show the same distributions corrected for epidemic growth. The black line (panel A) shows the posterior estimate of the onset-to-death distribution following fitting to the aggregate case data.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)(A) Onset-to-death data from 24 cases in mainland China early in the epidemic. (B) Onset-to-recovery data from 169 cases outside of mainland China. Red lines show the best fit (posterior mode) gamma distributions, uncorrected for epidemic growth, which are biased towards shorter durations. Blue lines show the same distributions corrected for epidemic growth. The black line (panel A) shows the posterior estimate of the onset-to-death distribution following fitting to the aggregate case data.Using data on the outcomes of 169 cases reported outside of mainland China, we estimated a mean onset-to-recovery time of 24·7 days (95% CrI 22·9–28·1) and coefficient of variation of 0·35 (0·31–0·39; figure 2). Both these onset-to-outcome estimates are consistent with a separate study in China.23Zhou F Yu T Du R et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020;  (published online March 11.)https://doi.org/10.1016/S0140-6736(20)30566-3Google ScholarCase fatality ratios were estimated from aggregate data on cases and deaths in mainland China (table 1). A large proportion of the cases, including all of those early in the epidemic, were reported in Wuhan, where the local health system was quickly overwhelmed. As a result, the age distribution of cases reported in Wuhan differed to that in the rest of China (figure 3A). Reported cases in Wuhan were more frequent in older age groups, perhaps reflecting higher severity (and therefore prioritisation for hospitalisation in Wuhan), while cases outside of Wuhan might also show a bias in terms of the relationship between age and travel. Adjusting for differences in underlying demography and assuming no overall difference in the attack rate by age, we estimated high under-ascertainment of cases in younger age groups both inside and outside of Wuhan (figure 3C, D). Furthermore, we estimated a higher level of under-ascertainment overall in Wuhan compared with outside of Wuhan (figure 3C). Accounting for this under-ascertainment, we estimated the highest case fatality ratio (13·4% [11·2–15·9%]) in the 80 years and older age group (figure 3B, table 1), with lower case fatality ratios associated with lower age groups, and the lowest in the 0–9 years age group (0·00260% [0·000312–0·0382]).Table 1Estimates of case fatality ratio and infection fatality ratio obtained from aggregate time series of cases in mainland ChinaDeathsLaboratory-confirmed cases** Values do not include the clinically diagnosed cases included in our estimates.Case fatality ratioInfection fatality ratio†† Obtained by combining estimates of case fatality ratios with information on infection prevalence obtained from those returning home on repatriation flights.CrudeAdjusted for censoringAdjusted for censoring, demography, and under-ascertainment‡‡ Accounts for the underlying demography in Wuhan and elsewhere in China and corrects for under-ascertainment.Overall102344 6722·29% (2·15–2·43)3·67% (3·56–3·80)1·38% (1·23–1·53)0·657% (0·389–1·33)Age group, years0–904160·000% (0·000–0·883)0·0954% (0·0110–1·34)0·00260% (0·000312–0·0382)0·00161% (0·000185–0·0249)10–1915490·182% (0·00461–1·01)0·352% (0·0663–1·74)0·0148% (0·00288–0·0759)0·00695% (0·00149–0·0502)20–29736190·193% (0·0778–0·398)0·296% (0·158–0·662)0·0600% (0·0317–0·132)0·0309% (0·0138–0·0923)30–391876000·237% (0·140–0·374)0·348% (0·241–0·577)0·146% (0·103–0·255)0·0844% (0·0408–0·185)40–493885710·443% (0·314–0·608)0·711% (0·521–0·966)0·295% (0·221–0·422)0·161% (0·0764–0·323)50–5913010 0081·30% (1·09–1·54)2·06% (1·74–2·43)1·25% (1·03–1·55)0·595% (0·344–1·28)60–6930985833·60% (3·22–4·02)5·79% (5·20–6·34)3·99% (3·41–4·55)1·93% (1·11–3·89)70–7931239187·96% (7·13–8·86)12·7% (11·5–13·9)8·61% (7·48–9·99)4·28% (2·45–8·44)≥80208140814·8% (13·0–16·7)23·3% (20·3–26·7)13·4% (11·2–15·9)7·80% (3·80–13·3)Age category (binary), years<6019430 7630·631% (0·545–0·726)1·01% (0·900–1·17)0·318% (0·274–0·378)0·145% (0·0883–0·317)≥6082913 9095·96% (5·57–6·37)9·49% (9·11–9·95)6·38% (5·70–7·17)3·28% (1·82–6·18)Crude case fatality ratios are presented as mean (95% confidence interval). All other fatality ratios are presented as posterior mode (95% credible interval). Estimates are shown to three significant figures. Cases and deaths are aggregate numbers reported from Jan 1 to Feb 11, 2020.8WHOReport of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19).https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)Date: Feb 28, 2020Date accessed: March 26, 2020Google Scholar Crude case fatality ratios are calculated as the number of deaths divided by the number of laboratory-confirmed cases. Our estimates also include clinically diagnosed cases (a scaling of 1·31 applied across all age-groups, as the breakdown by age was not reported for clinically diagnosed cases), which gives larger denominators and thus lower case fatality ratios than if only laboratory-confirmed cases were included.* Values do not include the clinically diagnosed cases included in our estimates.† Obtained by combining estimates of case fatality ratios with information on infection prevalence obtained from those returning home on repatriation flights.‡ Accounts for the underlying demography in Wuhan and elsewhere in China and corrects for under-ascertainment.
                            Open table in a new tab
                        Figure 3Estimates of case fatality ratio by age, obtained from aggregate data from mainland ChinaShow full caption(A) Age-distribution of cases in Wuhan and elsewhere in China. (B) Estimates of the case fatality ratio by age group, adjusted for demography and under-ascertainment. Boxes represent median (central horizontal line) and IQR, vertical lines represent 1·5 × IQR, and individual points represent any estimates outside of this range. (C) Estimated proportions of cases ascertained in the rest of China and in Wuhan relative to the 50–59 years age group elsewhere in China. Error bars represent 95% CrIs.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Crude case fatality ratios are presented as mean (95% confidence interval). All other fatality ratios are presented as posterior mode (95% credible interval). Estimates are shown to three significant figures. Cases and deaths are aggregate numbers reported from Jan 1 to Feb 11, 2020.8WHOReport of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19).https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)Date: Feb 28, 2020Date accessed: March 26, 2020Google Scholar Crude case fatality ratios are calculated as the number of deaths divided by the number of laboratory-confirmed cases. Our estimates also include clinically diagnosed cases (a scaling of 1·31 applied across all age-groups, as the breakdown by age was not reported for clinically diagnosed cases), which gives larger denominators and thus lower case fatality ratios than if only laboratory-confirmed cases were included.(A) Age-distribution of cases in Wuhan and elsewhere in China. (B) Estimates of the case fatality ratio by age group, adjusted for demography and under-ascertainment. Boxes represent median (central horizontal line) and IQR, vertical lines represent 1·5 × IQR, and individual points represent any estimates outside of this range. (C) Estimated proportions of cases ascertained in the rest of China and in Wuhan relative to the 50–59 years age group elsewhere in China. Error bars represent 95% CrIs.In cases reported outside of mainland China, we estimated an overall modal case fatality ratio of 2·7% (95% CrI 1·4–4·7) using the parametric model (table 2). In those who reported travel to mainland China (and would therefore have been detected in the surveillance system), we estimated an overall modal case fatality ratio of 1·1% (0·4–4·1), and in those without any reported travel to China (therefore detected either through contact tracing or through hospital surveillance), we estimated a case fatality ratio of 3·6% (1·9–7·2) using the parametric model. The estimated case fatality ratio was lower in those aged under 60 years of age (1·4% [0·4–3·5]) compared with those aged 60 years and over (4·5% [1·8–11·1]). Similar estimates were obtained using non-parametric methods (table 2).Table 2Estimates of case fatality ratio obtained from individual-level data on cases identified outside of mainland ChinaParametricNon-parametricnCase fatality rationCase fatality ratioOverall5852·7% (1·4–4·7)13344·1% (2·1–7·8)Travel versus local transmissionTravellers to mainland China2031·1% (0·4–4·1)2082·4% (0·6–8·5)Local transmission3823·6% (1·9–7·2)3873·8% (1·7–8·2)Age group, years<603601·4% (0·4–3·5)4491·5% (0·6–3·9)≥601514·5% (1·8–11·1)18112·8% (4·1–33·5)Parametric estimates are presented as posterior mode (95% credible interval), and were obtained using the gamma-distributed estimates of onset-to-death and onset-to-recovery. Non-parametric estimates are presented as maximum likelihood estimate (95% confidence interval) and were obtained using a modified Kaplan-Meier method.11Ghani AC Donnelly CA Cox DR et al.Methods for estimating the case fatality ratio for a novel, emerging infectious disease.Am J Epidemiol. 2005; 162: 479-486Google Scholar,  23Zhou F Yu T Du R et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020;  (published online March 11.)https://doi.org/10.1016/S0140-6736(20)30566-3Google Scholar Note that due to missing data on age and travel status, numbers in the stratified analysis are lower than for the overall analysis. In addition, the parametric method requires a correction for the epidemic growth rate, and these estimates were therefore obtained from the subset of data for which the travel or local transmission and age was known.
                            Open table in a new tab
                        Parametric estimates are presented as posterior mode (95% credible interval), and were obtained using the gamma-distributed estimates of onset-to-death and onset-to-recovery. Non-parametric estimates are presented as maximum likelihood estimate (95% confidence interval) and were obtained using a modified Kaplan-Meier method.11Ghani AC Donnelly CA Cox DR et al.Methods for estimating the case fatality ratio for a novel, emerging infectious disease.Am J Epidemiol. 2005; 162: 479-486Google Scholar,  23Zhou F Yu T Du R et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020;  (published online March 11.)https://doi.org/10.1016/S0140-6736(20)30566-3Google Scholar Note that due to missing data on age and travel status, numbers in the stratified analysis are lower than for the overall analysis. In addition, the parametric method requires a correction for the epidemic growth rate, and these estimates were therefore obtained from the subset of data for which the travel or local transmission and age was known.In international Wuhan residents repatriated on six flights, we estimated a prevalence of infection of 0·87% (95% CI 0·32–1·9; six of 689). Adjusting for demography and under-ascertainment, we estimate an infection fatality ratio of 0·66% (95% CrI 0·39–1·33). As for the case fatality ratio, this is strongly age-dependent, with estimates rising steeply from age 50 years upwards (table 1). The demography-adjusted and under-ascertainment-adjusted proportion of infected individuals requiring hospitalisation ranges from 1·1% in the 20–29 years age group up to 18·4% in those 80 years and older (table 3). Using these age-stratified infection fatality ratio estimates, we estimate the infection fatality ratio in the Diamond Princess population to be 2·9%. Given the delay from onset of symptoms to death, we would expect 97% of these deaths to have occurred by March 25, 2020, giving an estimate of the current infection fatality ratio of 2·8%, compared with the empirical estimate of 1·4% (95% CI 0·7–2·6; ten of 712).Table 3Estimates of the proportion of all infections that would lead to hospitalisation, obtained from a subset of cases reported in mainland China22Griffin J Ghani A CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease. Boston College of Economics.https://ideas.repec.org/c/boc/bocode/s454601.htmlDate: May 7, 2009Date accessed: March 26, 2020Google ScholarSevere casesAll casesProportion of infected individuals hospitalised0–9 years0130·00% (0·00–0·00)10–19 years1500·0408% (0·0243–0·0832)20–29 years494371·04% (0·622–2·13)30–39 years1247333·43% (2·04–7·00)40–49 years1547434·25% (2·53–8·68)50–59 years2227908·16% (4·86–16·7)60–69 years20156011·8% (7·01–24·0)70–79 years13326316·6% (9·87–33·8)≥80 years517618·4% (11·0–37·6)Proportions of infected individuals hospitalised are presented as posterior mode (95% credible interval) and are adjusted for under-ascertainment and corrected for demography. Estimates are shown to three signficant figures. We assumed, based on severity classification from a UK context, that cases defined as severe would be hospitalised.
                            Open table in a new tab
                        Proportions of infected individuals hospitalised are presented as posterior mode (95% credible interval) and are adjusted for under-ascertainment and corrected for demography. Estimates are shown to three signficant figures. We assumed, based on severity classification from a UK context, that cases defined as severe would be hospitalised.From an extensive analysis of data from different regions of the world, our best estimate at the current time for the case fatality ratio of COVID-19 in China is 1·38% (95% CrI 1·23–1·53). Although this value remains lower than estimates for other coronaviruses, including SARS24Lau EHY Hsiung CA Cowling BJ et al.A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.BMC Infect Dis. 2010; 10: 50Google Scholar and Middle East respiratory syndrome (MERS),25Lessler J Salje H Van Kerkhove MD et al.Estimating the severity and subclinical burden of middle east respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia.Am J Epidemiol. 2016; 183: 657-663Google Scholar it is substantially higher than estimates from the 2009 H1N1 influenza pandemic.26Riley S Kwok KO Wu KM et al.Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.PLoS Med. 2011; 8e1000442Google Scholar,  27Kwok KO Riley S Perera RAPM et al.Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.BMC Infect Dis. 2017; 17: 337Google Scholar Our estimate of an infection fatality ratio of 0·66% in China was informed by PCR testing of international Wuhan residents returning on repatriation flights. This value was consistent with the infection fatality ratio observed in passengers on the Diamond Princess cruise ship up to March 5, 2020, although it is slightly above the upper 95% confidence limit of the age-adjusted infection fatality ratio observed by March 25 (of 712 confirmed cases, 601 have been discharged, ten have died, and 11 remain in a critical condition). This difference might be due to repatriation flight data slightly underestimating milder infections, or due to cruise passengers having better outcomes because of a potentially higher-than-average quality of health care.Our estimates of the probability of requiring hospitalisation assume that only severe cases require hospitalisation. This assumption is clearly different from the pattern of hospitalisation that occurred in China, where hospitalisation was also used to ensure case isolation. Mortality can also be expected to vary with the underlying health of specific populations, given that the risks associated with COVID-19 will be heavily influenced by the presence of underlying comorbidities.Our estimate of the case fatality ratio is substantially lower than the crude case fatality ratio obtained from China based on the cases and deaths observed to date, which is currently 3·67%, as well as many of the estimates currently in the literature. The principle reason for this difference is that the crude estimate does not take into account the severity of cases. For example, various estimates have been made from patient populations ranging from those with generally milder symptoms (for example international travellers detected through screening of travel history)13Jung S Akhmetzhanov AR Hayashi K et al.Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases.J Clin Med. 2020; 9: E523Google Scholar through to those identified in the hospital setting.14Mizumoto K Kagaya K Chowell G Yoshida-Nakaadachi-cho U Early epidemiological assessment of the transmission potential and virulence of 2019 novel coronavirus in Wuhan City: China, January–February, 2020.medRxiv. 2020;  (published online March 13.) (preprint).DOI: 10.1101/2020.02.12.20022434Google Scholar,  15Famulare M 2019-nCoV: preliminary estimates of the confirmed-case-fatality-ratio and infection-fatality-ratio, and initial pandemic risk assessment.https://institutefordiseasemodeling.github.io/nCoV-public/analyses/first_adjusted_mortality_estimates_and_risk_assessment/2019-nCoV-preliminary_age_and_time_adjusted_mortality_rates_and_pandemic_risk_assessment.htmlDate: Feb 19, 2020Date accessed: March 26, 2020Google ScholarIt is clear from the data that have emerged from China that case fatality ratio increases substantially with age. Our results suggest a very low fatality ratio in those under the age of 20 years. As there are very few cases in this age group, it remains unclear whether this reflects a low risk of death or a difference in susceptibility, although early results indicate young people are not at lower risk of infection than adults.28Bi Q Wu Y Mei S et al.Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts.medRxiv. 2020;  (published online March 19.) (preprint).DOI: 10.1101/2020.03.03.20028423Google Scholar Serological testing in this age group will be crucial in the coming weeks to understand the significance of this age group in driving population transmission. The estimated increase in severity with age is clearly reflected in case reports, in which the mean age tends to be in the range of 50–60 years. Different surveillance systems will pick up a different age case mix, and we find that those with milder symptoms detected through a history of travel are younger on average than those detected through hospital surveillance. Our correction for this surveillance bias therefore allows us to obtain estimates that can be applied to different case mixes and demographic population structures. However, it should be noted that this correction is applicable under the assumption of a uniform infection attack rate (ie, exposure) across the population. We also assumed perfect case ascertainment outside of Wuhan in the age group with the most cases relative to their population size (50–59-year-olds); however, if many cases were missed, the case fatality ratio and infection fatality ratio estimates might be lower. In the absence of random population surveys of infection prevalence, our adjustment from case fatality ratio to infection fatality ratio relied on repatriation flight data, which was not age specific. The reported proportion of infected individuals who were asymptomatic on the Diamond Princess did not vary considerably by age, supporting this approach, but future larger representative population prevalence surveys and seroprevalence surveys will inform such estimates further.Much of the data informing global estimates of the case fatality ratio at present are from the early outbreak in Wuhan. Given that the health system in this city was quickly overwhelmed, our estimates suggest that there is substantial under-ascertainment of cases in the younger age groups (who we estimate to have milder disease) by comparison with elsewhere in mainland China. This under-ascertainment is the main factor driving the difference between our estimate of the crude case fatality ratio from China (3·67%) and our best estimate of the overall case fatality ratio (1·38%). The case fatality ratio is likely to be strongly influenced by the availability of health-care facilities. However surprisingly, although health-care availability in Wuhan was stretched, our estimates from international cases are of a similar magnitude, suggesting relatively little difference in health outcome. Finally, as clinical knowledge of this new disease accrues, it is possible that outcomes will improve. It will therefore be important to revise these estimates as epidemics unfold.The world is currently experiencing the early stages of a global pandemic. Although China has succeeded in containing the disease spread for 2 months, such containment is unlikely to be achievable in most countries. Thus, much of the world will experience very large community epidemics of COVID-19 over the coming weeks and months. Our estimates of the underlying infection fatality ratio of this virus will inform assessments of health effects likely to be experienced in different countries, and thus decisions around appropriate mitigation policies to be adopted.This online publication has been corrected. The corrected version first appeared at thelancet.com/infection on April 15, 2020This online publication has been corrected. The corrected version first appeared at thelancet.com/infection on April 15, 2020ContributorsNMF and ACG conceived the study with input from RV, LCO, ID, PW, and CW. RV, LCO, and ID led the analysis of individual-case data for the international cases and estimation of the onset-to-outcome distributions, with input from CAD, ACG, and NMF. RV, PW, CW, and PGTW led the analysis of the China data, with input from ACG and NMF. NI coordinated management of the team, including the data collation and processing. NI and GC-D undertook the extraction of the international case data. HT undertook the extraction of flight repatriation data, with input from NI and AD. HF led the extraction of the China mainland data from national and regional websites with input from HW, YW, and XX. JTG developed the code for the non-parametric model. ACG produced the first draft of the manuscript. All authors contributed to the final draft.Declaration of interestsLCO reports grants from WHO outside of the submitted work. CAD reports grants from the UK Medical Research Council and from the National Institute for Health Research during the conduct of the study. NMF reports grants from the UK Medical Research Council and the UK National Institute for Health Research during the conduct of the study, and grants from Gavi, the Vaccine Alliance, Janssen Pharmaceuticals, and the Bill and Melinda Gates Foundation outside of the submitted work. All other authors declare no competing interests.All data and code used in this study are available in a GitHub repository.AcknowledgmentsThis work was supported by centre funding from the UK Medical Research Council (MRC) under a concordat with the UK Department for International Development, the National Institute for Health Research Health Protection Research Unit in Modelling Methodology, and the Abdul Latif Jameel Foundation. We are grateful for the input from the following volunteers and hackathon participants from the MRC Centre at Imperial College London: Kylie Ainslie, Sumali Bajaj, Lorenzo Cattarino, Joseph Challenger, Giovanni Charles, Georgina Charnley, Paula Christen, Constance Ciavarella, Victoria Cox, Zulma Cucunubá, Joshua D'Aeth, Tamsin Dewé, Lorna Dunning, Oliver Eales, Keith Fraser, Tini Garske, Lily Geidelberg, Nan Hong, Samuel Horsfield, Min J Kwun, David Jørgensen, Mara Kont, Alice Ledda, Xiang Li, Alessandra Lochen, Tara Mangal, Ruth McCabe, Kevin McRae-McKee, Kate Mitchell, Andria Mousa, Rebecca Nash, Daniela Olivera, Saskia Ricks, Nora Schmit, Ellie Sherrard-Smith, Janetta Skarp, Isaac Stopard, Juliette Unwin, Juan Vesga, Caroline Walters, Lilith Whittles.
                                            Download .pdf (.32
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendixLikelihood of survival of coronavirus disease 2019Full-TextPDFOpen AccessCorrection to Lancet Infect Dis 2020; published online March 30. https://doi.org/10.1016/S1473-3099(20)30243-7Full-TextPDFProtecting workers aged 60–69 years from COVID-19Full-TextPDF",10.1016/j.jtcvs.2020.03.061N/A10.1016/S1473-3099(20)30243-7,DOI:10.1016/j.jtcvs.2020.03.061N/AN/A,,ELSEVIEREMALANCET,COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research NetworkTreatments and vaccines for COVID-19Estimates of the severity of coronavirus disease 2019: a model-based analysis,The Journal of Thoracic and Cardiovascular SurgeryUpdateArticles,"['covid', '19', 'guidance', 'triage', 'operation', 'thoracic', 'malignancy', 'consensus', 'statement', 'thoracic', 'surgery', 'outcome', 'research', 'networktreatments', 'vaccine', 'covid', '19estimates', 'severity', 'coronavirus', 'disease', '2019', 'model', 'base', 'analysis']","['n', 'many', 'request', 'ema', 'human', 'medicine', 'committee', 'chmp', 'give', 'recommendation', 'investigational', 'antiviral', 'medicine', 'remdesivir', 'use', 'compassionate', 'use', 'programme', 'across', 'europe', 'treat', 'covid', '19', 'patient', 'eligible', 'inclusion', 'clinical', 'trial', 'recommendation', 'aim', 'ensure', 'harmonise', 'approach', 'across', 'eu', 'member', 'state', 'also', 'explain', 'group', 'patient', 'may', 'benefit', 'treatment', 'provide', 'preliminary', 'information', 'medicine', 'safety', 'backgroundin', 'face', 'rapidly', 'change', 'data', 'range', 'case', 'fatality', 'ratio', 'estimate', 'coronavirus', 'disease', '2019', 'covid', '19', 'produce', 'differ', 'substantially', 'magnitude', 'aim', 'provide', 'robust', 'estimate', 'account', 'censor', 'ascertainment', 'bias', 'methodswe', 'collect', 'individual', 'case', 'data', 'patient', 'die', 'covid', '19', 'hubei', 'mainland', 'china', 'report', 'national', 'provincial', 'health', 'commission', 'feb', '8', '2020', 'case', 'outside', 'mainland', 'china', 'government', 'ministry', 'health', 'website', 'medium', 'report', '37', 'country', 'well', 'hong', 'kong', 'macau', 'feb', '25', '2020', 'individual', 'case', 'data', 'use', 'estimate', 'time', 'onset', 'symptom', 'outcome', 'death', 'discharge', 'hospital', 'next', 'obtain', 'age', 'stratify', 'estimate', 'case', 'fatality', 'ratio', 'relate', 'aggregate', 'distribution', 'case', 'observe', 'cumulative', 'death', 'china', 'assume', 'constant', 'attack', 'rate', 'age', 'adjust', 'demography', 'age', 'base', 'location', 'base', 'ascertainment', 'also', 'estimate', 'case', 'fatality', 'ratio', 'individual', 'line', 'list', 'data', '1334', 'case', 'identify', 'outside', 'mainland', 'china', 'use', 'data', 'prevalence', 'pcr', 'confirm', 'case', 'international', 'resident', 'repatriate', 'china', 'obtain', 'age', 'stratify', 'estimate', 'infection', 'fatality', 'ratio', 'furthermore', 'data', 'age', 'stratify', 'severity', 'subset', '3665', 'case', 'china', 'use', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'require', 'hospitalisation', 'findingsusing', 'data', '24', 'death', 'occur', 'mainland', 'china', '165', 'recovery', 'outside', 'china', 'estimate', 'mean', 'duration', 'onset', 'symptom', 'death', '17', '8', 'day', '95', 'credible', 'interval', 'cri', '16', '9', '19', '2', 'hospital', 'discharge', '24', '7', 'day', '22', '9', '28', '1', 'laboratory', 'confirm', 'clinically', 'diagnose', 'case', 'mainland', 'china', 'n', '70', '117', 'estimate', 'crude', 'case', 'fatality', 'ratio', 'adjust', 'censor', '3', '67', '95', 'cri', '3', '56', '3', '80', 'however', 'adjust', 'demography', 'ascertainment', 'obtain', 'best', 'estimate', 'case', 'fatality', 'ratio', 'china', '1', '38', '1', '23', '1', '53', 'substantially', 'higher', 'ratio', 'older', 'age', 'group', '0', '32', '0', '27', '0', '38', 'age', '60', 'year', 'v', '6', '4', '5', '7', '7', '2', 'age', '60', 'year', '13', '4', '11', '2', '15', '9', 'age', '80', 'year', 'older', 'estimate', 'case', 'fatality', 'ratio', 'international', 'case', 'stratify', 'age', 'consistent', 'china', 'parametric', 'estimate', '1', '4', '0', '4', '3', '5', 'age', '60', 'year', 'n', '360', '4', '5', '1', '8', '11', '1', 'age', '60', 'year', 'n', '151', 'estimate', 'overall', 'infection', 'fatality', 'ratio', 'china', '0', '66', '0', '39', '1', '33', 'increase', 'profile', 'age', 'similarly', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'hospitalise', 'increase', 'age', 'maximum', '18', '4', '11', '0', '37', '6', 'age', '80', 'year', 'older', 'interpretationthese', 'early', 'estimate', 'give', 'indication', 'fatality', 'ratio', 'across', 'spectrum', 'covid', '19', 'disease', 'show', 'strong', 'age', 'gradient', 'risk', 'death', 'fundinguk', 'medical', 'research', 'council', 'face', 'rapidly', 'change', 'data', 'range', 'case', 'fatality', 'ratio', 'estimate', 'coronavirus', 'disease', '2019', 'covid', '19', 'produce', 'differ', 'substantially', 'magnitude', 'aim', 'provide', 'robust', 'estimate', 'account', 'censor', 'ascertainment', 'bias', 'collect', 'individual', 'case', 'data', 'patient', 'die', 'covid', '19', 'hubei', 'mainland', 'china', 'report', 'national', 'provincial', 'health', 'commission', 'feb', '8', '2020', 'case', 'outside', 'mainland', 'china', 'government', 'ministry', 'health', 'website', 'medium', 'report', '37', 'country', 'well', 'hong', 'kong', 'macau', 'feb', '25', '2020', 'individual', 'case', 'data', 'use', 'estimate', 'time', 'onset', 'symptom', 'outcome', 'death', 'discharge', 'hospital', 'next', 'obtain', 'age', 'stratify', 'estimate', 'case', 'fatality', 'ratio', 'relate', 'aggregate', 'distribution', 'case', 'observe', 'cumulative', 'death', 'china', 'assume', 'constant', 'attack', 'rate', 'age', 'adjust', 'demography', 'age', 'base', 'location', 'base', 'ascertainment', 'also', 'estimate', 'case', 'fatality', 'ratio', 'individual', 'line', 'list', 'data', '1334', 'case', 'identify', 'outside', 'mainland', 'china', 'use', 'data', 'prevalence', 'pcr', 'confirm', 'case', 'international', 'resident', 'repatriate', 'china', 'obtain', 'age', 'stratify', 'estimate', 'infection', 'fatality', 'ratio', 'furthermore', 'data', 'age', 'stratify', 'severity', 'subset', '3665', 'case', 'china', 'use', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'require', 'hospitalisation', 'use', 'data', '24', 'death', 'occur', 'mainland', 'china', '165', 'recovery', 'outside', 'china', 'estimate', 'mean', 'duration', 'onset', 'symptom', 'death', '17', '8', 'day', '95', 'credible', 'interval', 'cri', '16', '9', '19', '2', 'hospital', 'discharge', '24', '7', 'day', '22', '9', '28', '1', 'laboratory', 'confirm', 'clinically', 'diagnose', 'case', 'mainland', 'china', 'n', '70', '117', 'estimate', 'crude', 'case', 'fatality', 'ratio', 'adjust', 'censor', '3', '67', '95', 'cri', '3', '56', '3', '80', 'however', 'adjust', 'demography', 'ascertainment', 'obtain', 'best', 'estimate', 'case', 'fatality', 'ratio', 'china', '1', '38', '1', '23', '1', '53', 'substantially', 'higher', 'ratio', 'older', 'age', 'group', '0', '32', '0', '27', '0', '38', 'age', '60', 'year', 'v', '6', '4', '5', '7', '7', '2', 'age', '60', 'year', '13', '4', '11', '2', '15', '9', 'age', '80', 'year', 'older', 'estimate', 'case', 'fatality', 'ratio', 'international', 'case', 'stratify', 'age', 'consistent', 'china', 'parametric', 'estimate', '1', '4', '0', '4', '3', '5', 'age', '60', 'year', 'n', '360', '4', '5', '1', '8', '11', '1', 'age', '60', 'year', 'n', '151', 'estimate', 'overall', 'infection', 'fatality', 'ratio', 'china', '0', '66', '0', '39', '1', '33', 'increase', 'profile', 'age', 'similarly', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'hospitalise', 'increase', 'age', 'maximum', '18', '4', '11', '0', '37', '6', 'age', '80', 'year', 'older', 'early', 'estimate', 'give', 'indication', 'fatality', 'ratio', 'across', 'spectrum', 'covid', '19', 'disease', 'show', 'strong', 'age', 'gradient', 'risk', 'death', 'uk', 'medical', 'research', 'council', 'march', '25', '2020', '414', '179', 'case', '18', '440', 'death', 'due', 'coronavirus', 'disease', '2019', 'covid', '19', 'cause', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'report', 'worldwide', '1whocoronavirus', 'disease', '2019', 'covid', '19', 'situation', 'report', '43', 'http', 'www', 'int', 'doc', 'default', 'source', 'coronaviruse', 'situation', 'report', '20200303', 'sitrep', '43', 'covid', '19', 'pdf', 'sfvrsn', '2c21c09c', '2date', 'march', '3', '2020date', 'access', 'march', '5', '2020google', 'scholar', 'epidemic', 'begin', 'mainland', 'china', 'geographical', 'focus', 'city', 'wuhan', 'hubei', 'however', 'feb', '26', '2020', 'rate', 'increase', 'case', 'become', 'greater', 'rest', 'world', 'inside', 'china', 'substantial', 'outbreak', 'occur', 'italy', '69', '176', 'case', 'usa', '51', '914', 'case', 'iran', '24', '811', 'case', 'geographical', 'expansion', 'epidemic', 'continue', 'clinical', 'study', 'hospitalise', 'patient', 'show', 'onset', 'covid', '19', 'patient', 'frequently', 'show', 'symptom', 'associate', 'viral', 'pneumonia', 'commonly', 'fever', 'cough', 'sore', 'throat', 'myalgia', 'fatigue', '2chan', 'jfw', 'yuan', 'kok', 'kh', 'et', 'al', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person', 'person', 'transmission', 'study', 'family', 'cluster', 'lancet', '2020', '395', '514', '523google', 'scholar', '3chen', 'n', 'zhou', 'dong', 'x', 'et', 'al', 'epidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', 'china', 'descriptive', 'study', 'lancet', '2020', '395', '507', '513google', 'scholar', '4guan', 'wj', 'ni', 'zy', 'hu', 'et', 'al', 'clinical', 'characteristic', 'coronavirus', 'disease', '2019', 'china', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'feb', '28', 'doi', '10', '1056', 'nejmoa2002032google', 'scholar', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', '6li', 'q', 'guan', 'x', 'wu', 'p', 'et', 'al', 'early', 'transmission', 'dynamic', 'wuhan', 'china', 'novel', 'coronavirus', 'infect', 'pneumonia', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'jan', '29', 'doi', '10', '1056', 'nejmoa2001316google', 'scholar', 'case', 'definition', 'adopt', 'china', 'elsewhere', 'include', 'stratification', 'case', 'severe', 'define', 'tachypnoea', '30', 'breath', 'per', 'min', 'oxygen', 'saturation', '93', 'rest', 'pao2', 'fio2', 'ratio', '300', 'mm', 'hg', 'critical', 'respiratory', 'failure', 'require', 'mechanical', 'ventilation', 'septic', 'shock', 'organ', 'dysfunction', 'failure', 'require', 'intensive', 'care', '7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', 'covid', '19', 'china', 'zhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '2020', '41', 'chinese', '145', '151google', 'scholar', 'accord', 'report', 'china', 'joint', 'mission', 'covid', '19', '80', '55', '924', 'patient', 'laboratory', 'confirm', 'covid', '19', 'china', 'feb', '20', '2020', 'mild', 'moderate', 'disease', 'include', 'non', 'pneumonia', 'pneumonia', 'case', '13', '8', 'develop', 'severe', 'disease', '6', '1', 'develop', 'critical', 'stage', 'require', 'intensive', 'care', '8whoreport', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'http', 'www', 'int', 'publication', 'detail', 'report', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'date', 'feb', '28', '2020date', 'access', 'march', '26', '2020google', 'scholar', 'study', 'clinical', 'progression', '1099', 'patient', '4guan', 'wj', 'ni', 'zy', 'hu', 'et', 'al', 'clinical', 'characteristic', 'coronavirus', 'disease', '2019', 'china', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'feb', '28', 'doi', '10', '1056', 'nejmoa2002032google', 'scholar', 'highest', 'risk', 'severe', 'disease', 'death', 'include', 'people', 'age', '60', 'year', 'underlie', 'condition', 'include', 'hypertension', 'diabetes', 'cardiovascular', 'disease', 'chronic', 'respiratory', 'disease', 'cancer', 'research', 'contextevidence', 'studywe', 'search', 'pubmed', 'medrxiv', 'biorxiv', 'arxiv', 'ssrn', 'research', 'square', 'virological', 'wellcome', 'open', 'research', 'peer', 'review', 'article', 'preprints', 'research', 'report', 'severity', 'coronavirus', 'disease', '2019', 'covid', '19', 'use', 'search', 'term', 'coronavirus', '2019', 'ncov', 'similar', 'term', 'fatality', 'march', '6', '2020', 'several', 'study', 'estimate', 'case', 'fatality', 'ratio', 'percentage', 'individual', 'symptomatic', 'confirm', 'disease', 'die', 'disease', 'infection', 'fatality', 'ratio', 'percentage', 'infect', 'individual', 'die', 'disease', 'include', 'mild', 'disease', 'covid', '19', 'use', 'range', 'different', 'statistical', 'model', 'method', 'study', 'do', 'solely', 'hospitalise', 'patient', 'report', 'highest', 'fatality', 'ratio', '8', '28', 'represent', 'outcome', 'severely', 'ill', 'patient', 'estimate', 'population', 'level', 'case', 'fatality', 'ratio', 'case', 'report', 'range', '2', '8', 'estimate', 'infection', 'fatality', 'ratio', 'average', 'across', 'age', 'group', 'range', '0', '2', '1', '6', 'estimate', 'infection', 'fatality', 'ratio', 'oldest', 'age', 'group', '80', 'year', 'range', '8', '36', 'none', 'identify', 'study', 'adjust', 'difference', 'denominator', 'population', 'obtain', 'estimate', 'could', 'apply', 'across', 'population', 'study', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'add', 'value', 'studyby', 'synthesise', 'data', 'across', 'range', 'surveillance', 'set', 'obtain', 'estimate', 'age', 'stratify', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'take', 'account', 'different', 'denominator', 'population', 'datasets', 'underlie', 'assumption', 'attack', 'rate', 'ie', 'probability', 'become', 'infect', 'vary', 'substantially', 'age', 'consistent', 'previous', 'study', 'respiratory', 'infection', 'assumption', 'difference', 'age', 'pattern', 'among', 'case', 'wuhan', 'versus', 'elsewhere', 'china', 'would', 'probably', 'due', 'ascertainment', 'case', 'give', 'different', 'surveillance', 'system', 'place', 'result', 'consistent', 'hypothesis', 'case', 'wuhan', 'see', 'older', 'individual', 'would', 'identify', 'attendance', 'hospital', 'whereas', 'case', 'elsewhere', 'china', 'younger', 'overall', 'would', 'explain', 'policy', 'test', 'travel', 'history', 'wuhan', 'correct', 'bias', 'find', 'estimate', 'case', 'fatality', 'ratio', 'china', 'consistent', 'obtain', 'early', 'international', 'case', 'age', 'stratify', 'estimate', 'infection', 'fatality', 'ratio', 'apply', 'demography', 'give', 'estimate', 'infection', 'fatality', 'ratio', 'older', 'younger', 'population', 'estimate', 'combine', 'estimate', 'infection', 'attack', 'rate', 'approximately', '80', 'unmitigated', 'epidemic', 'give', 'rough', 'projection', 'scale', 'similarly', 'estimate', 'proportion', 'infection', 'require', 'hospitalisation', 'combine', 'infection', 'attack', 'rate', 'forecast', 'health', 'care', 'requirement', 'implication', 'available', 'evidenceour', 'estimate', 'case', 'fatality', 'ratio', 'covid', '19', 'although', 'lower', 'crude', 'estimate', 'make', 'date', 'substantially', 'higher', 'recent', 'influenza', 'pandemic', 'eg', 'h1n1', 'influenza', '2009', 'rapid', 'geographical', 'spread', 'observe', 'date', 'covid', '19', 'therefore', 'represent', 'major', 'global', 'health', 'threat', 'come', 'week', 'month', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'combine', 'likely', 'infection', 'attack', 'rate', 'around', '50', '80', 'show', 'even', 'advance', 'health', 'care', 'system', 'likely', 'overwhelm', 'estimate', 'therefore', 'crucial', 'enable', 'country', 'around', 'world', 'best', 'prepare', 'global', 'pandemic', 'continue', 'unfold', 'evidence', 'studywe', 'search', 'pubmed', 'medrxiv', 'biorxiv', 'arxiv', 'ssrn', 'research', 'square', 'virological', 'wellcome', 'open', 'research', 'peer', 'review', 'article', 'preprints', 'research', 'report', 'severity', 'coronavirus', 'disease', '2019', 'covid', '19', 'use', 'search', 'term', 'coronavirus', '2019', 'ncov', 'similar', 'term', 'fatality', 'march', '6', '2020', 'several', 'study', 'estimate', 'case', 'fatality', 'ratio', 'percentage', 'individual', 'symptomatic', 'confirm', 'disease', 'die', 'disease', 'infection', 'fatality', 'ratio', 'percentage', 'infect', 'individual', 'die', 'disease', 'include', 'mild', 'disease', 'covid', '19', 'use', 'range', 'different', 'statistical', 'model', 'method', 'study', 'do', 'solely', 'hospitalise', 'patient', 'report', 'highest', 'fatality', 'ratio', '8', '28', 'represent', 'outcome', 'severely', 'ill', 'patient', 'estimate', 'population', 'level', 'case', 'fatality', 'ratio', 'case', 'report', 'range', '2', '8', 'estimate', 'infection', 'fatality', 'ratio', 'average', 'across', 'age', 'group', 'range', '0', '2', '1', '6', 'estimate', 'infection', 'fatality', 'ratio', 'oldest', 'age', 'group', '80', 'year', 'range', '8', '36', 'none', 'identify', 'study', 'adjust', 'difference', 'denominator', 'population', 'obtain', 'estimate', 'could', 'apply', 'across', 'population', 'study', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'add', 'value', 'studyby', 'synthesise', 'data', 'across', 'range', 'surveillance', 'set', 'obtain', 'estimate', 'age', 'stratify', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'take', 'account', 'different', 'denominator', 'population', 'datasets', 'underlie', 'assumption', 'attack', 'rate', 'ie', 'probability', 'become', 'infect', 'vary', 'substantially', 'age', 'consistent', 'previous', 'study', 'respiratory', 'infection', 'assumption', 'difference', 'age', 'pattern', 'among', 'case', 'wuhan', 'versus', 'elsewhere', 'china', 'would', 'probably', 'due', 'ascertainment', 'case', 'give', 'different', 'surveillance', 'system', 'place', 'result', 'consistent', 'hypothesis', 'case', 'wuhan', 'see', 'older', 'individual', 'would', 'identify', 'attendance', 'hospital', 'whereas', 'case', 'elsewhere', 'china', 'younger', 'overall', 'would', 'explain', 'policy', 'test', 'travel', 'history', 'wuhan', 'correct', 'bias', 'find', 'estimate', 'case', 'fatality', 'ratio', 'china', 'consistent', 'obtain', 'early', 'international', 'case', 'age', 'stratify', 'estimate', 'infection', 'fatality', 'ratio', 'apply', 'demography', 'give', 'estimate', 'infection', 'fatality', 'ratio', 'older', 'younger', 'population', 'estimate', 'combine', 'estimate', 'infection', 'attack', 'rate', 'approximately', '80', 'unmitigated', 'epidemic', 'give', 'rough', 'projection', 'scale', 'similarly', 'estimate', 'proportion', 'infection', 'require', 'hospitalisation', 'combine', 'infection', 'attack', 'rate', 'forecast', 'health', 'care', 'requirement', 'implication', 'available', 'evidenceour', 'estimate', 'case', 'fatality', 'ratio', 'covid', '19', 'although', 'lower', 'crude', 'estimate', 'make', 'date', 'substantially', 'higher', 'recent', 'influenza', 'pandemic', 'eg', 'h1n1', 'influenza', '2009', 'rapid', 'geographical', 'spread', 'observe', 'date', 'covid', '19', 'therefore', 'represent', 'major', 'global', 'health', 'threat', 'come', 'week', 'month', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'combine', 'likely', 'infection', 'attack', 'rate', 'around', '50', '80', 'show', 'even', 'advance', 'health', 'care', 'system', 'likely', 'overwhelm', 'estimate', 'therefore', 'crucial', 'enable', 'country', 'around', 'world', 'best', 'prepare', 'global', 'pandemic', 'continue', 'unfold', 'assess', 'severity', 'covid', '19', 'crucial', 'determine', 'appropriateness', 'mitigation', 'strategy', 'enable', 'plan', 'health', 'care', 'need', 'epidemic', 'unfold', 'however', 'crude', 'case', 'fatality', 'ratio', 'obtain', 'divide', 'number', 'death', 'number', 'case', 'mislead', '9garske', 'legrand', 'j', 'donnelly', 'ca', 'et', 'al', 'assess', 'severity', 'novel', 'influenza', 'h1n1', 'pandemic', 'bmj', '2009', '339b2840google', 'scholar', '10lipsitch', 'donnelly', 'ca', 'fraser', 'c', 'et', 'al', 'potential', 'bias', 'estimate', 'absolute', 'relative', 'case', 'fatality', 'risk', 'outbreak', 'plo', 'negl', 'trop', 'dis', '2015', '9e0003846google', 'scholar', 'first', 'period', '2', '3', 'week', 'person', 'develop', 'symptom', 'case', 'subsequently', 'detect', 'report', 'observation', 'final', 'clinical', 'outcome', 'grow', 'epidemic', 'final', 'clinical', 'outcome', 'report', 'case', 'typically', 'unknown', 'simply', 'divide', 'cumulative', 'report', 'number', 'death', 'cumulative', 'number', 'report', 'case', 'therefore', 'underestimate', 'true', 'case', 'fatality', 'ratio', 'early', 'epidemic', '9garske', 'legrand', 'j', 'donnelly', 'ca', 'et', 'al', 'assess', 'severity', 'novel', 'influenza', 'h1n1', 'pandemic', 'bmj', '2009', '339b2840google', 'scholar', '10lipsitch', 'donnelly', 'ca', 'fraser', 'c', 'et', 'al', 'potential', 'bias', 'estimate', 'absolute', 'relative', 'case', 'fatality', 'risk', 'outbreak', 'plo', 'negl', 'trop', 'dis', '2015', '9e0003846google', 'scholar', '11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'et', 'al', 'method', 'estimate', 'case', 'fatality', 'ratio', 'novel', 'emerge', 'infectious', 'disease', 'j', 'epidemiol', '2005', '162', '479', '486google', 'scholar', 'effect', 'observe', 'past', 'epidemic', 'respiratory', 'pathogen', 'include', 'severe', 'acute', 'respiratory', 'syndrome', 'sars', '12donnelly', 'ca', 'ghani', 'ac', 'leung', 'gm', 'et', 'al', 'epidemiological', 'determinant', 'spread', 'causal', 'agent', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'kong', 'lancet', '2003', '361', '1761', '1766google', 'scholar', 'h1n19garske', 'legrand', 'j', 'donnelly', 'ca', 'et', 'al', 'assess', 'severity', 'novel', 'influenza', 'h1n1', 'pandemic', 'bmj', '2009', '339b2840google', 'scholar', 'influenza', 'widely', 'recognise', 'thus', 'many', 'estimate', 'case', 'fatality', 'ratio', 'obtain', 'date', 'covid', '19', 'correct', 'effect', '13jung', 'akhmetzhanov', 'ar', 'hayashi', 'k', 'et', 'al', 'real', 'time', 'estimation', 'risk', 'death', 'novel', 'coronavirus', 'covid', '19', 'infection', 'inference', 'use', 'export', 'case', 'j', 'clin', 'med', '2020', '9', 'e523google', 'scholar', '14mizumoto', 'k', 'kagaya', 'k', 'chowell', 'g', 'yoshida', 'nakaadachi', 'cho', 'u', 'early', 'epidemiological', 'assessment', 'transmission', 'potential', 'virulence', '2019', 'novel', 'coronavirus', 'wuhan', 'city', 'china', 'january', 'february', '2020', 'medrxiv', '2020', 'publish', 'online', 'march', '13', 'preprint', 'doi', '10', '1101', '2020', '02', '12', '20022434google', 'scholar', '15famulare', '2019', 'ncov', 'preliminary', 'estimate', 'confirm', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'initial', 'pandemic', 'risk', 'assessment', 'http', 'institutefordiseasemodeling', 'github', 'io', 'ncov', 'public', 'analysis', 'first', 'adjust', 'mortality', 'estimate', 'risk', 'assessment', '2019', 'ncov', 'preliminary', 'age', 'time', 'adjust', 'mortality', 'rate', 'pandemic', 'risk', 'assessment', 'htmldate', 'feb', '19', '2020date', 'access', 'march', '26', '2020google', 'scholar', '16wu', 'p', 'hao', 'x', 'lau', 'ehy', 'et', 'al', 'real', 'time', 'tentative', 'assessment', 'epidemiological', 'characteristic', 'novel', 'coronavirus', 'infection', 'wuhan', 'china', '22', 'january', '2020', 'euro', 'surveill', '2020', '25', '1', '6google', 'scholar', 'additionally', 'however', 'exponential', 'growth', 'phase', 'epidemic', 'observe', 'time', 'lag', 'onset', 'symptom', 'outcome', 'recovery', 'death', 'censor', 'naive', 'estimate', 'observe', 'time', 'symptom', 'onset', 'outcome', 'provide', 'bias', 'estimate', 'actual', 'distribution', 'ignore', 'effect', 'tend', 'bias', 'estimate', 'case', 'fatality', 'ratio', 'downwards', 'early', 'growth', 'phase', 'epidemic', 'second', 'surveillance', 'newly', 'emerge', 'pathogen', 'typically', 'bias', 'towards', 'detect', 'clinically', 'severe', 'case', 'especially', 'start', 'epidemic', 'diagnostic', 'capacity', 'low', 'figure', '1', 'estimate', 'case', 'fatality', 'ratio', 'thus', 'bias', 'upwards', 'extent', 'clinically', 'milder', 'disease', 'determine', '9garske', 'legrand', 'j', 'donnelly', 'ca', 'et', 'al', 'assess', 'severity', 'novel', 'influenza', 'h1n1', 'pandemic', 'bmj', '2009', '339b2840google', 'scholar', 'data', 'epicentre', 'outbreak', 'wuhan', 'primarily', 'obtain', 'hospital', 'surveillance', 'thus', 'likely', 'represent', 'patient', 'moderate', 'severe', 'illness', 'atypical', 'pneumonia', 'acute', 'respiratory', 'distress', 'use', 'define', 'suspect', 'case', 'eligible', 'test', '7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', 'covid', '19', 'china', 'zhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '2020', '41', 'chinese', '145', '151google', 'scholar', 'individual', 'clinical', 'outcome', 'likely', 'severe', 'estimate', 'case', 'fatality', 'ratio', 'higher', 'elsewhere', 'mainland', 'china', 'rest', 'world', 'country', 'administrative', 'region', 'alert', 'risk', 'infection', 'import', 'via', 'travel', 'initially', 'institute', 'surveillance', 'covid', '19', 'broader', 'set', 'clinical', 'criterion', 'define', 'suspect', 'case', 'criterion', 'typically', 'include', 'combination', 'symptom', 'eg', 'cough', 'fever', 'combine', 'recent', 'travel', 'history', 'affect', 'region', 'wuhan', 'hubei', 'province', '2chan', 'jfw', 'yuan', 'kok', 'kh', 'et', 'al', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person', 'person', 'transmission', 'study', 'family', 'cluster', 'lancet', '2020', '395', '514', '523google', 'scholar', '17xu', 'xw', 'wu', 'xx', 'jiang', 'xg', 'et', 'al', 'clinical', 'find', 'group', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'sars', 'cov', '2', 'outside', 'wuhan', 'china', 'retrospective', 'case', 'series', 'bmj', '2020', '368', 'm606google', 'scholar', 'surveillance', 'likely', 'detect', 'clinically', 'mild', 'case', 'initially', 'restrict', 'test', 'travel', 'history', 'link', 'might', 'miss', 'symptomatic', 'case', 'figure', '1spectrum', 'covid', '19', 'casesshow', 'full', 'captionat', 'top', 'pyramid', 'meet', 'case', 'criterion', 'severe', 'critical', 'case', 'likely', 'identify', 'hospital', 'set', 'present', 'atypical', 'viral', 'pneumonia', 'case', 'identify', 'mainland', 'china', 'among', 'categorise', 'internationally', 'local', 'transmission', 'many', 'case', 'likely', 'symptomatic', 'ie', 'fever', 'cough', 'myalgia', 'might', 'require', 'hospitalisation', 'case', 'identify', 'link', 'international', 'travel', 'high', 'risk', 'area', 'contact', 'trace', 'contact', 'confirm', 'case', 'might', 'also', 'identify', 'population', 'surveillance', 'example', 'influenza', 'like', 'illness', 'bottom', 'part', 'pyramid', 'represent', 'mild', 'possibly', 'asymptomatic', 'case', 'case', 'might', 'identify', 'contact', 'trace', 'subsequently', 'via', 'serological', 'test', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'top', 'pyramid', 'meet', 'case', 'criterion', 'severe', 'critical', 'case', 'likely', 'identify', 'hospital', 'set', 'present', 'atypical', 'viral', 'pneumonia', 'case', 'identify', 'mainland', 'china', 'among', 'categorise', 'internationally', 'local', 'transmission', 'many', 'case', 'likely', 'symptomatic', 'ie', 'fever', 'cough', 'myalgia', 'might', 'require', 'hospitalisation', 'case', 'identify', 'link', 'international', 'travel', 'high', 'risk', 'area', 'contact', 'trace', 'contact', 'confirm', 'case', 'might', 'also', 'identify', 'population', 'surveillance', 'example', 'influenza', 'like', 'illness', 'bottom', 'part', 'pyramid', 'represent', 'mild', 'possibly', 'asymptomatic', 'case', 'case', 'might', 'identify', 'contact', 'trace', 'subsequently', 'via', 'serological', 'test', 'attempt', 'adjust', 'bias', 'data', 'source', 'obtain', 'estimate', 'case', 'fatality', 'ratio', 'proportion', 'case', 'eventually', 'lead', 'death', 'infection', 'fatality', 'ratio', 'proportion', 'infection', 'eventually', 'lead', 'death', 'use', 'individual', 'level', 'case', 'report', 'data', 'aggregate', 'case', 'death', 'count', 'mainland', 'china', 'hong', 'kong', 'macau', 'international', 'case', 'report', 'adjust', 'underlie', 'demography', 'potential', 'ascertainment', 'different', 'level', 'severity', 'pyramid', 'figure', '1', 'estimate', 'broadly', 'applicable', 'across', 'range', 'set', 'inform', 'health', 'plan', 'detail', 'case', 'data', 'accrue', 'identify', 'information', 'characteristic', '48', 'patient', 'die', 'covid', '19', 'hubei', 'report', 'national', 'health', 'commission', 'hubei', 'province', 'health', 'commission', 'website', 'feb', '8', '2020', 'record', 'follow', 'data', 'element', 'available', 'sex', 'age', 'date', 'symptom', 'onset', 'date', 'hospitalisation', 'date', 'death', '48', 'case', 'neither', 'date', 'symptom', 'onset', 'date', 'report', 'available', '13', 'case', 'also', 'remove', 'eight', 'case', 'onset', 'jan', '1', '2020', 'death', 'jan', '21', '2020', 'three', 'death', 'jan', '28', '2020', 'date', 'consistent', 'reliable', 'report', 'onset', 'death', 'set', 'respectively', 'consider', 'onset', 'death', 'time', 'include', 'early', 'onset', 'create', 'bias', 'towards', 'long', 'onset', 'death', 'time', 'reflect', 'ascertainment', 'death', 'early', 'leave', '24', 'death', 'use', 'estimate', 'onset', 'death', 'distribution', 'collate', 'data', '2010', 'case', 'report', '37', 'country', 'two', 'special', 'administrative', 'region', 'china', 'hong', 'kong', 'macau', 'government', 'ministry', 'health', 'website', 'medium', 'report', 'feb', '25', '2020', 'record', 'follow', 'information', 'available', 'country', 'administrative', 'region', 'case', 'detect', 'whether', 'infection', 'acquire', 'china', 'abroad', 'date', 'travel', 'date', 'symptom', 'onset', 'date', 'hospitalisation', 'date', 'confirmation', 'date', 'recovery', 'date', 'death', 'use', 'data', '165', 'recover', 'individual', 'report', 'recovery', 'date', 'report', 'impute', 'onset', 'date', 'estimate', 'onset', 'recovery', 'distribution', 'exclude', '26', 'recovery', 'without', 'appropriate', 'information', 'date', 'recovery', 'report', 'locality', 'use', 'data', '1334', 'international', 'case', 'obtain', 'estimate', 'case', 'fatality', 'ratio', 'include', 'case', 'without', 'date', 'report', 'data', '70', '117', 'pcr', 'confirm', 'clinically', 'diagnose', 'case', 'date', 'onset', 'wuhan', 'elsewhere', 'china', 'jan', '1', 'feb', '11', '2020', 'extract', 'china', 'joint', 'mission', 'report', '8whoreport', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'http', 'www', 'int', 'publication', 'detail', 'report', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'date', 'feb', '28', '2020date', 'access', 'march', '26', '2020google', 'scholar', 'period', 'total', '1023', 'death', 'report', 'across', 'china', 'data', 'available', 'disaggregated', '10', 'year', 'age', 'band', '0', '9', 'year', '70', '79', 'year', 'old', 'age', 'band', 'age', '80', 'year', 'older', '7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', 'covid', '19', 'china', 'zhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '2020', '41', 'chinese', '145', '151google', 'scholar', 'use', 'collate', 'data', 'daily', 'report', 'death', 'obtain', 'day', 'national', 'health', 'commission', 'regional', 'website', 'estimate', '74', 'death', 'occur', 'wuhan', 'remainder', 'outside', 'wuhan', 'additionally', 'recent', 'available', 'cumulative', 'estimate', 'march', '3', '2020', '80', '304', 'confirm', 'case', '2946', 'death', 'within', 'china', 'extract', 'covid', '19', 'situation', 'report', 'number', '43', '1whocoronavirus', 'disease', '2019', 'covid', '19', 'situation', 'report', '43', 'http', 'www', 'int', 'doc', 'default', 'source', 'coronaviruse', 'situation', 'report', '20200303', 'sitrep', '43', 'covid', '19', 'pdf', 'sfvrsn', '2c21c09c', '2date', 'march', '3', '2020date', 'access', 'march', '5', '2020google', 'scholaran', 'earlier', 'preprint', 'subset', 'case', 'jan', '26', '2020', 'report', 'age', 'distribution', 'case', 'categorise', 'severity', '3665', 'case', '18yang', 'lu', 'q', 'liu', 'et', 'al', 'epidemiological', 'clinical', 'feature', '2019', 'novel', 'coronavirus', 'outbreak', 'china', 'medrxiv', '2020', 'publish', 'online', 'feb', '21', 'preprint', 'doi', '10', '1101', '2020', '02', '10', '20021675google', 'scholar', 'china', 'case', 'definition', 'severe', 'case', 'define', 'tachypnoea', '30', 'breath', 'per', 'min', 'oxygen', 'saturation', '93', 'higher', 'rest', 'pao2', 'fio2', 'ratio', 'le', '300', 'mm', 'hg', '7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', 'covid', '19', 'china', 'zhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '2020', '41', 'chinese', '145', '151google', 'scholar', 'assume', 'severe', 'case', 'require', 'hospitalisation', 'oppose', 'patient', 'hospitalise', 'china', 'hospitalise', 'reduce', 'onward', 'transmission', 'use', 'proportion', 'severe', 'case', 'age', 'patient', 'estimate', 'proportion', 'case', 'infection', 'require', 'hospitalisation', 'data', 'infection', 'prevalence', 'repatriate', 'expatriate', 'return', 'home', 'country', 'obtain', 'government', 'ministry', 'health', 'website', 'medium', 'report', 'match', 'incidence', 'report', 'wuhan', 'jan', '30', '2020', 'use', 'data', 'six', 'flight', 'depart', 'jan', '30', 'feb', '1', '2020', 'inclusive', 'early', 'february', '2020', 'cruise', 'liner', 'name', 'diamond', 'princess', 'quarantine', 'disembark', 'passenger', 'test', 'positive', 'virus', 'subsequently', '3711', 'passenger', 'board', 'test', 'next', 'month', 'extract', 'data', 'age', 'passenger', 'onboard', 'feb', '5', '2020', 'date', 'positive', 'test', 'report', 'available', '657', '712', 'pcr', 'confirm', 'case', 'date', 'ten', 'death', 'among', 'case', 'report', 'japan', 'ministry', 'health', 'labour', 'welfare19government', 'japanministry', 'health', 'labour', 'welfare', 'http', 'www', 'niid', 'go', 'jp', 'niid', 'en', '2019', 'ncov', 'e', 'htmldate', '2020date', 'access', 'march', '26', '2020google', 'scholar', 'international', 'medium', 'age', 'stratify', 'population', 'data', '2018', 'obtain', 'national', 'bureau', 'statistic', 'china', '20national', 'bureau', 'statistic', 'chinachina', 'statistical', 'yearbook', 'http', 'www', 'stats', 'gov', 'cn', 'tjsj', 'ndsj', '2018', 'indexeh', 'htmdate', '2018date', 'access', 'february', '14', '2020google', 'scholar', 'accord', 'data', 'population', 'wuhan', '2018', 'approximately', '11', 'million', 'people', 'analysis', 'do', 'r', 'software', 'version', '3', '6', '2', 'bayesian', 'marko', 'chain', 'monte', 'carlo', 'via', 'package', 'drjacoby', 'version', '1', '0', '0', '21verity', 'r', 'winskill', 'p', 'drjacoby', 'http', 'mrc', 'ide', 'github', 'io', 'drjacoby', 'index', 'htmldate', 'access', 'march', '26', '2020google', 'scholar', 'data', 'code', 'available', 'online', 'github', 'estimate', 'time', 'interval', 'symptom', 'onset', 'outcome', 'necessary', 'account', 'fact', 'grow', 'epidemic', 'higher', 'proportion', 'case', 'infect', 'recently', 'appendix', 'p', '7', 'therefore', 'parameterised', 'gamma', 'model', 'account', 'exponential', 'growth', 'use', 'growth', 'rate', '0', '14', 'per', 'day', 'obtain', 'early', 'case', 'onset', 'data', 'appendix', 'p', '6', 'use', 'bayesian', 'method', 'fit', 'gamma', 'distribution', 'data', 'time', 'onset', 'death', 'onset', 'recovery', 'conditional', 'observe', 'final', 'outcome', 'miss', 'onset', 'date', 'impute', 'basis', 'date', 'report', 'available', 'estimate', 'distribution', 'time', 'onset', 'death', 'use', 'project', 'expect', 'cumulative', 'number', 'death', 'give', 'onset', 'observe', 'wuhan', 'outside', 'wuhan', 'assume', 'uniform', 'attack', 'rate', 'across', 'age', 'group', 'use', 'age', 'distribution', 'population', 'obtain', 'estimate', 'expect', 'number', 'infection', 'age', 'group', 'ascertainment', 'estimate', 'outside', 'wuhan', 'compare', 'number', 'observe', 'case', 'age', 'expect', 'distribution', 'assume', 'perfect', 'ascertainment', '50', '59', 'age', 'group', 'group', 'highest', 'number', 'detect', 'case', 'relative', 'population', 'size', 'also', 'sensitivity', 'analysis', 'assume', 'differential', 'attack', 'rate', 'age', 'appendix', 'p', '9', 'wuhan', 'add', 'scale', 'account', 'ascertainment', 'compare', 'outside', 'wuhan', 'step', 'give', 'u', 'expect', 'age', 'distribution', 'case', 'give', 'onset', 'death', 'distribution', 'obtain', 'model', 'estimate', 'cumulative', 'number', 'death', 'age', 'age', 'dependent', 'case', 'fatality', 'ratio', 'fit', 'relative', 'case', 'fatality', 'ratio', 'oldest', 'age', 'group', 'represent', 'highest', 'crude', 'case', 'fatality', 'ratio', 'estimate', 'compare', 'observe', 'death', 'age', 'use', 'poisson', 'likelihood', 'data', 'jointly', 'fit', 'alongside', 'recent', 'age', 'aggregate', 'cumulative', 'death', 'case', 'mainland', 'china', 'give', 'number', 'observe', 'case', 'death', 'drop', 'substantially', 'follow', 'peak', 'late', 'january', 'ratio', 'current', 'cumulative', 'case', 'current', 'number', 'death', 'correct', 'ascertainment', 'provide', 'good', 'estimate', 'final', 'case', 'fatality', 'ratio', '11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'et', 'al', 'method', 'estimate', 'case', 'fatality', 'ratio', 'novel', 'emerge', 'infectious', 'disease', 'j', 'epidemiol', '2005', '162', '479', '486google', 'scholarto', 'estimate', 'infection', 'fatality', 'ratio', 'fit', 'data', 'infection', 'prevalence', 'international', 'wuhan', 'resident', 'repatriate', 'home', 'country', 'age', 'stratify', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'model', 'jointly', 'fit', 'case', 'data', 'infection', 'prevalence', 'data', 'use', 'bayesian', 'method', 'use', 'previous', 'estimate', 'onset', 'death', 'distribution', 'prior', 'full', 'mathematical', 'detail', 'provide', 'appendix', 'p', '8', 'assume', 'uniform', 'attack', 'rate', 'age', 'group', 'use', 'demography', 'adjust', 'ascertainment', 'rate', 'calculate', 'obtain', 'estimate', 'proportion', 'infect', 'individual', 'would', 'require', 'hospitalisation', 'independently', 'validate', 'infection', 'fatality', 'ratio', 'estimate', 'analyse', 'data', 'outbreak', 'diamond', 'princess', 'cruise', 'liner', 'take', 'date', 'report', 'positive', 'test', 'proxy', 'onset', 'date', 'calculate', 'expect', 'proportion', 'death', 'observe', 'march', '25', '2020', 'give', 'onset', 'time', 'estimate', 'onset', 'death', 'distribution', 'appendix', 'p', '13', 'use', 'parametric', 'non', 'parametric', 'methods11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'et', 'al', 'method', 'estimate', 'case', 'fatality', 'ratio', 'novel', 'emerge', 'infectious', 'disease', 'j', 'epidemiol', '2005', '162', '479', '486google', 'scholar', '22griffin', 'j', 'ghani', 'casefat', 'stata', 'module', 'estimate', 'case', 'fatality', 'ratio', 'new', 'infectious', 'disease', 'boston', 'college', 'economics', 'http', 'idea', 'repec', 'org', 'c', 'boc', 'bocode', 's454601', 'htmldate', 'may', '7', '2009date', 'access', 'march', '26', '2020google', 'scholar', 'estimate', 'case', 'fatality', 'ratio', 'case', 'report', 'outside', 'mainland', 'china', 'use', 'individual', 'level', 'data', 'case', 'outcome', 'unknown', 'treat', 'censor', 'observation', 'parametric', 'non', 'parametric', 'analysis', 'miss', 'onset', 'date', 'multiply', 'impute', 'use', 'information', 'onset', 'report', 'distribution', 'unreported', 'recovery', 'impute', 'use', 'onset', 'outcome', 'distribution', 'country', 'summary', 'data', 'parametric', 'model', 'fit', 'data', 'use', 'bayesian', 'method', 'appendix', 'p', '12', 'funder', 'study', 'role', 'study', 'design', 'data', 'collection', 'data', 'analysis', 'data', 'interpretation', 'write', 'report', 'correspond', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', 'subset', '24', 'death', 'covid', '19', 'occur', 'mainland', 'china', 'early', 'epidemic', 'correction', 'bias', 'introduce', 'growth', 'epidemic', 'estimate', 'mean', 'time', 'onset', 'death', '18', '8', 'day', '95', 'credible', 'interval', 'cri', '15', '7', '49', '7', 'figure', '2', 'coefficient', 'variation', '0', '45', '95', 'cri', '0', '29', '0', '54', 'small', 'number', 'observation', 'data', 'give', 'early', 'epidemic', 'could', 'rule', 'many', 'death', 'occur', 'longer', 'time', 'onset', 'death', 'hence', 'high', 'upper', 'limit', 'credible', 'interval', 'however', 'give', 'epidemic', 'china', 'since', 'decline', 'posterior', 'estimate', 'mean', 'time', 'onset', 'death', 'inform', 'analysis', 'aggregate', 'data', 'china', 'precise', 'mean', '17', '8', 'day', '16', '9', '19', '2', 'figure', '2', 'figure', '2onset', 'death', 'onset', 'recovery', 'distributionsshow', 'full', 'caption', 'onset', 'death', 'data', '24', 'case', 'mainland', 'china', 'early', 'epidemic', 'b', 'onset', 'recovery', 'data', '169', 'case', 'outside', 'mainland', 'china', 'red', 'line', 'show', 'best', 'fit', 'posterior', 'mode', 'gamma', 'distribution', 'uncorrected', 'epidemic', 'growth', 'bias', 'towards', 'shorter', 'duration', 'blue', 'line', 'show', 'distribution', 'correct', 'epidemic', 'growth', 'black', 'line', 'panel', 'show', 'posterior', 'estimate', 'onset', 'death', 'distribution', 'follow', 'fit', 'aggregate', 'case', 'data', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'onset', 'death', 'data', '24', 'case', 'mainland', 'china', 'early', 'epidemic', 'b', 'onset', 'recovery', 'data', '169', 'case', 'outside', 'mainland', 'china', 'red', 'line', 'show', 'best', 'fit', 'posterior', 'mode', 'gamma', 'distribution', 'uncorrected', 'epidemic', 'growth', 'bias', 'towards', 'shorter', 'duration', 'blue', 'line', 'show', 'distribution', 'correct', 'epidemic', 'growth', 'black', 'line', 'panel', 'show', 'posterior', 'estimate', 'onset', 'death', 'distribution', 'follow', 'fit', 'aggregate', 'case', 'data', 'use', 'data', 'outcome', '169', 'case', 'report', 'outside', 'mainland', 'china', 'estimate', 'mean', 'onset', 'recovery', 'time', '24', '7', 'day', '95', 'cri', '22', '9', '28', '1', 'coefficient', 'variation', '0', '35', '0', '31', '0', '39', 'figure', '2', 'onset', 'outcome', 'estimate', 'consistent', 'separate', 'study', 'china', '23zhou', 'f', 'yu', 'du', 'r', 'et', 'al', 'clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid', '19', 'wuhan', 'china', 'retrospective', 'cohort', 'study', 'lancet', '2020', 'publish', 'online', 'march', '11', 'http', 'doi', 'org', '10', '1016', 's0140', '6736', '20', '30566', '3google', 'scholarcase', 'fatality', 'ratio', 'estimate', 'aggregate', 'data', 'case', 'death', 'mainland', 'china', 'table', '1', 'large', 'proportion', 'case', 'include', 'early', 'epidemic', 'report', 'wuhan', 'local', 'health', 'system', 'quickly', 'overwhelm', 'result', 'age', 'distribution', 'case', 'report', 'wuhan', 'differ', 'rest', 'china', 'figure', '3a', 'report', 'case', 'wuhan', 'frequent', 'older', 'age', 'group', 'perhaps', 'reflect', 'higher', 'severity', 'therefore', 'prioritisation', 'hospitalisation', 'wuhan', 'case', 'outside', 'wuhan', 'might', 'also', 'show', 'bias', 'term', 'relationship', 'age', 'travel', 'adjust', 'difference', 'underlie', 'demography', 'assume', 'overall', 'difference', 'attack', 'rate', 'age', 'estimate', 'high', 'ascertainment', 'case', 'younger', 'age', 'group', 'inside', 'outside', 'wuhan', 'figure', '3c', 'furthermore', 'estimate', 'higher', 'level', 'ascertainment', 'overall', 'wuhan', 'compare', 'outside', 'wuhan', 'figure', '3c', 'account', 'ascertainment', 'estimate', 'highest', 'case', 'fatality', 'ratio', '13', '4', '11', '2', '15', '9', '80', 'year', 'older', 'age', 'group', 'figure', '3b', 'table', '1', 'lower', 'case', 'fatality', 'ratio', 'associate', 'lower', 'age', 'group', 'lowest', '0', '9', 'year', 'age', 'group', '0', '00260', '0', '000312', '0', '0382', 'table', '1estimates', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'obtain', 'aggregate', 'time', 'series', 'case', 'mainland', 'chinadeathslaboratory', 'confirm', 'case', 'value', 'include', 'clinically', 'diagnose', 'case', 'include', 'estimate', 'case', 'fatality', 'ratioinfection', 'fatality', 'ratio', 'obtain', 'combine', 'estimate', 'case', 'fatality', 'ratio', 'information', 'infection', 'prevalence', 'obtain', 'return', 'home', 'repatriation', 'flight', 'crudeadjusted', 'censoringadjusted', 'censor', 'demography', 'ascertainment', 'account', 'underlie', 'demography', 'wuhan', 'elsewhere', 'china', 'correct', 'ascertainment', 'overall102344', '6722', '29', '2', '15', '2', '43', '3', '67', '3', '56', '3', '80', '1', '38', '1', '23', '1', '53', '0', '657', '0', '389', '1', '33', 'age', 'group', 'years0', '904160', '000', '0', '000', '0', '883', '0', '0954', '0', '0110', '1', '34', '0', '00260', '0', '000312', '0', '0382', '0', '00161', '0', '000185', '0', '0249', '10', '1915490', '182', '0', '00461', '1', '01', '0', '352', '0', '0663', '1', '74', '0', '0148', '0', '00288', '0', '0759', '0', '00695', '0', '00149', '0', '0502', '20', '29736190', '193', '0', '0778', '0', '398', '0', '296', '0', '158', '0', '662', '0', '0600', '0', '0317', '0', '132', '0', '0309', '0', '0138', '0', '0923', '30', '391876000', '237', '0', '140', '0', '374', '0', '348', '0', '241', '0', '577', '0', '146', '0', '103', '0', '255', '0', '0844', '0', '0408', '0', '185', '40', '493885710', '443', '0', '314', '0', '608', '0', '711', '0', '521', '0', '966', '0', '295', '0', '221', '0', '422', '0', '161', '0', '0764', '0', '323', '50', '5913010', '0081', '30', '1', '09', '1', '54', '2', '06', '1', '74', '2', '43', '1', '25', '1', '03', '1', '55', '0', '595', '0', '344', '1', '28', '60', '6930985833', '60', '3', '22', '4', '02', '5', '79', '5', '20', '6', '34', '3', '99', '3', '41', '4', '55', '1', '93', '1', '11', '3', '89', '70', '7931239187', '96', '7', '13', '8', '86', '12', '7', '11', '5', '13', '9', '8', '61', '7', '48', '9', '99', '4', '28', '2', '45', '8', '44', '80208140814', '8', '13', '0', '16', '7', '23', '3', '20', '3', '26', '7', '13', '4', '11', '2', '15', '9', '7', '80', '3', '80', '13', '3', 'age', 'category', 'binary', 'year', '6019430', '7630', '631', '0', '545', '0', '726', '1', '01', '0', '900', '1', '17', '0', '318', '0', '274', '0', '378', '0', '145', '0', '0883', '0', '317', '6082913', '9095', '96', '5', '57', '6', '37', '9', '49', '9', '11', '9', '95', '6', '38', '5', '70', '7', '17', '3', '28', '1', '82', '6', '18', 'crude', 'case', 'fatality', 'ratio', 'present', 'mean', '95', 'confidence', 'interval', 'fatality', 'ratio', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'estimate', 'show', 'three', 'significant', 'figure', 'case', 'death', 'aggregate', 'number', 'report', 'jan', '1', 'feb', '11', '2020', '8whoreport', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'http', 'www', 'int', 'publication', 'detail', 'report', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'date', 'feb', '28', '2020date', 'access', 'march', '26', '2020google', 'scholar', 'crude', 'case', 'fatality', 'ratio', 'calculate', 'number', 'death', 'divide', 'number', 'laboratory', 'confirm', 'case', 'estimate', 'also', 'include', 'clinically', 'diagnose', 'case', 'scale', '1', '31', 'apply', 'across', 'age', 'group', 'breakdown', 'age', 'report', 'clinically', 'diagnose', 'case', 'give', 'larger', 'denominator', 'thus', 'lower', 'case', 'fatality', 'ratio', 'laboratory', 'confirm', 'case', 'include', 'value', 'include', 'clinically', 'diagnose', 'case', 'include', 'estimate', 'obtain', 'combine', 'estimate', 'case', 'fatality', 'ratio', 'information', 'infection', 'prevalence', 'obtain', 'return', 'home', 'repatriation', 'flight', 'account', 'underlie', 'demography', 'wuhan', 'elsewhere', 'china', 'correct', 'ascertainment', 'open', 'table', 'new', 'tab', 'figure', '3estimates', 'case', 'fatality', 'ratio', 'age', 'obtain', 'aggregate', 'data', 'mainland', 'chinashow', 'full', 'caption', 'age', 'distribution', 'case', 'wuhan', 'elsewhere', 'china', 'b', 'estimate', 'case', 'fatality', 'ratio', 'age', 'group', 'adjust', 'demography', 'ascertainment', 'box', 'represent', 'median', 'central', 'horizontal', 'line', 'iqr', 'vertical', 'line', 'represent', '1', '5', 'iqr', 'individual', 'point', 'represent', 'estimate', 'outside', 'range', 'c', 'estimate', 'proportion', 'case', 'ascertain', 'rest', 'china', 'wuhan', 'relative', '50', '59', 'year', 'age', 'group', 'elsewhere', 'china', 'error', 'bar', 'represent', '95', 'cris', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'crude', 'case', 'fatality', 'ratio', 'present', 'mean', '95', 'confidence', 'interval', 'fatality', 'ratio', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'estimate', 'show', 'three', 'significant', 'figure', 'case', 'death', 'aggregate', 'number', 'report', 'jan', '1', 'feb', '11', '2020', '8whoreport', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'http', 'www', 'int', 'publication', 'detail', 'report', 'china', 'joint', 'mission', 'coronavirus', 'disease', '2019', 'covid', '19', 'date', 'feb', '28', '2020date', 'access', 'march', '26', '2020google', 'scholar', 'crude', 'case', 'fatality', 'ratio', 'calculate', 'number', 'death', 'divide', 'number', 'laboratory', 'confirm', 'case', 'estimate', 'also', 'include', 'clinically', 'diagnose', 'case', 'scale', '1', '31', 'apply', 'across', 'age', 'group', 'breakdown', 'age', 'report', 'clinically', 'diagnose', 'case', 'give', 'larger', 'denominator', 'thus', 'lower', 'case', 'fatality', 'ratio', 'laboratory', 'confirm', 'case', 'include', 'age', 'distribution', 'case', 'wuhan', 'elsewhere', 'china', 'b', 'estimate', 'case', 'fatality', 'ratio', 'age', 'group', 'adjust', 'demography', 'ascertainment', 'box', 'represent', 'median', 'central', 'horizontal', 'line', 'iqr', 'vertical', 'line', 'represent', '1', '5', 'iqr', 'individual', 'point', 'represent', 'estimate', 'outside', 'range', 'c', 'estimate', 'proportion', 'case', 'ascertain', 'rest', 'china', 'wuhan', 'relative', '50', '59', 'year', 'age', 'group', 'elsewhere', 'china', 'error', 'bar', 'represent', '95', 'cris', 'case', 'report', 'outside', 'mainland', 'china', 'estimate', 'overall', 'modal', 'case', 'fatality', 'ratio', '2', '7', '95', 'cri', '1', '4', '4', '7', 'use', 'parametric', 'model', 'table', '2', 'report', 'travel', 'mainland', 'china', 'would', 'therefore', 'detect', 'surveillance', 'system', 'estimate', 'overall', 'modal', 'case', 'fatality', 'ratio', '1', '1', '0', '4', '4', '1', 'without', 'report', 'travel', 'china', 'therefore', 'detect', 'either', 'contact', 'trace', 'hospital', 'surveillance', 'estimate', 'case', 'fatality', 'ratio', '3', '6', '1', '9', '7', '2', 'use', 'parametric', 'model', 'estimate', 'case', 'fatality', 'ratio', 'lower', 'age', '60', 'year', 'age', '1', '4', '0', '4', '3', '5', 'compare', 'age', '60', 'year', '4', '5', '1', '8', '11', '1', 'similar', 'estimate', 'obtain', 'use', 'non', 'parametric', 'method', 'table', '2', 'table', '2estimates', 'case', 'fatality', 'ratio', 'obtain', 'individual', 'level', 'data', 'case', 'identify', 'outside', 'mainland', 'chinaparametricnon', 'parametricncase', 'fatality', 'rationcase', 'fatality', 'ratiooverall5852', '7', '1', '4', '4', '7', '13344', '1', '2', '1', '7', '8', 'travel', 'versus', 'local', 'transmissiontravellers', 'mainland', 'china2031', '1', '0', '4', '4', '1', '2082', '4', '0', '6', '8', '5', 'local', 'transmission3823', '6', '1', '9', '7', '2', '3873', '8', '1', '7', '8', '2', 'age', 'group', 'year', '603601', '4', '0', '4', '3', '5', '4491', '5', '0', '6', '3', '9', '601514', '5', '1', '8', '11', '1', '18112', '8', '4', '1', '33', '5', 'parametric', 'estimate', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'obtain', 'use', 'gamma', 'distribute', 'estimate', 'onset', 'death', 'onset', 'recovery', 'non', 'parametric', 'estimate', 'present', 'maximum', 'likelihood', 'estimate', '95', 'confidence', 'interval', 'obtain', 'use', 'modify', 'kaplan', 'meier', 'method', '11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'et', 'al', 'method', 'estimate', 'case', 'fatality', 'ratio', 'novel', 'emerge', 'infectious', 'disease', 'j', 'epidemiol', '2005', '162', '479', '486google', 'scholar', '23zhou', 'f', 'yu', 'du', 'r', 'et', 'al', 'clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid', '19', 'wuhan', 'china', 'retrospective', 'cohort', 'study', 'lancet', '2020', 'publish', 'online', 'march', '11', 'http', 'doi', 'org', '10', '1016', 's0140', '6736', '20', '30566', '3google', 'scholar', 'note', 'due', 'miss', 'data', 'age', 'travel', 'status', 'number', 'stratify', 'analysis', 'lower', 'overall', 'analysis', 'addition', 'parametric', 'method', 'require', 'correction', 'epidemic', 'growth', 'rate', 'estimate', 'therefore', 'obtain', 'subset', 'data', 'travel', 'local', 'transmission', 'age', 'know', 'open', 'table', 'new', 'tab', 'parametric', 'estimate', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'obtain', 'use', 'gamma', 'distribute', 'estimate', 'onset', 'death', 'onset', 'recovery', 'non', 'parametric', 'estimate', 'present', 'maximum', 'likelihood', 'estimate', '95', 'confidence', 'interval', 'obtain', 'use', 'modify', 'kaplan', 'meier', 'method', '11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'et', 'al', 'method', 'estimate', 'case', 'fatality', 'ratio', 'novel', 'emerge', 'infectious', 'disease', 'j', 'epidemiol', '2005', '162', '479', '486google', 'scholar', '23zhou', 'f', 'yu', 'du', 'r', 'et', 'al', 'clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid', '19', 'wuhan', 'china', 'retrospective', 'cohort', 'study', 'lancet', '2020', 'publish', 'online', 'march', '11', 'http', 'doi', 'org', '10', '1016', 's0140', '6736', '20', '30566', '3google', 'scholar', 'note', 'due', 'miss', 'data', 'age', 'travel', 'status', 'number', 'stratify', 'analysis', 'lower', 'overall', 'analysis', 'addition', 'parametric', 'method', 'require', 'correction', 'epidemic', 'growth', 'rate', 'estimate', 'therefore', 'obtain', 'subset', 'data', 'travel', 'local', 'transmission', 'age', 'know', 'international', 'wuhan', 'resident', 'repatriate', 'six', 'flight', 'estimate', 'prevalence', 'infection', '0', '87', '95', 'ci', '0', '32', '1', '9', 'six', '689', 'adjust', 'demography', 'ascertainment', 'estimate', 'infection', 'fatality', 'ratio', '0', '66', '95', 'cri', '0', '39', '1', '33', 'case', 'fatality', 'ratio', 'strongly', 'age', 'dependent', 'estimate', 'rise', 'steeply', 'age', '50', 'year', 'upwards', 'table', '1', 'demography', 'adjust', 'ascertainment', 'adjust', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'range', '1', '1', '20', '29', 'year', 'age', 'group', '18', '4', '80', 'year', 'older', 'table', '3', 'use', 'age', 'stratify', 'infection', 'fatality', 'ratio', 'estimate', 'estimate', 'infection', 'fatality', 'ratio', 'diamond', 'princess', 'population', '2', '9', 'give', 'delay', 'onset', 'symptom', 'death', 'would', 'expect', '97', 'death', 'occur', 'march', '25', '2020', 'give', 'estimate', 'current', 'infection', 'fatality', 'ratio', '2', '8', 'compare', 'empirical', 'estimate', '1', '4', '95', 'ci', '0', '7', '2', '6', 'ten', '712', 'table', '3estimates', 'proportion', 'infection', 'would', 'lead', 'hospitalisation', 'obtain', 'subset', 'case', 'report', 'mainland', 'china22griffin', 'j', 'ghani', 'casefat', 'stata', 'module', 'estimate', 'case', 'fatality', 'ratio', 'new', 'infectious', 'disease', 'boston', 'college', 'economics', 'http', 'idea', 'repec', 'org', 'c', 'boc', 'bocode', 's454601', 'htmldate', 'may', '7', '2009date', 'access', 'march', '26', '2020google', 'scholarsevere', 'casesall', 'casesproportion', 'infect', 'individual', 'hospitalised0', '9', 'years0130', '00', '0', '00', '0', '00', '10', '19', 'years1500', '0408', '0', '0243', '0', '0832', '20', '29', 'years494371', '04', '0', '622', '2', '13', '30', '39', 'years1247333', '43', '2', '04', '7', '00', '40', '49', 'years1547434', '25', '2', '53', '8', '68', '50', '59', 'years2227908', '16', '4', '86', '16', '7', '60', '69', 'years20156011', '8', '7', '01', '24', '0', '70', '79', 'years13326316', '6', '9', '87', '33', '8', '80', 'years517618', '4', '11', '0', '37', '6', 'proportion', 'infect', 'individual', 'hospitalise', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'adjust', 'ascertainment', 'correct', 'demography', 'estimate', 'show', 'three', 'signficant', 'figure', 'assume', 'base', 'severity', 'classification', 'uk', 'context', 'case', 'define', 'severe', 'would', 'hospitalise', 'open', 'table', 'new', 'tab', 'proportion', 'infect', 'individual', 'hospitalise', 'present', 'posterior', 'mode', '95', 'credible', 'interval', 'adjust', 'ascertainment', 'correct', 'demography', 'estimate', 'show', 'three', 'signficant', 'figure', 'assume', 'base', 'severity', 'classification', 'uk', 'context', 'case', 'define', 'severe', 'would', 'hospitalise', 'extensive', 'analysis', 'data', 'different', 'region', 'world', 'best', 'estimate', 'current', 'time', 'case', 'fatality', 'ratio', 'covid', '19', 'china', '1', '38', '95', 'cri', '1', '23', '1', '53', 'although', 'value', 'remain', 'lower', 'estimate', 'coronaviruses', 'include', 'sars24lau', 'ehy', 'hsiung', 'ca', 'cowl', 'bj', 'et', 'al', 'comparative', 'epidemiologic', 'analysis', 'sars', 'hong', 'kong', 'beijing', 'taiwan', 'bmc', 'infect', 'dis', '2010', '10', '50google', 'scholar', 'middle', 'east', 'respiratory', 'syndrome', 'mers', '25lessler', 'j', 'salje', 'h', 'van', 'kerkhove', 'md', 'et', 'al', 'estimate', 'severity', 'subclinical', 'burden', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'kingdom', 'saudi', 'arabia', 'j', 'epidemiol', '2016', '183', '657', '663google', 'scholar', 'substantially', 'higher', 'estimate', '2009', 'h1n1', 'influenza', 'pandemic', '26riley', 'kwok', 'ko', 'wu', 'km', 'et', 'al', 'epidemiological', 'characteristic', '2009', 'h1n1', 'pandemic', 'influenza', 'base', 'pair', 'serum', 'longitudinal', 'community', 'cohort', 'study', 'plo', 'med', '2011', '8e1000442google', 'scholar', '27kwok', 'ko', 'riley', 'perera', 'rapm', 'et', 'al', 'relative', 'incidence', 'individual', 'level', 'severity', 'seasonal', 'influenza', 'h3n2', 'compare', '2009', 'pandemic', 'h1n1', 'bmc', 'infect', 'dis', '2017', '17', '337google', 'scholar', 'estimate', 'infection', 'fatality', 'ratio', '0', '66', 'china', 'inform', 'pcr', 'test', 'international', 'wuhan', 'resident', 'return', 'repatriation', 'flight', 'value', 'consistent', 'infection', 'fatality', 'ratio', 'observe', 'passenger', 'diamond', 'princess', 'cruise', 'ship', 'march', '5', '2020', 'although', 'slightly', 'upper', '95', 'confidence', 'limit', 'age', 'adjust', 'infection', 'fatality', 'ratio', 'observe', 'march', '25', '712', 'confirm', 'case', '601', 'discharge', 'ten', 'die', '11', 'remain', 'critical', 'condition', 'difference', 'might', 'due', 'repatriation', 'flight', 'data', 'slightly', 'underestimate', 'milder', 'infection', 'due', 'cruise', 'passenger', 'better', 'outcome', 'potentially', 'higher', 'average', 'quality', 'health', 'care', 'estimate', 'probability', 'require', 'hospitalisation', 'assume', 'severe', 'case', 'require', 'hospitalisation', 'assumption', 'clearly', 'different', 'pattern', 'hospitalisation', 'occur', 'china', 'hospitalisation', 'also', 'use', 'ensure', 'case', 'isolation', 'mortality', 'also', 'expect', 'vary', 'underlie', 'health', 'specific', 'population', 'give', 'risk', 'associate', 'covid', '19', 'heavily', 'influence', 'presence', 'underlie', 'comorbidities', 'estimate', 'case', 'fatality', 'ratio', 'substantially', 'lower', 'crude', 'case', 'fatality', 'ratio', 'obtain', 'china', 'base', 'case', 'death', 'observe', 'date', 'currently', '3', '67', 'well', 'many', 'estimate', 'currently', 'literature', 'principle', 'reason', 'difference', 'crude', 'estimate', 'take', 'account', 'severity', 'case', 'example', 'various', 'estimate', 'make', 'patient', 'population', 'range', 'generally', 'milder', 'symptom', 'example', 'international', 'traveller', 'detect', 'screen', 'travel', 'history', '13jung', 'akhmetzhanov', 'ar', 'hayashi', 'k', 'et', 'al', 'real', 'time', 'estimation', 'risk', 'death', 'novel', 'coronavirus', 'covid', '19', 'infection', 'inference', 'use', 'export', 'case', 'j', 'clin', 'med', '2020', '9', 'e523google', 'scholar', 'identify', 'hospital', 'set', '14mizumoto', 'k', 'kagaya', 'k', 'chowell', 'g', 'yoshida', 'nakaadachi', 'cho', 'u', 'early', 'epidemiological', 'assessment', 'transmission', 'potential', 'virulence', '2019', 'novel', 'coronavirus', 'wuhan', 'city', 'china', 'january', 'february', '2020', 'medrxiv', '2020', 'publish', 'online', 'march', '13', 'preprint', 'doi', '10', '1101', '2020', '02', '12', '20022434google', 'scholar', '15famulare', '2019', 'ncov', 'preliminary', 'estimate', 'confirm', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'initial', 'pandemic', 'risk', 'assessment', 'http', 'institutefordiseasemodeling', 'github', 'io', 'ncov', 'public', 'analysis', 'first', 'adjust', 'mortality', 'estimate', 'risk', 'assessment', '2019', 'ncov', 'preliminary', 'age', 'time', 'adjust', 'mortality', 'rate', 'pandemic', 'risk', 'assessment', 'htmldate', 'feb', '19', '2020date', 'access', 'march', '26', '2020google', 'scholarit', 'clear', 'data', 'emerge', 'china', 'case', 'fatality', 'ratio', 'increase', 'substantially', 'age', 'result', 'suggest', 'low', 'fatality', 'ratio', 'age', '20', 'year', 'case', 'age', 'group', 'remain', 'unclear', 'whether', 'reflect', 'low', 'risk', 'death', 'difference', 'susceptibility', 'although', 'early', 'result', 'indicate', 'young', 'people', 'lower', 'risk', 'infection', 'adult', '28bi', 'q', 'wu', 'mei', 'et', 'al', 'epidemiology', 'transmission', 'covid', '19', 'shenzhen', 'china', 'analysis', '391', 'case', '1', '286', 'close', 'contact', 'medrxiv', '2020', 'publish', 'online', 'march', '19', 'preprint', 'doi', '10', '1101', '2020', '03', '03', '20028423google', 'scholar', 'serological', 'test', 'age', 'group', 'crucial', 'come', 'week', 'understand', 'significance', 'age', 'group', 'drive', 'population', 'transmission', 'estimate', 'increase', 'severity', 'age', 'clearly', 'reflect', 'case', 'report', 'mean', 'age', 'tend', 'range', '50', '60', 'year', 'different', 'surveillance', 'system', 'pick', 'different', 'age', 'case', 'mix', 'find', 'milder', 'symptom', 'detect', 'history', 'travel', 'younger', 'average', 'detect', 'hospital', 'surveillance', 'correction', 'surveillance', 'bias', 'therefore', 'allow', 'u', 'obtain', 'estimate', 'apply', 'different', 'case', 'mix', 'demographic', 'population', 'structure', 'however', 'note', 'correction', 'applicable', 'assumption', 'uniform', 'infection', 'attack', 'rate', 'ie', 'exposure', 'across', 'population', 'also', 'assume', 'perfect', 'case', 'ascertainment', 'outside', 'wuhan', 'age', 'group', 'case', 'relative', 'population', 'size', '50', '59', 'year', 'old', 'however', 'many', 'case', 'miss', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'estimate', 'might', 'lower', 'absence', 'random', 'population', 'survey', 'infection', 'prevalence', 'adjustment', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'rely', 'repatriation', 'flight', 'data', 'age', 'specific', 'report', 'proportion', 'infect', 'individual', 'asymptomatic', 'diamond', 'princess', 'vary', 'considerably', 'age', 'support', 'approach', 'future', 'larger', 'representative', 'population', 'prevalence', 'survey', 'seroprevalence', 'survey', 'inform', 'estimate', 'much', 'data', 'inform', 'global', 'estimate', 'case', 'fatality', 'ratio', 'present', 'early', 'outbreak', 'wuhan', 'give', 'health', 'system', 'city', 'quickly', 'overwhelm', 'estimate', 'suggest', 'substantial', 'ascertainment', 'case', 'younger', 'age', 'group', 'estimate', 'milder', 'disease', 'comparison', 'elsewhere', 'mainland', 'china', 'ascertainment', 'main', 'factor', 'drive', 'difference', 'estimate', 'crude', 'case', 'fatality', 'ratio', 'china', '3', '67', 'best', 'estimate', 'overall', 'case', 'fatality', 'ratio', '1', '38', 'case', 'fatality', 'ratio', 'likely', 'strongly', 'influence', 'availability', 'health', 'care', 'facility', 'however', 'surprisingly', 'although', 'health', 'care', 'availability', 'wuhan', 'stretch', 'estimate', 'international', 'case', 'similar', 'magnitude', 'suggest', 'relatively', 'little', 'difference', 'health', 'outcome', 'finally', 'clinical', 'knowledge', 'new', 'disease', 'accrue', 'possible', 'outcome', 'improve', 'therefore', 'important', 'revise', 'estimate', 'epidemic', 'unfold', 'world', 'currently', 'experience', 'early', 'stage', 'global', 'pandemic', 'although', 'china', 'succeed', 'contain', 'disease', 'spread', '2', 'month', 'containment', 'unlikely', 'achievable', 'country', 'thus', 'much', 'world', 'experience', 'large', 'community', 'epidemic', 'covid', '19', 'come', 'week', 'month', 'estimate', 'underlie', 'infection', 'fatality', 'ratio', 'virus', 'inform', 'assessment', 'health', 'effect', 'likely', 'experience', 'different', 'country', 'thus', 'decision', 'around', 'appropriate', 'mitigation', 'policy', 'adopt', 'online', 'publication', 'correct', 'correct', 'version', 'first', 'appear', 'thelancet', 'com', 'infection', 'april', '15', '2020this', 'online', 'publication', 'correct', 'correct', 'version', 'first', 'appear', 'thelancet', 'com', 'infection', 'april', '15', '2020contributorsnmf', 'acg', 'conceive', 'study', 'input', 'rv', 'lco', 'id', 'pw', 'cw', 'rv', 'lco', 'id', 'lead', 'analysis', 'individual', 'case', 'data', 'international', 'case', 'estimation', 'onset', 'outcome', 'distribution', 'input', 'cad', 'acg', 'nmf', 'rv', 'pw', 'cw', 'pgtw', 'lead', 'analysis', 'china', 'data', 'input', 'acg', 'nmf', 'ni', 'coordinate', 'management', 'team', 'include', 'data', 'collation', 'process', 'ni', 'gc', 'undertake', 'extraction', 'international', 'case', 'data', 'ht', 'undertake', 'extraction', 'flight', 'repatriation', 'data', 'input', 'ni', 'ad', 'hf', 'lead', 'extraction', 'china', 'mainland', 'data', 'national', 'regional', 'website', 'input', 'hw', 'yw', 'xx', 'jtg', 'develop', 'code', 'non', 'parametric', 'model', 'acg', 'produce', 'first', 'draft', 'manuscript', 'author', 'contribute', 'final', 'draft', 'declaration', 'interestslco', 'report', 'grant', 'outside', 'submit', 'work', 'cad', 'report', 'grant', 'uk', 'medical', 'research', 'council', 'national', 'institute', 'health', 'research', 'conduct', 'study', 'nmf', 'report', 'grant', 'uk', 'medical', 'research', 'council', 'uk', 'national', 'institute', 'health', 'research', 'conduct', 'study', 'grant', 'gavi', 'vaccine', 'alliance', 'janssen', 'pharmaceutical', 'bill', 'melinda', 'gate', 'foundation', 'outside', 'submit', 'work', 'author', 'declare', 'compete', 'interest', 'data', 'code', 'use', 'study', 'available', 'github', 'repository', 'acknowledgmentsthis', 'work', 'support', 'centre', 'fund', 'uk', 'medical', 'research', 'council', 'mrc', 'concordat', 'uk', 'department', 'international', 'development', 'national', 'institute', 'health', 'research', 'health', 'protection', 'research', 'unit', 'model', 'methodology', 'abdul', 'latif', 'jameel', 'foundation', 'grateful', 'input', 'follow', 'volunteer', 'hackathon', 'participant', 'mrc', 'centre', 'imperial', 'college', 'london', 'kylie', 'ainslie', 'sumali', 'bajaj', 'lorenzo', 'cattarino', 'joseph', 'challenger', 'giovanni', 'charles', 'georgina', 'charnley', 'paula', 'christen', 'constance', 'ciavarella', 'victoria', 'cox', 'zulma', 'cucunub', 'joshua', 'aeth', 'tamsin', 'dew', 'lorna', 'dun', 'oliver', 'eales', 'keith', 'fraser', 'tini', 'garske', 'lily', 'geidelberg', 'nan', 'hong', 'samuel', 'horsfield', 'min', 'j', 'kwun', 'david', 'j', 'rgensen', 'mara', 'kont', 'alice', 'ledda', 'xiang', 'li', 'alessandra', 'lochen', 'tara', 'mangal', 'ruth', 'mccabe', 'kevin', 'mcrae', 'mckee', 'kate', 'mitchell', 'andria', 'mousa', 'rebecca', 'nash', 'daniela', 'olivera', 'saskia', 'rick', 'nora', 'schmit', 'ellie', 'sherrard', 'smith', 'janetta', 'skarp', 'isaac', 'stopard', 'juliette', 'unwin', 'juan', 'vesga', 'caroline', 'walter', 'lilith', 'whittle', 'download', 'pdf', '32', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendixlikelihood', 'survival', 'coronavirus', 'disease', '2019full', 'textpdfopen', 'accesscorrection', 'lancet', 'infect', 'dis', '2020', 'publish', 'online', 'march', '30', 'http', 'doi', 'org', '10', '1016', 's1473', '3099', '20', '30243', '7full', 'textpdfprotecting', 'worker', 'age', '60', '69', 'year', 'covid', '19full', 'textpdf']",
,10.1016/j.ajogmf.2020.100110N/A10.1016/S0140-6736(20)30628-0,DOI:10.1016/j.ajogmf.2020.100110N/AN/A,,ELSEVIEREMALANCET,Labor and delivery guidance for COVID-19International Coalition of Medicines Regulatory Authorities (ICMRA)COVID-19: consider cytokine storm syndromes and immunosuppression,American Journal of Obstetrics & Gynecology MFMUpdateCorrespondence,"['labor', 'delivery', 'guidance', 'covid', '19international', 'coalition', 'medicine', 'regulatory', 'authority', 'icmra', 'covid', '19', 'consider', 'cytokine', 'storm', 'syndrome', 'immunosuppression']",N/A,N/A
"N/A (Too many requests)EMA advised patients and healthcare professionals to only use chloroquine and hydroxychloroquine medicines for their authorised indications or as part of clinical trials or national emergency use programmes for the treatment of COVID-19. This is to ensure patient safety and the best use of available supplies.BackgroundSince December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.MethodsIn this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death.Findings191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days.InterpretationThe potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.FundingChinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death.191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days.The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.In December, 2019, Wuhan city, the capital of Hubei province in China, became the centre of an outbreak of pneumonia of unknown cause. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV), from these patients with virus-infected pneumonia,1Phelan AL Katz R Gostin LO The novel coronavirus originating in Wuhan, China: challenges for global health governance.JAMA. 2020;  (published online Jan 30.)DOI:10.1001/jama.2020.1097Google Scholar,  2Gorbalenya AE Baker SC Baric RS et al.Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group.bioRxiv. 2020;  (published online Feb 11.) (preprint).DOI:10.1101/2020.02.07.937862Google Scholar which was later designated coronavirus disease 2019 (COVID-19) in February, 2020, by WHO.3Chan JWM Ng CK Chan YH et al.Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).Thorax. 2003; 58: 686-689Google ScholarAlthough the outbreak is likely to have started from a zoonotic transmission event associated with a large seafood market that also traded in live wild animals, it soon became clear that efficient person-to-person transmission was also occurring.4Li Q Guan X Wu P et al.Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.N Engl J Med. 2020;  (published online Jan 29.)DOI:10.1056/NEJMoa2001316Google Scholar The clinical spectrum of SARS-CoV-2 infection appears to be wide, encompassing asymptomatic infection, mild upper respiratory tract illness, and severe viral pneumonia with respiratory failure and even death, with many patients being hospitalised with pneumonia in Wuhan.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar,  6Wang D Hu B Hu C et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA. 2020;  (published online Feb 7.)DOI:10.1001/jama.2020.1585Google Scholar,  7Chen N Zhou M Dong X et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395: 507-513Google Scholar Although some case series have been published, many patients in these series remained hospitalised at time of publication. To our knowledge, no previous studies have been done among patients with definite outcomes. The estimation of risk factors for severe disease and death in these earlier case series are therefore not very robust. Additionally, details of the clinical and virological course of illness have not yet been well described.Here, we present details of all patients admitted to the two designated hospitals in Wuhan—Jinyintan Hospital and Wuhan Pulmonary Hospital—with laboratory-confirmed COVID-19 and a definite clinical outcome (death or discharge) as of Jan 31, 2020. We aim to explore risk factors of in-hospital death for patients and describe the clinical course of symptoms, viral shedding, and temporal changes of laboratory findings during hospitalisation.Research in contextEvidence before this studyWe searched PubMed on Feb 23, 2020, for articles that documented the risk factors of mortality and viral shedding in patients with coronavirus disease 2019 (COVID-19), resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the search terms (“novel coronavirus” OR “SARS-CoV-2” OR “COVID-19”) AND (“death” OR “mortality” OR “viral shedding”) with no language or time restrictions. Age, comorbidities, lymphocytopenia and elevated alanine aminotransferase, d-dimer, creatine kinase, high-sensitivity cardiac troponin I, prothrombin time, and disease severity were reported to be associated with intensive care unit admission. However, no published works were found about the risk factors of mortality for adult patients with COVID-19. One study compared the sensitivity of SARS-CoV-2 RNA detection in throat and nasopharyngeal swab in 17 patients with COVID-19.Added value of this studyIn this retrospective cohort study of adult inpatients in two hospitals in Wuhan, China, we found increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer levels greater than 1·0 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Duration of viral shedding ranged between 8 and 37 days. The median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but continued until death in fatal cases.Implications of all the available evidenceOlder age, elevated d-dimer levels, and high SOFA score could help clinicians to identify at an early stage those patients with COVID-19 who have poor prognosis. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.Evidence before this studyWe searched PubMed on Feb 23, 2020, for articles that documented the risk factors of mortality and viral shedding in patients with coronavirus disease 2019 (COVID-19), resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the search terms (“novel coronavirus” OR “SARS-CoV-2” OR “COVID-19”) AND (“death” OR “mortality” OR “viral shedding”) with no language or time restrictions. Age, comorbidities, lymphocytopenia and elevated alanine aminotransferase, d-dimer, creatine kinase, high-sensitivity cardiac troponin I, prothrombin time, and disease severity were reported to be associated with intensive care unit admission. However, no published works were found about the risk factors of mortality for adult patients with COVID-19. One study compared the sensitivity of SARS-CoV-2 RNA detection in throat and nasopharyngeal swab in 17 patients with COVID-19.Added value of this studyIn this retrospective cohort study of adult inpatients in two hospitals in Wuhan, China, we found increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer levels greater than 1·0 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Duration of viral shedding ranged between 8 and 37 days. The median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but continued until death in fatal cases.Implications of all the available evidenceOlder age, elevated d-dimer levels, and high SOFA score could help clinicians to identify at an early stage those patients with COVID-19 who have poor prognosis. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.This retrospective cohort study included two cohorts of adult inpatients (≥18 years old) from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China). All adult patients who were diagnosed with COVID-19 according to WHO interim guidance were screened, and those who died or were discharged between Dec 29, 2019 (ie, when the first patients were admitted), and Jan 31, 2020, were included in our study. Since these two hospitals were the only designated hospitals for transfer of patients with COVID-19 from other hospitals in Wuhan until Feb 1, 2020, our study enrolled all adult inpatients who were hospitalised for COVID-19 and had a definite outcome (dead or discharged) at the early stage of the outbreak.Before Jan 11, 2020, SARS-CoV-2 RNA detection results were not available in the electronic medical records, from which data for this study were obtained retrospectively; therefore, this study includes 29 of the 41 patients originally reported on.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google ScholarThe study was approved by the Research Ethics Commission of Jinyintan Hospital (KY-2020–01.01) and the requirement for informed consent was waived by the Ethics Commission as described previously.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google ScholarEpidemiological, demographic, clinical, laboratory, treatment, and outcome data were extracted from electronic medical records using a standardised data collection form, which was a modified version of the WHO/International Severe Acute Respiratory and Emerging Infection Consortium case record form for severe acute respiratory infections. All data were checked by two physicians (FZ and ZL) and a third researcher (GF) adjudicated any difference in interpretation between the two primary reviewers.Methods for laboratory confirmation of SARS-CoV-2 infection have been described elsewhere.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar Briefly, four institutions—the Chinese Center for Disease Control and Prevention, the Chinese Academy of Medical Science, the Academy of Military Medical Sciences, and the Wuhan Institute of Virology, Chinese Academy of Sciences—were responsible for SARS-CoV-2 detection in respiratory specimens by next-generation sequencing or real-time RT-PCR methods. From Jan 11, 2020, SARS-CoV-2 RNA were detected by local Centers for Disease Control and Prevention, local health institutions, and Jingyintan Hospital and Wuhan Pulmonary Hospital. Throat-swab specimens were obtained for SARS-CoV-2 PCR re-examination every other day after clinical remission of symptoms, including fever, cough, and dyspnoea, but only qualitative data were available. The criteria for discharge were absence of fever for at least 3 days, substantial improvement in both lungs in chest CT, clinical remission of respiratory symptoms, and two throat-swab samples negative for SARS-CoV-2 RNA obtained at least 24 h apart.Routine blood examinations were complete blood count, coagulation profile, serum biochemical tests (including renal and liver function, creatine kinase, lactate dehydrogenase, and electrolytes), myocardial enzymes, interleukin-6 (IL-6), serum ferritin, and procalcitonin. Chest radiographs or CT scan were also done for all inpatients. Frequency of examinations was determined by the treating physician.Fever was defined as axillary temperature of at least 37·3°C. Sepsis and septic shock were defined according to the 2016 Third International Consensus Definition for Sepsis and Septic Shock.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar Secondary infection was diagnosed when patients showed clinical symptoms or signs of pneumonia or bacteraemia and a positive culture of a new pathogen was obtained from lower respiratory tract specimens (qualified sputum, endotracheal aspirate, or bronchoalveolar lavage fluid) or blood samples after admission.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar Ventilator-associated pneumonia was diagnosed according to the guidelines for treatment of hospital-acquired and ventilator-associated pneumonia.8Kalil AC Metersky ML Klompas M et al.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clin Infect Dis. 2016; 63: e61-e111Google Scholar Acute kidney injury was diagnosed according to the KDIGO clinical practice guidelines9Khwaja A KDIGO clinical practice guidelines for acute kidney injury.Nephron Clin Pract. 2012; 120: c179-c184Google Scholar and acute respiratory distress syndrome (ARDS) was diagnosed according to the Berlin Definition.10Ranieri VM Rubenfeld GD Thompson BT et al.Acute respiratory distress syndrome: the Berlin Definition.JAMA. 2012; 307: 2526-2533Google Scholar Acute cardiac injury was diagnosed if serum levels of cardiac biomarkers (eg, high-sensitivity cardiac troponin I) were above the 99th percentile upper reference limit, or if new abnormalities were shown in electrocardiography and echocardiography.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar The illness severity of COVID-19 was defined according to the Chinese management guideline for COVID-19 (version 6.0).11National Health Commission of the People's Republic of ChinaChinese management guideline for COVID-19 (version 6.0).http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdfDate: Feb 19, 2020Google Scholar Coagulopathy was defined as a 3-second extension of prothrombin time or a 5-second extension of activated partial thromboplastin time. Hypoproteinaemia was defined as blood albumin of less than 25 g/L. Exposure history was defined as exposure to people with confirmed SARS-CoV-2 infection or to the Wuhan seafood market.Continuous and categorical variables were presented as median (IQR) and n (%), respectively. We used the Mann-Whitney U test, χ2 test, or Fisher's exact test to compare differences between survivors and non-survivors where appropriate. To explore the risk factors associated with in-hospital death, univariable and multivariable logistic regression models were used. Considering the total number of deaths (n=54) in our study and to avoid overfitting in the model, five variables were chosen for multivariable analysis on the basis of previous findings and clinical constraints. Previous studies have shown blood levels of d-dimer and Sequential Organ Failure Assessment (SOFA) scores to be higher in critically ill or fatal cases, whereas lymphopenia and cardiovascular disease have been less commonly observed in non-critical or surviving patients with SARS-COV-2 infection.5Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Google Scholar,  6Wang D Hu B Hu C et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA. 2020;  (published online Feb 7.)DOI:10.1001/jama.2020.1585Google Scholar,  12Yang X Yu Y Xu J et al.Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.Lancet Respir Med. 2020;  (published online Feb 24)https://doi.org/10.1016/S2213-2600(20)30079-5Google Scholar Similar risk factors, including older age, have been reported associated with adverse clinical outcomes in adults with SARS and Middle East respiratory syndrome (MERS).3Chan JWM Ng CK Chan YH et al.Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).Thorax. 2003; 58: 686-689Google Scholar,  13Arabi YM Balkhy HH Hayden FG et al.Middle East respiratory syndrome.N Engl J Med. 2017; 376: 584-594Google Scholar Some laboratory findings, including alanine aminotransferase (ALT), lactate dehydrogenase, high-sensitivity cardiac troponin I, creatine kinase, d-dimer, serum ferritin, and IL-6, might be unavailable in emergency circumstances. Therefore, we chose lymphocyte count, d-dimer, SOFA score, coronary heart disease, and age as the five variables for our multivariable logistic regression model.We excluded variables from the univariable analysis if their between-group differences were not significant, if their accuracy was unconfirmed (eg, exposure, which was self-reported), if the number of events was too small to calculate odds ratios, and if they had colinearity with the SOFA score.We compared patient characteristics between the two hospitals and used a generalised linear model to adjust for possible differences in patients’ characteristics and treatment between the two study centres.A two-sided α of less than 0·05 was considered statistically significant. Statistical analyses were done using the SAS software (version 9.4), unless otherwise indicated.The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors (BC and HC) had full access to all the data in the study and had final responsibility for the decision to submit for publication.813 adult patients were hospitalised in Jinyintan Hospital or Wuhan Pulmonary Hospital with COVID-19 before Jan 31, 2020. After excluding 613 patients that were still hospitalised or not confirmed by SARS-CoV-2 RNA detection as of Jan 31, 2020, and nine inpatients without available key information in their medical records, we included 191 inpatients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) in the final analysis. 54 patients died during hospitalisation and 137 were discharged. The median age of the 191 patients was 56·0 years (IQR 46·0–67·0), ranging from 18 years to 87 years, and most patients were male (table 1). Comorbidities were present in nearly half of patients, with hypertension being the most common comorbidity, followed by diabetes and coronary heart disease (table 1). The most common symptoms on admission were fever and cough, followed by sputum production and fatigue (table 1). Lymphocytopenia occurred in 77 (40%) patients. 181 (95%) patients received antibiotics and 41 (21%) received antivirals (lopinavir/ritonavir; table 2). Systematic corticosteroid and intravenous immunoglobulin use differed significantly between non-survivors and survivors (table 2). The comparison of characteristics, treatment, and outcomes of patients from the two hospitals are shown in the appendix (pp 2–4).Table 1Demographic, clinical, laboratory, and radiographic findings of patients on admissionTotal (n=191)Non-survivor (n=54)Survivor (n=137)p valueDemographics and clinical characteristicsAge, years56·0 (46·0–67·0)69·0 (63·0–76·0)52·0 (45·0–58·0)<0·0001Sex......0·15Female72 (38%)16 (30%)56 (41%)..Male119 (62%)38 (70%)81 (59%)..Exposure history73 (38%)14 (26%)59 (43%)0·028Current smoker11 (6%)5 (9%)6 (4%)0·21Comorbidity91 (48%)36 (67%)55 (40%)0·0010Hypertension58 (30%)26 (48%)32 (23%)0·0008Diabetes36 (19%)17 (31%)19 (14%)0·0051Coronary heart disease15 (8%)13 (24%)2 (1%)<0·0001Chronic obstructive lung disease6 (3%)4 (7%)2 (1%)0·047Carcinoma2 (1%)02 (1%)0·37Chronic kidney disease2 (1%)2 (4%)00·024Other22 (12%)11 (20%)11 (8%)0·016Respiratory rate >24 breaths per min56 (29%)34 (63%)22 (16%)<0·0001Pulse ≥125 beats per min2 (1%)2 (4%)00·024Systolic blood pressure <90 mm Hg1 (1%)01 (1%)0·53Fever (temperature ≥37·3°C)180 (94%)51 (94%)129 (94%)0·94Cough151 (79%)39 (72%)112 (82%)0·15Sputum44 (23%)14 (26%)30 (22%)0·55Myalgia29 (15%)8 (15%)21 (15%)0·93Fatigue44 (23%)15 (28%)29 (21%)0·33Diarrhoea9 (5%)2 (4%)7 (5%)0·67Nausea or vomiting7 (4%)3 (6%)4 (3%)0·40SOFA score2·0 (1·0–4·0)4·5 (4·0–6·0)1·0 (1·0–2·0)<0·0001qSOFA score1·0 (0·0–1·0)1·0 (1·0–1·0)0·0 (0·0–1·0)<0·0001CURB-65 score0·0 (0·0–2·0)2·0 (1·0–3·0)0·0 (0·0–1·0)<0·00010–1141/188 (75%)16 (30%)125/134 (93%)<0·0001** χ2 test comparing all subcategories.232/188 (17%)23 (43%)9/134 (7%)..3–515/188 (8%)15 (28%)0/134..Disease severity status......<0·0001General72 (38%)072 (53%)..Severe66 (35%)12 (22%)54 (39%)..Critical53 (28%)42 (78%)11 (8%)..Time from illness onset to hospital admission, days11·0 (8·0–14·0)11·0 (8·0–15·0)11·0 (8·0–13·0)0·53Laboratory findingsWhite blood cell count, × 109 per L6·2 (4·5–9·5)9·8 (6·9–13·9)5·2 (4·3–7·7)<0·0001<432 (17%)5 (9%)27 (20%)<0·0001** χ2 test comparing all subcategories.4–10119 (62%)24 (44%)95 (69%)..>1040 (21%)25 (46%)15 (11%)..Lymphocyte count, × 109 per L1·0 (0·6–1·3)0·6 (0·5–0·8)1·1 (0·8–1·5)<0·0001<0·877 (40%)41 (76%)36 (26%)<0·0001Haemoglobin, g/L128·0 (119·0–140·0)126·0 (115·0–138·0)128·0 (120·0–140·0)0·30Anaemia29 (15%)14 (26%)15 (11%)0·0094Platelet count, × 109 per L206·0 (155·0–262·0)165·5 (107·0–229·0)220·0 (168·0–271·0)<0·0001<10013 (7%)11 (20%)2 (1%)<0·0001Albumin, g/L32·3 (29·1–35·8)29·1 (26·5–31·3)33·6 (30·6–36·4)<0·0001ALT, U/L30·0 (17·0–46·0)40·0 (24·0–51·0)27·0 (15·0–40·0)0·0050>4059/189 (31%)26 (48%)33/135 (24%)0·0015Creatinine >133 μmol/L8/186 (4%)5 (9%)3/132 (2%)0·045Lactate dehydrogenase, U/L300·0 (234·0–407·0)521·0 (363·0–669·0)253·5 (219·0–318·0)<0·0001>245123/184 (67%)53 (98%)70/130 (54%)<0·0001Creatine kinase, U/L21·5 (13·0–72·4)39·0 (19·5–151·0)18·0 (12·5–52·1)0·0010>18522/168 (13%)11/52 (21%)11/116 (9%)0·038High-sensitivity cardiac troponin I, pg/mL4·1 (2·0–14·1)22·2 (5·6–83·1)3·0 (1·1–5·5)<0·0001>2824/145 (17%)23/50 (46%)1/95 (1%)<0·0001Prothrombin time, s11·6 (10·6–13·0)12·1 (11·2–13·7)11·4 (10·4–12·6)0·0004<16171/182 (94%)47 (87%)124/128 (97%)0·016** χ2 test comparing all subcategories.≥1611/182 (6%)7 (13%)4/128 (3%)..D-dimer, μg/mL0·8 (0·4–3·2)5·2 (1·5–21·1)0·6 (0·3–1·0)<0·0001≤0·555/172 (32%)4 (7%)51/118 (43%)<0·0001** χ2 test comparing all subcategories.>0·5 to ≤145/172 (26%)6 (11%)39/118 (33%)..>172/172 (42%)44 (81%)28/118 (24%)..Serum ferritin, μg/L722·0 (377·2–1435·3)1435·3 (728·9–2000·0)503·2 (264·0–921·5)<0·0001>300102/128 (80%)44/46 (96%)58/82 (71%)0·0008IL-6, pg/mL7·4 (5·3–10·8)11·0 (7·5–14·4)6·3 (5·0–7·9)<0·0001Procalcitonin, ng/mL0·1 (0·1–0·1)0·1 (0·1–0·5)0·1 (0·1–0·1)<0·0001<0·1114/164 (70%)19/51 (37%)95/113 (84%)<0·0001** χ2 test comparing all subcategories.≥0·1 to <0·2530/164 (18%)16/51 (31%)14/113 (12%)..≥0·25 to <0·56/164 (4%)3/51 (6%)3/113 (3%)..≥0·514/164 (9%)13/51 (25%)1/113 (1%)..Imaging featuresConsolidation112 (59%)40 (74%)72 (53%)0·0065Ground-glass opacity136 (71%)44 (81%)92 (67%)0·049Bilateral pulmonary infiltration143 (75%)45 (83%)98 (72%)0·090Data are median (IQR), n (%), or n/N (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher's exact test, as appropriate. SOFA=Sequential Organ Failure Assessment. qSOFA=Quick SOFA. ALT=alanine aminotransferase. IL-6=interleukin-6.* χ2 test comparing all subcategories.
                            Open table in a new tab
                        Table 2Treatments and outcomesTotal (n=191)Non-survivor (n=54)Survivor (n=137)p valueTreatments** Ordered by escalating scale of respiratory support.Antibiotics181 (95%)53 (98%)128 (93%)0·15Antiviral treatment41 (21%)12 (22%)29 (21%)0·87Corticosteroids57 (30%)26 (48%)31 (23%)0·0005Intravenous immunoglobin46 (24%)36 (67%)10 (7%)<0·0001High-flow nasal cannula oxygen therapy41 (21%)33 (61%)8 (6%)<0·0001Non-invasive mechanical ventilation26 (14%)24 (44%)2 (1%)<0·0001Invasive mechanical ventilation32 (17%)31 (57%)1 (1%)<0·0001ECMO3 (2%)3 (6%)00·0054Renal replacement therapy10 (5%)10 (19%)0<0·0001OutcomesSepsis112 (59%)54 (100%)58 (42%)<0·0001Respiratory failure103 (54%)53 (98%)50 (36%)<0·0001ARDS59 (31%)50 (93%)9 (7%)<0·0001Heart failure44 (23%)28 (52%)16 (12%)<0·0001Septic shock38 (20%)38 (70%)0<0·0001Coagulopathy37 (19%)27 (50%)10 (7%)<0·0001Acute cardiac injury33 (17%)32 (59%)1 (1%)<0·0001Acute kidney injury28 (15%)27 (50%)1 (1%)<0·0001Secondary infection28 (15%)27 (50%)1 (1%)<0·0001Hypoproteinaemia22 (12%)20 (37%)2 (1%)<0·0001Acidosis17 (9%)16 (30%)1 (1%)<0·0001ICU admission50 (26%)39 (72%)11 (8%)<0·0001ICU length of stay, days8·0 (4·0–12·0)8·0 (4·0–12·0)7·0 (2·0–9·0)0·41Hospital length of stay, days11·0 (7·0–14·0)7·5 (5·0–11·0)12·0 (9·0–15·0)<0·0001Time from illness onset to fever, days1·0 (1·0–1·0)1·0 (1·0–1·0)1·0 (1·0–1·0)0·16Time from illness onset to cough, days1·0 (1·0–3·0)1·0 (1·0–1·0)1·0 (1·0–4·0)0·30Time from illness onset to dyspnoea, days7·0 (4·0–9·0)7·0 (4·0–10·0)7·0 (4·0–9·0)0·51Time from illness onset to sepsis, days9·0 (7·0–13·0)10·0 (7·0–14·0)9·0 (7·0–12·0)0·22Time from illness onset to ARDS, days12·0 (8·0–15·0)12·0 (8·0–15·0)10·0 (8·0–13·0)0·65Time from illness onset to ICU admission, days12·0 (8·0–15·0)12·0 (8·0–15·0)11·5 (8·0–14·0)0·88Time from illness onset to corticosteroids treatment, days12·0 (10·0–16·0)13·0 (10·0–17·0)12·0 (10·0–15·0)0·55Time from illness onset to death or discharge, days21·0 (17·0–25·0)18·5 (15·0–22·0)22·0 (18·0–25·0)0·0003Duration of viral shedding after COVID-19 onset, days20·0 (16·0–23·0)18·5 (15·0–22·0)†† Detectable until death.20·0 (17·0–24·0)0·024Data are median (IQR) or n (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher's exact test, as appropriate. ECMO=extracorporeal membrane oxygenation. ARDS=acute respiratory distress syndrome. ICU=intensive care unit. COVID-19=coronavirus disease 2019.* Ordered by escalating scale of respiratory support.† Detectable until death.
                            Open table in a new tab
                        Data are median (IQR), n (%), or n/N (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher's exact test, as appropriate. SOFA=Sequential Organ Failure Assessment. qSOFA=Quick SOFA. ALT=alanine aminotransferase. IL-6=interleukin-6.Data are median (IQR) or n (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher's exact test, as appropriate. ECMO=extracorporeal membrane oxygenation. ARDS=acute respiratory distress syndrome. ICU=intensive care unit. COVID-19=coronavirus disease 2019.The median time from illness onset (ie, before admission) to discharge was 22·0 days (IQR 18·0–25·0), whereas the median time to death was 18·5 days (15·0–22·0; table 2). 32 patients required invasive mechanical ventilation, of whom 31 (97%) died. The median time from illness onset to invasive mechanical ventilation was 14·5 days (12·0–19·0). Extracorporeal membrane oxygenation was used in three patients, none of whom survived. Sepsis was the most frequently observed complication, followed by respiratory failure, ARDS, heart failure, and septic shock (table 2). Half of non-survivors experienced a secondary infection, and ventilator-associated pneumonia occurred in ten (31%) of 32 patients requiring invasive mechanical ventilation. The frequency of complications were higher in non-survivors than survivors (table 2).In univariable analysis, odds of in-hospital death was higher in patients with diabetes or coronary heart disease (table 3). Age, lymphopenia, leucocytosis, and elevated ALT, lactate dehydrogenase, high-sensitivity cardiac troponin I, creatine kinase, d-dimer, serum ferritin, IL-6, prothrombin time, creatinine, and procalcitonin were also associated with death (table 3).Table 3Risk factors associated with in-hospital deathUnivariable OR (95% CI)p valueMultivariable OR (95% CI)p valueDemographics and clinical characteristicsAge, years** Per 1 unit increase.1·14 (1·09–1·18)<0·00011·10 (1·03–1·17)0·0043Female sex (vs male)0·61 (0·31–1·20)0·15....Current smoker (vs non-smoker)2·23 (0·65–7·63)0·20....Comorbidity present (vs not present)Chronic obstructive lung disease5·40 (0·96–30·40)0·056....Coronary heart disease21·40 (4·64–98·76)<0·00012·14 (0·26–17·79)0·48Diabetes2·85 (1·35–6·05)0·0062....Hypertension3·05 (1·57–5·92)0·0010....Respiratory rate, breaths per min≤241 (ref)......>248·89 (4·34–18·19)<0·0001....SOFA score6·14 (3·48–10·85)<0·00015·65 (2·61–12·23)<0·0001qSOFA score12·00 (5·06–28·43)<0·0001....Laboratory findingsWhite blood cell count, × 109 per L<40·73 (0·26–2·10)0·56....4–101 (ref)......>106·60 (3·02–14·41)<0·0001....Lymphocyte count, × 109 per L** Per 1 unit increase.0·02 (0·01–0·08)<0·00010·19 (0·02–1·62)0·13ALT, U/L≤401 (ref)......>402·87 (1·48–5·57)0·0018....Creatinine, μmol/L≤1331 (ref)......>1334·39 (1·01–19·06)0·048....Lactate dehydrogenase, U/L≤2451 (ref)......>24545·43 (6·10–338·44)0·0002....Creatine kinase, U/L≤1851 (ref)......>1852·56 (1·03–6·36)0·043....High-sensitivity cardiac troponin I, pg/mL≤281 (ref)......>2880·07 (10·34–620·36)<0·0001....D-dimer, μg/mL≤0·51 (ref)..1 (ref)..> 0·51·96 (0·52–7·43)0·322·14 (0·21–21·39)0·52> 120·04 (6·52–61·56)<0·000118·42 (2·64–128·55)0·0033Prothrombin time, s<161 (ref)......≥164·62 (1·29–16·50)0·019....Serum ferritin, μg/L≤3001 (ref)......>3009·10 (2·04–40·58)0·0038....IL-6, pg/mL** Per 1 unit increase.1·12 (1·03–1·23)0·0080....Procalcitonin, ng/mL** Per 1 unit increase.13·75 (1·81–104·40)0·011....OR=odds ratio. SOFA=Sequential Organ Failure Assessment. qSOFA=Quick SOFA. ALT=alanine aminotransferase. IL-6=interleukin-6.* Per 1 unit increase.
                            Open table in a new tab
                        OR=odds ratio. SOFA=Sequential Organ Failure Assessment. qSOFA=Quick SOFA. ALT=alanine aminotransferase. IL-6=interleukin-6.We included 171 patients with complete data for all variables (53 non-survivors and 118 survivors) in the multivariable logistic regression model. We found that older age, higher SOFA score, and d-dimer greater than 1 μg/mL at admission were associated with increased odds of death (table 3). When adjusting for study centre, our generalised linear model showed similar results (appendix p 5).For survivors, the median duration of viral shedding was 20·0 days (IQR 17·0–24·0) from illness onset, but the virus was continuously detectable until death in non-survivors (table 2; figure 1). The shortest observed duration of viral shedding among survivors was 8 days, whereas the longest was 37 days. Among 29 patients who received lopinavir/ritonavir and were discharged, the median time from illness onset to initiation of antiviral treatment was 14·0 days (IQR 10·0–17·0) and the median duration of viral shedding was 22·0 days (18·0–24·0). The median duration of viral shedding was 19·0 days (17·0–22·0) in patients with severe disease status and 24·0 days (22·0–30·0) in patients with critical disease status.Figure 1Clinical courses of major symptoms and outcomes and duration of viral shedding from illness onset in patients hospitalised with COVID-19Show full captionFigure shows median duration of symptoms and onset of complications and outcomes. ICU=intensive care unit. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. ARDS=acute respiratory distress syndrome. COVID-19=coronavirus disease 2019.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Figure shows median duration of symptoms and onset of complications and outcomes. ICU=intensive care unit. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. ARDS=acute respiratory distress syndrome. COVID-19=coronavirus disease 2019.Major laboratory markers were tracked from illness onset (figure 2). Baseline lymphocyte count was significantly higher in survivors than non-survivors; in survivors, lymphocyte count was lowest on day 7 after illness onset and improved during hospitalisation, whereas severe lymphopenia was observed until death in non-survivors. Levels of d-dimer, high-sensitivity cardiac troponin I, serum ferritin, lactate dehydrogenase, and IL-6 were clearly elevated in non-survivors compared with survivors throughout the clinical course, and increased with illness deterioration (figure 2). In non-survivors, high-sensitivity cardiac troponin I increased rapidly from day 16 after disease onset, whereas lactate dehydrogenase increased for both survivors and non-survivors in the early stage of illness, but decreased from day 13 for survivors.Figure 2Temporal changes in laboratory markers from illness onset in patients hospitalised with COVID-19Show full captionFigure shows temporal changes in d-dimer (A), lymphocytes (B), IL-6 (C), serum ferritin (D), high-sensitivity cardiac troponin I (E), and lactate dehydrogenase (F). Differences between survivors and non-survivors were significant for all timepoints shown, except for day 4 after illness onset for d-dimer, IL-6, and high-sensitivity cardiac troponin I. For serum ferritin (D), the median values after day 16 exceeded the upper limit of detection, as indicated by the dashed line. COVID-19=coronavirus disease 2019. IL-6=interleukin-6.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Figure shows temporal changes in d-dimer (A), lymphocytes (B), IL-6 (C), serum ferritin (D), high-sensitivity cardiac troponin I (E), and lactate dehydrogenase (F). Differences between survivors and non-survivors were significant for all timepoints shown, except for day 4 after illness onset for d-dimer, IL-6, and high-sensitivity cardiac troponin I. For serum ferritin (D), the median values after day 16 exceeded the upper limit of detection, as indicated by the dashed line. COVID-19=coronavirus disease 2019. IL-6=interleukin-6.Median time from illness onset to dyspnoea was similar in survivors and non-survivors, with a median duration of dyspnoea of 13·0 days (9·0–16·5) for survivors (table 2; figure 1). In survivors, the median duration of fever was 12·0 days (8·0–13·0) and cough persisted for 19·0 days (IQR 12·0–23·0; figure 1). 62 (45%) survivors still had cough on discharge and 39 (72%) non-survivors still had cough at the time of death. The dynamic profiles of fever, cough, and dyspnoea are shown in the appendix (p 6). Sepsis developed at a median of 9·0 days (7·0–13·0) after illness onset among all patients, followed by ARDS (12·0 days [8·0–15·0]), acute cardiac injury (15·0 days [10·0–17·0]), acute kidney injury (15·0 days [13·0–19·5]), and secondary infection (17·0 days [13·0–19·0]). The initiation time and duration of systematic corticosteroid use was also similar between the two groups. Among non-survivors, the median time from illness onset was 10·0 days (7·0–14·0) to sepsis, 12·0 days (8·0–15·0) to ARDS, 14·5 days (9·5–17·0) to acute cardiac injury, and 17·0 days (13·0–19·0) to secondary infection (figure 1; table 2). Among survivors, secondary infection, acute kidney injury, and acute cardiac injury were observed in one patient each, occurring 9 days (acute kidney injury), 14 days (secondary infection), and 21 days (acute cardiac injury) after illness onset.The median time from dyspnoea to intubation was 10·0 days (IQR 5·0–12·5) for patients who received invasive mechanical ventilation and the time from invasive mechanical ventilation to occurrence of ventilator-associated pneumonia was 8·0 days (2·0–9·0; figure 1).This retrospective cohort study identified several risk factors for death in adults in Wuhan who were hospitalised with COVID-19. In particular, older age, d-dimer levels greater than 1 μg/mL, and higher SOFA score on admission were associated with higher odds of in-hospital death. Additionally, elevated levels of blood IL-6, high-sensitivity cardiac troponin I, and lactate dehydrogenase and lymphopenia were more commonly seen in severe COVID-19 illness. Sustained viral detection in throat samples was observed in both survivors and non-survivors.Previously, older age has been reported as an important independent predictor of mortality in SARS and MERS.14Choi KW Chau TN Tsang O et al.Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong.Ann Intern Med. 2003; 139: 715-723Google Scholar,  15Hong K-H Choi J-P Hong S-H et al.Predictors of mortality in Middle East respiratory syndrome (MERS).Thorax. 2018; 73: 286-289Google Scholar The current study confirmed that increased age was associated with death in patients with COVID-19. Previous studies in macaques inoculated with SARS-CoV found that older macaques had stronger host innate responses to virus infection than younger adults, with an increase in differential expression of genes associated with inflammation, whereas expression of type I interferon beta was reduced.16Smits SL de Lang A van den Brand JMA et al.Exacerbated innate host response to SARS-CoV in aged non-human primates.PLoS Pathog. 2010; 6: e1000756-eGoogle Scholar The age-dependent defects in T-cell and B-cell function and the excess production of type 2 cytokines could lead to a deficiency in control of viral replication and more prolonged proinflammatory responses, potentially leading to poor outcome.17Opal SM Girard TD Ely EW The immunopathogenesis of sepsis in elderly patients.Clin Infect Dis. 2005; 41: S504-S512Google ScholarSOFA score is a good diagnostic marker for sepsis and septic shock, and reflects the state and degree of multi-organ dysfunction.18Singer M Deutschman CS Seymour CW et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA. 2016; 315: 801-810Google Scholar,  19Ferreira FL Bota DP Bross A Mélot C Vincent JL Serial evaluation of the SOFA score to predict outcome in critically ill patients.JAMA. 2001; 286: 1754-1758Google Scholar Although bacterial infections are usually regarded as a leading cause of sepsis, viral infection can also cause sepsis syndrome. Previously, we determined that sepsis occurred in nearly 40% of adults with community-acquired pneumonia due to viral infection.20Zhou F Wang Y Liu Y et al.Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network.Eur Respir J. 2019; 54: 1802406Google Scholar In the current study, we found that more than half of patients developed sepsis. Additionally, we found that more than 70% of patients had white blood cell count below 10·0 × 109 per L or procalcitonin below 0·25 ng/mL, and no bacterial pathogens were detected in these patients on admission. Sepsis was a common complication, which might be directly caused by SARS-CoV-2 infection, but further research is needed to investigate the pathogenesis of sepsis in COVID-19 illness.Cardiac complications, including new or worsening heart failure, new or worsening arrhythmia, or myocardial infarction are common in patients with pneumonia. Cardiac arrest occurs in about 3% of inpatients with pneumonia.21Marrie TJ Shariatzadeh MR Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.Medicine (Baltimore). 2007; 86: 103-111Google Scholar Risk factors of cardiac events after pneumonia include older age, pre-existing cardiovascular diseases, and greater severity of pneumonia at presentation.22Corrales-Medina VF Musher DM Shachkina S Chirinos JA Acute pneumonia and the cardiovascular system.Lancet. 2013; 381: 496-505Google Scholar Coronary heart disease has also been found to be associated with acute cardiac events and poor outcomes in influenza and other respiratory viral infections.22Corrales-Medina VF Musher DM Shachkina S Chirinos JA Acute pneumonia and the cardiovascular system.Lancet. 2013; 381: 496-505Google Scholar,  23Udell JA Zawi R Bhatt DL et al.Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.JAMA. 2013; 310: 1711-1720Google Scholar,  24Blackburn R Zhao H Pebody R Hayward A Warren-Gash C Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004–2015.Clin Infect Dis. 2018; 67: 8-17Google Scholar In this study, increased high-sensitivity cardiac troponin I during hospitalisation was found in more than half of those who died. The first autopsy of a 53-year-old woman with chronic renal failure in Jinyintan Hospital showed acute myocardial infarction (data not published; personal communication with a pathologist from the Chinese Academy of Science). About 90% of inpatients with pneumonia had increased coagulation activity, marked by increased d-dimer concentrations.25Milbrandt EB Reade MC Lee M et al.Prevalence and significance of coagulation abnormalities in community-acquired pneumonia.Mol Med. 2009; 15: 438-445Google Scholar In this study, we found d-dimer greater than 1 μg/mL is associated with fatal outcome of COVID-19. High levels of d-dimer have a reported association with 28-day mortality in patients with infection or sepsis identified in the emergency department.26Rodelo JR De la Rosa G Valencia ML et al.D-dimer is a significant prognostic factor in patients with suspected infection and sepsis.Am J Emerg Med. 2012; 30: 1991-1999Google Scholar Contributory mechanisms include systemic pro-inflammatory cytokine responses that are mediators of atherosclerosis directly contributing to plaque rupture through local inflammation, induction of procoagulant factors, and haemodynamic changes, which predispose to ischaemia and thrombosis.27Smeeth L Thomas SL Hall AJ Hubbard R Farrington P Vallance P Risk of myocardial infarction and stroke after acute infection or vaccination.N Engl J Med. 2004; 351: 2611-2618Google Scholar,  28Corrales-Medina VF Musher DM Wells GA Chirinos JA Chen L Fine MJ Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.Circulation. 2012; 125: 773-781Google Scholar,  29Davidson JA Warren-Gash C Cardiovascular complications of acute respiratory infections: current research and future directions.Expert Rev Anti Infect Ther. 2019; 17: 939-942Google Scholar In addition, angiotensin converting enzyme 2, the receptor for SARS-CoV-2, is expressed on myocytes and vascular endothelial cells,30Gallagher PE Ferrario CM Tallant EA Regulation of ACE2 in cardiac myocytes and fibroblasts.Am J Physiol Heart Circ Physiol. 2008; 295: H2373-H2479Google Scholar,  31Mendoza-Torres E Oyarzún A Mondaca-Ruff D et al.ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.Ther Adv Cardiovasc Dis. 2015; 9: 217-237Google Scholar so there is at least theoretical potential possibility of direct cardiac involvement by the virus. Of note, interstitial mononuclear inflammatory infiltrates in heart tissue has been documented in fatal cases of COVID-19, although viral detection studies were not reported.32Xu Z Shi L Wang Y et al.Pathological findings of COVID-19 associated with acute respiratory distress syndrome.Lancet Respir Med. 2020;  (published online Feb 18)https://doi.org/10.1016/S2213-2600(20)30076-XGoogle ScholarThe level and duration of infectious virus replication are important factors in assessing the risk of transmission and guiding decisions regarding isolation of patients. Because coronavirus RNA detection is more sensitive than virus isolation, most studies have used qualitative or quantitative viral RNA tests as a potential marker for infectious coronavirus. For SARS-CoV, viral RNA was detected in respiratory specimens from about a third of patients as long as 4 weeks after disease onset.33Xu D Zhang Z Jin L et al.Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase.Eur J Clin Microbiol Infect Dis. 2005; 24: 165-171Google Scholar Similarly, the duration of MERS-CoV RNA detection in lower respiratory specimans persisted for at least 3 weeks,34Corman VM Albarrak AM Omrani AS et al.Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection.Clin Infect Dis. 2016; 62: 477-483Google Scholar,  35Oh MD Park WB Choe PG et al.Viral load kinetics of MERS coronavirus infection.N Engl J Med. 2016; 375: 1303-1405Google Scholar whereas the duration of SARS-CoV-2 RNA detection has not been well characterised. In the current study, we found that the detectable SARS-CoV-2 RNA persisted for a median of 20 days in survivors and that it was sustained until death in non-survivors. This has important implications for both patient isolation decision making and guidance around the length of antiviral treatment. In severe influenza virus infection, prolonged viral shedding was associated with fatal outcome and delayed antiviral treatment was an independent risk factor for prolonged virus detection.36Wang Y Guo Q Yan Z et al.Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection.J Infect Dis. 2018; 217: 1708-1717Google Scholar Similarly, effective antiviral treatment might improve outcomes in COVID-19, although we did not observe shortening of viral shedding duration after lopinavir/ritonavir treatment in the current study. Randomised clinical trials for lopinavir/ritonavir (ChiCTR2000029308) and intravenous remdesivir (NCT04257656, NCT04252664) in treatment of COVID-19 are currently in progress.Our study has some limitations. First, due to the retrospective study design, not all laboratory tests were done in all patients, including lactate dehydrogenase, IL-6, and serum ferritin. Therefore, their role might be underestimated in predicting in-hospital death. Second, patients were sometimes transferred late in their illness to the two included hospitals. Lack of effective antivirals, inadequate adherence to standard supportive therapy, and high-dose corticosteroid use might have also contributed to the poor clinical outcomes in some patients. Third, the estimated duration of viral shedding is limited by the frequency of respiratory specimen collection, lack of quantitative viral RNA detection, and relatively low positive rate of SARS-CoV-2 RNA detection in throat-swabs.37Zou L Ruan F Huang M et al.SARS-CoV-2 viral load in upper respiratory specimens of infected patients.N Engl J Med. 2020;  (published online Feb 19.)DOI:10.1056/NEJMc2001737Google Scholar Fourth, by excluding patients still in hospital as of Jan 31, 2020, and thus relatively more severe disease at an earlier stage, the case fatality ratio in our study cannot reflect the true mortality of COVID-19. Last but not least, interpretation of our findings might be limited by the sample size. However, by including all adult patients in the two designated hospitals for COVID-19, we believe our study population is representative of cases diagnosed and treated in Wuhan.To the best of our knowledge, this is the largest retrospective cohort study among patients with COVID-19 who have experienced a definite outcome. We found that older age, higher SOFA score, and elevated d-dimer at admission were risk factors for death of adult patients with COVID-19. The prolonged viral shedding provides the rationale for testing novel coronavirus antiviral interventions in efforts to improve outcomes.This online publication has been corrected. The corrected version first appeared at thelancet.com on March 12, 2020This online publication has been corrected. The corrected version first appeared at thelancet.com on March 12, 2020ContributorsBC and HC had the idea for and designed the study and had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. BC, FZ, GF, ZL, JXi, and YL drafted the paper. BC, FZ, RD, GF, ZL, XG, HL, and YWa did the analysis, and all authors critically revised the manuscript for important intellectual content and gave final approval for the version to be published. FZ, RD, GF, ZL, YL, BS, LG, YWe, XW, JXu, ST, and YZ collected the data. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.Declaration of interestsWe declare no competing interests.AcknowledgmentsThis study received the following funding: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2018-I2M-1–003); National Science Grant for Distinguished Young Scholars (81425001/H0104); National Key Research and Development Program of China (2018YFC1200100, 2018YFC1200102); The Beijing Science and Technology Project (Z19110700660000); Major Projects of National Science and Technology on New Drug Creation and Development (2020ZX09201001). We acknowledge all health-care workers involved in the diagnosis and treatment of patients in Wuhan; and we thank Chen Wang (Peking Union Medical College, Beijing, China), Peter W Horby (University of Oxford, Oxford, UK), and Frederick G Hayden (University of Virginia School of Medicine, Charlottesville, VA, USA) for guidance in study design and interpretation of results, and review of the manuscript.
                                            Download .pdf (.53
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendixDepartment of ErrorFull-TextPDFDepartment of ErrorFull-TextPDFCOVID-19 cytokine storm: the interplay between inflammation and coagulationFull-TextPDFEndothelial cell infection and endotheliitis in COVID-19Full-TextPDF",10.1016/j.jns.2020.116832N/A10.1016/S0140-6736(20)30566-3,DOI:10.1016/j.jns.2020.116832N/AN/A,,ELSEVIEREMALANCET,"Central nervous system manifestations of COVID-19: A systematic reviewPublic-health advice during COVID-19 pandemicClinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",Journal of the Neurological SciencesUpdateArticles,"['central', 'nervous', 'system', 'manifestation', 'covid', '19', 'systematic', 'reviewpublic', 'health', 'advice', 'covid', '19', 'pandemicclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid', '19', 'wuhan', 'china', 'retrospective', 'cohort', 'study']","['n', 'many', 'request', 'ema', 'advise', 'patient', 'healthcare', 'professional', 'use', 'chloroquine', 'hydroxychloroquine', 'medicine', 'authorise', 'indication', 'part', 'clinical', 'trial', 'national', 'emergency', 'use', 'programme', 'treatment', 'covid', '19', 'ensure', 'patient', 'safety', 'best', 'use', 'available', 'supply', 'backgroundsince', 'december', '2019', 'wuhan', 'china', 'experience', 'outbreak', 'coronavirus', 'disease', '2019', 'covid', '19', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'epidemiological', 'clinical', 'characteristic', 'patient', 'covid', '19', 'report', 'risk', 'factor', 'mortality', 'detail', 'clinical', 'course', 'illness', 'include', 'viral', 'shed', 'well', 'describe', 'methodsin', 'retrospective', 'multicentre', 'cohort', 'study', 'include', 'adult', 'inpatient', '18', 'year', 'old', 'laboratory', 'confirm', 'covid', '19', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'wuhan', 'china', 'discharge', 'die', 'jan', '31', '2020', 'demographic', 'clinical', 'treatment', 'laboratory', 'data', 'include', 'serial', 'sample', 'viral', 'rna', 'detection', 'extract', 'electronic', 'medical', 'record', 'compare', 'survivor', 'non', 'survivor', 'use', 'univariable', 'multivariable', 'logistic', 'regression', 'method', 'explore', 'risk', 'factor', 'associate', 'hospital', 'death', 'findings191', 'patient', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', 'include', 'study', '137', 'discharge', '54', 'die', 'hospital', '91', '48', 'patient', 'comorbidity', 'hypertension', 'common', '58', '30', 'patient', 'follow', 'diabetes', '36', '19', 'patient', 'coronary', 'heart', 'disease', '15', '8', 'patient', 'multivariable', 'regression', 'show', 'increase', 'odds', 'hospital', 'death', 'associate', 'older', 'age', 'odds', 'ratio', '1', '10', '95', 'ci', '1', '03', '1', '17', 'per', 'year', 'increase', 'p', '0', '0043', 'higher', 'sequential', 'organ', 'failure', 'assessment', 'sofa', 'score', '5', '65', '2', '61', '12', '23', 'p', '0', '0001', 'dimer', 'greater', '1', 'g', 'ml', '18', '42', '2', '64', '128', '55', 'p', '0', '0033', 'admission', 'median', 'duration', 'viral', 'shed', '20', '0', 'day', 'iqr', '17', '0', '24', '0', 'survivor', 'sars', 'cov', '2', 'detectable', 'death', 'non', 'survivor', 'longest', 'observe', 'duration', 'viral', 'shed', 'survivor', '37', 'day', 'interpretationthe', 'potential', 'risk', 'factor', 'older', 'age', 'high', 'sofa', 'score', 'dimer', 'greater', '1', 'g', 'ml', 'could', 'help', 'clinician', 'identify', 'patient', 'poor', 'prognosis', 'early', 'stage', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', 'fundingchinese', 'academy', 'medical', 'science', 'innovation', 'fund', 'medical', 'science', 'national', 'science', 'grant', 'distinguish', 'young', 'scholar', 'national', 'key', 'research', 'development', 'program', 'china', 'beijing', 'science', 'technology', 'project', 'major', 'project', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', 'since', 'december', '2019', 'wuhan', 'china', 'experience', 'outbreak', 'coronavirus', 'disease', '2019', 'covid', '19', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'epidemiological', 'clinical', 'characteristic', 'patient', 'covid', '19', 'report', 'risk', 'factor', 'mortality', 'detail', 'clinical', 'course', 'illness', 'include', 'viral', 'shed', 'well', 'describe', 'retrospective', 'multicentre', 'cohort', 'study', 'include', 'adult', 'inpatient', '18', 'year', 'old', 'laboratory', 'confirm', 'covid', '19', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'wuhan', 'china', 'discharge', 'die', 'jan', '31', '2020', 'demographic', 'clinical', 'treatment', 'laboratory', 'data', 'include', 'serial', 'sample', 'viral', 'rna', 'detection', 'extract', 'electronic', 'medical', 'record', 'compare', 'survivor', 'non', 'survivor', 'use', 'univariable', 'multivariable', 'logistic', 'regression', 'method', 'explore', 'risk', 'factor', 'associate', 'hospital', 'death', '191', 'patient', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', 'include', 'study', '137', 'discharge', '54', 'die', 'hospital', '91', '48', 'patient', 'comorbidity', 'hypertension', 'common', '58', '30', 'patient', 'follow', 'diabetes', '36', '19', 'patient', 'coronary', 'heart', 'disease', '15', '8', 'patient', 'multivariable', 'regression', 'show', 'increase', 'odds', 'hospital', 'death', 'associate', 'older', 'age', 'odds', 'ratio', '1', '10', '95', 'ci', '1', '03', '1', '17', 'per', 'year', 'increase', 'p', '0', '0043', 'higher', 'sequential', 'organ', 'failure', 'assessment', 'sofa', 'score', '5', '65', '2', '61', '12', '23', 'p', '0', '0001', 'dimer', 'greater', '1', 'g', 'ml', '18', '42', '2', '64', '128', '55', 'p', '0', '0033', 'admission', 'median', 'duration', 'viral', 'shed', '20', '0', 'day', 'iqr', '17', '0', '24', '0', 'survivor', 'sars', 'cov', '2', 'detectable', 'death', 'non', 'survivor', 'longest', 'observe', 'duration', 'viral', 'shed', 'survivor', '37', 'day', 'potential', 'risk', 'factor', 'older', 'age', 'high', 'sofa', 'score', 'dimer', 'greater', '1', 'g', 'ml', 'could', 'help', 'clinician', 'identify', 'patient', 'poor', 'prognosis', 'early', 'stage', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', 'chinese', 'academy', 'medical', 'science', 'innovation', 'fund', 'medical', 'science', 'national', 'science', 'grant', 'distinguish', 'young', 'scholar', 'national', 'key', 'research', 'development', 'program', 'china', 'beijing', 'science', 'technology', 'project', 'major', 'project', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', 'december', '2019', 'wuhan', 'city', 'capital', 'hubei', 'province', 'china', 'become', 'centre', 'outbreak', 'pneumonia', 'unknown', 'cause', 'jan', '7', '2020', 'chinese', 'scientist', 'isolate', 'novel', 'coronavirus', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'previously', 'know', '2019', 'ncov', 'patient', 'virus', 'infect', 'pneumonia', '1phelan', 'al', 'katz', 'r', 'gostin', 'lo', 'novel', 'coronavirus', 'originate', 'wuhan', 'china', 'challenge', 'global', 'health', 'governance', 'jama', '2020', 'publish', 'online', 'jan', '30', 'doi', '10', '1001', 'jama', '2020', '1097google', 'scholar', '2gorbalenya', 'ae', 'baker', 'sc', 'baric', 'r', 'et', 'al', 'severe', 'acute', 'respiratory', 'syndrome', 'relate', 'coronavirus', 'specie', 'virus', 'statement', 'coronavirus', 'study', 'group', 'biorxiv', '2020', 'publish', 'online', 'feb', '11', 'preprint', 'doi', '10', '1101', '2020', '02', '07', '937862google', 'scholar', 'later', 'designate', 'coronavirus', 'disease', '2019', 'covid', '19', 'february', '2020', '3chan', 'jwm', 'ng', 'ck', 'chan', 'yh', 'et', 'al', 'short', 'term', 'outcome', 'risk', 'factor', 'adverse', 'clinical', 'outcome', 'adult', 'severe', 'acute', 'respiratory', 'syndrome', 'sars', 'thorax', '2003', '58', '686', '689google', 'scholaralthough', 'outbreak', 'likely', 'start', 'zoonotic', 'transmission', 'event', 'associate', 'large', 'seafood', 'market', 'also', 'trade', 'live', 'wild', 'animal', 'soon', 'become', 'clear', 'efficient', 'person', 'person', 'transmission', 'also', 'occur', '4li', 'q', 'guan', 'x', 'wu', 'p', 'et', 'al', 'early', 'transmission', 'dynamic', 'wuhan', 'china', 'novel', 'coronavirus', 'infect', 'pneumonia', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'jan', '29', 'doi', '10', '1056', 'nejmoa2001316google', 'scholar', 'clinical', 'spectrum', 'sars', 'cov', '2', 'infection', 'appear', 'wide', 'encompass', 'asymptomatic', 'infection', 'mild', 'upper', 'respiratory', 'tract', 'illness', 'severe', 'viral', 'pneumonia', 'respiratory', 'failure', 'even', 'death', 'many', 'patient', 'hospitalise', 'pneumonia', 'wuhan', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', '6wang', 'hu', 'b', 'hu', 'c', 'et', 'al', 'clinical', 'characteristic', '138', 'hospitalize', 'patient', '2019', 'novel', 'coronavirus', 'infect', 'pneumonia', 'wuhan', 'china', 'jama', '2020', 'publish', 'online', 'feb', '7', 'doi', '10', '1001', 'jama', '2020', '1585google', 'scholar', '7chen', 'n', 'zhou', 'dong', 'x', 'et', 'al', 'epidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', 'china', 'descriptive', 'study', 'lancet', '2020', '395', '507', '513google', 'scholar', 'although', 'case', 'series', 'publish', 'many', 'patient', 'series', 'remain', 'hospitalise', 'time', 'publication', 'knowledge', 'previous', 'study', 'do', 'among', 'patient', 'definite', 'outcome', 'estimation', 'risk', 'factor', 'severe', 'disease', 'death', 'earlier', 'case', 'series', 'therefore', 'robust', 'additionally', 'detail', 'clinical', 'virological', 'course', 'illness', 'yet', 'well', 'describe', 'present', 'detail', 'patient', 'admit', 'two', 'designate', 'hospital', 'wuhan', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'laboratory', 'confirm', 'covid', '19', 'definite', 'clinical', 'outcome', 'death', 'discharge', 'jan', '31', '2020', 'aim', 'explore', 'risk', 'factor', 'hospital', 'death', 'patient', 'describe', 'clinical', 'course', 'symptom', 'viral', 'shed', 'temporal', 'change', 'laboratory', 'find', 'hospitalisation', 'research', 'contextevidence', 'studywe', 'search', 'pubmed', 'feb', '23', '2020', 'article', 'document', 'risk', 'factor', 'mortality', 'viral', 'shed', 'patient', 'coronavirus', 'disease', '2019', 'covid', '19', 'result', 'infection', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'use', 'search', 'term', 'novel', 'coronavirus', 'sars', 'cov', '2', 'covid', '19', 'death', 'mortality', 'viral', 'shed', 'language', 'time', 'restriction', 'age', 'comorbidities', 'lymphocytopenia', 'elevate', 'alanine', 'aminotransferase', 'dimer', 'creatine', 'kinase', 'high', 'sensitivity', 'cardiac', 'troponin', 'prothrombin', 'time', 'disease', 'severity', 'report', 'associate', 'intensive', 'care', 'unit', 'admission', 'however', 'publish', 'work', 'find', 'risk', 'factor', 'mortality', 'adult', 'patient', 'covid', '19', 'one', 'study', 'compare', 'sensitivity', 'sars', 'cov', '2', 'rna', 'detection', 'throat', 'nasopharyngeal', 'swab', '17', 'patient', 'covid', '19', 'add', 'value', 'studyin', 'retrospective', 'cohort', 'study', 'adult', 'inpatient', 'two', 'hospital', 'wuhan', 'china', 'find', 'increase', 'odds', 'hospital', 'death', 'associate', 'older', 'age', 'odds', 'ratio', '1', '10', '95', 'ci', '1', '03', '1', '17', 'p', '0', '0043', 'higher', 'sequential', 'organ', 'failure', 'assessment', 'sofa', 'score', '5', '65', '2', '61', '12', '23', 'p', '0', '0001', 'dimer', 'level', 'greater', '1', '0', 'g', 'ml', '18', '42', '2', '64', '128', '55', 'p', '0', '0033', 'admission', 'duration', 'viral', 'shed', 'range', '8', '37', 'day', 'median', 'duration', 'viral', 'shed', '20', '0', 'day', 'iqr', '17', '0', '24', '0', 'survivor', 'continue', 'death', 'fatal', 'case', 'implication', 'available', 'evidenceolder', 'age', 'elevate', 'dimer', 'level', 'high', 'sofa', 'score', 'could', 'help', 'clinician', 'identify', 'early', 'stage', 'patient', 'covid', '19', 'poor', 'prognosis', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', 'evidence', 'studywe', 'search', 'pubmed', 'feb', '23', '2020', 'article', 'document', 'risk', 'factor', 'mortality', 'viral', 'shed', 'patient', 'coronavirus', 'disease', '2019', 'covid', '19', 'result', 'infection', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'use', 'search', 'term', 'novel', 'coronavirus', 'sars', 'cov', '2', 'covid', '19', 'death', 'mortality', 'viral', 'shed', 'language', 'time', 'restriction', 'age', 'comorbidities', 'lymphocytopenia', 'elevate', 'alanine', 'aminotransferase', 'dimer', 'creatine', 'kinase', 'high', 'sensitivity', 'cardiac', 'troponin', 'prothrombin', 'time', 'disease', 'severity', 'report', 'associate', 'intensive', 'care', 'unit', 'admission', 'however', 'publish', 'work', 'find', 'risk', 'factor', 'mortality', 'adult', 'patient', 'covid', '19', 'one', 'study', 'compare', 'sensitivity', 'sars', 'cov', '2', 'rna', 'detection', 'throat', 'nasopharyngeal', 'swab', '17', 'patient', 'covid', '19', 'add', 'value', 'studyin', 'retrospective', 'cohort', 'study', 'adult', 'inpatient', 'two', 'hospital', 'wuhan', 'china', 'find', 'increase', 'odds', 'hospital', 'death', 'associate', 'older', 'age', 'odds', 'ratio', '1', '10', '95', 'ci', '1', '03', '1', '17', 'p', '0', '0043', 'higher', 'sequential', 'organ', 'failure', 'assessment', 'sofa', 'score', '5', '65', '2', '61', '12', '23', 'p', '0', '0001', 'dimer', 'level', 'greater', '1', '0', 'g', 'ml', '18', '42', '2', '64', '128', '55', 'p', '0', '0033', 'admission', 'duration', 'viral', 'shed', 'range', '8', '37', 'day', 'median', 'duration', 'viral', 'shed', '20', '0', 'day', 'iqr', '17', '0', '24', '0', 'survivor', 'continue', 'death', 'fatal', 'case', 'implication', 'available', 'evidenceolder', 'age', 'elevate', 'dimer', 'level', 'high', 'sofa', 'score', 'could', 'help', 'clinician', 'identify', 'early', 'stage', 'patient', 'covid', '19', 'poor', 'prognosis', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', 'retrospective', 'cohort', 'study', 'include', 'two', 'cohort', 'adult', 'inpatient', '18', 'year', 'old', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'wuhan', 'china', 'adult', 'patient', 'diagnose', 'covid', '19', 'accord', 'interim', 'guidance', 'screen', 'die', 'discharge', 'dec', '29', '2019', 'ie', 'first', 'patient', 'admit', 'jan', '31', '2020', 'include', 'study', 'since', 'two', 'hospital', 'designate', 'hospital', 'transfer', 'patient', 'covid', '19', 'hospital', 'wuhan', 'feb', '1', '2020', 'study', 'enrol', 'adult', 'inpatient', 'hospitalise', 'covid', '19', 'definite', 'outcome', 'dead', 'discharge', 'early', 'stage', 'outbreak', 'jan', '11', '2020', 'sars', 'cov', '2', 'rna', 'detection', 'result', 'available', 'electronic', 'medical', 'record', 'data', 'study', 'obtain', 'retrospectively', 'therefore', 'study', 'include', '29', '41', 'patient', 'originally', 'report', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholarthe', 'study', 'approve', 'research', 'ethic', 'commission', 'jinyintan', 'hospital', 'ky', '2020', '01', '01', 'requirement', 'inform', 'consent', 'waive', 'ethic', 'commission', 'describe', 'previously', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholarepidemiological', 'demographic', 'clinical', 'laboratory', 'treatment', 'outcome', 'data', 'extract', 'electronic', 'medical', 'record', 'use', 'standardise', 'data', 'collection', 'form', 'modify', 'version', 'international', 'severe', 'acute', 'respiratory', 'emerge', 'infection', 'consortium', 'case', 'record', 'form', 'severe', 'acute', 'respiratory', 'infection', 'data', 'check', 'two', 'physician', 'fz', 'zl', 'third', 'researcher', 'gf', 'adjudicate', 'difference', 'interpretation', 'two', 'primary', 'reviewer', 'method', 'laboratory', 'confirmation', 'sars', 'cov', '2', 'infection', 'describe', 'elsewhere', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', 'briefly', 'four', 'institution', 'chinese', 'center', 'disease', 'control', 'prevention', 'chinese', 'academy', 'medical', 'science', 'academy', 'military', 'medical', 'science', 'wuhan', 'institute', 'virology', 'chinese', 'academy', 'science', 'responsible', 'sars', 'cov', '2', 'detection', 'respiratory', 'specimen', 'next', 'generation', 'sequence', 'real', 'time', 'rt', 'pcr', 'method', 'jan', '11', '2020', 'sars', 'cov', '2', 'rna', 'detect', 'local', 'center', 'disease', 'control', 'prevention', 'local', 'health', 'institution', 'jingyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'throat', 'swab', 'specimen', 'obtain', 'sars', 'cov', '2', 'pcr', 'examination', 'every', 'day', 'clinical', 'remission', 'symptom', 'include', 'fever', 'cough', 'dyspnoea', 'qualitative', 'data', 'available', 'criterion', 'discharge', 'absence', 'fever', 'least', '3', 'day', 'substantial', 'improvement', 'lung', 'chest', 'ct', 'clinical', 'remission', 'respiratory', 'symptom', 'two', 'throat', 'swab', 'sample', 'negative', 'sars', 'cov', '2', 'rna', 'obtain', 'least', '24', 'h', 'apart', 'routine', 'blood', 'examination', 'complete', 'blood', 'count', 'coagulation', 'profile', 'serum', 'biochemical', 'test', 'include', 'renal', 'liver', 'function', 'creatine', 'kinase', 'lactate', 'dehydrogenase', 'electrolyte', 'myocardial', 'enzyme', 'interleukin', '6', 'il', '6', 'serum', 'ferritin', 'procalcitonin', 'chest', 'radiograph', 'ct', 'scan', 'also', 'do', 'inpatient', 'frequency', 'examination', 'determine', 'treat', 'physician', 'fever', 'define', 'axillary', 'temperature', 'least', '37', '3', 'c', 'sepsis', 'septic', 'shock', 'define', 'accord', '2016', 'third', 'international', 'consensus', 'definition', 'sepsis', 'septic', 'shock', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', 'secondary', 'infection', 'diagnose', 'patient', 'show', 'clinical', 'symptom', 'sign', 'pneumonia', 'bacteraemia', 'positive', 'culture', 'new', 'pathogen', 'obtain', 'lower', 'respiratory', 'tract', 'specimen', 'qualify', 'sputum', 'endotracheal', 'aspirate', 'bronchoalveolar', 'lavage', 'fluid', 'blood', 'sample', 'admission', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', 'ventilator', 'associate', 'pneumonia', 'diagnose', 'accord', 'guideline', 'treatment', 'hospital', 'acquire', 'ventilator', 'associate', 'pneumonia', '8kalil', 'ac', 'metersky', 'ml', 'klompas', 'et', 'al', 'management', 'adult', 'hospital', 'acquire', 'ventilator', 'associate', 'pneumonia', '2016', 'clinical', 'practice', 'guideline', 'infectious', 'disease', 'society', 'america', 'american', 'thoracic', 'society', 'clin', 'infect', 'dis', '2016', '63', 'e61', 'e111google', 'scholar', 'acute', 'kidney', 'injury', 'diagnose', 'accord', 'kdigo', 'clinical', 'practice', 'guidelines9khwaja', 'kdigo', 'clinical', 'practice', 'guideline', 'acute', 'kidney', 'injury', 'nephron', 'clin', 'pract', '2012', '120', 'c179', 'c184google', 'scholar', 'acute', 'respiratory', 'distress', 'syndrome', 'ards', 'diagnose', 'accord', 'berlin', 'definition', '10ranieri', 'vm', 'rubenfeld', 'gd', 'thompson', 'bt', 'et', 'al', 'acute', 'respiratory', 'distress', 'syndrome', 'berlin', 'definition', 'jama', '2012', '307', '2526', '2533google', 'scholar', 'acute', 'cardiac', 'injury', 'diagnose', 'serum', 'level', 'cardiac', 'biomarkers', 'eg', 'high', 'sensitivity', 'cardiac', 'troponin', '99th', 'percentile', 'upper', 'reference', 'limit', 'new', 'abnormality', 'show', 'electrocardiography', 'echocardiography', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', 'illness', 'severity', 'covid', '19', 'define', 'accord', 'chinese', 'management', 'guideline', 'covid', '19', 'version', '6', '0', '11national', 'health', 'commission', 'people', 'republic', 'chinachinese', 'management', 'guideline', 'covid', '19', 'version', '6', '0', 'http', 'www', 'nhc', 'gov', 'cn', 'yzygj', 's7653p', '202002', '8334a8326dd94d329df351d7da8aefc2', 'file', 'b218cfeb1bc54639af227f922bf6b817', 'pdfdate', 'feb', '19', '2020google', 'scholar', 'coagulopathy', 'define', '3', 'second', 'extension', 'prothrombin', 'time', '5', 'second', 'extension', 'activate', 'partial', 'thromboplastin', 'time', 'hypoproteinaemia', 'define', 'blood', 'albumin', 'le', '25', 'g', 'l', 'exposure', 'history', 'define', 'exposure', 'people', 'confirm', 'sars', 'cov', '2', 'infection', 'wuhan', 'seafood', 'market', 'continuous', 'categorical', 'variable', 'present', 'median', 'iqr', 'n', 'respectively', 'use', 'mann', 'whitney', 'u', 'test', '2', 'test', 'fisher', 'exact', 'test', 'compare', 'difference', 'survivor', 'non', 'survivor', 'appropriate', 'explore', 'risk', 'factor', 'associate', 'hospital', 'death', 'univariable', 'multivariable', 'logistic', 'regression', 'model', 'use', 'consider', 'total', 'number', 'death', 'n', '54', 'study', 'avoid', 'overfitting', 'model', 'five', 'variable', 'choose', 'multivariable', 'analysis', 'basis', 'previous', 'find', 'clinical', 'constraint', 'previous', 'study', 'show', 'blood', 'level', 'dimer', 'sequential', 'organ', 'failure', 'assessment', 'sofa', 'score', 'higher', 'critically', 'ill', 'fatal', 'case', 'whereas', 'lymphopenia', 'cardiovascular', 'disease', 'le', 'commonly', 'observe', 'non', 'critical', 'survive', 'patient', 'sars', 'cov', '2', 'infection', '5huang', 'c', 'wang', 'li', 'x', 'et', 'al', 'clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', 'china', 'lancet', '2020', '395', '497', '506google', 'scholar', '6wang', 'hu', 'b', 'hu', 'c', 'et', 'al', 'clinical', 'characteristic', '138', 'hospitalize', 'patient', '2019', 'novel', 'coronavirus', 'infect', 'pneumonia', 'wuhan', 'china', 'jama', '2020', 'publish', 'online', 'feb', '7', 'doi', '10', '1001', 'jama', '2020', '1585google', 'scholar', '12yang', 'x', 'yu', 'xu', 'j', 'et', 'al', 'clinical', 'course', 'outcome', 'critically', 'ill', 'patient', 'sars', 'cov', '2', 'pneumonia', 'wuhan', 'china', 'single', 'center', 'retrospective', 'observational', 'study', 'lancet', 'respir', 'med', '2020', 'publish', 'online', 'feb', '24', 'http', 'doi', 'org', '10', '1016', 's2213', '2600', '20', '30079', '5google', 'scholar', 'similar', 'risk', 'factor', 'include', 'older', 'age', 'report', 'associate', 'adverse', 'clinical', 'outcome', 'adult', 'sars', 'middle', 'east', 'respiratory', 'syndrome', 'mers', '3chan', 'jwm', 'ng', 'ck', 'chan', 'yh', 'et', 'al', 'short', 'term', 'outcome', 'risk', 'factor', 'adverse', 'clinical', 'outcome', 'adult', 'severe', 'acute', 'respiratory', 'syndrome', 'sars', 'thorax', '2003', '58', '686', '689google', 'scholar', '13arabi', 'ym', 'balkhy', 'hh', 'hayden', 'fg', 'et', 'al', 'middle', 'east', 'respiratory', 'syndrome', 'n', 'engl', 'j', 'med', '2017', '376', '584', '594google', 'scholar', 'laboratory', 'find', 'include', 'alanine', 'aminotransferase', 'alt', 'lactate', 'dehydrogenase', 'high', 'sensitivity', 'cardiac', 'troponin', 'creatine', 'kinase', 'dimer', 'serum', 'ferritin', 'il', '6', 'might', 'unavailable', 'emergency', 'circumstance', 'therefore', 'choose', 'lymphocyte', 'count', 'dimer', 'sofa', 'score', 'coronary', 'heart', 'disease', 'age', 'five', 'variable', 'multivariable', 'logistic', 'regression', 'model', 'exclude', 'variable', 'univariable', 'analysis', 'group', 'difference', 'significant', 'accuracy', 'unconfirmed', 'eg', 'exposure', 'self', 'report', 'number', 'event', 'small', 'calculate', 'odds', 'ratio', 'colinearity', 'sofa', 'score', 'compare', 'patient', 'characteristic', 'two', 'hospital', 'use', 'generalise', 'linear', 'model', 'adjust', 'possible', 'difference', 'patient', 'characteristic', 'treatment', 'two', 'study', 'centre', 'two', 'side', 'le', '0', '05', 'consider', 'statistically', 'significant', 'statistical', 'analysis', 'do', 'use', 'sa', 'software', 'version', '9', '4', 'unless', 'otherwise', 'indicate', 'funder', 'study', 'role', 'study', 'design', 'data', 'collection', 'data', 'analysis', 'data', 'interpretation', 'write', 'report', 'correspond', 'author', 'bc', 'hc', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '813', 'adult', 'patient', 'hospitalise', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'covid', '19', 'jan', '31', '2020', 'exclude', '613', 'patient', 'still', 'hospitalise', 'confirm', 'sars', 'cov', '2', 'rna', 'detection', 'jan', '31', '2020', 'nine', 'inpatient', 'without', 'available', 'key', 'information', 'medical', 'record', 'include', '191', 'inpatient', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', 'final', 'analysis', '54', 'patient', 'die', 'hospitalisation', '137', 'discharge', 'median', 'age', '191', 'patient', '56', '0', 'year', 'iqr', '46', '0', '67', '0', 'range', '18', 'year', '87', 'year', 'patient', 'male', 'table', '1', 'comorbidities', 'present', 'nearly', 'half', 'patient', 'hypertension', 'common', 'comorbidity', 'follow', 'diabetes', 'coronary', 'heart', 'disease', 'table', '1', 'common', 'symptom', 'admission', 'fever', 'cough', 'follow', 'sputum', 'production', 'fatigue', 'table', '1', 'lymphocytopenia', 'occur', '77', '40', 'patient', '181', '95', 'patient', 'receive', 'antibiotic', '41', '21', 'receive', 'antiviral', 'lopinavir', 'ritonavir', 'table', '2', 'systematic', 'corticosteroid', 'intravenous', 'immunoglobulin', 'use', 'differ', 'significantly', 'non', 'survivor', 'survivor', 'table', '2', 'comparison', 'characteristic', 'treatment', 'outcome', 'patient', 'two', 'hospital', 'show', 'appendix', 'pp', '2', '4', 'table', '1demographic', 'clinical', 'laboratory', 'radiographic', 'find', 'patient', 'admissiontotal', 'n', '191', 'non', 'survivor', 'n', '54', 'survivor', 'n', '137', 'p', 'valuedemographics', 'clinical', 'characteristicsage', 'years56', '0', '46', '0', '67', '0', '69', '0', '63', '0', '76', '0', '52', '0', '45', '0', '58', '0', '0', '0001sex', '0', '15female72', '38', '16', '30', '56', '41', 'male119', '62', '38', '70', '81', '59', 'exposure', 'history73', '38', '14', '26', '59', '43', '0', '028current', 'smoker11', '6', '5', '9', '6', '4', '0', '21comorbidity91', '48', '36', '67', '55', '40', '0', '0010hypertension58', '30', '26', '48', '32', '23', '0', '0008diabetes36', '19', '17', '31', '19', '14', '0', '0051coronary', 'heart', 'disease15', '8', '13', '24', '2', '1', '0', '0001chronic', 'obstructive', 'lung', 'disease6', '3', '4', '7', '2', '1', '0', '047carcinoma2', '1', '02', '1', '0', '37chronic', 'kidney', 'disease2', '1', '2', '4', '00', '024other22', '12', '11', '20', '11', '8', '0', '016respiratory', 'rate', '24', 'breath', 'per', 'min56', '29', '34', '63', '22', '16', '0', '0001pulse', '125', 'beat', 'per', 'min2', '1', '2', '4', '00', '024systolic', 'blood', 'pressure', '90', 'mm', 'hg1', '1', '01', '1', '0', '53fever', 'temperature', '37', '3', 'c', '180', '94', '51', '94', '129', '94', '0', '94cough151', '79', '39', '72', '112', '82', '0', '15sputum44', '23', '14', '26', '30', '22', '0', '55myalgia29', '15', '8', '15', '21', '15', '0', '93fatigue44', '23', '15', '28', '29', '21', '0', '33diarrhoea9', '5', '2', '4', '7', '5', '0', '67nausea', 'vomiting7', '4', '3', '6', '4', '3', '0', '40sofa', 'score2', '0', '1', '0', '4', '0', '4', '5', '4', '0', '6', '0', '1', '0', '1', '0', '2', '0', '0', '0001qsofa', 'score1', '0', '0', '0', '1', '0', '1', '0', '1', '0', '1', '0', '0', '0', '0', '0', '1', '0', '0', '0001curb', '65', 'score0', '0', '0', '0', '2', '0', '2', '0', '1', '0', '3', '0', '0', '0', '0', '0', '1', '0', '0', '00010', '1141', '188', '75', '16', '30', '125', '134', '93', '0', '0001', '2', 'test', 'compare', 'subcategories', '232', '188', '17', '23', '43', '9', '134', '7', '3', '515', '188', '8', '15', '28', '0', '134', 'disease', 'severity', 'status', '0', '0001general72', '38', '072', '53', 'severe66', '35', '12', '22', '54', '39', 'critical53', '28', '42', '78', '11', '8', 'time', 'illness', 'onset', 'hospital', 'admission', 'days11', '0', '8', '0', '14', '0', '11', '0', '8', '0', '15', '0', '11', '0', '8', '0', '13', '0', '0', '53laboratory', 'findingswhite', 'blood', 'cell', 'count', '109', 'per', 'l6', '2', '4', '5', '9', '5', '9', '8', '6', '9', '13', '9', '5', '2', '4', '3', '7', '7', '0', '0001', '432', '17', '5', '9', '27', '20', '0', '0001', '2', 'test', 'compare', 'subcategories', '4', '10119', '62', '24', '44', '95', '69', '1040', '21', '25', '46', '15', '11', 'lymphocyte', 'count', '109', 'per', 'l1', '0', '0', '6', '1', '3', '0', '6', '0', '5', '0', '8', '1', '1', '0', '8', '1', '5', '0', '0001', '0', '877', '40', '41', '76', '36', '26', '0', '0001haemoglobin', 'g', 'l128', '0', '119', '0', '140', '0', '126', '0', '115', '0', '138', '0', '128', '0', '120', '0', '140', '0', '0', '30anaemia29', '15', '14', '26', '15', '11', '0', '0094platelet', 'count', '109', 'per', 'l206', '0', '155', '0', '262', '0', '165', '5', '107', '0', '229', '0', '220', '0', '168', '0', '271', '0', '0', '0001', '10013', '7', '11', '20', '2', '1', '0', '0001albumin', 'g', 'l32', '3', '29', '1', '35', '8', '29', '1', '26', '5', '31', '3', '33', '6', '30', '6', '36', '4', '0', '0001alt', 'u', 'l30', '0', '17', '0', '46', '0', '40', '0', '24', '0', '51', '0', '27', '0', '15', '0', '40', '0', '0', '0050', '4059', '189', '31', '26', '48', '33', '135', '24', '0', '0015creatinine', '133', 'mol', 'l8', '186', '4', '5', '9', '3', '132', '2', '0', '045lactate', 'dehydrogenase', 'u', 'l300', '0', '234', '0', '407', '0', '521', '0', '363', '0', '669', '0', '253', '5', '219', '0', '318', '0', '0', '0001', '245123', '184', '67', '53', '98', '70', '130', '54', '0', '0001creatine', 'kinase', 'u', 'l21', '5', '13', '0', '72', '4', '39', '0', '19', '5', '151', '0', '18', '0', '12', '5', '52', '1', '0', '0010', '18522', '168', '13', '11', '52', '21', '11', '116', '9', '0', '038high', 'sensitivity', 'cardiac', 'troponin', 'pg', 'ml4', '1', '2', '0', '14', '1', '22', '2', '5', '6', '83', '1', '3', '0', '1', '1', '5', '5', '0', '0001', '2824', '145', '17', '23', '50', '46', '1', '95', '1', '0', '0001prothrombin', 'time', 's11', '6', '10', '6', '13', '0', '12', '1', '11', '2', '13', '7', '11', '4', '10', '4', '12', '6', '0', '0004', '16171', '182', '94', '47', '87', '124', '128', '97', '0', '016', '2', 'test', 'compare', 'subcategories', '1611', '182', '6', '7', '13', '4', '128', '3', 'dimer', 'g', 'ml0', '8', '0', '4', '3', '2', '5', '2', '1', '5', '21', '1', '0', '6', '0', '3', '1', '0', '0', '0001', '0', '555', '172', '32', '4', '7', '51', '118', '43', '0', '0001', '2', 'test', 'compare', 'subcategories', '0', '5', '145', '172', '26', '6', '11', '39', '118', '33', '172', '172', '42', '44', '81', '28', '118', '24', 'serum', 'ferritin', 'g', 'l722', '0', '377', '2', '1435', '3', '1435', '3', '728', '9', '2000', '0', '503', '2', '264', '0', '921', '5', '0', '0001', '300102', '128', '80', '44', '46', '96', '58', '82', '71', '0', '0008il', '6', 'pg', 'ml7', '4', '5', '3', '10', '8', '11', '0', '7', '5', '14', '4', '6', '3', '5', '0', '7', '9', '0', '0001procalcitonin', 'ng', 'ml0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '5', '0', '1', '0', '1', '0', '1', '0', '0001', '0', '1114', '164', '70', '19', '51', '37', '95', '113', '84', '0', '0001', '2', 'test', 'compare', 'subcategories', '0', '1', '0', '2530', '164', '18', '16', '51', '31', '14', '113', '12', '0', '25', '0', '56', '164', '4', '3', '51', '6', '3', '113', '3', '0', '514', '164', '9', '13', '51', '25', '1', '113', '1', 'image', 'featuresconsolidation112', '59', '40', '74', '72', '53', '0', '0065ground', 'glass', 'opacity136', '71', '44', '81', '92', '67', '0', '049bilateral', 'pulmonary', 'infiltration143', '75', '45', '83', '98', '72', '0', '090data', 'median', 'iqr', 'n', 'n', 'n', 'p', 'value', 'calculate', 'mann', 'whitney', 'u', 'test', '2', 'test', 'fisher', 'exact', 'test', 'appropriate', 'sofa', 'sequential', 'organ', 'failure', 'assessment', 'qsofa', 'quick', 'sofa', 'alt', 'alanine', 'aminotransferase', 'il', '6', 'interleukin', '6', '2', 'test', 'compare', 'subcategories', 'open', 'table', 'new', 'tab', 'table', '2treatments', 'outcomestotal', 'n', '191', 'non', 'survivor', 'n', '54', 'survivor', 'n', '137', 'p', 'valuetreatments', 'order', 'escalate', 'scale', 'respiratory', 'support', 'antibiotics181', '95', '53', '98', '128', '93', '0', '15antiviral', 'treatment41', '21', '12', '22', '29', '21', '0', '87corticosteroids57', '30', '26', '48', '31', '23', '0', '0005intravenous', 'immunoglobin46', '24', '36', '67', '10', '7', '0', '0001high', 'flow', 'nasal', 'cannula', 'oxygen', 'therapy41', '21', '33', '61', '8', '6', '0', '0001non', 'invasive', 'mechanical', 'ventilation26', '14', '24', '44', '2', '1', '0', '0001invasive', 'mechanical', 'ventilation32', '17', '31', '57', '1', '1', '0', '0001ecmo3', '2', '3', '6', '00', '0054renal', 'replacement', 'therapy10', '5', '10', '19', '0', '0', '0001outcomessepsis112', '59', '54', '100', '58', '42', '0', '0001respiratory', 'failure103', '54', '53', '98', '50', '36', '0', '0001ards59', '31', '50', '93', '9', '7', '0', '0001heart', 'failure44', '23', '28', '52', '16', '12', '0', '0001septic', 'shock38', '20', '38', '70', '0', '0', '0001coagulopathy37', '19', '27', '50', '10', '7', '0', '0001acute', 'cardiac', 'injury33', '17', '32', '59', '1', '1', '0', '0001acute', 'kidney', 'injury28', '15', '27', '50', '1', '1', '0', '0001secondary', 'infection28', '15', '27', '50', '1', '1', '0', '0001hypoproteinaemia22', '12', '20', '37', '2', '1', '0', '0001acidosis17', '9', '16', '30', '1', '1', '0', '0001icu', 'admission50', '26', '39', '72', '11', '8', '0', '0001icu', 'length', 'stay', 'days8', '0', '4', '0', '12', '0', '8', '0', '4', '0', '12', '0', '7', '0', '2', '0', '9', '0', '0', '41hospital', 'length', 'stay', 'days11', '0', '7', '0', '14', '0', '7', '5', '5', '0', '11', '0', '12', '0', '9', '0', '15', '0', '0', '0001time', 'illness', 'onset', 'fever', 'days1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '0', '16time', 'illness', 'onset', 'cough', 'days1', '0', '1', '0', '3', '0', '1', '0', '1', '0', '1', '0', '1', '0', '1', '0', '4', '0', '0', '30time', 'illness', 'onset', 'dyspnoea', 'days7', '0', '4', '0', '9', '0', '7', '0', '4', '0', '10', '0', '7', '0', '4', '0', '9', '0', '0', '51time', 'illness', 'onset', 'sepsis', 'days9', '0', '7', '0', '13', '0', '10', '0', '7', '0', '14', '0', '9', '0', '7', '0', '12', '0', '0', '22time', 'illness', 'onset', 'ards', 'days12', '0', '8', '0', '15', '0', '12', '0', '8', '0', '15', '0', '10', '0', '8', '0', '13', '0', '0', '65time', 'illness', 'onset', 'icu', 'admission', 'days12', '0', '8', '0', '15', '0', '12', '0', '8', '0', '15', '0', '11', '5', '8', '0', '14', '0', '0', '88time', 'illness', 'onset', 'corticosteroid', 'treatment', 'days12', '0', '10', '0', '16', '0', '13', '0', '10', '0', '17', '0', '12', '0', '10', '0', '15', '0', '0', '55time', 'illness', 'onset', 'death', 'discharge', 'days21', '0', '17', '0', '25', '0', '18', '5', '15', '0', '22', '0', '22', '0', '18', '0', '25', '0', '0', '0003duration', 'viral', 'shed', 'covid', '19', 'onset', 'days20', '0', '16', '0', '23', '0', '18', '5', '15', '0', '22', '0', 'detectable', 'death', '20', '0', '17', '0', '24', '0', '0', '024data', 'median', 'iqr', 'n', 'p', 'value', 'calculate', 'mann', 'whitney', 'u', 'test', '2', 'test', 'fisher', 'exact', 'test', 'appropriate', 'ecmo', 'extracorporeal', 'membrane', 'oxygenation', 'ards', 'acute', 'respiratory', 'distress', 'syndrome', 'icu', 'intensive', 'care', 'unit', 'covid', '19', 'coronavirus', 'disease', '2019', 'order', 'escalate', 'scale', 'respiratory', 'support', 'detectable', 'death', 'open', 'table', 'new', 'tab', 'data', 'median', 'iqr', 'n', 'n', 'n', 'p', 'value', 'calculate', 'mann', 'whitney', 'u', 'test', '2', 'test', 'fisher', 'exact', 'test', 'appropriate', 'sofa', 'sequential', 'organ', 'failure', 'assessment', 'qsofa', 'quick', 'sofa', 'alt', 'alanine', 'aminotransferase', 'il', '6', 'interleukin', '6', 'data', 'median', 'iqr', 'n', 'p', 'value', 'calculate', 'mann', 'whitney', 'u', 'test', '2', 'test', 'fisher', 'exact', 'test', 'appropriate', 'ecmo', 'extracorporeal', 'membrane', 'oxygenation', 'ards', 'acute', 'respiratory', 'distress', 'syndrome', 'icu', 'intensive', 'care', 'unit', 'covid', '19', 'coronavirus', 'disease', '2019', 'median', 'time', 'illness', 'onset', 'ie', 'admission', 'discharge', '22', '0', 'day', 'iqr', '18', '0', '25', '0', 'whereas', 'median', 'time', 'death', '18', '5', 'day', '15', '0', '22', '0', 'table', '2', '32', 'patient', 'require', 'invasive', 'mechanical', 'ventilation', '31', '97', 'die', 'median', 'time', 'illness', 'onset', 'invasive', 'mechanical', 'ventilation', '14', '5', 'day', '12', '0', '19', '0', 'extracorporeal', 'membrane', 'oxygenation', 'use', 'three', 'patient', 'none', 'survive', 'sepsis', 'frequently', 'observe', 'complication', 'follow', 'respiratory', 'failure', 'ards', 'heart', 'failure', 'septic', 'shock', 'table', '2', 'half', 'non', 'survivor', 'experience', 'secondary', 'infection', 'ventilator', 'associate', 'pneumonia', 'occur', 'ten', '31', '32', 'patient', 'require', 'invasive', 'mechanical', 'ventilation', 'frequency', 'complication', 'higher', 'non', 'survivor', 'survivor', 'table', '2', 'univariable', 'analysis', 'odds', 'hospital', 'death', 'higher', 'patient', 'diabetes', 'coronary', 'heart', 'disease', 'table', '3', 'age', 'lymphopenia', 'leucocytosis', 'elevate', 'alt', 'lactate', 'dehydrogenase', 'high', 'sensitivity', 'cardiac', 'troponin', 'creatine', 'kinase', 'dimer', 'serum', 'ferritin', 'il', '6', 'prothrombin', 'time', 'creatinine', 'procalcitonin', 'also', 'associate', 'death', 'table', '3', 'table', '3risk', 'factor', 'associate', 'hospital', 'deathunivariable', '95', 'ci', 'p', 'valuemultivariable', '95', 'ci', 'p', 'valuedemographics', 'clinical', 'characteristicsage', 'year', 'per', '1', 'unit', 'increase', '1', '14', '1', '09', '1', '18', '0', '00011', '10', '1', '03', '1', '17', '0', '0043female', 'sex', 'v', 'male', '0', '61', '0', '31', '1', '20', '0', '15', 'current', 'smoker', 'v', 'non', 'smoker', '2', '23', '0', '65', '7', '63', '0', '20', 'comorbidity', 'present', 'v', 'present', 'chronic', 'obstructive', 'lung', 'disease5', '40', '0', '96', '30', '40', '0', '056', 'coronary', 'heart', 'disease21', '40', '4', '64', '98', '76', '0', '00012', '14', '0', '26', '17', '79', '0', '48diabetes2', '85', '1', '35', '6', '05', '0', '0062', 'hypertension3', '05', '1', '57', '5', '92', '0', '0010', 'respiratory', 'rate', 'breath', 'per', 'min', '241', 'ref', '248', '89', '4', '34', '18', '19', '0', '0001', 'sofa', 'score6', '14', '3', '48', '10', '85', '0', '00015', '65', '2', '61', '12', '23', '0', '0001qsofa', 'score12', '00', '5', '06', '28', '43', '0', '0001', 'laboratory', 'findingswhite', 'blood', 'cell', 'count', '109', 'per', 'l', '40', '73', '0', '26', '2', '10', '0', '56', '4', '101', 'ref', '106', '60', '3', '02', '14', '41', '0', '0001', 'lymphocyte', 'count', '109', 'per', 'l', 'per', '1', 'unit', 'increase', '0', '02', '0', '01', '0', '08', '0', '00010', '19', '0', '02', '1', '62', '0', '13alt', 'u', 'l', '401', 'ref', '402', '87', '1', '48', '5', '57', '0', '0018', 'creatinine', 'mol', 'l', '1331', 'ref', '1334', '39', '1', '01', '19', '06', '0', '048', 'lactate', 'dehydrogenase', 'u', 'l', '2451', 'ref', '24545', '43', '6', '10', '338', '44', '0', '0002', 'creatine', 'kinase', 'u', 'l', '1851', 'ref', '1852', '56', '1', '03', '6', '36', '0', '043', 'high', 'sensitivity', 'cardiac', 'troponin', 'pg', 'ml', '281', 'ref', '2880', '07', '10', '34', '620', '36', '0', '0001', 'dimer', 'g', 'ml', '0', '51', 'ref', '1', 'ref', '0', '51', '96', '0', '52', '7', '43', '0', '322', '14', '0', '21', '21', '39', '0', '52', '120', '04', '6', '52', '61', '56', '0', '000118', '42', '2', '64', '128', '55', '0', '0033prothrombin', 'time', '161', 'ref', '164', '62', '1', '29', '16', '50', '0', '019', 'serum', 'ferritin', 'g', 'l', '3001', 'ref', '3009', '10', '2', '04', '40', '58', '0', '0038', 'il', '6', 'pg', 'ml', 'per', '1', 'unit', 'increase', '1', '12', '1', '03', '1', '23', '0', '0080', 'procalcitonin', 'ng', 'ml', 'per', '1', 'unit', 'increase', '13', '75', '1', '81', '104', '40', '0', '011', 'odds', 'ratio', 'sofa', 'sequential', 'organ', 'failure', 'assessment', 'qsofa', 'quick', 'sofa', 'alt', 'alanine', 'aminotransferase', 'il', '6', 'interleukin', '6', 'per', '1', 'unit', 'increase', 'open', 'table', 'new', 'tab', 'odds', 'ratio', 'sofa', 'sequential', 'organ', 'failure', 'assessment', 'qsofa', 'quick', 'sofa', 'alt', 'alanine', 'aminotransferase', 'il', '6', 'interleukin', '6', 'include', '171', 'patient', 'complete', 'data', 'variable', '53', 'non', 'survivor', '118', 'survivor', 'multivariable', 'logistic', 'regression', 'model', 'find', 'older', 'age', 'higher', 'sofa', 'score', 'dimer', 'greater', '1', 'g', 'ml', 'admission', 'associate', 'increase', 'odds', 'death', 'table', '3', 'adjust', 'study', 'centre', 'generalise', 'linear', 'model', 'show', 'similar', 'result', 'appendix', 'p', '5', 'survivor', 'median', 'duration', 'viral', 'shed', '20', '0', 'day', 'iqr', '17', '0', '24', '0', 'illness', 'onset', 'virus', 'continuously', 'detectable', 'death', 'non', 'survivor', 'table', '2', 'figure', '1', 'shortest', 'observe', 'duration', 'viral', 'shed', 'among', 'survivor', '8', 'day', 'whereas', 'longest', '37', 'day', 'among', '29', 'patient', 'receive', 'lopinavir', 'ritonavir', 'discharge', 'median', 'time', 'illness', 'onset', 'initiation', 'antiviral', 'treatment', '14', '0', 'day', 'iqr', '10', '0', '17', '0', 'median', 'duration', 'viral', 'shed', '22', '0', 'day', '18', '0', '24', '0', 'median', 'duration', 'viral', 'shed', '19', '0', 'day', '17', '0', '22', '0', 'patient', 'severe', 'disease', 'status', '24', '0', 'day', '22', '0', '30', '0', 'patient', 'critical', 'disease', 'status', 'figure', '1clinical', 'course', 'major', 'symptom', 'outcome', 'duration', 'viral', 'shed', 'illness', 'onset', 'patient', 'hospitalise', 'covid', '19show', 'full', 'captionfigure', 'show', 'median', 'duration', 'symptom', 'onset', 'complication', 'outcome', 'icu', 'intensive', 'care', 'unit', 'sars', 'cov', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'ards', 'acute', 'respiratory', 'distress', 'syndrome', 'covid', '19', 'coronavirus', 'disease', '2019', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'figure', 'show', 'median', 'duration', 'symptom', 'onset', 'complication', 'outcome', 'icu', 'intensive', 'care', 'unit', 'sars', 'cov', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'ards', 'acute', 'respiratory', 'distress', 'syndrome', 'covid', '19', 'coronavirus', 'disease', '2019', 'major', 'laboratory', 'marker', 'track', 'illness', 'onset', 'figure', '2', 'baseline', 'lymphocyte', 'count', 'significantly', 'higher', 'survivor', 'non', 'survivor', 'survivor', 'lymphocyte', 'count', 'lowest', 'day', '7', 'illness', 'onset', 'improve', 'hospitalisation', 'whereas', 'severe', 'lymphopenia', 'observe', 'death', 'non', 'survivor', 'level', 'dimer', 'high', 'sensitivity', 'cardiac', 'troponin', 'serum', 'ferritin', 'lactate', 'dehydrogenase', 'il', '6', 'clearly', 'elevate', 'non', 'survivor', 'compare', 'survivor', 'throughout', 'clinical', 'course', 'increase', 'illness', 'deterioration', 'figure', '2', 'non', 'survivor', 'high', 'sensitivity', 'cardiac', 'troponin', 'increase', 'rapidly', 'day', '16', 'disease', 'onset', 'whereas', 'lactate', 'dehydrogenase', 'increase', 'survivor', 'non', 'survivor', 'early', 'stage', 'illness', 'decrease', 'day', '13', 'survivor', 'figure', '2temporal', 'change', 'laboratory', 'marker', 'illness', 'onset', 'patient', 'hospitalise', 'covid', '19show', 'full', 'captionfigure', 'show', 'temporal', 'change', 'dimer', 'lymphocyte', 'b', 'il', '6', 'c', 'serum', 'ferritin', 'high', 'sensitivity', 'cardiac', 'troponin', 'e', 'lactate', 'dehydrogenase', 'f', 'difference', 'survivor', 'non', 'survivor', 'significant', 'timepoints', 'show', 'except', 'day', '4', 'illness', 'onset', 'dimer', 'il', '6', 'high', 'sensitivity', 'cardiac', 'troponin', 'serum', 'ferritin', 'median', 'value', 'day', '16', 'exceed', 'upper', 'limit', 'detection', 'indicate', 'dash', 'line', 'covid', '19', 'coronavirus', 'disease', '2019', 'il', '6', 'interleukin', '6', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'figure', 'show', 'temporal', 'change', 'dimer', 'lymphocyte', 'b', 'il', '6', 'c', 'serum', 'ferritin', 'high', 'sensitivity', 'cardiac', 'troponin', 'e', 'lactate', 'dehydrogenase', 'f', 'difference', 'survivor', 'non', 'survivor', 'significant', 'timepoints', 'show', 'except', 'day', '4', 'illness', 'onset', 'dimer', 'il', '6', 'high', 'sensitivity', 'cardiac', 'troponin', 'serum', 'ferritin', 'median', 'value', 'day', '16', 'exceed', 'upper', 'limit', 'detection', 'indicate', 'dash', 'line', 'covid', '19', 'coronavirus', 'disease', '2019', 'il', '6', 'interleukin', '6', 'median', 'time', 'illness', 'onset', 'dyspnoea', 'similar', 'survivor', 'non', 'survivor', 'median', 'duration', 'dyspnoea', '13', '0', 'day', '9', '0', '16', '5', 'survivor', 'table', '2', 'figure', '1', 'survivor', 'median', 'duration', 'fever', '12', '0', 'day', '8', '0', '13', '0', 'cough', 'persist', '19', '0', 'day', 'iqr', '12', '0', '23', '0', 'figure', '1', '62', '45', 'survivor', 'still', 'cough', 'discharge', '39', '72', 'non', 'survivor', 'still', 'cough', 'time', 'death', 'dynamic', 'profile', 'fever', 'cough', 'dyspnoea', 'show', 'appendix', 'p', '6', 'sepsis', 'develop', 'median', '9', '0', 'day', '7', '0', '13', '0', 'illness', 'onset', 'among', 'patient', 'follow', 'ards', '12', '0', 'day', '8', '0', '15', '0', 'acute', 'cardiac', 'injury', '15', '0', 'day', '10', '0', '17', '0', 'acute', 'kidney', 'injury', '15', '0', 'day', '13', '0', '19', '5', 'secondary', 'infection', '17', '0', 'day', '13', '0', '19', '0', 'initiation', 'time', 'duration', 'systematic', 'corticosteroid', 'use', 'also', 'similar', 'two', 'group', 'among', 'non', 'survivor', 'median', 'time', 'illness', 'onset', '10', '0', 'day', '7', '0', '14', '0', 'sepsis', '12', '0', 'day', '8', '0', '15', '0', 'ards', '14', '5', 'day', '9', '5', '17', '0', 'acute', 'cardiac', 'injury', '17', '0', 'day', '13', '0', '19', '0', 'secondary', 'infection', 'figure', '1', 'table', '2', 'among', 'survivor', 'secondary', 'infection', 'acute', 'kidney', 'injury', 'acute', 'cardiac', 'injury', 'observe', 'one', 'patient', 'occur', '9', 'day', 'acute', 'kidney', 'injury', '14', 'day', 'secondary', 'infection', '21', 'day', 'acute', 'cardiac', 'injury', 'illness', 'onset', 'median', 'time', 'dyspnoea', 'intubation', '10', '0', 'day', 'iqr', '5', '0', '12', '5', 'patient', 'receive', 'invasive', 'mechanical', 'ventilation', 'time', 'invasive', 'mechanical', 'ventilation', 'occurrence', 'ventilator', 'associate', 'pneumonia', '8', '0', 'day', '2', '0', '9', '0', 'figure', '1', 'retrospective', 'cohort', 'study', 'identify', 'several', 'risk', 'factor', 'death', 'adult', 'wuhan', 'hospitalise', 'covid', '19', 'particular', 'older', 'age', 'dimer', 'level', 'greater', '1', 'g', 'ml', 'higher', 'sofa', 'score', 'admission', 'associate', 'higher', 'odds', 'hospital', 'death', 'additionally', 'elevate', 'level', 'blood', 'il', '6', 'high', 'sensitivity', 'cardiac', 'troponin', 'lactate', 'dehydrogenase', 'lymphopenia', 'commonly', 'see', 'severe', 'covid', '19', 'illness', 'sustain', 'viral', 'detection', 'throat', 'sample', 'observe', 'survivor', 'non', 'survivor', 'previously', 'older', 'age', 'report', 'important', 'independent', 'predictor', 'mortality', 'sars', 'mers', '14choi', 'kw', 'chau', 'tn', 'tsang', 'et', 'al', 'outcome', 'prognostic', 'factor', '267', 'patient', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'kong', 'ann', 'intern', 'med', '2003', '139', '715', '723google', 'scholar', '15hong', 'k', 'h', 'choi', 'j', 'p', 'hong', 'h', 'et', 'al', 'predictor', 'mortality', 'middle', 'east', 'respiratory', 'syndrome', 'mers', 'thorax', '2018', '73', '286', '289google', 'scholar', 'current', 'study', 'confirm', 'increase', 'age', 'associate', 'death', 'patient', 'covid', '19', 'previous', 'study', 'macaque', 'inoculate', 'sars', 'cov', 'find', 'older', 'macaque', 'stronger', 'host', 'innate', 'response', 'virus', 'infection', 'younger', 'adult', 'increase', 'differential', 'expression', 'gene', 'associate', 'inflammation', 'whereas', 'expression', 'type', 'interferon', 'beta', 'reduce', '16smits', 'sl', 'de', 'lang', 'van', 'den', 'brand', 'jma', 'et', 'al', 'exacerbate', 'innate', 'host', 'response', 'sars', 'cov', 'age', 'non', 'human', 'primate', 'plo', 'pathog', '2010', '6', 'e1000756', 'egoogle', 'scholar', 'age', 'dependent', 'defect', 'cell', 'b', 'cell', 'function', 'excess', 'production', 'type', '2', 'cytokine', 'could', 'lead', 'deficiency', 'control', 'viral', 'replication', 'prolong', 'proinflammatory', 'response', 'potentially', 'lead', 'poor', 'outcome', '17opal', 'sm', 'girard', 'td', 'ely', 'ew', 'immunopathogenesis', 'sepsis', 'elderly', 'patient', 'clin', 'infect', 'dis', '2005', '41', 's504', 's512google', 'scholarsofa', 'score', 'good', 'diagnostic', 'marker', 'sepsis', 'septic', 'shock', 'reflect', 'state', 'degree', 'multi', 'organ', 'dysfunction', '18singer', 'deutschman', 'c', 'seymour', 'cw', 'et', 'al', 'third', 'international', 'consensus', 'definition', 'sepsis', 'septic', 'shock', 'sepsis', '3', 'jama', '2016', '315', '801', '810google', 'scholar', '19ferreira', 'fl', 'bota', 'dp', 'bross', 'lot', 'c', 'vincent', 'jl', 'serial', 'evaluation', 'sofa', 'score', 'predict', 'outcome', 'critically', 'ill', 'patient', 'jama', '2001', '286', '1754', '1758google', 'scholar', 'although', 'bacterial', 'infection', 'usually', 'regard', 'lead', 'cause', 'sepsis', 'viral', 'infection', 'also', 'cause', 'sepsis', 'syndrome', 'previously', 'determine', 'sepsis', 'occur', 'nearly', '40', 'adult', 'community', 'acquire', 'pneumonia', 'due', 'viral', 'infection', '20zhou', 'f', 'wang', 'liu', 'et', 'al', 'disease', 'severity', 'clinical', 'outcome', 'community', 'acquire', 'pneumonia', 'cause', 'non', 'influenza', 'respiratory', 'virus', 'adult', 'multicentre', 'prospective', 'registry', 'study', 'cap', 'china', 'network', 'eur', 'respir', 'j', '2019', '54', '1802406google', 'scholar', 'current', 'study', 'find', 'half', 'patient', 'develop', 'sepsis', 'additionally', 'find', '70', 'patient', 'white', 'blood', 'cell', 'count', '10', '0', '109', 'per', 'l', 'procalcitonin', '0', '25', 'ng', 'ml', 'bacterial', 'pathogen', 'detect', 'patient', 'admission', 'sepsis', 'common', 'complication', 'might', 'directly', 'cause', 'sars', 'cov', '2', 'infection', 'research', 'need', 'investigate', 'pathogenesis', 'sepsis', 'covid', '19', 'illness', 'cardiac', 'complication', 'include', 'new', 'worsen', 'heart', 'failure', 'new', 'worsen', 'arrhythmia', 'myocardial', 'infarction', 'common', 'patient', 'pneumonia', 'cardiac', 'arrest', 'occur', '3', 'inpatient', 'pneumonia', '21marrie', 'tj', 'shariatzadeh', 'mr', 'community', 'acquire', 'pneumonia', 'require', 'admission', 'intensive', 'care', 'unit', 'descriptive', 'study', 'medicine', 'baltimore', '2007', '86', '103', '111google', 'scholar', 'risk', 'factor', 'cardiac', 'event', 'pneumonia', 'include', 'older', 'age', 'pre', 'exist', 'cardiovascular', 'disease', 'greater', 'severity', 'pneumonia', 'presentation', '22corrales', 'medina', 'vf', 'musher', 'dm', 'shachkina', 'chirinos', 'ja', 'acute', 'pneumonia', 'cardiovascular', 'system', 'lancet', '2013', '381', '496', '505google', 'scholar', 'coronary', 'heart', 'disease', 'also', 'find', 'associate', 'acute', 'cardiac', 'event', 'poor', 'outcome', 'influenza', 'respiratory', 'viral', 'infection', '22corrales', 'medina', 'vf', 'musher', 'dm', 'shachkina', 'chirinos', 'ja', 'acute', 'pneumonia', 'cardiovascular', 'system', 'lancet', '2013', '381', '496', '505google', 'scholar', '23udell', 'ja', 'zawi', 'r', 'bhatt', 'dl', 'et', 'al', 'association', 'influenza', 'vaccination', 'cardiovascular', 'outcome', 'high', 'risk', 'patient', 'meta', 'analysis', 'jama', '2013', '310', '1711', '1720google', 'scholar', '24blackburn', 'r', 'zhao', 'h', 'pebody', 'r', 'hayward', 'warren', 'gash', 'c', 'laboratory', 'confirm', 'respiratory', 'infection', 'predictor', 'hospital', 'admission', 'myocardial', 'infarction', 'stroke', 'time', 'series', 'analysis', 'english', 'data', '2004', '2015', 'clin', 'infect', 'dis', '2018', '67', '8', '17google', 'scholar', 'study', 'increase', 'high', 'sensitivity', 'cardiac', 'troponin', 'hospitalisation', 'find', 'half', 'die', 'first', 'autopsy', '53', 'year', 'old', 'woman', 'chronic', 'renal', 'failure', 'jinyintan', 'hospital', 'show', 'acute', 'myocardial', 'infarction', 'data', 'publish', 'personal', 'communication', 'pathologist', 'chinese', 'academy', 'science', '90', 'inpatient', 'pneumonia', 'increase', 'coagulation', 'activity', 'mark', 'increase', 'dimer', 'concentration', '25milbrandt', 'eb', 'reade', 'mc', 'lee', 'et', 'al', 'prevalence', 'significance', 'coagulation', 'abnormality', 'community', 'acquire', 'pneumonia', 'mol', 'med', '2009', '15', '438', '445google', 'scholar', 'study', 'find', 'dimer', 'greater', '1', 'g', 'ml', 'associate', 'fatal', 'outcome', 'covid', '19', 'high', 'level', 'dimer', 'report', 'association', '28', 'day', 'mortality', 'patient', 'infection', 'sepsis', 'identify', 'emergency', 'department', '26rodelo', 'jr', 'de', 'la', 'rosa', 'g', 'valencia', 'ml', 'et', 'al', 'dimer', 'significant', 'prognostic', 'factor', 'patient', 'suspect', 'infection', 'sepsis', 'j', 'emerg', 'med', '2012', '30', '1991', '1999google', 'scholar', 'contributory', 'mechanism', 'include', 'systemic', 'pro', 'inflammatory', 'cytokine', 'response', 'mediator', 'atherosclerosis', 'directly', 'contribute', 'plaque', 'rupture', 'local', 'inflammation', 'induction', 'procoagulant', 'factor', 'haemodynamic', 'change', 'predispose', 'ischaemia', 'thrombosis', '27smeeth', 'l', 'thomas', 'sl', 'hall', 'aj', 'hubbard', 'r', 'farrington', 'p', 'vallance', 'p', 'risk', 'myocardial', 'infarction', 'stroke', 'acute', 'infection', 'vaccination', 'n', 'engl', 'j', 'med', '2004', '351', '2611', '2618google', 'scholar', '28corrales', 'medina', 'vf', 'musher', 'dm', 'well', 'ga', 'chirinos', 'ja', 'chen', 'l', 'fine', 'mj', 'cardiac', 'complication', 'patient', 'community', 'acquire', 'pneumonia', 'incidence', 'time', 'risk', 'factor', 'association', 'short', 'term', 'mortality', 'circulation', '2012', '125', '773', '781google', 'scholar', '29davidson', 'ja', 'warren', 'gash', 'c', 'cardiovascular', 'complication', 'acute', 'respiratory', 'infection', 'current', 'research', 'future', 'direction', 'expert', 'rev', 'anti', 'infect', 'ther', '2019', '17', '939', '942google', 'scholar', 'addition', 'angiotensin', 'convert', 'enzyme', '2', 'receptor', 'sars', 'cov', '2', 'express', 'myocytes', 'vascular', 'endothelial', 'cell', '30gallagher', 'pe', 'ferrario', 'cm', 'tallant', 'ea', 'regulation', 'ace2', 'cardiac', 'myocytes', 'fibroblast', 'j', 'physiol', 'heart', 'circ', 'physiol', '2008', '295', 'h2373', 'h2479google', 'scholar', '31mendoza', 'torres', 'e', 'oyarz', 'n', 'mondaca', 'ruff', 'et', 'al', 'ace2', 'vasoactive', 'peptide', 'novel', 'player', 'cardiovascular', 'renal', 'remodel', 'hypertension', 'ther', 'adv', 'cardiovasc', 'dis', '2015', '9', '217', '237google', 'scholar', 'least', 'theoretical', 'potential', 'possibility', 'direct', 'cardiac', 'involvement', 'virus', 'note', 'interstitial', 'mononuclear', 'inflammatory', 'infiltrate', 'heart', 'tissue', 'document', 'fatal', 'case', 'covid', '19', 'although', 'viral', 'detection', 'study', 'report', '32xu', 'z', 'shi', 'l', 'wang', 'et', 'al', 'pathological', 'find', 'covid', '19', 'associate', 'acute', 'respiratory', 'distress', 'syndrome', 'lancet', 'respir', 'med', '2020', 'publish', 'online', 'feb', '18', 'http', 'doi', 'org', '10', '1016', 's2213', '2600', '20', '30076', 'xgoogle', 'scholarthe', 'level', 'duration', 'infectious', 'virus', 'replication', 'important', 'factor', 'assess', 'risk', 'transmission', 'guide', 'decision', 'regard', 'isolation', 'patient', 'coronavirus', 'rna', 'detection', 'sensitive', 'virus', 'isolation', 'study', 'use', 'qualitative', 'quantitative', 'viral', 'rna', 'test', 'potential', 'marker', 'infectious', 'coronavirus', 'sars', 'cov', 'viral', 'rna', 'detect', 'respiratory', 'specimen', 'third', 'patient', 'long', '4', 'week', 'disease', 'onset', '33xu', 'zhang', 'z', 'jin', 'l', 'et', 'al', 'persistent', 'shed', 'viable', 'sars', 'cov', 'urine', 'stool', 'sars', 'patient', 'convalescent', 'phase', 'eur', 'j', 'clin', 'microbiol', 'infect', 'dis', '2005', '24', '165', '171google', 'scholar', 'similarly', 'duration', 'mers', 'cov', 'rna', 'detection', 'lower', 'respiratory', 'specimans', 'persist', 'least', '3', 'week', '34corman', 'vm', 'albarrak', 'omrani', 'et', 'al', 'viral', 'shed', 'antibody', 'response', '37', 'patient', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'clin', 'infect', 'dis', '2016', '62', '477', '483google', 'scholar', '35oh', 'md', 'park', 'wb', 'choe', 'pg', 'et', 'al', 'viral', 'load', 'kinetics', 'mers', 'coronavirus', 'infection', 'n', 'engl', 'j', 'med', '2016', '375', '1303', '1405google', 'scholar', 'whereas', 'duration', 'sars', 'cov', '2', 'rna', 'detection', 'well', 'characterise', 'current', 'study', 'find', 'detectable', 'sars', 'cov', '2', 'rna', 'persist', 'median', '20', 'day', 'survivor', 'sustain', 'death', 'non', 'survivor', 'important', 'implication', 'patient', 'isolation', 'decision', 'make', 'guidance', 'around', 'length', 'antiviral', 'treatment', 'severe', 'influenza', 'virus', 'infection', 'prolong', 'viral', 'shed', 'associate', 'fatal', 'outcome', 'delay', 'antiviral', 'treatment', 'independent', 'risk', 'factor', 'prolong', 'virus', 'detection', '36wang', 'guo', 'q', 'yan', 'z', 'et', 'al', 'factor', 'associate', 'prolong', 'viral', 'shed', 'patient', 'avian', 'influenza', 'h7n9', 'virus', 'infection', 'j', 'infect', 'dis', '2018', '217', '1708', '1717google', 'scholar', 'similarly', 'effective', 'antiviral', 'treatment', 'might', 'improve', 'outcome', 'covid', '19', 'although', 'observe', 'shorten', 'viral', 'shed', 'duration', 'lopinavir', 'ritonavir', 'treatment', 'current', 'study', 'randomise', 'clinical', 'trial', 'lopinavir', 'ritonavir', 'chictr2000029308', 'intravenous', 'remdesivir', 'nct04257656', 'nct04252664', 'treatment', 'covid', '19', 'currently', 'progress', 'study', 'limitation', 'first', 'due', 'retrospective', 'study', 'design', 'laboratory', 'test', 'do', 'patient', 'include', 'lactate', 'dehydrogenase', 'il', '6', 'serum', 'ferritin', 'therefore', 'role', 'might', 'underestimate', 'predict', 'hospital', 'death', 'second', 'patient', 'sometimes', 'transfer', 'late', 'illness', 'two', 'include', 'hospital', 'lack', 'effective', 'antiviral', 'inadequate', 'adherence', 'standard', 'supportive', 'therapy', 'high', 'dose', 'corticosteroid', 'use', 'might', 'also', 'contribute', 'poor', 'clinical', 'outcome', 'patient', 'third', 'estimate', 'duration', 'viral', 'shed', 'limit', 'frequency', 'respiratory', 'specimen', 'collection', 'lack', 'quantitative', 'viral', 'rna', 'detection', 'relatively', 'low', 'positive', 'rate', 'sars', 'cov', '2', 'rna', 'detection', 'throat', 'swab', '37zou', 'l', 'ruan', 'f', 'huang', 'et', 'al', 'sars', 'cov', '2', 'viral', 'load', 'upper', 'respiratory', 'specimen', 'infect', 'patient', 'n', 'engl', 'j', 'med', '2020', 'publish', 'online', 'feb', '19', 'doi', '10', '1056', 'nejmc2001737google', 'scholar', 'fourth', 'exclude', 'patient', 'still', 'hospital', 'jan', '31', '2020', 'thus', 'relatively', 'severe', 'disease', 'earlier', 'stage', 'case', 'fatality', 'ratio', 'study', 'reflect', 'true', 'mortality', 'covid', '19', 'last', 'least', 'interpretation', 'find', 'might', 'limit', 'sample', 'size', 'however', 'include', 'adult', 'patient', 'two', 'designate', 'hospital', 'covid', '19', 'believe', 'study', 'population', 'representative', 'case', 'diagnose', 'treat', 'wuhan', 'best', 'knowledge', 'largest', 'retrospective', 'cohort', 'study', 'among', 'patient', 'covid', '19', 'experience', 'definite', 'outcome', 'find', 'older', 'age', 'higher', 'sofa', 'score', 'elevate', 'dimer', 'admission', 'risk', 'factor', 'death', 'adult', 'patient', 'covid', '19', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'test', 'novel', 'coronavirus', 'antiviral', 'intervention', 'effort', 'improve', 'outcome', 'online', 'publication', 'correct', 'correct', 'version', 'first', 'appear', 'thelancet', 'com', 'march', '12', '2020this', 'online', 'publication', 'correct', 'correct', 'version', 'first', 'appear', 'thelancet', 'com', 'march', '12', '2020contributorsbc', 'hc', 'idea', 'design', 'study', 'full', 'access', 'data', 'study', 'take', 'responsibility', 'integrity', 'data', 'accuracy', 'data', 'analysis', 'bc', 'fz', 'gf', 'zl', 'jxi', 'yl', 'draft', 'paper', 'bc', 'fz', 'rd', 'gf', 'zl', 'xg', 'hl', 'ywa', 'analysis', 'author', 'critically', 'revise', 'manuscript', 'important', 'intellectual', 'content', 'give', 'final', 'approval', 'version', 'publish', 'fz', 'rd', 'gf', 'zl', 'yl', 'b', 'lg', 'ywe', 'xw', 'jxu', 'st', 'yz', 'collect', 'data', 'author', 'agree', 'accountable', 'aspect', 'work', 'ensure', 'question', 'relate', 'accuracy', 'integrity', 'part', 'work', 'appropriately', 'investigate', 'resolve', 'declaration', 'interestswe', 'declare', 'compete', 'interest', 'acknowledgmentsthis', 'study', 'receive', 'follow', 'fund', 'chinese', 'academy', 'medical', 'science', 'innovation', 'fund', 'medical', 'science', 'cifms', '2018', 'i2m', '1', '003', 'national', 'science', 'grant', 'distinguish', 'young', 'scholar', '81425001', 'h0104', 'national', 'key', 'research', 'development', 'program', 'china', '2018yfc1200100', '2018yfc1200102', 'beijing', 'science', 'technology', 'project', 'z19110700660000', 'major', 'project', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', '2020zx09201001', 'acknowledge', 'health', 'care', 'worker', 'involve', 'diagnosis', 'treatment', 'patient', 'wuhan', 'thank', 'chen', 'wang', 'peking', 'union', 'medical', 'college', 'beijing', 'china', 'peter', 'w', 'horby', 'university', 'oxford', 'oxford', 'uk', 'frederick', 'g', 'hayden', 'university', 'virginia', 'school', 'medicine', 'charlottesville', 'va', 'usa', 'guidance', 'study', 'design', 'interpretation', 'result', 'review', 'manuscript', 'download', 'pdf', '53', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendixdepartment', 'errorfull', 'textpdfdepartment', 'errorfull', 'textpdfcovid', '19', 'cytokine', 'storm', 'interplay', 'inflammation', 'coagulationfull', 'textpdfendothelial', 'cell', 'infection', 'endotheliitis', 'covid', '19full', 'textpdf']",
"N/A (Too many requests)EMA announced that it has held discussions with developers of around 40 potential treatments and a dozen vaccines against COVID-19. No potential COVID-19 treatments had demonstrated efficacy based on the preliminary data available. EMA welcomes the launch of large clinical trials to test promising treatments and to generate conclusive evidence. Two vaccines had already entered phase I clinical trials. EMA estimated that it might take at least a year before a vaccine is ready for approval and available in sufficient quantities to enable widespread use.In December, 2019, a local outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and was quickly determined to be caused by a novel coronavirus,1WHOWHO statement regarding cluster of pneumonia cases in Wuhan, China.https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-chinaDate: Jan 9, 2020Date accessed: February 11, 2020Google Scholar namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak has since spread to every province of mainland China as well as 27 other countries and regions, with more than 70 000 confirmed cases as of Feb 17, 2020.2WHOCoronavirus disease 2019 (COVID-19) situation reports.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reportsDate accessed: February 17, 2020Google Scholar In response to this ongoing public health emergency, we developed an online interactive dashboard, hosted by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, Baltimore, MD, USA, to visualise and track reported cases of coronavirus disease 2019 (COVID-19) in real time. The dashboard, first shared publicly on Jan 22, illustrates the location and number of confirmed COVID-19 cases, deaths, and recoveries for all affected countries. It was developed to provide researchers, public health authorities, and the general public with a user-friendly tool to track the outbreak as it unfolds. All data collected and displayed are made freely available, initially through Google Sheets and now through a GitHub repository, along with the feature layers of the dashboard, which are now included in the Esri Living Atlas.The dashboard reports cases at the province level in China; at the city level in the USA, Australia, and Canada; and at the country level otherwise. During Jan 22–31, all data collection and processing were done manually, and updates were typically done twice a day, morning and night (US Eastern Time). As the outbreak evolved, the manual reporting process became unsustainable; therefore, on Feb 1, we adopted a semi-automated living data stream strategy. Our primary data source is DXY, an online platform run by members of the Chinese medical community, which aggregates local media and government reports to provide cumulative totals of COVID-19 cases in near real time at the province level in China and at the country level otherwise. Every 15 min, the cumulative case counts are updated from DXY for all provinces in China and for other affected countries and regions. For countries and regions outside mainland China (including Hong Kong, Macau, and Taiwan), we found DXY cumulative case counts to frequently lag behind other sources; we therefore manually update these case numbers throughout the day when new cases are identified. To identify new cases, we monitor various Twitter feeds, online news services, and direct communication sent through the dashboard. Before manually updating the dashboard, we confirm the case numbers with regional and local health departments, including the respective centres for disease control and prevention (CDC) of China, Taiwan, and Europe, the Hong Kong Department of Health, the Macau Government, and WHO, as well as city-level and state-level health authorities. For city-level case reports in the USA, Australia, and Canada, which we began reporting on Feb 1, we rely on the US CDC, the government of Canada, the Australian Government Department of Health, and various state or territory health authorities. All manual updates (for countries and regions outside mainland China) are coordinated by a team at Johns Hopkins University.The case data reported on the dashboard aligns with the daily Chinese CDC3Chinese Center for Disease Control and PreventionTracking the epidemic.http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htmDate accessed: February 11, 2020Google Scholar and WHO situation reports2WHOCoronavirus disease 2019 (COVID-19) situation reports.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reportsDate accessed: February 17, 2020Google Scholar for within and outside of mainland China, respectively (figure). Furthermore, the dashboard is particularly effective at capturing the timing of the first reported case of COVID-19 in new countries or regions (appendix). With the exception of Australia, Hong Kong, and Italy, the CSSE at Johns Hopkins University has reported newly infected countries ahead of WHO, with Hong Kong and Italy reported within hours of the corresponding WHO situation report.FigureComparison of COVID-19 case reporting from different sourcesShow full captionDaily cumulative case numbers (starting Jan 22, 2020) reported by the Johns Hopkins University Center for Systems Science and Engineering (CSSE), WHO situation reports, and the Chinese Center for Disease Control and Prevention (Chinese CDC) for within (A) and outside (B) mainland China.View Large
                                            Image
                                        Figure ViewerDownload Hi-res
                                            image
                                        Download (PPT)Daily cumulative case numbers (starting Jan 22, 2020) reported by the Johns Hopkins University Center for Systems Science and Engineering (CSSE), WHO situation reports, and the Chinese Center for Disease Control and Prevention (Chinese CDC) for within (A) and outside (B) mainland China.Given the popularity and impact of the dashboard to date, we plan to continue hosting and managing the tool throughout the entirety of the COVID-19 outbreak and to build out its capabilities to establish a standing tool to monitor and report on future outbreaks. We believe our efforts are crucial to help inform modelling efforts and control measures during the earliest stages of the outbreak.We declare no competing interests.We are grateful for the technical support from the Esri Living Atlas team and the Johns Hopkins University Applied Physics Lab.
                                            Download .pdf (.29
                                            MB)
                                        
                                    Help with
                                    pdf files
                                Supplementary appendixMental health services in Italy during the COVID-19 outbreakFull-TextPDF",10.1016/j.chest.2020.03.032N/A10.1016/S1473-3099(20)30120-1,DOI:10.1016/j.chest.2020.03.032N/AN/A,,ELSEVIEREMALANCET,Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1Treatments and vaccines for COVID-19An interactive web-based dashboard to track COVID-19 in real time,ChestUpdateCorrespondence,"['comparison', 'hospitalize', 'patient', 'ards', 'cause', 'covid', '19', 'h1n1treatments', 'vaccine', 'covid', '19an', 'interactive', 'web', 'base', 'dashboard', 'track', 'covid', '19', 'real', 'time']","['n', 'many', 'request', 'ema', 'announce', 'hold', 'discussion', 'developer', 'around', '40', 'potential', 'treatment', 'dozen', 'vaccine', 'covid', '19', 'potential', 'covid', '19', 'treatment', 'demonstrate', 'efficacy', 'base', 'preliminary', 'data', 'available', 'ema', 'welcome', 'launch', 'large', 'clinical', 'trial', 'test', 'promise', 'treatment', 'generate', 'conclusive', 'evidence', 'two', 'vaccine', 'already', 'enter', 'phase', 'clinical', 'trial', 'ema', 'estimate', 'might', 'take', 'least', 'year', 'vaccine', 'ready', 'approval', 'available', 'sufficient', 'quantity', 'enable', 'widespread', 'use', 'december', '2019', 'local', 'outbreak', 'pneumonia', 'initially', 'unknown', 'cause', 'detect', 'wuhan', 'hubei', 'china', 'quickly', 'determine', 'cause', 'novel', 'coronavirus', '1whowho', 'statement', 'regard', 'cluster', 'pneumonia', 'case', 'wuhan', 'china', 'http', 'www', 'int', 'china', 'news', 'detail', '09', '01', '2020', 'statement', 'regard', 'cluster', 'pneumonia', 'case', 'wuhan', 'chinadate', 'jan', '9', '2020date', 'access', 'february', '11', '2020google', 'scholar', 'namely', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'outbreak', 'since', 'spread', 'every', 'province', 'mainland', 'china', 'well', '27', 'country', 'region', '70', '000', 'confirm', 'case', 'feb', '17', '2020', '2whocoronavirus', 'disease', '2019', 'covid', '19', 'situation', 'report', 'http', 'www', 'int', 'emergency', 'disease', 'novel', 'coronavirus', '2019', 'situation', 'reportsdate', 'access', 'february', '17', '2020google', 'scholar', 'response', 'ongoing', 'public', 'health', 'emergency', 'develop', 'online', 'interactive', 'dashboard', 'host', 'center', 'system', 'science', 'engineer', 'csse', 'john', 'hopkins', 'university', 'baltimore', 'md', 'usa', 'visualise', 'track', 'report', 'case', 'coronavirus', 'disease', '2019', 'covid', '19', 'real', 'time', 'dashboard', 'first', 'share', 'publicly', 'jan', '22', 'illustrate', 'location', 'number', 'confirm', 'covid', '19', 'case', 'death', 'recovery', 'affect', 'country', 'develop', 'provide', 'researcher', 'public', 'health', 'authority', 'general', 'public', 'user', 'friendly', 'tool', 'track', 'outbreak', 'unfold', 'data', 'collect', 'display', 'make', 'freely', 'available', 'initially', 'google', 'sheet', 'github', 'repository', 'along', 'feature', 'layer', 'dashboard', 'include', 'esri', 'live', 'atlas', 'dashboard', 'report', 'case', 'province', 'level', 'china', 'city', 'level', 'usa', 'australia', 'canada', 'country', 'level', 'otherwise', 'jan', '22', '31', 'data', 'collection', 'process', 'do', 'manually', 'update', 'typically', 'do', 'twice', 'day', 'morning', 'night', 'u', 'eastern', 'time', 'outbreak', 'evolve', 'manual', 'report', 'process', 'become', 'unsustainable', 'therefore', 'feb', '1', 'adopt', 'semi', 'automate', 'live', 'data', 'stream', 'strategy', 'primary', 'data', 'source', 'dxy', 'online', 'platform', 'run', 'member', 'chinese', 'medical', 'community', 'aggregate', 'local', 'medium', 'government', 'report', 'provide', 'cumulative', 'total', 'covid', '19', 'case', 'near', 'real', 'time', 'province', 'level', 'china', 'country', 'level', 'otherwise', 'every', '15', 'min', 'cumulative', 'case', 'count', 'update', 'dxy', 'province', 'china', 'affect', 'country', 'region', 'country', 'region', 'outside', 'mainland', 'china', 'include', 'hong', 'kong', 'macau', 'taiwan', 'find', 'dxy', 'cumulative', 'case', 'count', 'frequently', 'lag', 'behind', 'source', 'therefore', 'manually', 'update', 'case', 'number', 'throughout', 'day', 'new', 'case', 'identify', 'identify', 'new', 'case', 'monitor', 'various', 'twitter', 'fee', 'online', 'news', 'service', 'direct', 'communication', 'send', 'dashboard', 'manually', 'update', 'dashboard', 'confirm', 'case', 'number', 'regional', 'local', 'health', 'department', 'include', 'respective', 'centre', 'disease', 'control', 'prevention', 'cdc', 'china', 'taiwan', 'europe', 'hong', 'kong', 'department', 'health', 'macau', 'government', 'well', 'city', 'level', 'state', 'level', 'health', 'authority', 'city', 'level', 'case', 'report', 'usa', 'australia', 'canada', 'begin', 'report', 'feb', '1', 'rely', 'u', 'cdc', 'government', 'canada', 'australian', 'government', 'department', 'health', 'various', 'state', 'territory', 'health', 'authority', 'manual', 'update', 'country', 'region', 'outside', 'mainland', 'china', 'coordinate', 'team', 'john', 'hopkins', 'university', 'case', 'data', 'report', 'dashboard', 'align', 'daily', 'chinese', 'cdc3chinese', 'center', 'disease', 'control', 'preventiontracking', 'epidemic', 'http', 'weekly', 'chinacdc', 'cn', 'news', 'trackingtheepidemic', 'htmdate', 'access', 'february', '11', '2020google', 'scholar', 'situation', 'reports2whocoronavirus', 'disease', '2019', 'covid', '19', 'situation', 'report', 'http', 'www', 'int', 'emergency', 'disease', 'novel', 'coronavirus', '2019', 'situation', 'reportsdate', 'access', 'february', '17', '2020google', 'scholar', 'within', 'outside', 'mainland', 'china', 'respectively', 'figure', 'furthermore', 'dashboard', 'particularly', 'effective', 'capture', 'time', 'first', 'report', 'case', 'covid', '19', 'new', 'country', 'region', 'appendix', 'exception', 'australia', 'hong', 'kong', 'italy', 'csse', 'john', 'hopkins', 'university', 'report', 'newly', 'infect', 'country', 'ahead', 'hong', 'kong', 'italy', 'report', 'within', 'hour', 'correspond', 'situation', 'report', 'figurecomparison', 'covid', '19', 'case', 'report', 'different', 'sourcesshow', 'full', 'captiondaily', 'cumulative', 'case', 'number', 'start', 'jan', '22', '2020', 'report', 'john', 'hopkins', 'university', 'center', 'system', 'science', 'engineer', 'csse', 'situation', 'report', 'chinese', 'center', 'disease', 'control', 'prevention', 'chinese', 'cdc', 'within', 'outside', 'b', 'mainland', 'china', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi', 're', 'image', 'download', 'ppt', 'daily', 'cumulative', 'case', 'number', 'start', 'jan', '22', '2020', 'report', 'john', 'hopkins', 'university', 'center', 'system', 'science', 'engineer', 'csse', 'situation', 'report', 'chinese', 'center', 'disease', 'control', 'prevention', 'chinese', 'cdc', 'within', 'outside', 'b', 'mainland', 'china', 'give', 'popularity', 'impact', 'dashboard', 'date', 'plan', 'continue', 'host', 'manage', 'tool', 'throughout', 'entirety', 'covid', '19', 'outbreak', 'build', 'capability', 'establish', 'stand', 'tool', 'monitor', 'report', 'future', 'outbreak', 'believe', 'effort', 'crucial', 'help', 'inform', 'model', 'effort', 'control', 'measure', 'earliest', 'stage', 'outbreak', 'declare', 'compete', 'interest', 'grateful', 'technical', 'support', 'esri', 'live', 'atlas', 'team', 'john', 'hopkins', 'university', 'apply', 'physic', 'lab', 'download', 'pdf', '29', 'mb', 'help', 'pdf', 'file', 'supplementary', 'appendixmental', 'health', 'service', 'italy', 'covid', '19', 'outbreakfull', 'textpdf']",
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
,,,,,,,N/A,N/A,N/A
